prednisone has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1697 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 353 (20.80) | 18.7374 |
| 1990's | 568 (33.47) | 18.2507 |
| 2000's | 484 (28.52) | 29.6817 |
| 2010's | 245 (14.44) | 24.3611 |
| 2020's | 47 (2.77) | 2.80 |
| Authors | Studies |
|---|---|
| Çeneli, Ö; Demircioğlu, S; Dikici, HZ; Kars, TU; Tekinalp, A; Yılmaz, PD | 1 |
| Leslie, LA | 1 |
| Grommes, C; Modelevsky, L; Reiss, SN; Yerram, P | 1 |
| Alinari, L; Baiocchi, RA; Bond, DA; Brammer, J; Christian, BA; Dotson, E; Epperla, N; Fleming, M; Huang, Y; Maddocks, K; Reneau, J; Sawalha, Y | 1 |
| Dong, T; Jing, F; Song, W; Wang, L; Wang, Y; Xiao, S; Xue, H | 1 |
| Agreda-Vásquez, GP; Avendano, O; Barreyro, P; Cubero, D; Enrico, A; Fogliatto, L; Machnicki, G; Mela-Osorio, MJ; Ovilla, R; Pavlovsky, M; San Sebastián, JA; Trufelli, D; Villanova, P | 1 |
| Baech, J; Brown, P; Clausen, MR; Ekström Smedby, K; El-Galaly, TC; Eloranta, S; Frederiksen, H; Gang, AO; Jakobsen, LH; Jørgensen, J; Pedersen, RS; Poulsen, CB; Severinsen, MT; Torp-Pedersen, C; Vestergaard, P; Øvlisen, AK | 1 |
| Abou Dalle, I; Awada, H; Bazarbachi, A; El-Cheikh, J; Mohty, R; Nassereldine, H | 1 |
| Edina, BC; Rinaldi, I | 1 |
| Bauer, F; Camus, V; Contentin, N; Etancelin, P; Jardin, F; Kammoun-Quique, L; Lanic, H; Lemasle, E; Lenain, P; Leprêtre, S; Lévêque, E; Ménard, AL; Pépin, LF; Perdrix, A; Stamatoullas-Bastard, A; Tilly, H; Zduniak, A | 1 |
| Dührsen, U; Fendler, WP; Ferdinandus, J; Hanoun, C; Herrmann, K; Hüttmann, A; Kersting, D; Rahbar, K; Reinhardt, HC; Rischpler, C; Sandach, P; Schäfers, M; Seifert, R; Umutlu, L; von Tresckow, B; Weckesser, M | 1 |
| Balinisteanu, A; Memis, H; Mihaila, S; Mihalcea, D; Vinereanu, D; Vladareanu, AM | 1 |
| Chen, YJ; Hsieh, CH; Huang, YM; Lee, JC; Tsao, CH; Wang, SY | 1 |
| Garza-Arrieta, J; Malfavón-Farias, M; Porras-Ibarra, GD; Santiago-Sanabria, L | 1 |
| Atherton, MJ; Ferrari, JT; Keuler, NS; Lenz, JA; Walsh, KA; Zimmerman, K | 1 |
| Adlowitz, D; Burack, WR; Friedberg, JW; Kaminski, MS; Leblanc, ML; Leonard, JP; Li, H; Rimsza, LM; Shadman, M; Smith, SM; Spence, JM; Spier, CM | 1 |
| Abutalib, SA; Awan, FT; Carpenter, PA; Chen, YB; Epperla, N; Gopal, AK; Hamadani, M; Holter-Chakrabarty, J; Kekre, N; Kharfan-Dabaja, MA; Kumar, A; Lee, CJ; Lekakis, L; Lin, Y; Locke, FL; Mei, M; Nastoupil, L; Nathan, S; Oluwole, O; Perales, MA; Phillips, AA; Reid, E; Rezvani, AR; Sauter, CS; Trotman, J; Zurko, J | 1 |
| Boldig, K; Gagadam, V; Gujarathi, R; Kiamos, A | 1 |
| Aktar, SJ; Ante, Z; Chan, KKW; Cheung, MC; Liu, N; Prica, A; Suleman, A | 1 |
| Bella, SD; Cricchio, D; D'Accardo, C; Florena, AM; Gaggianesi, M; Lo Iacono, M; Mancuso, S; Modica, C; Pillitteri, I; Porcasi, R; Porcelli, G; Roozafzay, N; Stassi, G; Todaro, M; Turdo, A; Verona, F | 1 |
| Li, J; Ping, P; Sun, Y; Xu, Y; Yao, C; Yin, H | 1 |
| Chikasema, M; Chimzimu, F; Chiyoyola, S; Ellis, GK; Fedoriw, G; Gopal, S; Kaimila, B; Kampani, C; Kasonkanji, E; Mhango, W; Montgomery, ND; Mtangwanika, A; Mulenga, M; Nicholas, S; Nyasosela, R; Nyirenda, R; Painschab, MS; Randall, C; Tewete, B; Tomoka, T; Westmoreland, KD; Zuze, T | 1 |
| Bienzle, D; Coomber, BL; Guo, B; Lin, LL; Narendrula, R; Parissenti, AM; Pei, J; Pritzker, KPH; Pritzker, LB; Skowronski, K; Wang, SX; Woods, JP | 1 |
| Chen, G; Li, MX; Wu, D | 1 |
| Aboulafia, D; Ambinder, RF; Cesarman, E; Chadburn, A; Henry, DH; Kaplan, LD; Lee, JY; Mitsuyasu, R; Noy, A; Ramos, JC; Ratner, L; Sparano, JA; Wachsman, W | 1 |
| Długosz-Danecka, M; Jurczak, W; Szmit, S | 1 |
| Asselbergs, FW; Bosman, LP; Cramer, MJ; Doevendans, PA; Kamphuis, JAM; Linschoten, M; Teske, AJ; van Rhenen, A | 1 |
| Bartlett, NL | 1 |
| Hashimoto, R; Kato, H; Ogawa, T; Okada, S; Suzuki, T; Tetsuka, S | 1 |
| Aboulafia, D; Ambinder, RF; Baiocchi, R; Capoferri, AA; Cesarman, E; Chadburn, A; Durand, CM; Kaplan, L; Lee, JY; Mitsuyasu, R; Moore, PC; Noy, A; Ramos, JC; Ratner, L; Reid, EG; Rubinstein, PG; Siegel, ER; Sparano, JA | 1 |
| Ashizawa, M; Fujiwara, SI; Hatano, K; Ikeda, T; Ito, S; Kanda, Y; Kawaguchi, SI; Kawasaki, Y; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakajima, H; Nakano, H; Ochi, S; Oh, I; Ohmine, K; Sato, K; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Alkabes, M; De Cilla, S; Muraca, A; Nucci, P; Toma, C; Villani, E; Vujosevic, S | 1 |
| Fedele, PL; Gilbertson, M; Gregory, GP; Grigoriadis, G; Kumar, B; Low, M; Opat, S; Shortt, J; Simpson, I; Tedjaseputra, A | 1 |
| Alexander, E; Attygalle, A; Chau, I; Cunningham, D; El-Sharkawi, D; Hujairi, N; Iyengar, S; Kumar, R; Mohammed, K; Sharma, B | 1 |
| Jayaraj, R; Kumarasamy, C; Raymond, G; Shaw, P | 1 |
| Asselbergs, FW; Kamphuis, JA; Linschoten, M | 1 |
| Li, D; Li, R; Lu, X; Ma, C; Yang, B; Yu, B; Zhang, H | 1 |
| Bruja, R; Florescu, M; Mihalcea, D; Patrascu, N; Vinereanu, D; Vladareanu, AM | 1 |
| Grauer, D; Hoffmann, M; Konrardy, K; Roder, L | 1 |
| Ai, W; Andreadis, C; Huang, LW; Kaplan, LD; Lang, T; Link, TM; Steinman, MA; Sun, D | 1 |
| Aboukameel, A; Azmi, AS; Bhutani, D; Chaker, M; Corona, K; Houde, C; Huddlestun, A; Kauffman, M; Khan, HY; Landesman, Y; Li, Y; Mohammad, RM; Muqbil, I; Neveux, C; Pregja, S; Ramchandren, R; Reichel, K; Seymour, EK; Shacham, S; Shah, J; Sterbis, G; Yang, J; Zonder, JA | 1 |
| Akashi, K; Asaoku, H; Ayano, M; Fujisaki, T; Harada, T; Iwasaki, H; Kato, K; Kohno, K; Mitoma, H; Miyamoto, T; Miyamura, T; Miyoshi, H; Mori, Y; Muta, T; Niiro, H; Ohshima, K; Oryoji, K; Oshiro, Y; Sakamoto, A; Sawabe, T; Takase, K; Takeshita, M; Urata, S; Yamamoto, H; Yoshimoto, G | 1 |
| Hatake, K; Inoue, N; Kusano, Y; Mishima, Y; Nishimura, N; Nukada, T; Terui, Y; Yokoyama, M | 1 |
| Cao, YJ; Duan, J; Liu, LF; Ren, L; Wei, X; Zhang, LN; Zhang, W | 1 |
| Komatsu, N; Yasuda, H; Yasuda, M | 1 |
| Abraham, I; MacDonald, K; McBride, A | 1 |
| Maruyama, D; Ohmachi, K | 1 |
| Kim, JS; Kim, SJ; Kim, YR; Mun, YC; Oh, SY; Park, Y; Yun, HJ | 1 |
| Menna, P; Minotti, G; Salvatorelli, E | 1 |
| Farooq, S; Islam, N; Ram, N; Rashid, O; Ulhaq, I | 1 |
| Brugmann, B; Budke, CM; Burgess, K; Childress, M; DeRegis, C; Dervisis, N; Gillings, S; Laver, T; Lawrence, J; Lori, J; Miller, T; Novosad, A; Post, G; Rau, S; Reeds, K; Saba, C; Schleis, S; Silver, M; Smrkovski, O; Stein, T; Thamm, DH; Vickery, K; Wilson-Robles, H; Wright, Z | 1 |
| Hayashi, H; Ishihara, M; Itoh, Y; Kitagawa, J; Kobayashi, R; Kubota, Y; Nakamura, H; Nakamura, N; Ohata, K; Shibata, Y; Shimizu, M; Suzuki, A; Tsurumi, H | 1 |
| Hatake, K; Inoue, N; Kusano, Y; Mishima, Y; Nishimura, N; Nomura, T; Nukada, T; Takahashi, A; Terui, Y; Ueda, K; Yokoyama, M | 1 |
| Bairey, O; Berger, T; Cohen, YC; Eshel, L; Raanani, P; Shpilberg, O; Stern, D | 1 |
| Ayed, AO; Chu, B; Farooq, U; Galanina, N; Link, BK; Malecek, MK; Maurer, M; Nabhan, C; Nowakowski, GS; Petrich, AM; Rozell, S; Trifilio, S | 1 |
| Abe, M; Arai, N; Ariizumi, H; Baba, Y; Fujiwara, S; Harada, H; Hattori, N; Kabasawa, N; Kawaguchi, Y; Murai, S; Nakamaki, T; Nakashima, H; Saito, B; Tsukamoto, H; Uto, Y; Yanagisawa, K | 1 |
| Akashi, K; Kadoyama, K; Kamezaki, K; Kato, K; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Takenaka, K; Uchida, M | 1 |
| Jamil, MO; Khelfa, Y; Lebowicz, Y | 1 |
| Jin, J; Mao, L; Wang, H; Wang, L; Wang, M; Wei, J | 1 |
| Chao, T; Huang, L; Jiang, Y; Peng, H; Shen, Q; Thapa, S; Yang, K; Yu, S; Zhang, L; Zhou, T | 1 |
| Carrilho, PAM; de Souza, KJ; Ferro, RS; Prestes-Carneiro, LE; Vasconcelos, DM | 1 |
| Adams, HJA; Kwee, TC | 1 |
| Dothard, A; Hurd, D; Isom, S; Kennedy, L; Lamar, ZS; Lesser, G; McClain, D; Robinson, M; Vaidya, R | 1 |
| Jeon, SY; Kim, HS; Kim, JA; Kwak, JY; Yang, DH; Yhim, HY | 1 |
| Anavekar, NS; Bhatia, S | 1 |
| Bascuas, T; Chabalgoity, JA; Grille, S; Moreno, M | 1 |
| Bochev, P; Cirocchi, R; Hristoskova, R; Mutafchiyski, VM; Philipov, A; Popivanov, GI; Tabakov, M | 1 |
| Chinceşan, MI; Gozar, H; Horvath, E; Mărginean, CO; Meliţ, LE | 1 |
| Bhansali, S; Choudhary, NS; Nasa, M; Sud, R | 1 |
| Bruckner, T; Hensel, M; Ho, AD; Kriegsmann, K; Kriegsmann, M; Rieger, M; Schwarzbich, MA; Sitter, S; Witzens-Harig, M; Wuchter, P | 1 |
| Behringer, D; Bengel, FM; Berdel, WE; Bernhard, H; Bockisch, A; Brink, I; Brinkmann, M; Dührsen, U; Dürig, J; Franzius, C; Freesmeyer, M; Gaska, T; Geworski, L; Giagounidis, A; Griesshammer, M; Haberkorn, U; Hertel, A; Hertenstein, B; Hoelzer, D; Höffkes, HG; Holzinger, J; Hüttmann, A; Jöckel, KH; Klapper, W; Kofahl-Krause, D; Kotzerke, J; Krohn, T; Kroschinsky, F; Kurch, L; La Rosée, P; Maschmeyer, G; Matschke, J; Mesters, R; Müller, S; Ose, C; Pöppel, T; Prange-Krex, G; Raghavachar, A; Rekowski, J; Scherag, A; Schmitz, C; Thomssen, H; van Assema, DME; Weckesser, M; Wilop, S | 1 |
| Li, CL; Lu, L; Shi, HZ; Wang, D; Xiao, ZJ | 1 |
| Chbicheb, S; El Wady, W; Hakkou, F | 1 |
| Abramson, JS; Bigger, E; Chabner, BA; Dryden-Peterson, SL; Kayembe, MKA; Lockman, S; Medhin, H; Milligan, MG; Sohani, AR; Suneja, G; Zola, M | 1 |
| Baran, A; Barr, PM; Casulo, C; David, RJ; Friedberg, JW; Loh, KP; Reagan, PM | 1 |
| Balena, R; Barkhoudarian, G; Barnard, ZR; Batra, A; Lekovic, GP; Palejwala, S; Wilkinson, EP | 1 |
| Avilés, A; Nambo, MJ; Neri, N | 1 |
| Długosz-Danecka, M; Gruszka, AM; Jaroszyński, A; Jurczak, W; Krawczyk, K; Ogórka, T; Olszanecka, A; Skotnicki, AB; Sobociński, M; Szmit, S | 1 |
| DeWeerdt, S | 1 |
| Cannon, CM; Childress, MO; Lindley, SES; Marquardt, TM; Northrup, NC; Rodriguez, CO; Smith, AN; Thamm, DH | 1 |
| Burke, JM; Chang, J; Chen, L; Flinn, IW; Hallman, D; Hawkins, T; Issa, S; Kahl, B; Kolibaba, K; MacDonald, D; Simpson, D; Trotman, J; van der Jagt, R; Wood, P | 1 |
| Cartron, G; Casulo, C; Chamuleau, MED; Goy, A; Herter, S; Ingalla, E; Klein, C; Kornacker, M; Le Gouill, S; Lugtenburg, PJ; Mason, KD; Mobasher, M; Morschhauser, F; Petrich, AM; Salles, G; Samineni, D; Sampath, D; Sehn, LH; Sinha, A; Szafer-Glusman, E; Tam, CS; Tilly, H; Zelenetz, AD | 1 |
| Cartenì, G; Fusco, M; Pirozzi, A; Riccardi, F; Scagliarini, S | 1 |
| Anthony, S; Broussais-Guillaumot, F; Busson, R; Casasnovas, RO; Damaj, G; Delarue, R; Feugier, P; Haioun, C; Henry-Amar, M; Jais, JP; Laborde, L; Morschhauser, F; Mounier, N; Nerich, V; Ribrag, V; Salles, G; Sebban, C; Thieblemont, C; Tilly, H; Ysebaert, L | 1 |
| Izumitani, S; Kataoka, T; Matsuo, H; Murase, T; Nishigakiuchi, R; Saeki, Y; Sakurashita, H; Taogoshi, T | 1 |
| Al-Darraji, AF; Al-Hadad, S; Al-Jadiry, MF; Foà, R; Mohamed, S; Moleti, ML; Piciocchi, A; Shateh, WA; Testi, AM; Uccini, S | 1 |
| Bhagat, N; Kalkur, P; Kalkur, S | 1 |
| Cao, L; Fan, L; Li, JY; Liang, JH; Liao, H; Qian, J; Wang, L; Wu, JZ; Wu, W; Xia, Y; Xu, W; Zhu, HY | 1 |
| Aránguiz, N; Vega, J | 1 |
| Gurdogan, M; Ozkan, U | 1 |
| Dimitrova, M; Jovanovska, RP; Kostova, NM; Serafimoski, V; Stardelova, KG; Stavrik, S; Stojanovik, A | 1 |
| Collins, GP; Eyre, TA; Kesavan, M | 1 |
| Fadda, V; Maratea, D; Messori, A; Trippoli, S | 1 |
| Bar-Tal, Y; Barnoy, S; Menshadi, N | 1 |
| Czuczman, MS | 2 |
| Buppajarntham, S; Junpaparp, P; Madueno, FV; Varadi, G | 1 |
| Azkur, D; Demir, HA; Emir, S; Metin, A; Vezir, E | 1 |
| Abdelmoula, M; Ben Salah Lahiani, H; Chaabouni, S; Daoud, J; Elloumi, M; Ghorbel, L | 1 |
| Brain, T; Mohamed, M; Sharma, S | 1 |
| Briganti, T; Buda, G; Pietrini, M; Seccia, V | 1 |
| Makarov, AA; Markov, OV; Mironova, NL; Mitkevich, VA; Patutina, OA; Petrushanko, IY; Sen'kova, AV; Simonenko, OV; Zenkova, MA | 1 |
| Chen, MB; Hong, XN; Zhang, Y; Zhou, XY | 1 |
| Choe, R; Farhad, N; Feng, M; Glickson, JD; Lee, SC; Li, LZ; Mir, TA; Xu, HN | 1 |
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 2 |
| Jiao, Y; Wan, N | 1 |
| Huang, S; Xu, Q; Yuan, XH; Zheng, ZX | 1 |
| Ahn, HK; Ahn, JY; Cho, EK; Hong, J; Lee, JH; Park, J; Park, PW; Park, S; Shin, DB; Sym, SJ; Yoon, HH | 1 |
| Barta, SK; Boue, F; Dunleavy, K; Galicier, L; Garcia, O; Kaplan, LD; Lee, JY; Little, RF; Morgades, M; Mounier, N; Navarro, JT; Noy, A; Oriol, A; Ratner, L; Remick, SC; Ribera, JM; Sparano, JA; Spina, M; Tamari, R; Tirelli, U; Wang, D; Weiss, R; Wilson, WH; Wyen, C; Xue, X | 1 |
| Vinogradova, IuN | 1 |
| Cairo, MS; Galardy, PJ; Goldman, S; Harrison, L; Hochberg, J; Perkins, SL | 1 |
| Engert, ZV; Iványi, JL; Marton, E; Plander, M; Tóth, C | 1 |
| Ahn, JS; Cheong, JW; Do, YR; Hyun, SY; Kim, JS; Kim, SJ; Lee, HS; Lee, JH; Lee, WS; Min, YH; Oh, SY; Ryoo, HM; Suh, C; Yang, DH; Yhim, HY | 1 |
| Barton, KP; Constine, LS; Cook, JR; Couban, S; Fisher, RI; Forman, SJ; Friedberg, JW; Kahl, BS; LeBlanc, M; Marcellus, D; Miller, TP; Mills, GM; Porcu, P; Rimsza, LM; Shea, TC; Stewart, DA; Stiff, PJ; Tubbs, RR; Unger, JM; Winter, JN | 1 |
| Milpied, N | 1 |
| Levine, AM | 1 |
| Castaigne, JG; Dewilde, S; Dunlop, W; Parker, C; Woods, B | 1 |
| Ben Salah, H; Boudawara, T; Daoud, J; Elloumi, M; Fourati, N; Frikha, M | 1 |
| El Khannoussi, B; Errihani, H; Ichou, M; Khmamouche, MR; Mahfoud, T; Mesmoudi, M; Tanz, R | 1 |
| Brion, A; Cahn, JY; Daguindau, E; Deconinck, E; Limat, S; Nerich, V; Perrin, S; Woronoff-Lemsi, MC | 1 |
| Demeter, J; Nyirády, P; Romics, I; Romics, M | 1 |
| Berinstein, NL; Buckstein, R; Cheung, MC; Guirguis, HR; Imrie, K; Piliotis, E; Spaner, D; Zhang, L | 1 |
| Elgendy, IY; Lo, MC | 1 |
| Chen, H; Cheng, L; Kang, Y; Li, L; Pan, C; Shu, X; Sun, M; Xu, X | 1 |
| Abdi, E; Benson, W; Bonaventura, A; Browett, P; Cannell, P; Dubosq, MC; Ellis, D; Green, M; Grigg, A; Hertzberg, M; Horvath, N; Januszewicz, H; Marlton, P; Matthews, JP; Stone, JM; Wolf, M | 1 |
| Said, R; Tsimberidou, AM | 1 |
| De Renzo, A; La Mura, V; Masarone, M; Pane, F; Perna, F; Persico, M; Romano, M; Rosato, V; Sasso, FC; Signoriello, G | 1 |
| Abella, E; Saleh, M; Schwartzberg, LS; Whittaker, S | 1 |
| Baiocchi, RA; Blum, KA; Christian, BA; Cohen, JB; Devine, SM; Flynn, JM; Geyer, SM; Hall, NC; Heerema, NA; Hemminger, JA; Jones, JA; Lozanski, G; Maddocks, KJ; Nagar, VA; Porcu, P; Zhao, W | 1 |
| Burke, JM; Chen, L; Clementi, R; Craig, M; Flinn, IW; Hallman, DM; Hawkins, TE; Hertzberg, M; Issa, S; Kahl, BS; Kolibaba, K; Kwan, YL; Macdonald, D; Munteanu, M; Simpson, D; van der Jagt, R; Wood, P | 1 |
| Kato, K | 1 |
| Chia, VM; Langeberg, WJ; Morrow, PK; Page, JH; Siozon, CC | 1 |
| Alterini, R; Baldini, S; Bosi, A; Carrai, V; Puccini, B; Rigacci, L | 1 |
| Barosi, G; Billio, A; Corradini, P; Gallamini, A; Marchetti, M; Pileri, S; Pimpinelli, N; Rossi, G; Tura, S; Zinzani, PL | 1 |
| Baumann, FT; Bloch, W; Elter, T; Fiebig, L; Hahn, M; Hallek, M; Hülsdünker, T; Mierau, A; Reinart, N; Schenk, A; Strüder, HK; Zimmer, P | 1 |
| Bonizzoni, E; Bosi, A; Fabbri, E; Kovalchuk, S; Perrone, T; Puccini, B; Rigacci, L | 1 |
| Guerrero, MD; Swenson, KK | 1 |
| Hara, T; Koga, Y; Ohga, S; Suminoe, A; Takada, H | 1 |
| Aaldriks, AA; Giltay, EJ; le Cessie, S; Maartense, E; Nortier, JW; Tanis, BC; van der Geest, LG; Ypma, P | 1 |
| Held, G; Hohloch, K; Loeffler, M; Pfreundschuh, M; Schmitz, N; Trümper, L; Wulf, G; Zeynalova, S; Ziepert, M | 1 |
| Ahmad, AK; Azodi, M; Hui, P; Litkouhi, B; McCarthy, S; Ratner, E; Rutherford, T; Schwartz, PE; Xu, ML | 1 |
| Zinzani, PL | 1 |
| Amorim, S; Balasubramanian, S; Bandyopadhyay, N; de Vries, R; Flinn, I; Fourneau, N; Friedberg, JW; Hellemans, P; Hivert, B; Morschhauser, F; Oki, Y; Smit, JW; Thieblemont, C; Vermeulen, J; Westin, J; Younes, A | 1 |
| Auger, J; Berthaut, I; Brugnon, F; Bujan, L; Daudin, M; Hennebicq, S; Moinard, N; Rives, N; Saias, J; Szerman, E; Walschaerts, M | 1 |
| Ancochea, Á; Fernández-Rodriguez, C; García-Pallarols, F; Gimeno, E; Salar, A; Sánchez-González, B | 1 |
| Chang, Y; Fu, X; Li, L; Li, X; Sun, Z; Wu, X; Zhang, L; Zhang, M | 1 |
| Arican, A; Besen, AA; Erdogdu, S; Kose, F; Mertsoylu, H; Muallaoglu, S; Ozyilkan, O; Sedef, AM; Sezer, A | 1 |
| Akahoshi, Y; Ashizawa, M; Hangaishi, A; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kida, M; Kikuchi, M; Kimura, S; Nakano, H; Nakasone, H; Nishida, J; Noto, S; Sakamoto, K; Sato, M; Sekiguchi, N; Terasako-Saito, K; Ugai, T; Usuki, K; Wada, H; Yamasaki, R; Yamazaki, R | 1 |
| Amorim, S; Brice, P; Brière, J; Coiffier, B; de Kerviler, E; Dupuis, J; Filliatre, L; Fleury, I; Mazari, MA; Mounier, N; Thieblemont, C; Tilly, H | 1 |
| Abella, E; Balducci, L; Mo, M; Saven, A | 1 |
| Crump, M; Kukreti, V; Kuruvilla, J; Li, M; Panzarella, T; Salmasi, G; Sivabalasundaram, V; Tsang, R | 1 |
| Drozd-Sokołowska, J; Długosz-Danecka, M; Joks, M; Jurczak, W; Spychałowicz, W; Szmit, S; Torbicki, A; Zaucha, JM | 1 |
| Anselmi, M; Catalucci, A; Di Sibio, A; Felli, V; Gallucci, M; Gennarelli, A; Marini, C; Splendiani, A; Sucapane, P | 1 |
| Copeland, RA; Iwanowicz, D; Johnston, LD; Keilhack, H; Klaus, CR; Knutson, SK; Kuntz, KW; Littlefield, BA; Moyer, MP; Pollock, RM; Porter-Scott, M; Raimondi, A; Smith, JJ; Warholic, NM; Wigle, TJ | 1 |
| Cao, J; Guo, Y; Hong, X; Ji, D; Shen, W; Xue, K; Zhang, Q | 1 |
| Delarue, R; Demangel, D; Dumontet, C; Ghesquieres, H; Haioun, C; Jardin, F; Jordheim, LP; Pallardy, S; Ribrag, V; Salles, GA; Tilly, H | 1 |
| Chiappella, A; Czuczman, MS; Fowler, N; Goy, A; Habermann, TM; Hernandez-Ilizaliturri, FJ; Nowakowski, GS; Vitolo, U; Witzig, TE | 1 |
| Jung, CW; Ki, CS; Kim, HJ; Kim, JW; Kim, SH; Lee, ST; Shin, SY | 1 |
| Anyfanti, P; Argyropoulos, E; Bakatselos, S; Bekiaropoulos, D; Damianidis, G; Gouridou, E; Morichovitou, A; Papathanasiou, M; Petrou, I; Sousos, N; Tsinaridis, A | 1 |
| Chawla, A; Mishra, DK; Monappa, V; Ratkal, V | 1 |
| Kato, H | 1 |
| Catalano, PJ; Chen, YH; Ng, A; Tseng, YD | 1 |
| Bhuyan, C; Das, R; Hazarika, M; Iqbal, A; Kataki, AC; Krishnatreya, M; Nandy, P; Roy, PS; Saikia, BJ; Sharma, JD | 1 |
| Errihani, H; Lkhoyaali, S; Mrabti, H; Ouafki, I; Sghiri, T | 1 |
| Maksymiuk, B; Opoka, L; Polaczek, MM; Roszkowski-Sliż, K; Zych, J | 1 |
| Gafter-Gvili, A; Gurion, R; Monsef, I; Raanani, P; Ram, R; Shpilberg, O; Vidal, L | 1 |
| Allstadt, SD; Chon, EM; Choy, K; Collette, SA; Garrett, LD; Rebhun, RB; Rodriguez, CO; Skorupski, KA; Smith, AN; Vernau, W | 1 |
| Ganovska, A; Kovachev, S | 1 |
| Bumpers, N; Cohen, JB; Colbert, A; Flowers, CR; Heffner, LT; Hutchison-Rzepka, A; Kaufman, JL; Khoury, HJ; Koff, JL; Langston, AA; Lechowicz, MJ; Lonial, S; Nastoupil, LJ; Sinha, R; Switchenko, JM | 1 |
| Curran, K; Thamm, DH | 1 |
| Gui, L; Han, X; He, X; Liu, P; Qin, Y; Shi, Y; Yang, J; Yang, S; Yao, J; Zhang, C; Zhang, S; Zhao, L; Zhou, P; Zhou, S | 1 |
| Ambinder, RF; Epeldegui, M; Lee, JY; Magpantay, LI; Martínez, AC; Martínez-Maza, O; Mitsuyasu, R; Regidor, D; Sparano, JA; Widney, DP | 1 |
| Bhasker, S; Biswas, A; Giridhar, P; Mallick, S; Mohanti, BK; Pathy, S; Sharma, A | 1 |
| Ahn, JY; Cho, EK; Cho, EY; Hong, J; Hwang, I; Lee, JH; Park, J; Park, S; Shin, DB | 1 |
| Anand, DV; Banerjee, P; Khan-Kheil, AM; Mustafa, HM | 1 |
| Annechini, G; Capria, S; D'Elia, GM; De Angelis, F; Foà, R; Pulsoni, A; Russo, E; Stefanizzi, C; Tosti, ME | 1 |
| Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD | 1 |
| Samura, B | 1 |
| Cao, XM; Chen, YX; Gu, LF; He, AL; Lei, B; Liu, J; Ma, XR; Wang, FX; Wang, J; Wang, JL; Xu, Y; Yang, Y; Zhang, PY; Zhang, WG; Zhao, WH | 1 |
| Fino, N; Gruber, L; Hurd, D; Kennedy, L; Lamar, ZS; Morris, BB; Palmer, J; Raetskaya-Solntseva, O; Vaidya, R; Zamkoff, K | 1 |
| Baer, MR; Hassan, HE; Hedrich, WD; Heyward, S; Wang, H; Xiao, J; Zhang, J; Zhang, Y | 1 |
| Amirtham, U; Karthikeyan, VS; Mallya, A; Sreenivas, J | 1 |
| Chan, A; Farid, M; Lim, ST; Quek, R; Tang, T; Tao, M; Wang, XJ; Wee, HL | 1 |
| Burke, JM; Craig, M; Flinn, IW; Hawkins, TE; Hertzberg, M; Issa, S; Kahl, BS; Kolibaba, K; MacDonald, D; Munteanu, M; Simpson, D; van der Jagt, RH; Victor, TW; Wood, P | 1 |
| Chikasema, M; Chimzimu, F; Dhungel, BM; Fedoriw, Y; Gopal, S; Itimu, S; Kaimila, B; Kamiza, S; Kampani, C; Kasonkanji, E; Krysiak, R; Liomba, NG; Makwakwa, V; Montgomery, ND; Moses, A; Mzumara, S; Nyasosela, R; Richards, KL; Shea, TC; Tomoka, T; Varela, C | 1 |
| Chan, H; Issa, S; Jackson, S; Knox, A; Lee, J; McLay, J; Wang, S | 1 |
| Bianchi, L; Campione, E; Chimenti, S; Citarella, L; Del Principe, I; Di Prete, M; Diluvio, L; Orlandi, A | 1 |
| Najafi, S; Payandeh, M; Sadeghi, M; Shojaiyan, FZ | 1 |
| Annibali, O; Avvisati, G; Cavallari, I; Cenfra, N; Chiodi, F; Cimino, G; Mecarocci, S; Mega, S; Rago, A; Sarlo, C; Tomassini, S | 1 |
| Fukuhara, S; Fukushima, R; Kim, SW; Kobayashi, Y; Maeshima, A; Maruyama, D; Miyamoto, K; Munakata, W; Taniguchi, H; Tobinai, K; Watanabe, T | 1 |
| Cuzzocrea, S; Ferrero, S; Ghione, P; Mauro, E; Mian, M; Mondello, P; Pitini, V; Steiner, N; Visentin, A; Wasle, I; Willenbacher, W; Zaja, F; Zambello, R | 1 |
| Adachi, K; Ikejiri, F; Inoue, M; Jo, Y; Kawakami, K; Kumanomidou, S; Miyake, T; Moriyama, I; Okada, T; Onishi, C; Suzuki, R; Suzumiya, J; Takahashi, T; Takami, S | 1 |
| Kumar, A; Persky, DO; Puvvada, S; Sundararajan, S | 1 |
| Clemmons, AB; DeRemer, DL; Evans, SS; Gandhi, AS | 1 |
| Chen, XC; Fu, TW; Huang, HW; Jiang, YB; Jin, ZM; Wu, DP; Xu, T | 1 |
| Song, Z; Wang, H; Yang, F; Zhang, H; Zhang, M; Zhao, K | 1 |
| Hao, X; He, Z; Hong, T; Huang, F; Lei, J; Lu, Y; Sun, H; Yang, L; Zeng, J | 1 |
| Amioka, M; Asaoku, H; Kihara, Y; Kyo, T; Ochi, T; Okada, T; Sairaku, A | 1 |
| Cabanillas, F; Pardo, WI; Rivera, N | 1 |
| Aboukameel, A; Azmi, AS; Baloglu, E; Bhutani, D; Carlson, R; Elloul, S; Kauffman, M; Mohammad, RM; Muqbil, I; Senapedis, W; Shacham, S; Zonder, J | 1 |
| Arad, A; Avni, B; Elias, S; Gatt, M; Grisariu, S; Paltiel, O; Pasvolsky, O; Raanani, P; Vaxman, I | 1 |
| Li, Y; Song, C; Tu, S; Wu, X; Zhong, D | 1 |
| Ekhzaimy, A; Mujamammi, A | 1 |
| Al-Rawi, NH | 1 |
| Cortes, JE; Estrov, Z; Ferrajoli, A; Garcia-Manero, G; Jabbour, E; Kantarjian, HM; Khouri, M; Khoury, JD; Ko, H; O'Brien, SM; Pierce, S; Ravandi, F; Short, NJ; Thomas, DA; Thompson, PA; Verstovsek, S; Wierda, WG | 1 |
| Zucca, E | 1 |
| McCann, MH; Moser, BK | 1 |
| Daoud, J; Lahiani Ben Salah, H | 1 |
| Birkmann, J; Bodenstein, H; Clemens, M; Fuchs, R; Hänel, M; Hensel, M; Peter, N; Pfreundschuh, M; Reiser, M; Zeynalova, S; Ziepert, M; Zwick, C | 1 |
| Ando, J; Isobe, Y; Masuda, A; Oshimi, K; Sugimoto, K | 1 |
| Coiffier, B; Michallet, AS | 1 |
| Bolu, E; Kebapcilar, L; Kutlu, M; Sahin, M; Taslipinar, A; Uckaya, G | 1 |
| Akutsu, M; Fukushima, M; Furukawa, Y; Hirabayashi, K; Igarashi, S; Inoue, K; Izumi, T; Kano, Y; Katano, S; Kirito, K; Kobayashi, H; Nagashima, T; Ohmine, K; Ozawa, K; Sato, K; Tanaka, M; Teramukai, S; Tsunoda, S | 1 |
| Daruwalla, ZJ; Duke, D; Grogan, L; Razak, AR | 1 |
| Batista, MD; de Almeida, FA; Enokihara, MM; Lopes, RD; Michalany, NS; Takano, D | 1 |
| Cao, JN; Guo, HY; Hong, XN; Hu, XC; Li, J; Yin, JL; Zhao, XM | 1 |
| Castelino, FV; Collier, D; Wasfy, JH | 1 |
| Okada, S | 1 |
| Escalón, MP; Han, HS; Hsiao, B; Lossos, IS; Serafini, A | 1 |
| Daimaru, O; Fukaya, N; Imai, T; Ito, S; Nagata, T; Uchida, H; Yamane, T; Yoshiya, K | 1 |
| Chiron, P; Gomez-Brouchet, A; Laffosse, JM; Molinier, F; Puget, J; Roché, H | 1 |
| Cheson, BD | 1 |
| Jonathan, F | 1 |
| Endo, T; Fujimoto, K; Goto, H; Kasahara, I; Koike, T; Nishio, M; Obara, M; Sato, N; Takeda, Y; Yamaguchi, K; Yamamoto, S | 1 |
| Bosly, A; Constenla, M; Jackisch, C; Leonard, R; Paridaens, R; Pettengell, R; Schwenkglenks, M; Szucs, TD | 1 |
| Chung, CS; Liao, WC; Wang, HP | 1 |
| Aharoni, J; Ben-Harush, M; Kapelushnik, J; Sarid, L; Shabbat, S | 1 |
| Boehme, V; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S | 1 |
| Petit, J; Petit, T; Saint, F; Sénéchal, C | 1 |
| Hansen, MR; Hong, RS; Woodson, EA | 1 |
| Bochkareva, TN; Cherviakov, AM; Il'in, NV; Leenman, EE; Vinogradova, IuN | 1 |
| Clarke, SJ; Cunningham, D; Dent, O; Robertson, G; Sharma, R; Smith, P | 1 |
| Capucchio, MT; Catalano, D; Cavana, P; Farca, AM; Sammartano, F; Valazza, A | 1 |
| Avitia, S; Hamilton, JS; Osborne, RF | 1 |
| Dannaher, C; Greco, FA; Hainsworth, JD; Markus, TM; Rotman, R; Shipley, D; Spigel, DR; Thompson, D | 1 |
| Angelucci, E; Cabras, MG; Dessalvi, P; Freilone R, R; Lay, G; Levis, A; Liberati, M; Mamusa, AM; Orsucci, L; Tonso, A; Vitolo, U | 1 |
| Bertino, JR; Gharibo, M; Levitt, MJ; Rubin, A; Schaar, D; Strair, R | 1 |
| Brice, P; Hennequin, C; Quero, L | 1 |
| Bonilla, F; Cantos, B; Maximiano, C; Méndez, M; Provencio, M; Sanchez, A | 1 |
| Anoop, P; Bain, BJ; Dearden, CE; Matutes, E; Osuji, N; Ravindranathan, G; Wotherspoon, A | 1 |
| Ilardi, G; Mascolo, M; Staibano, S; Valentini, G; Vettori, S | 1 |
| Czumbil, L; Gyánó, G; Iványi, JL; Marton, E; Plander, M; Tóth, C | 1 |
| Cartron, G; Girard, P; Hénin, E; Paintaud, G; Ternant, D; Tod, M | 1 |
| Berthou, C; Boisramé, S; Ianotto, JC; Querellou, S; Tempescul, A; Valette, G | 1 |
| Azim, HA; Bociek, RG; Gandini, S; Malek, RA; Santoro, L | 1 |
| Dührsen, U; Hüttmann, A; Jöckel, KH; Müller, S | 1 |
| Beutner, EH; Grover, RK; Hashimoto, T; Helm, TN; Stites, PC | 1 |
| Coll, R; Gallardo, D; García, O; Gardella, S; Moreno, M; Ribera, JM; Sancho, JM | 1 |
| Bilici, A; Canpolat, N; Gumus, M; Ozdemir, N; Salepci, T; Seker, M; Ustaalioglu, BB | 1 |
| Antonelli, A; Carpi, A; Cervetti, G; Fallahi, P; Franzoni, F; Galetta, F; Petrini, M; Regoli, F; Santoro, G; Tocchini, L | 1 |
| Kim, JA; Kim, K; Kim, SJ; Kim, WS; Ko, YH; Kong, JH; Lee, SH; Yun, J | 1 |
| Aksu, K; Cagirgan, S; Keser, G; Ozsan, N; Sahin, F | 1 |
| Chung, YS; Kim, YJ; Kwon, SI | 1 |
| Cao, Y; Fu, X; Guan, Z; Guo, C; Huang, H; Huang, J; Lin, T; Xiao, J; Zhai, L | 1 |
| Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C | 1 |
| Bishop, MR; Dean, RM; Fowler, DH; Gress, RE; Odom, J; Pavletic, SZ; Pollack, SM; Sportes, C; Steinberg, SM | 1 |
| Song, YQ; Zhu, J | 1 |
| Delbès, G; Hales, BF; Luu, T; Marcon, L; Robaire, B; Vaisheva, F | 1 |
| Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J | 1 |
| He, E; Ji, XY; Pan, ZL; Shi, YM; Skog, S; Zhou, J | 1 |
| Ross, E | 1 |
| Bang, SM; Kang, YA; Kim, JH; Lee, CT; Lee, JH; Lee, JS; Lee, KW; Lim, KH; Yoon, HI | 1 |
| Tilly, H | 1 |
| Dunleavy, K; Tay, K; Wilson, WH | 1 |
| Ali, ZB; Ben Othmen, T; Bouaouina, N; Daoud, J; Elloumi, M; Ghannem, H; Laatiri, MA; Maalej, M; Meddeb, B; Msadek, F; Toumi, N | 1 |
| Hollstein, S; Kriwalsky, MS; Kunkel, M; Schroers, R; Stricker, I | 1 |
| Coleman, M; Goldsmith, SJ; Kaminski, MS; Leonard, JP; Link, BK; Martin, P | 1 |
| Amoêdo, ND; Apa, AG; Bacchi, CE; Da Silva Robaina, MC; Klumb, CE; Machado, AS; Magalhães De Rezende, LM | 1 |
| Cao, JN; Chang, JH; Guo, Y; Hong, XN; Leaw, SJ; Li, ZT; Zhao, XY | 1 |
| Gandhi, MK; Jones, K | 1 |
| Aarden, L; Baars, JW; Beijnen, JH; Huitema, AD; Tran, L | 1 |
| Fylaktou, I; Goussetis, E; Graphakos, S; Kanariou, M; Kanavakis, E; Kitra, V; Peristeri, I; Petrakou, E; Psarra, K; Theodosaki, M; Traeger-Synodinos, J; Tzortzatou-Stathopoulou, F | 1 |
| Brunello, A; Extermann, M; Kapoor, R | 1 |
| Aghakhani, R; Alavi, S; Arzanian, MT; Gharib, A; Goudarzipour, K; Jadali, F; Rezaei, N; Shamsian, BS | 1 |
| Barton, M; Christie, D; Dear, K; Le, T; Porter, D; Pratt, G; Roos, D; Wirth, A | 1 |
| Ho, AD; Loeffler, M; Metzner, B; Nickelsen, M; Peter, N; Pfreundschuh, M; Rosenwald, A; Schmitz, N; Trümper, L; Ziepert, M | 1 |
| Aversa, SM; Canova, F; Ghiotto, C; Marino, D; Soldà, C; Trentin, C | 1 |
| Abella, E; Alvarez-Larrán, A; Besses, C; Comín, J; García-Pallarols, F; Gimeno, E; Gómez, M; Pedro, C; Salar, A; Sánchez-González, B; Saumell, S | 1 |
| Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M | 1 |
| Abd El-Bary, N; Alkilani, A; El-Bassal, F; Fathy, AA; Soliman, MA | 1 |
| Buric, M; Buric, N; Jovanovic, G; Radovanovic, Z; Tijanic, M | 1 |
| Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Quirini, F; Stefoni, V; Zinzani, PL | 1 |
| Ainoda, Y; Hirai, Y; Shoji, T; Totsuka, K | 1 |
| Bestul, DJ; Hannawa, IS | 1 |
| Kaya, H; Kurokawa, T; Yoshida, T | 1 |
| Aikawa, K; Fukuda, H; Hotta, T; Itoh, K; Kobayashi, Y; Morishima, Y; Nakamura, S; Nakata, M; Ogura, M; Ohmachi, K; Shibata, T; Shimoyama, M; Suzuki, T; Tobinai, K; Ueda, R | 1 |
| Li, JM; Liang, H; Shen, ZX; Wang, C; Wang, X; Wang, YY; Wu, DP; Zhang, JL; Zhu, J | 1 |
| Alfonso, R; Miralles, J; Moragón, M; Onrubia, J; Pérez-Crespo, M; Requena, L; Sevila, A | 1 |
| Avery, AC; Dow, SW; Eickhoff, J; Perry, JA; Thamm, DH | 1 |
| Pettengell, R; Schwenkglenks, M | 1 |
| Bilgir, F; Bilgir, O; Calan, M; Oztekin, O; Sari, F; Yuksel, A | 1 |
| Dumitrescu, O; Gerecitano, J; Hamlin, P; Horanlli, E; Iasonos, A; Mo, Q; Moskowitz, CH; Noy, A; O'Connor, OA; Pappanicholaou, J; Portlock, C; Rojas, CN; Sarasohn, D; Schulman, P; Straus, D; Zelenetz, AD; Zhang, Z | 1 |
| Borchmann, P; Cernohous, P; Engert, A; Herbrecht, R; Hess, G; Morschhauser, F; Singer, JW; Veals, SA; Wilhelm, M | 1 |
| Hasegawa, M; Isobe, K; Kagami, Y; Kodaira, T; Nakamura, K; Oguchi, M; Sasaki, S; Shikama, N; Tamaki, Y | 1 |
| Andjelic, BM; Antic, DA; Mihaljevic, BS; Perunicic Jovanovic, MD; Todorovic, MR | 1 |
| Macharia, WM | 1 |
| Bergstresser, P; Chan, J; Dai, W; Dharamsi, JW; Gander, R; Ricotti, C; Soliman, S | 1 |
| Hou, S; Yang, W | 1 |
| Butera, JN; Mega, AE; Nadeem, A; Reagan, JL; Rosmarin, A; Schiffman, FJ; Sikov, WM; Winer, E | 1 |
| Goto, H; Hirooka, Y; Kinoshita, T; Kitamura, K; Kosugi, H; Nakamura, S; Niwa, Y; Shimada, K; Sugiura, I; Tanaka, T; Yamamoto, K | 1 |
| Dietrich, S; Ho, AD; Schmitt, CJ; Witzens-Harig, M | 1 |
| Ambrose, D; Brown, CA; Frontera-Acevedo, K; Moorhead, AR; Saba, CF; Stone, RH | 1 |
| Cavallin-Stahl, E; Glass, B; Haenel, M; Kaiser, U; Loeffler, M; Pfreundschuh, M; Schmitz, N; Truemper, L; Wolf, M; Zeynalova, S | 1 |
| Aversa, SM; De Franchis, G; Farina, P; Jirillo, A; Marino, D; Simonetto, M | 1 |
| Hotta, T; Shimoyama, M; Tobinai, K; Tsukasaki, K | 1 |
| Barta, SK; Kaplan, LD; Lee, JY; Noy, A; Sparano, JA | 1 |
| Bondioli, A; Calabresi, L; Ferraro, G; Franceschini, G; Gianazza, E; Mombelli, G; Penco, S; Simonelli, S; Sirtori, CR | 1 |
| Gopalakrishnan, S; Madana, J; Saxena, SK; Yolmo, D | 1 |
| Jantunen, E; Kuittinen, T; Mäntymaa, P; Nousiainen, T; Varmavuo, V | 1 |
| Castillo, JJ; Echenique, IA | 1 |
| Jiang, L; Xie, JL; Zhou, XG | 1 |
| Champlin, R; Cooper, LJ; Craig, S; Davis, RE; Hartline, CA; Huls, H; Johnson, M; Lee, DA; Ma, W; Maiti, S; O'Connor, CM; Palla, SL; Sheppard, S; Wilson, H | 1 |
| Asazuma, N; Igarashi, H; Machinami, R; Nakamura, H; Ogata, I; Yamashita, H | 1 |
| Bruno, M; Cabanillas, F; Cotto, M; Liboy, I; Pavia, OA; Rivera, E | 1 |
| Atoini, F; Lhou, FA; Ouarssani, A; Rguibi, MI | 1 |
| Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD | 1 |
| Lekhakula, A; Rujirojindakul, P | 1 |
| Chou, T; Fukuda, H; Fukushima, N; Hotta, T; Itoh, K; Kagami, Y; Kinoshita, T; Kiyama, Y; Mikuni, C; Mukai, K; Ogura, M; Sasaki, T; Shimoyama, M; Suzuki, T; Tobinai, K; Tsukasaki, K; Watanabe, Y | 1 |
| Dousias, V; Michos, GM; Navrozoglou, I; Papadopoulos, G; Stefos, T | 1 |
| Addabbo, F; Festa, VM; Rullo, R | 1 |
| Bhattacharyya, T; Revannasiddaiah, S | 1 |
| Lesmana, LA; Sanityoso, A; Wijaya, I | 1 |
| Bruno, F; Gesualdo, L; Grandaliano, G; Infante, B; Stallone, G; Tartaglia, L | 1 |
| Brown, JM; Fan, AC; Felsher, DW; Fischbein, NJ; Howard, W; Hsieh, RW; McClellan, JS; To, CA | 1 |
| Blacklock, H; Coomarasamy, C; Issa, S; Knox, A; Lee, S; Zeng, IS | 1 |
| Alvarez Burneo, LE; Arce-Álvarez, A; Mercedes, LK | 1 |
| Choi, SH; Jeong, JY; Kim, MN; Kim, SH; Kim, T; Kim, YS; Lee, SO; Suh, C; Sung, H; Woo, JH; Yoon, DH | 1 |
| Campana, F; Casanova, L; Casteñeda, CA; de Mendoza, FH; Flores, C; Gómez, HL; Leon, J; Neciosup, SP; Pinto, JA; Samanéz, C; Vallejos, CS; Vera, L | 1 |
| Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY; Yoon, JH | 1 |
| Arunachalam, M; Bassi, A; Difonzo, E; Galeone, M; Scarfi, F | 1 |
| Adalsteinsson, O; Black, RR; Peress, NL; Segal, D; Strum, SB; Waldenfels, J | 1 |
| Azuma, T; Shikata, H; Yakushijin, Y; Yamanouchi, J; Yasukawa, M | 1 |
| El Kabbaj, H; Errihani, H; Kairouani, M; M'rabti, H; Mellas, N; Sekkate, S | 1 |
| Fernández, A; Guldrís, EM; Vázquez, P | 1 |
| Cabanillas, F; Cox, JD; Ha, CS; Hess, MA; Medeiros, LJ; Pro, B; Rodriguez, MA; Romaguera, JE; Tucker, SL; Wilder, RB | 1 |
| Dan, K; Nakamura, N; Toyota, S | 1 |
| Bergmann, M; Busch, R; Emmerich, B; Franke, A; Hallek, M; Hiddemann, W; Hopfinger, G; Pasold, R; Schlag, R; Schmitt, B; Wendtner, CM | 1 |
| Angel, CA; Jones, EA; Pringle, JH; Rees, RC | 1 |
| Butt, A; Chadburn, A; Gergis, U; Gotlib, V; Guevara, E; Nayak, A; Patel, A; Singareddy, S; Vakios, J; Yavorkovsky, LL | 1 |
| Aoun, P; Armitage, JO; Bast, M; Bierman, PJ; Bociek, G; Chan, JC; Greiner, T; Lynch, JC; Vose, JM; Weisenburger, DD | 1 |
| Delwail, V; Lacotte-Thierry, L; Paccalin, M | 1 |
| Fridman, M; Gupta, S; Morrow, TJ; Tannous, RE; Volpe, S | 1 |
| Fenyvesi, T; Karádi, I; Rosta, A; Sármán, P; Schneider, T; Szücs, S; Zsáry, A | 1 |
| Aitini, E; Alinari, L; Baccarani, M; Ciccone, F; De Renzo, A; Falini, B; Fattori, PP; Gentilini, P; Gherlinzoni, F; Guardigni, L; Lauria, F; Lauta, VM; Mannina, D; Mazza, P; Moretti, L; Pavone, E; Stefoni, V; Storti, S; Tani, M; Tura, S; Volpe, E; Zaccaria, A; Zaja, F; Zinzani, PL | 1 |
| Büchler, T; Ferra, C; Grañena, A; Montanya, E; Virgili, N | 1 |
| Fukuno, K; Goto, H; Hara, T; Kanemura, N; Kasahara, S; Moriwaki, H; Oyama, M; Sawada, M; Shimizu, M; Takami, T; Tsurumi, H; Yamada, T; Yoshikawa, T | 1 |
| Schwarzenberger, P; Theodossiou, C | 1 |
| Ayala, A; Cabanillas, F; Hagemeister, FB; Hess, M; Lee, MS; McLaughlin, P; Preti, A; Rodriguez, MA; Romaguera, J; Sarris, A; Smith, TL; Tsimberidou, AM; Yang, Y; Younes, A | 1 |
| Gan, H; Lin, Y; Zhang, F | 1 |
| Franchini, M; Krampera, M; Pizzolo, G; Veneri, D; Zanetti, F | 1 |
| Iwuagwu, OC; Kober, R | 1 |
| Grenier, JF; Guévin, R; Klasa, RJ; Laplante, S; Maksymiuk, A; Meyer, RM; Rubinger, M; Samosh, M; Sawka, CA; Shustik, C; Smith, A | 1 |
| Jackson, AS; Lightman, S; Pavesio, C; Plowman, PN; Taylor, A | 1 |
| Colombat, P; Desablens, B; Escoffre, M; Gandhour, C; Haillot, O; Harousseau, JL; Jacob, C; Le Prise, PY; Lefrancq, T; Leloup, R; Linassier, C; Lucas, V; Tabuteau, S | 1 |
| Afanas'ev, BV; Alekseeva, IuA; Medvedeva, NV; Mikhaĭlova, NB; Zaritskiĭ, AIu; Zubarovskaia, LS | 2 |
| Horie, T; Ito, T; Kaneita, Y; Kura, Y; Sawada, U; Yamazaki, T; Yasukawa, K | 1 |
| ChanYan, C; Gill, S; Haley, L; Melosky, B | 1 |
| Leelasiri, A; Mongkonsritragoon, W; Numbenjapon, T; Prayoonwiwat, W; Sriswasdi, C | 1 |
| Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
| Bessell, EM; Burton, A; Child, JA; Cullen, MH; Davies, JM; Ellis, IO; Glaholm, J; Haynes, AP; Jack, A; Jones, EL; Smith, GM | 1 |
| Bernard, Y; Brion, A; Cahn, JY; Deconinck, E; Demesmay, K; Limat, S; Sabbah, A; Voillat, L; Woronoff-Lemsi, MC | 1 |
| Chou, T; Kasai, M; Kawano, F; Kiyama, Y; Masaki, Y; Mitsuya, H; Morishima, Y; Ogura, M; Ohnishi, K; Sasaki, T; Takeyama, K; Tobinai, K; Yokozawa, T | 1 |
| Boye, J; Elter, T; Engert, A | 1 |
| Coiffier, B | 7 |
| Cantonetti, M; De Renzo, A; De Vivo, A; Falini, B; Gherlinzoni, F; Guardigni, L; Lauria, F; Lauta, VM; Mandelli, F; Martelli, M; Mazza, P; Meloni, G; Molinari, AL; Moretti, L; Pescarmona, E; Pileri, SA; Rizzo, M; Storti, S; Tura, S; Zinzani, PL | 1 |
| Buse, G; Zanssen, S | 1 |
| Li, A; Luo, R; Ma, S; Sheng, X | 1 |
| Baehring, JM; Hochberg, FH; Longtine, J | 1 |
| Barbón García, JJ; Carballo Fernández, C; Fernández Alvarez, C; Menéndez Fernández, CL; Villarreal Renedo, PM; Viña Escalar, C | 1 |
| Angrilli, F; Bertè, R; Broglia, C; Brugiatelli, M; Cavanna, L; Federico, M; Ilariucci, F; Lombardo, M; Luisi, D; Luminari, S; Merli, F; Molica, S; Morabito, F; Sacchi, S; Stelitano, C | 1 |
| Bálega J, Já; Csapó, Z; Matolcsy, A; Papp, Z; Sréter L, Lí; Szánthó, A | 1 |
| Guan, ZZ; He, YJ; Xu, RH; Yuan, ZY | 1 |
| Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, XB; Liu, DG; Sun, XF; Wang, W; Xia, ZJ; Xu, GC; Xu, RH; Zhang, L; Zhou, ZM | 1 |
| Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Xia, ZJ; Xu, RH | 1 |
| Abdelkefi, M; Belcadhi, M; Bouzouita, H; Bouzouita, K; el Omri, H; Ennabli, S; Gnaba, K; Mani, R | 1 |
| Coiffier, B; Pfreundschuh, M; Stahel, R; Vose, J; Zinzani, PL | 1 |
| Braziel, RM; Fisher, RI; Gaynor, ER; LeBlanc, M; Maloney, DG; Miller, TP; Press, OW; Rivkin, SE; Unger, JM | 1 |
| Oh, KC; Zang, DY | 1 |
| Angelopoulou, MK; Bourantas, KL; Christopoulos, G; Grigorakis, V; Kalmantis, T; Kokkinis, G; Korantzis, J; Michalis, E; Mihalakeas, I; Pangalis, GA; Papayiannis, A; Repousis, P; Roussou, P; Siakantaris, MP; Stamatellou, M; Stefanoudakis, E; Symeonidis, A; Vassilakopoulos, TP; Vrakidou, E | 1 |
| Paschal, BR | 1 |
| Ayala, A; Cabanillas, F; Cox, JD; Fuller, LM; Ha, CS; Hagemeister, FB; Hess, M; Manning, JT; McLaughlin, P; Pro, B; Rodriguez, MA; Romaguera, J; Seymour, JF; Smith, TL | 1 |
| Griniūte, R; Pileckyte, M | 1 |
| Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A | 1 |
| Cavalli, F; Cocorocchio, E; Conconi, A; De Luzio, K; Ferrucci, PF; Martinelli, G; Mazzetta, C; Mingrone, W; Peccatori, FA; Santoro, P; Zucca, E | 1 |
| Amess, J; Cornelius, V; Delves, T; Fitzgibbon, J; Last, KW; Lister, TA; Norton, A; Rohatiner, AZ; Sieniawska, C; Wilson, A | 1 |
| Ohmoto, K; Tsuduki, M; Yamamoto, S | 1 |
| Ahmed, A; Ahmed, AM; Garcia, G; Keeffe, EB; Nguyen, MH; Simpson, ND; Simpson, PW | 1 |
| Bearman, SI; Blayney, DW; Chapman, RA; Fisher, RI; Gaynor, ER; Grogan, T; LeBlanc, ML; Miller, TP; Spiridonidis, CH; Taylor, SA | 1 |
| Alliot, C | 2 |
| Aguilar Cuevas, R; Amores Ramírez, F; Leiva Vera, C; Mañas Uxó, J; Márquez Moreno, AJ; Ortega Jiménez, MV; Pérez Rodríguez, D | 1 |
| Akoum, R; Brihi, E; Chahine, G; Saade, M | 1 |
| Greco, FA; Hainsworth, JD; Lamb, MR; Litchy, S; Rodriguez, GI; Scroggin, C | 1 |
| Farber, C; Filippa, D; O'Brien, J; Pan, D; Portlock, CS; Qin, J | 1 |
| Bartlett, RJ; Shields, ML; Smyth, EF; Wengraf, C; White, TJ | 1 |
| Fievet, MH; Gabarre, J; Junot, H; Malliti, M; Taright, N; Thuillier, A; Vernant, JP | 1 |
| Buijt, I; Doorduijn, JK; Kramer, MH; Mulder, AH; Ossenkoppele, GJ; Schaafsma, MR; Sonneveld, P; Steijaert, MM; Uyl-de Groot, CA; van Agthoven, M; van der Hem, KG; van der Holt, B; van Imhoff, GW; van Oers, MH; Verdonck, LF; Verhoef, GE | 1 |
| Attal, M; Blanc, M; Bosly, A; Coiffier, B; Fillet, G; Gisselbrecht, C; Guettier, C; Herbrecht, R; Lepage, E; Molina, TJ; Reyes, F; Tilly, H | 1 |
| Cinelli, R; D'Andrea, M; Dal Maso, L; De Paoli, P; Di Gennaro, G; Nasti, G; Simonelli, C; Spina, M; Tirelli, U; Vaccher, E; Zanussi, S | 1 |
| Mead, G; Woodcock, J; Young, C | 1 |
| Filippa, DA; Mora, J; Qin, J; Wollner, N | 1 |
| MONTORSI, W | 1 |
| CAYLA, J; COSTE, F | 1 |
| DUBOIS-FERRIERE, H | 2 |
| GORSUCH, GE | 1 |
| SCHOYER, NH | 1 |
| Jäger, U | 1 |
| SCHNEIDER, H; SIEDE, W | 1 |
| DAMESHEK, W; KYLE, RA; McPARLAND, CE | 1 |
| GUPTA, NN; MITTAL, SP | 1 |
| HARTAI, F | 1 |
| BROWN, EB; BURNINGHAM, RA; HARRINGTON, WJ; KHURI, PD; LESSNER, HE; PUGH, RP; RESTREPO, A; SCHLOSSMAN, SF | 1 |
| IRVINE, RA; ROBERTSON, WB | 1 |
| BOOTSMA, BK | 1 |
| KARNOFSKY, DA | 1 |
| DEBLASIIS, M | 1 |
| DIETZSCH, HJ | 1 |
| LIBERTI, R | 1 |
| STEINFELD, JL; WATKIN, DM | 1 |
| EAKINS, D; FULTON, T; HADDEN, DR | 1 |
| D ANGIO, GJ; EVANS, AE; MIUS, A | 1 |
| Chao, TY; Dai, MS; Yu, CY | 1 |
| Doorduijn, JK; Hagberg, H; Johnsen, HE; Kvalheim, G; Kvaloy, S; Porcellini, A; Qian, W; Schouten, HC; Sydes, MR | 1 |
| Belt, RJ; Berry, WR; Bosserman, L; Case, DC; Gregory, SA; Kalman, LA; Litwak, DL; Saven, A | 1 |
| Al-Shemmari, SH; Ameen, RM; Ragheb, AM; Sajnani, KP | 1 |
| Bacon, P; Forstpointner, R; Grigg, A; Hiddemann, W; Hoskin, P; McMillan, A; Renwick, J; Solal-Celigny, P; Taylor, K | 1 |
| Gershanovich, ML; Korolenko, VO; Leenman, EE; Tikhonova, VV | 1 |
| André, M; Bosly, A; Brice, P; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Henry-Amar, M; Leleu, X; Morel, P; Mounier, N; Reyes, F; Sonet, A; Tilly, H | 1 |
| Carbone, A; Cinelli, R; Gloghini, A; Simonelli, C; Spina, M; Talamini, R; Tedeschi, R; Tirelli, U; Vaccher, E | 1 |
| Elfenbein, GJ; Lambert, JF | 1 |
| Ogawa, M | 2 |
| Chin, K; Furuta, N; Hatake, K; Itoh, Y; Mishima, Y; Mizunuma, N; Nagasaki, E; Shinozaki, E; Takahashi, S; Terui, Y; Tokutome, N; Usui, N | 1 |
| Harada, M; Hasegawa, M; Isobe, H; Kamachi, M; Mishina, T; Suzuki, H; Tokuchi, Y; Yamashiro, K | 1 |
| Comans, EF; Hoekstra, OS; Huijgens, PC; Jonkhoff, AR; Lammertsma, AA; Raijmakers, PG; Teule, GJ; v Tinteren, H; van der Hoeven, JJ; Zijlstra, JM | 1 |
| Delgado, DJ; Lyman, GH | 1 |
| Dekker, AW; Mandigers, CM; Meijerink, JP; Raemaekers, JM; Schattenberg, AV; Verdonck, LF | 1 |
| Fukuno, K; Hara, T; Kanemura, N; Kasahara, S; Kojima, Y; Moriwaki, H; Oyama, M; Ozawa, K; Saio, M; Sawada, M; Takahashi, T; Takami, T; Tsurumi, H; Yamada, T | 1 |
| Chen, SP; Wu, DS; Zhao, XL | 1 |
| Bologna, A; Camisa, R; Cascinu, S; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Dodero, A; Franciosi, V; Vasini, G | 1 |
| Hagenbeek, A; Sonneveld, P; Uyl-de Groot, CA; van Agthoven, M | 1 |
| Ardashev, VN; Korotkiĭ, AN; Mazurov, VI; Seriakov, AP; Ushakov, II | 1 |
| Case, D; George, S; Hackett, J; Liang, BC; Meza, LA; Neumann, TA; Shogan, JE; Yang, BB; Yunus, F | 1 |
| Hehn, ST; Miller, TP | 1 |
| Boswell, W; Espina, BM; Levine, AM; Palmer, M; Pedro Santabarbara, AB; Schiflett, J; Smith, S; Tulpule, A | 1 |
| Manca, E; Miccolis, I; Perego, D; Pogliani, EM; Rivolta, F; Rossini, F; Terruzzi, E | 1 |
| Ambrosetti, A; Cabras, MG; Di Vito, F; Fioritoni, G; Gabbas, A; Gallamini, A; Gallo, E; Gargantini, L; Gottin, L; Lazzarino, M; Menestrina, F; Morra, E; Orlandi, E; Palestro, M; Pasini, F; Paulli, M; Pizzolo, G; Pizzuti, M; Rossi, G; Secchi, S; Tarella, C; Tecchio, C; Todeschini, G; Vitolo, U | 1 |
| Budel, LM; Kramer, MH; Uyl-de Groot, CA; van Agthoven, M; Wittebol, S | 1 |
| Alzieu, C; Bardou, VJ; Charbonnier, A; Cohen, R; Costello, RT; de Colella, JM; Gastaut, JA; Lepeu, G; Nezri, M; Olive, D; Poizot-Martin, I; Xerri, L; Zerazhi, H | 1 |
| Baars, JW; Carde, P; de Wolf-Peeters, C; Kluin-Nelemans, JC; Moser, EC; Noordijk, EM; Raemaekers, JM; Teodorovic, I; Tirelli, U; van Glabbeke, M | 1 |
| Davaris, P; Dimitrakopoulos, A; Kosmas, C; Lazaris, A; Pangalis, GA; Papalambros, E; Rokana, S; Siakantaris, MP; Tsavaris, N; Vadiaka, M; Zorzos, H | 1 |
| Ben Dridi, M; Bouchriha, M; Bouslama, K; Harmel, A; Hendaoui, L; Mzabi-Rgaya, S; Rezgui-Marhoul, L | 1 |
| DaSilva, D; Doshi, M; Narayan, D | 1 |
| Bayram, I; Erkoc, R; Sayarlioglu, H; Sayarlioglu, M | 1 |
| Aleksza, M; Gergely, L; Illés, A; Ponyi, A; Sipka, S; Szegedi, G; Váróczy, L | 1 |
| Aversa, S; Candela, M; Centurioni, R; Chisesi, T; Congiu, M; De Souza, C; Gennaro, M; Nardi, V; Olivieri, A; Patti, C; Rubagotti, A; Santini, G; Tedeschi, L; Truini, M | 1 |
| Pamerneckas, A; Petrulis, A; Pijadin, A; Pilipavicius, G; Tamulaitis, G; Toliusis, V | 1 |
| Alinari, L; Baccarani, M; Gabriele, A; Marchi, E; Musuraca, G; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Blaive, B; Chichmanian, RM; Jullien, V; Lemoigne, F; Perrin, C; Peyrade, F | 1 |
| Askling, J; Björkholm, M; Dickman, PW; Ekbom, A; Landgren, O; Osby, E | 1 |
| Feng, FY; Gu, DZ; Hu, Y; Shi, YK; Wang, QL; Zhou, LQ | 1 |
| Gao, YH; Hu, WH; Nie, DH; Wu, Y; Zhang, SP | 1 |
| Bertz, H; Fetscher, S; Finke, J; Lange, W; Waller, CF; Zeiser, R | 1 |
| Bertè, R; Bertini, M; Botto, B; De Paoli, A; Federico, M; Luminari, S; Merli, F; Mozzana, R; Pizzuti, M; Quintana, G; Stelitano, C; Trottini, M | 1 |
| Hotta, T; Tobinai, K | 1 |
| Gao, YH; Gu, DZ; Li, YX; Liu, XF; Qian, TN; Yu, ZH; Yuan, ZY; Zhao, LJ | 1 |
| Erdoğan, S; Ergin, M; Hakverdi, S; Hazar, B; Seyrek, E; Tuncer, I | 1 |
| Aloulou, S; Cainap, C; Carde, P; Chalhoub, B; Fermé, C; Jabbour, E; Ribrag, V; Suzan, F; Toumi, N | 1 |
| Akkoush, H; Bayoumi, Y; Mahmoud, HK; Safwat, A | 1 |
| Aejaz Aziz, S; Ahmad Laway, B; Ahmad, M; Alam Bhat, K; Hamid Zargar, A; Hayat Bhat, M; Iftikhar Bashir, M; Iqbal Wani, A; Shah, A | 1 |
| Buijt, I; Doorduijn, JK; Sonneveld, P; Uyl-de Groot, CA; van Agthoven, M; van der Holt, B | 1 |
| Crawford, J; Dale, DC; Fisher, RI; Friedberg, J; Lyman, GH | 1 |
| Acquatella, G; Carneiro, M; García, R; Gómez, R; Hernández, M; Insausti, CL; Nouel, A; Santos, S | 1 |
| Aoyma, H; Homma, A; Kitahara, T; Nishioka, S; Nishioka, T; Ohmori, K; Shindoh, M; Shirato, H; Tsuchiya, K | 1 |
| Phillips, SW; Porrata, LF; Pruthi, S; Reynolds, CA; Stafyla, VK | 1 |
| Boiocchi, M; Cattarossi, G; Corona, G; Di Gennaro, G; Tirelli, U; Toffoli, G; Vaccher, E | 1 |
| Sun, XF; Wang, ZH; Wang, ZQ; Xia, Y; Zhang, CQ; Zhen, ZJ | 1 |
| Wang, XP; Xie, Y; Yong, WB; Zhang, YT; Zheng, W; Zhu, J | 1 |
| Hayashi, T; Ikeda, T; Katahira, T; Kato, J; Matsunaga, T; Miyanishi, K; Niitsu, Y; Takahashi, Y; Takayama, T; Takimoto, R | 1 |
| Aydin, F; Bektas, O; Kavgaci, H; Ozdemir, F; Yavuz, AA; Yavuz, MN; Yilmaz, M | 1 |
| Feng, FY; Luo, ZG; Wang, QL; Wang, XY; Zhang, P | 1 |
| Gershanovich, ML; Korolenko, VO; Tikhonova, VV | 1 |
| Baek, JH; Kim, DH; Kim, JG; Lee, KB; Park, TI; Sohn, SK | 1 |
| Dreyling, M; Haferlach, T; Hasford, J; Hiddemann, W; Lenz, G; Schiegnitz, E; Unterhalt, M | 1 |
| Rahman, F; Rahman, S; Rahman, W | 1 |
| Chang, JC; Hoefs, JC; Ignatius Ou, SH; Yoon, EJ; Zell, JA | 1 |
| Barulli, S; D'Adamo, F; Guiducci, B; Isidori, A; Leopardi, G; Malagola, M; Malerba, L; Mele, A; Nicolini, G; Piccaluga, PP; Sparaventi, G; Visani, G | 1 |
| Klasa, RJ | 1 |
| Umeda, M | 1 |
| Hotta, T; Ikeda, T | 1 |
| Fujino, H; Hayashi, K; Hirai, M; Hirose, A; Ishii, K; Katsurada, T; Kitajima, H; Kitayama, H; Mugitani, A; Ohta, T; Shigeki, T; Teshima, H; Urase, F; Yagi, T; Yamamoto, Y | 1 |
| Hanaoka, N; Hashiguchi, K; Hatano, B; Inoue, T; Itoh, K; Iwai, A; Kawaguchi, A; Matsuzaki, K; Miura, S; Miyazaki, J; Nagao, S; Okudaira, K; Satoh, S; Tsuzuki, Y; Yamamoto, R | 1 |
| Berthou, C; Casassus, P; Colombat, P; Deconinck, E; Delwail, V; Desablens, B; Foussard, C; Ghandour, C; Gressin, R; Lamy, T; Mahé, B; Maisonneuve, H; Pignon, B; Rachieru, P; Rousselet, MC | 1 |
| Blayney, DW; Cruickshank, SE; Johnson, DH; McGuire, BW | 1 |
| Caracciolo, D; Carlo-Stella, C; Compagno, M; D'Antico, S; De Marco, F; Dell'Aquila, M; Ferrero, D; Ladetto, M; Omedè, P; Ricca, I; Rocci, A; Tarella, C | 1 |
| Younes, A | 1 |
| Bassetti, D; Bassetti, M; Cinelli, R; Cruciani, M; Di Gennaro, G; Gatti, G; Tirelli, U; Vaccher, E | 1 |
| Bernard Hesseling, P; Wessels, G | 1 |
| Bosly, A; Brice, P; Coiffier, B; Ferme, C; Ganem, G; Laurent, G; Lederlin, P; Lepage, E; Molina, TJ; Morel, P; Reyes, F; Tilly, H | 1 |
| Armitage, JO | 2 |
| Frigerio, L; Garavaglia, E; Mangili, G; Montoli, S; Panacci, N; Ponzoni, M; Taccagni, G | 1 |
| Bravo, M; Carmona, L; Heredia, F; Majlis, A; Pierotic, M | 1 |
| Ogura, M | 1 |
| Rao, PS | 1 |
| Kluin, PM; Kluin-Nelemans, HC; Mackenzie, MA; Ossenkoppele, GJ; Schouten, HC; Sonneveld, P; Steijaert, MM; van der Holt, B; van Imhoff, GW; Van't Veer, MB; Verdonck, LF; Wijermans, PW | 1 |
| Harada, M; Hotta, T; Kitamura, K; Masaoka, T; Masuda, M; Matsuda, T; Miura, AB; Miyazaki, T; Mizoguchi, H; Mori, M; Niho, Y; Saito, H; Shibata, A; Takaku, F | 1 |
| Arlet-Suau, E; Astudillo, L; Danjoux, M; Peron, JM; Rigal-Huguet, F; Sailler, L | 1 |
| Avivi, I; Ben Shahar, M; Blumenfeld, Z; Dann, EJ; Epelbaum, R; Haim, N; Rowe, JM | 1 |
| He, YF; Huang, HQ; Jiang, WQ; Li, YH; Li, ZM; Lin, TY; Lin, XB; Sun, XF; Wang, FH; Wang, SS; Xia, ZJ; Yuan, ZY | 1 |
| Davidsen, UH; Johnsen, HE; Klausen, TW; Pedersen, LM | 1 |
| Fenyvesi, T; Jánoskuti, L; Karádi, I; Keltai, K; Pásztor, E; Rosta, A; Sármán, P; Schneider, T; Szücs, S; Zsáry, A | 1 |
| Aversa, SM; Basso, U; Benevolo, G; Bianco, A; Bordonaro, R; Crivellari, G; Crugnola, M; Monfardini, S; Salvagno, L; Torri, V; Vivaldi, P; Zoli, V | 1 |
| Cetinel, M; Ozkok, G; Postaci, H; Vardar, E | 1 |
| Basaran, G; Basaran, M; Onat, H | 1 |
| Ambinder, RF; Cesarman, E; Chadburn, A; Kaplan, LD; Lee, JY; Levine, AM; Scadden, DT; Sparano, JA | 1 |
| Gregory, SA; Trümper, L | 1 |
| Coiffier, B; Reyes, F | 1 |
| Honda, H; Nakamura, K; Ohga, S; Sasaki, T; Shioyama, Y; Terashima, H; Urashima, Y | 1 |
| Tanvetyanon, T | 1 |
| Hinkelbein, W; Hoecht, S | 1 |
| Adli, M; Kalender, ME; Sevinc, A | 1 |
| Bernard, M; Berthou, C; Branger, B; Cartron, G; Cassasus, P; Celigny, PS; Delwail, V; Desablens, B; Ghandour, C; Guyotat, D; Lamy, T; Le Maignan, C; LeMevel, A; Milpied, N; Rachieru, P | 1 |
| Berger, C; Brand, B; Fleisch, F; Reinhart, WH | 1 |
| Costello, RT; de Colella, JM; El Cheikh, J; Moal, V; Vacher-Copponat, H | 1 |
| Asai, O; Dobashi, N; Hagino, T; Kaito, K; Kobayashi, M; Okawa, Y; Osawa, H; Otubo, H; Saito, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yano, S | 1 |
| Buijt, I; Doorduijn, J; Holt, B; Sonneveld, P; Steijaert, M; Uyl-de Groot, C | 1 |
| Al-Kofide, A; Alviedo, C; Belgaumi, AF; Chaudhary, MA; Sabbah, R; Shalaby, L | 1 |
| Dührsen, U; Kasper, C; Müller-Beissenhirtz, H; Nückel, H | 1 |
| Ding, Y; Jiang, WQ; Li, YH; Liang, HZ; Wang, B; Xu, RH; Zeng, J; Zhang, DS; Zhang, XS | 1 |
| Chamorey, E; Delwail, V; Fabbro, M; Foussard, C; Gressin, R; Harrousseau, JL; Lepeu, G; Maisonneuve, H; Peyrade, F; Richard, B; Rossi, JF; Thyss, A; Vilque, JP | 1 |
| Arzberger, H; Boewer, C; Bremer, K; Dachselt, K; Franke, A; Freund, M; Fricke, HJ; Hahnfeld, S; Herold, M; Ismer, B; Klinkenstein, C; Müller, C; Niederwieser, D; Pasold, R; Richter, P; Schirmer, V; Schulze, A; Schulze, M; Schwarzer, A; Weniger, J; Winkelmann, C | 1 |
| Burton, C; Cunningham, D; Hancock, B; Hoskin, P; Linch, D; Qian, W; Smith, P; Vaughan-Hudson, G | 1 |
| Italiano, A; Jardin, F; Peyrade, F; Saudes, L; Thyss, A; Tilly, H | 1 |
| Enschede, SH; Gregory, SA; Porter, C; Venugopal, P | 1 |
| Chakravarti, A; Leslie, WT; Venugopal, P | 1 |
| Fisher, RI | 4 |
| Burkhardt, B; Mann, G; Niggli, F; Oschlies, I; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Zimmermann, M | 1 |
| Dzhumabaeva, BT; Frank, GA; Gemdzhian, EG; Gotman, LN; Kaplanskaia, IB; Kravchenko, SK; Kremenetskaia, AM; Shavlokhov, VS; Vishnevskaia, ES | 1 |
| Arts, K; Brandwein, J; Crump, M; Dotten, DA; Foote, M; Franssen, E; Routy, JP; Sawka, CA; Shepherd, FA; St-Louis, J; Taylor, M; Walker, IR | 1 |
| Baars, JW; Bron, D; Carde, P; Kluin-Nelemans, HC; Meerwaldt, JH; Moser, EC; Noordijk, EM; Raemaekers, JM; Thomas, J; Tirelli, U; van Glabbeke, M | 1 |
| Czuczman, M; Fisher, RI; Grillo-Lopez, A; Grossbard, ML; Link, BK; Vose, JM | 1 |
| Hino, M; Nakamae, H; Nakamae, M; Nakane, T; Ohta, K; Terada, Y; Tsumura, K; Yamane, T | 1 |
| Trümper, LH | 1 |
| Balzarotti, M; Ferreri, AJ; Santoro, A; Spina, M; Tirelli, U; Uziel, L | 1 |
| Abate, G; Comella, P; Di Finizio, G; Fiore, M; Zarrilli, D | 1 |
| Konopka, L; Pawelski, S | 1 |
| Bibb, J; Hromas, R; Rabinowitz, I | 1 |
| Advani, SH; Ambulkar, I; Borges, A; Jagannath, P; Kulkarni, B | 1 |
| Bertomeu, V; Fernández, JA; Martínez, S; Morillas, P; Nuñez, D; Quiles, J; Senent, C | 1 |
| Brugiatelli, M; Cervetti, G; Di Renzo, N; Federico, M; Giglio, G; Liberati, AM; Luminari, S; Montanini, A; Spedini, P; Vigliotti, ML | 1 |
| Aranha, FJ; Baldissera, RC; De Souza, CA; Lorand-Metze, I; Maiolino, A; Miranda, EC; Moraes, AA; Nucci, M; Pagnano, KB; Ruiz, MA; Simões, BP; Vigorito, AC | 1 |
| Bahlis, N; Balogh, A; Brown, C; Jones, A; Morris, DG; Russell, JA; Savoie, L; Stewart, DA; Valentine, K | 1 |
| Engel, C; Loeffler, M; Scholz, M | 1 |
| Anagnostopoulos, I; Arasteh, K; Duehrsen, U; Hentrich, M; Huhn, D; Mitrou, P; Schmidt-Wolf, IG; Schuermann, D; Sudeck, H; Weiss, R | 1 |
| Burton, C; Cunningham, D; Dyer, MJ; Hancock, B; Hoskin, P; Jack, A; Linch, D; MacLennan, K; Milligan, D; Mouncey, P; Qian, W; Smith, P; Webb, A | 1 |
| Epure, C; Hagima, N; Ionascu, L; Nan, S; Stefaniu, I | 1 |
| de Wolf-Peeters, C; Eghbali, H; Hagenbeek, A; Hoskin, PJ; Kalmus, J; MacLennan, K; Marcus, R; Monfardini, S; Negrouk, A; Schott, A; Staab-Renner, E; Teodorovic, I; van Glabbeke, M; Vitolo, U | 1 |
| Elbl, L; Jedlicka, F; Navratil, M; Pospisil, Z; Tomaskova, I; Vasova, I; Vorlicek, J | 1 |
| Avritscher, EB; Bekele, BN; Cooksley, CD; Elting, LS; Jones, JA; Michelet, M | 1 |
| Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ | 1 |
| Fang, H; Jin, J; Li, YX; Liu, XF; Yao, B; Yu, ZH | 1 |
| He, XH; Li, B; Qin, Y; Shi, YK; Sun, Y; Wang, QL; Yang, JL; Yang, S; Yu, YX; Zhou, LQ | 1 |
| Bu, Q; Guan, ZZ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lin, XB; Pan, ZH; Peng, YL; Wang, FH; Wang, SS; Xia, ZJ | 1 |
| Kanenishi, K; Komoto, D; Monden, T; Nishiyama, Y; Ohkawa, M; Ohno, M; Sasakawa, Y; Satoh, K; Toyama, Y; Yamamoto, Y | 1 |
| Bohlius, J; Engert, A; Hülsewede, H; Kober, T | 1 |
| Artibani, W; Boscolo Berto, R; El Mazloum, R; Fassina, A; Gottardo, F | 1 |
| Corrado, C; Gill, D; Hansen, M; Imrie, K; Jaeger, U; Kuhnt, E; Kvaloy, S; Lehtinen, T; Loeffler, M; López-Guillermo, A; Ma, D; Mendila, M; Milpied, N; Osterborg, A; Pettengell, R; Pfreundschuh, M; Rashford, M; Scheliga, A; Shpilberg, O; Stahel, R; Trneny, M; Trümper, L; Walewski, J; Zinzani, PL | 1 |
| Hancock, BW; Horsman, JM; Hough, R; Thomas, J | 1 |
| Abraham, A; Bairy, O; Blickstein, D; Blumenfeld, Z; Dann, EJ; Elis, A; Lishner, M; Manor, Y; Shpilberg, O; Tevet, A; Yerushalmi, R | 1 |
| Chiba, S; Igaki, H; Izutsu, K; Kurokawa, M; Nakagawa, K; Nakamura, N; Ohtomo, K; Shiraishi, K; Tago, M; Yamashita, H | 1 |
| Avilés, A; Cleto, S; Huerta-Guzman, J; Nambo, MJ; Neri, N | 1 |
| Chaloupka, V; Elbl, L; Jedlicka, F; Krejcí, M; Mayer, J; Navrátil, M; Tomásková, I; Vásová, I; Vorlícek, J | 1 |
| Shipp, M | 1 |
| Alexandroff, A; Meggit, SJ; Reynolds, NJ; Wahie, S | 1 |
| Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Sun, YT; Wang, SL; Wang, WH; Yao, B; Yu, ZH | 1 |
| Bai, CM; Chen, SC; Liu, XL; Shen, T; Xü, Y; Yang, T; Zhang, W; Zhu, YL | 1 |
| Chaloupka, V; Elbl, L; Jedlicka, F; Navrátil, M; Tomásková, I; Vásová, I; Vorlícek, J | 1 |
| Dabbas, B; Ford, CD; Gabor, F; Morgan, R | 1 |
| Bhatla, DM; Hariprasad, R; Kukreja, M; Kumar, L; Papaiah, S | 1 |
| Han, L; Wang, WL; Wen, XP | 1 |
| Berman, N; Boswell, WD; Buchanan, LH; Dharmapala, D; Espina, BM; Gee, C; Levine, AM; Nathwani, BN; Sherrod, A; Smith, DL; Tulpule, A; Welles, L | 1 |
| Seymour, JF; Stern, CJ | 1 |
| Smith, S | 1 |
| Decker, M; Holländer, G; Rochlitz, C; Rothermundt, C; Tichelli, A | 1 |
| Aulitzky, WE; Beck, J; Betticher, DC; Cerny, T; Cina, S; Cogliatti, SB; Dyer, MJ; Kaiser, U; Kaufmann, M; Kovascovics, T; Linch, DC; Maibach, R; Martinelli, G; Radford, JA; von Rohr, A | 1 |
| Lokich, JJ | 1 |
| Babu Rao, V; Farah, J; Ghosh, K; Kerketta, L; Madkaikar, M | 1 |
| Bunworasate, U; Intragumtornchai, T; Nakorn, TN; Rojnuckarin, P | 1 |
| Dalekos, GN; Daponte, A; Gioti, C; Ioannou, M; Kallitsaris, A; Messinis, IE | 1 |
| Huh, J; Jeong, YP; Kim, S; Kim, SB; Kim, SW; Ko, OB; Koo, JE; Lee, D; Lee, JL; Park, SH; Suh, C | 1 |
| Boehme, V; Kaiser, U; Kloess, M; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S | 1 |
| Miller, TP; Rimsza, L; Spier, CM | 1 |
| Baars, JW; Carde, P; Kluin-Nelemans, HC; Meerwaldt, JH; Moser, EC; Noordijk, EM; Thomas, J; van Glabbeke, M; van Leeuwen, FE | 1 |
| Cammarota, S; Garcia Parra, R; Isimbaldi, G; Maneo, A; Mangioni, C; Maria Pogliani, E; Perego, P; Signorelli, M | 1 |
| Kajdas, L; Krawczuk-Rybak, M; Muszynska-Roslan, K; Sawicka-Zukowska, M; Sonta-Jakimczyk, D; Szczepanski, T | 1 |
| Ballabeni, P; Cerny, T; Fey, M; Hess, U; Laurencet, F; Luthi, JM; Plancherel, C; Rufener, B; Zulian, GB | 1 |
| Anhalt, GJ; Cummins, DL; Meyerle, JH; Mimouni, D; Owens, N; Tzu, J | 1 |
| Connors, JM; Sehn, LH | 1 |
| Arthur, C; Bentley, M; Durrant, S; Herrmann, R; Horvath, N; Lewis, ID; MacMillan, J; Marlton, P; Mrongovius, R; Spencer, A; van Kerkhoven, M; Wolf, M | 1 |
| de Jong, DD; Doorduijn, JK; Kramer, MH; MacKenzie, MA; Notenboom, A; Ossenkoppele, GJ; Sonneveld, P; van Imhoff, GW; Verdonck, LF; Verhoef, GE | 1 |
| Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lu, TX; Xia, YF; Xian, CG; Zhang, YJ | 1 |
| Li, HX; Lin, TY; Lu, TX; Xia, YF; Xie, FY; Zhang, YJ; Zheng, W; Zou, GR | 1 |
| Arlotta, A; Larocca, LM; Maurizi, P; Riccardi, R; Ruggiero, A | 1 |
| Ali, A; Behani, A; Parvez, T | 1 |
| Omoti, AE; Omoti, CE | 1 |
| Hagenbeek, A; Marcus, R | 1 |
| Gaiger, A; Jaeger, U; Raderer, M; Schett, G; Skrabs, C; Troch, M; Wöhrer, S; Zielinski, CC; Zwerina, J | 1 |
| Inamura, K; Kakuta, K; Matano, S; Munemoto, S; Nishijima, H; Okamura, T; Satoh, S; Sugimoto, T | 1 |
| Chonabayashi, K; Hishizawa, M; Kaneko, H; Okamoto, K; Tsudo, M; Watanabe, M | 1 |
| Bouabdallah, K; Milpied, N | 1 |
| Alvarez Z, M; Bertín C-M, P; Besa de C, P; Bustos C, M; Lira V, P; Ocqueteau T, M; Ramírez V, P | 1 |
| Simonelli, C; Spina, M; Tirelli, U | 1 |
| Gadre, SA; Ge, Y; Lockhart, LH; Northup, JK; Velagaleti, GV | 1 |
| Collins-Burow, B; Santos, ES | 1 |
| Anderson, H; Björkholm, M; Cavallin-Ståhl, E; Hagberg, H; Holte, H; Kvaloy, S; Myhre, J; Nilsson, B; Osby, E; Ost, A; Pertovaara, H; Teerenhovi, L | 1 |
| Bakshi, A; Gujral, S; Gupta, S; Nair, R; Parikh, P; Prabhash, K; Sengar, M | 1 |
| Bellesi, S; d'Alò, F; Di Mario, A; Garzia, M; Massini, G; Rumi, C; Zini, G | 1 |
| Abbas, MM; Balah, AS; Seksaka, MA; Soliman, KB; Wafa, S | 1 |
| Barczyński, M; Buziak-Bereza, M; Cichoń, S; Gołkowski, F; Huszno, B; Stefańska, A; Wierzchowski, W | 1 |
| Barcos, M; Canellos, GP; Gockerman, JP; Johnson, J; Peterson, BA; Shipp, MA | 1 |
| Chen, YB; Hochberg, E; Rahemtullah, A | 1 |
| Alami, M; Baaj, M; Hadri, L; Hassikou, H; Homadi, A; Kassmaoui, H; Safi, S; Tabache, F | 1 |
| Inoue, Y; Iwasaki, H; Nakatsuka, S; Soma, T; Tamaki, H; Yamagami, T | 1 |
| Berrut, G; Foussard, C; Frein, D; Josselin, N; Lavigne, C; Moles, MP; Sivova, N | 1 |
| Allen, B; Case, DC; Desch, CE; Fridman, M; Kalman, LA; Mena, RR; Vongkovit, P | 1 |
| Ardolino, G; Nobile-Orazio, E; Terenghi, F | 1 |
| Buck, AK; Dechow, T; Duyster, J; Fend, F; Herrmann, K; Krause, BJ; Meyer zum Büschenfelde, C; Peschel, C; Schöffel, M; Schuster, T; Schwaiger, M; Wester, HJ; Wieder, HA | 1 |
| Halkar, RK; Kost, CB; Reilly, TB; Schuster, DM; Starsiak, MD | 1 |
| Cerno, M; Damiani, D; Fanin, R; Geromin, A; Grimaz, S; Rinaldi, C; Skert, C; Sperotto, A | 1 |
| Gemici, C; Salepci, T | 1 |
| Fujii, M; Kaiga, T; Kanamori, N; Kobayashi, M; Kochi, M; Takahashi, T; Takayama, T | 1 |
| Leithäuser, M; Maruschke, M; Schultz, A; Seiter, H | 1 |
| Avilés, A; Castañeda, C; Cleto, S; Nambo, MJ; Neri, N | 1 |
| Aupérin, A; Bonniaud, G; Bosq, J; Couanet, D; Edeline, V; Fermé, C; Leboulleux, S; Lumbroso, J; Masson, F; Pigneur, F; Ribrag, V; Schlumberger, M; Vanel, D | 1 |
| de Boer, JP; Dijkmans, BA; Lems, WF; Swaneveld, FH; van Vugt, RM | 1 |
| Hatake, K; Terui, Y; Yokoyama, M | 1 |
| Gergely, L; Illes, A; Kiss, E; Ress, Z; Simon, Z; Tarr, T | 1 |
| Belham, M; Blundell, J; Eller, T; Faganello, G; Thaman, R; Wilde, P | 1 |
| Kaplanskaia, IB; Kravchenko, SK; Kremenetskaia, AM; Magomedova, AU; Obukhova, TN; Ryzhko, VV; Samoĭlova, RS; Vorob'ev, AI; Vorob'ev, IA; Zvonkov, EE; Zybunova, EE | 1 |
| Bu, Q; Cai, QQ; Gao, Y; Guan, ZZ; Huang, HQ; Jiang, WQ; Lin, XB; Pan, ZH; Wang, BF; Xia, ZJ; Xu, RH | 1 |
| Asfour, IA; El-Desoky, H; Fayek, M; Hegab, HM; Moussa, MA; Raouf, S; Saleh, R; Soliman, M | 1 |
| Morrison, VA | 1 |
| Koffi, G; Kouakou, B; Ndathz, E; Ndiaye, FS; Sangare, A; Sanogo, I | 1 |
| Hong, XN; Li, J; Peng, LP; Ye, L; Yu, H | 1 |
| Cagirgan, S; Hekimgil, M; Saydam, G; Soyer, NA; Tombuloglu, M; Vural, F | 1 |
| Loeffler, M; Pfreundschuh, M; Schmits, R; Trümper, L; Ziepert, M | 1 |
| Beniwal, P; Garg, S; Gulati, S; Gupta, N; Jhamb, R; Kumar, S; Mishra, D | 1 |
| Ferrandina, G; Gagliardi, ML; Lorusso, D; Pagano, L; Scambia, G | 1 |
| Mortelmans, L; Moulin-Romsee, G; Spaepen, K; Stroobants, S | 1 |
| Fayad, LE; Provencio, M | 1 |
| Carbone, J; Carreño, L; Fernandez-Cruz, E; Muñoz, A; Perez-Fernandez, R; Sabin, P | 1 |
| Liu, L; Zhang, M; Zou, P | 1 |
| Bosly, A; Pettengell, R; Schwenkglenks, M | 1 |
| Ahlbom, A; Anders, A; Andersson, T; Björkholm, M; Eva, O; Magnus, B; Ösby, E; Tomas, A | 1 |
| Li, QC; Qiu, LG; Wang, YF; Yuan, XL; Zhao, YZ; Zou, DH | 1 |
| Blaes, AH; Hui, SK; Lee, CK; Peterson, BA; Santa-Cruz, KS | 1 |
| Deaver, D | 1 |
| Aksoy, S; Aytemir, K; Barista, I; Dincer, M; Erman, M; Harputluoglu, H; Kilickap, S; Sahiner, L; Tokgozoglu, L; Yavuz, B | 1 |
| Delattre, C; Gaxotte, V; Lambert, M; Morell-Dubois, S; Morschhauser, F; Mortier, L; Paccou, J; Piette, F; Terriou, L; Vercambre-Darras, S | 1 |
| Apostolopoulou, M; Hatzitolios, A; Kaiafa, G; Papadopoulos, A; Psomas, E; Savopoulos, C; Tzalokostas, V; Tzellos, TG | 1 |
| Aversa, SML; Bianco, A; Errante, D; Salvagno, L | 1 |
| Ezdinli, EZ; Han, T; Sokal, JE | 1 |
| Caldwell, IW; Montgomery, PR; Peachey, RD | 1 |
| Nuss, DD | 1 |
| Portlock, CS | 2 |
| Rassiga, AL | 1 |
| Klastersky, J | 1 |
| Bouhy, F; Cryns-Lenain, E; Focan, C; Lapière, CM | 1 |
| Cacciola, E; Di Raimondo, F; Giustolisi, R; Guglielmo, P; Milone, G | 1 |
| Haller, DG | 1 |
| Silber, R | 1 |
| Balentine, L; Lynch, SR; Park, CH; Skikne, BS | 1 |
| Anderson, JR; Chilcote, RR; Coccia, P; Exelby, P; Hammond, D; Jenkin, DT; Kersey, J; Kushner, J; Meadows, AT; Siegel, S; Wilson, JF | 1 |
| Auclerc, G; Bernard, J; Brocheriou, C; Chamseddine, N; Desprez-Curely, JP; Jacquillat, C; Khayat, D; Weil, M | 1 |
| Abdullaev, RA; Poddubnaia, IV; Shramko, AF | 1 |
| Coyne, J; Dervan, P | 1 |
| Brynes, RK; Chan, WC; O'Neal, S; Soffer, T; Vogler, WR | 1 |
| Denning, B; Fontana, JA; Knost, JA; Raich, PC; Rogers, JS; Subramanian, VP; Walker, BK | 1 |
| Berliner, S; Hazaz, B; Luria, D; Pecht, M; Pinkhas, J; Santo, M; Shoenfeld, Y; Sidi, Y; Weinberger, A; Zaizov, R | 1 |
| Abdyldaev, RA; Kruglova, GV | 1 |
| Cassady, JR; Levey, R; Weinstein, HJ | 1 |
| Kueh, YK; Rauff, A; Sng, I; Tan, YO | 1 |
| Lipp, K; Prindull, G; van der Meulen, N; Winge, JF | 1 |
| Amaro, A; Beristain, C; Cárdenas, JL; Mancera, VJ; Ramírez, G | 1 |
| Georges, LP; Osburne, RC; Sode, J; Taub, MA | 1 |
| Madewell, BR; Theilen, GH; Weller, RE | 1 |
| Autino, R; Büchi, G; Camaschella, C; Cambrin, GR; Enrico, E; Mazza, U; Saglio, G; Termine, G; Zappala, C | 1 |
| Carbone, A; Galligioni, E; Grigoletto, E; Tirelli, U; Trovo, MG; Veronesi, A; Volpe, R | 1 |
| De Vassal, F; Delgado, M; Dorval, T; Hayat, M; Jasmin, C; Machover, D; Mathe, G; Misset, JL; Musset, M; Ribaud, P; Schwarzenberg, L | 1 |
| Burke, JS; Cohen, JR; Coleman, CN; Rosenberg, SA | 1 |
| Holgado, J; Murias, A; Oliva, H; Rivas, C; Vicente, J | 1 |
| Berard, C; Costello, WG; Ezdinli, EZ; Hartsock, RJ; Silverstein, MN; Sokal, JE | 1 |
| Liffers, R | 1 |
| Deonarine, L; Kemel, S; MacDougall, BK; Weinerman, BH | 1 |
| Akbulut, H; Arican, A; Cay, F; Demirkazik, A; Dinçol, D; Içli, F; Karaoğuz, H | 1 |
| Nimer, SD; Portlock, C; Zelenetz, A | 1 |
| Amadori, S; Avvisati, G; Coluzzi, S; Giovannini, M; Guglielmi, C; Mandelli, F; Martelli, M; Torromeo, C | 1 |
| Andoh, A; Bamba, T; Fujiyama, Y; Hodohara, K; Hosoda, S; Inoue, T; Kitoh, K; Niwakawa, M | 1 |
| Leonard, RC; Mao, JH; Prescott, RJ; White, JM | 1 |
| Anglin, P; Brandwein, JM; Strauss, BA | 1 |
| Akman, N; Bilir, M; Ferhanoğlu, B; Soysal, T | 1 |
| Ambrosetti, A; Cetto, GL; Meneghini, V; Pasini, F; Perona, G; Sabbioni, R; Santo, A; Todeschini, G | 1 |
| Allen, PK; Cabanillas, FF; Fuller, LM; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Swan, F; Tucker, SL; Velasquez, WS | 1 |
| Brittinger, G; Engelhard, M; Engert, A; Fuchs, R; Geiseler, B; Gerhartz, D; Gerhartz, H; Hartlapp, HJ; Haunauske, AR; Huhn, D | 1 |
| Babare, R; Carbone, A; Lazzarini, R; Merola, MC; Monfardini, S; Talamini, R; Tirelli, U; Zagonel, V | 1 |
| Blaise, D; De Laurenzi, A; Goldstone, AH; Laurenzi A [corrected to De Laurenzi, A]; Pearce, R; Proctor, SJ; Sweetenham, JW; Taghipour, G | 1 |
| Byrne, A; Carney, DN; Corbally, N; Dervan, PA; Grogan, L | 1 |
| Björkholm, M; Gahrton, G; Glimelius, B; Hagberg, H; Järnmark, M; Johansson, B; Johansson, H; Juliusson, G; Kimby, E; Löfvenberg, E | 1 |
| Cabanillas, F; Hagemeister, FB; Lee, MS; McLaughlin, P; Pate, O; Rodriguez, MA; Romaguera, J; Sarris, A; Swan, F; Younes, A | 1 |
| Coltman, CA; Dahlberg, S; Fisher, RI; Gaynor, ER; Glick, JH; Grogan, TM; Miller, TP; Mize, EM; Oken, MM | 2 |
| Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U | 1 |
| Considine, N; Corbally, N; Devaney, D; McCann, SR; McShane, D; Molloy, K; O'Briain, DS; O'Riordan, JM | 1 |
| Chisesi, T; Congiu, AM; Contu, A; Coser, P; Porcellini, A; Rubagotti, A; Salvagno, L; Santini, G; Sertoli, MR; Vespignani, M | 1 |
| Ben-Dayan, D; Djaldetti, M; Floru, S; Mittelman, M | 1 |
| Baldini, L; Butti, C; Cassi, E; Ceriani, A; Confalonieri, C; De Paoli, A; Lombardi, F; Montalbetti, L; Pisoni, GB; Scandolaro, L | 1 |
| Lishner, M; Slingerland, J; Sutcliffe, SB; Theresa, C | 1 |
| Allan, SE; Andrade, CA; Carriço, MK; Costa, MA; Dobbin, JA; Froimtchuk, MJ; Gil, RA; Martino, JL; Olivatto, LO; Rabinowits, M | 1 |
| Anderson, JR; Armitage, JO; Bast, M; Bierman, PJ; Bishop, MR; Chan, WC; Vose, JM; Weisenburger, D | 1 |
| Niitsu, N; Umeda, M | 10 |
| DeVita, VT; Duffey, PL; Fisher, RI; Hubbard, SM; Jaffe, ES; Longo, DL; Raffeld, M; Wittes, RE; Young, RC | 1 |
| Johnson, PJ; Lei, KI; Leung, WT | 1 |
| Ben-Bassat, I; Chetrit, A; Ramot, B; Shiff, J; Shpilberg, O | 1 |
| Asano, S | 1 |
| Brittinger, G; Engelhard, M; Heinz, R; Huhn, D; Nerl, C; Parwaresch, R; Siegert, W; Tiemann, M | 1 |
| Brandmaier, R; Brittinger, G; Emmerich, B; Engelhard, M; Gerhartz, HH; Huber, C; Schadek, C; Schlimok, G; Stern, AC; Thiel, E | 1 |
| Wang, QL; Zhang, P; Zhou, LQ | 1 |
| Niitsu, N | 2 |
| Andersen, J; Cassileth, PA; Colgan, J; Glick, J; Gordon, LI; O'Connell, M; Resnick, GD | 1 |
| Fleischmann, T; Molnár, Z; Ringwald, G; Schneider, T; Várady, E | 1 |
| Cooper, I; Laidlaw, CR; Page, FJ; Stone, JM | 1 |
| Baltali, E; Barista, I; Firat, D; Kansu, E; Karaağaoğlu, E; Kars, A; Ozisik, Y; Ruacan, S; Tekuzman, G; Uzunalimoğlu, B | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A | 1 |
| Advani, SH; Dinshaw, KA; Gopal, R; Nair, R; Saikia, TK; Soman, CS | 1 |
| Bertini, M; Botto, B; Freilone, R; Gavarotti, P; Levis, A; Orlandi, E; Orsucci, L; Pini, M; Pizzuti, M; Vitolo, U | 1 |
| Grünewald, T; Jautzke, G; Pohle, HD; Ruf, B; Schürmann, D; Weiss, R | 1 |
| Aasebø, U; Norum, J | 1 |
| Hahn, J; Herndier, B; Kaplan, LD; McGrath, MS; Meeker, TC; Ng, V; Shiramizu, B; Volberding, PA | 1 |
| Brandi, M; De Lena, M; Ditonno, P; Lorusso, V; Marzullo, F; Pellecchia, A; Timurian, A; Ventrella, V | 1 |
| Baccarani, M; Barillari, G; Fanin, R; Silvestri, F; Velisig, M; Virgolini, L; Zaja, F | 1 |
| Amadori, S; Bocchia, M; Falini, B; Fiacchini, M; Martelli, M; Martelli, MF; Mazza, P; Papa, G; Pileri, S; Zinzani, PL | 1 |
| Fujimoto, N; Higuchi, M; Kawamura, M; Kuni-Eda, Y; Kurosawa, M; Maekawa, I; Morioka, M; Ohmura, T; Okabe, M; Suzuki, S | 1 |
| Aydiner, A; Buğra, Z; Meriç, M; Topuz, E | 1 |
| Tobinai, K | 3 |
| Dreger, P; Haferlach, T; Klöss, M; Loeffler, M; Löffler, H; Petersen, B; Schmitz, N | 1 |
| Cruz, JM; Greven, CM; Hurd, DD; Peacock, JE | 1 |
| Bendandi, M; Tura, S; Zinzani, PL | 1 |
| de Ridder, M; Hop, W; Lowenberg, B; Mulder, A; Nieuwenhuis, K; Schouten, H; Sonneveld, P; van der Lelie, H; van Reijswoud, I | 1 |
| Bijnens, L; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Peeters, CD; Pittaluga, S; Somers, R; Teodorovic, I; van Glabbeke, M | 1 |
| Memis, L; Türker, M; Ugar, DA | 1 |
| Soesan, M | 1 |
| Bates, SE; Bryant, G; Fojo, A; Herdt, J; Jaffe, ES; Regis, J; Steinberg, SM; Wilson, WH; Wittes, RE; Zhan, Z | 1 |
| Burke, HB | 1 |
| Mross, K | 1 |
| Fielding, AK; Goldstone, AH; Pearce, RM | 1 |
| Bezwoda, W; Diaz-Maqueo, JC; Erazo Valla, A; Moreno-Nogueira, JA; Morioka, H; Pavlovsky, S; Rastogi, RB; Resegotti, L; Rueckle, H; Somoza, N | 1 |
| Boisvieux, JF; Dreyfus, F; Morice, V; Séroussi, B | 1 |
| Benger, AM; Browman, GP; Bryant-Lukosius, D; Foster, GA; Frank, GL; Leber, BF; Meyer, RM; Samosh, ML; Sternbach, MS; Wilson, WE | 1 |
| Horie, T; Irie, T; Kura, Y; Satoh, Y; Sawada, U; Tsuboi, I | 1 |
| Hryniuk, W | 1 |
| Brower, M; Dudgeon, DJ | 1 |
| Cabanillas, F; Gutterman, JU; Hagemeister, FB; McLaughlin, P; Redman, JR; Rodriguez, MA; Romaguera, JE; Swan, F; Taylor, S; Velasquez, WS | 1 |
| Akagi, T; Hayashi, K; Kawashima, K; Kimura, I; Matsutomo, S; Mizuta, J; Ohnoshi, T; Saito, S; Tagawa, S | 1 |
| Hagemeister, FB | 1 |
| Cheson, BD; Feigal, EG | 1 |
| Almagro, M; Corrales, A; Herranz, MT; Martí, J; Molina, MA; Redondo, E | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Stein, RS; Waits, TM; Wolff, SN | 1 |
| Hayashi, K; Kawashima, K; Kimura, I; Matsutomo, S; Ohnoshi, T; Saito, S; Tagawa, S | 1 |
| Sawada, U | 1 |
| Craig, JI; Cuthbert, RJ; Ludlam, CA | 1 |
| Wu, GQ | 1 |
| Bates, S; Bryant, G; Cheson, BD; Fojo, A; Herdt, J; Jaffe, ES; Kohler, DR; Steinberg, SM; Wilson, WH; Wittes, RE | 1 |
| DeVita, VT; Longo, DL; Young, RC | 1 |
| Chan, TK; Lam, WK; Liang, RH; Ngan, HY | 1 |
| Brody, J; Goh, JC; Kaplan, MH; Koduru, P; Lichtman, SM; Susin, M | 1 |
| Müller, U; Stahel, RA | 1 |
| Hara, A; Niitsu, N; Shirai, T; Umeda, M | 1 |
| Brittinger, G; Engelhard, M; Gerhartz, HH; Huhn, D; Meusers, P; Mueller, P; Musch, R; Schlimok, G; Siegert, W; Wilmanns, W | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Waits, TM | 1 |
| Kaneko, H; Niitsu, N; Shirai, T; Umeda, M | 1 |
| Niitsu, N; Shirai, T; Umeda, M | 1 |
| Bramwell, VH; Burns, BF; Cripps, MC; Gospodarowicz, MK; Meyer, RM; Quirt, IC; Sargeant, AM; Shepherd, LE; Skillings, JR; Weinerman, BH | 1 |
| Endo, T; Hayakawa, H; Kawaguchi, N; Tei, H; Yashima, M | 1 |
| Hovgaard, DJ; Nissen, NI | 1 |
| Bekradda, M; Cazier, A; Culine, S; Devoldère, G; Droz, JP; Farhat, F; Kattan, J; Mounedji-Boudiaf, L; Terrier-Lacombe, MJ | 1 |
| Brandwein, J; Burkes, R; Imrie, KR; Kutas, G; McGeer, A; Quirt, I; Sawka, CA; Shepherd, FA; Warner, E | 1 |
| Cabanillas, F; Cox, J; Dimopoulos, MA; Hess, M; Pugh, W; Sarris, AH; Touroutoglou, N; Younes, A | 1 |
| Kadin, M; Kersey, JH; King, D; Krailo, MD; Meadows, AT; Morse, M; Rosenstock, J; Steinherz, PG; Tubergen, DG | 1 |
| Chang, JY; Hwang, WS; Juan, MT; Sheu, LF | 1 |
| Hunt, S; Johnson, F | 1 |
| Amenedo, M; Brunet, J; de Andres, L; Llanos, M; Lopez, JJ; Pallares, C; Tabernero, J | 1 |
| Carrión, JR; García Arroyo, FR; Salinas, P | 1 |
| Banks, PM; Dahlberg, S; Fisher, RI; Grogan, TM; Miller, TP; Nathwani, BN | 1 |
| Katou, H; Kuwabara, H; Miyaguchi, M; Sakai, S; Sakamoto, H; Yamauchi, A | 1 |
| Ben-Arie, Y; Ben-Shahar, M; Dror, Y; Epelbaum, R; Faraggi, D; Haim, N; Leviov, M | 1 |
| Haak, HL; Hagenbeek, A; Kluin-Nelemans, HC; Raemaekers, JM; Schouten, HC; Sonneveld, P; van Imhoff, GW; van Oers, RH; van Putten, WL; Verdonck, LF | 1 |
| Walker, AM | 1 |
| Makarewicz, R; Swirska, M; Terlikiewicz, J | 1 |
| Jalkanen, S; Joensuu, H; Ristamäki, R; Söderström, KO | 1 |
| Anderson, JR; Cecalupo, AJ; Finlay, JL; Hutchinson, RJ; Kadin, ME; Kjeldsberg, CR; Meadows, AT; Provisor, AJ; Woods, WG | 1 |
| Anderson, JR; Kessinger, A; Vose, J | 1 |
| Burkes, R; Gray, BG; Ichise, M; Kirsh, JC; White, LM | 1 |
| Obrist, R | 1 |
| Battista, C; Bevilacqua, N; Chiurazzi, B; Cocorocchio, E; Esposito, G; Iodice, G; Pacilio, G; Panza, N | 1 |
| Brown, AE; Crown, JP; Gulati, SC; Jurcic, JG; Koll, B; Yahalom, J | 1 |
| Shimoyama, M; Tobinai, K | 1 |
| Dekker, AW; Hordijk, GJ; Ruijs, CD; van Baarlen, J; van Kempen-Harteveld, ML | 1 |
| Jäger, U; Karth, GD; Knapp, S; Tueni, C | 1 |
| Larson, MV; Zighelboim, J | 1 |
| Burkes, R; Chow, W; Crump, M; Davidson, M; Goss, PE; King, M; Myers, R; Poldre, P; Rudinskas, L; Sutton, D | 1 |
| Herrmann, R; Hiddemann, W; Koch, P; Nahler, M; Unterhalt, M | 1 |
| Blijham, G; Hop, W; Michiels, JJ; Mulder, AH; Nieuwenhuis, K; Raemakers, JW; Sonneveld, P; van de Lelie, J; van der Heul, C | 1 |
| Baxter, JD; DiNubile, MJ | 1 |
| Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
| Bokemeyer, C; Kuczyk, M; Poliwoda, H; Schmoll, HJ; Schuppert, F; van Rhee, J | 1 |
| Anderson, K; Freedman, AS; Neuberg, D; O'Day, SJ; Pesek, K; Rabinowe, SN; Robertson, MJ; Soiffer, RJ; Spector, NA; Whelan, M | 1 |
| Birkmann, J; Eschenbach, I; Gropp, C; Holle, R; Köppler, H; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, UE; Zeller, W | 1 |
| Mayet, WJ; Meyer zum Büschenfelde, KH; Orth, T; Störkel, S; Treichel, U | 1 |
| Andersen, JW; Smalley, RV | 1 |
| Levato, D; Levato, L; Manfredi, L; Molica, S; Tucci, L | 1 |
| Koralewski, P; Pawlicki, M; Rolski, J | 1 |
| Oguro, M; Sakai, C; Takagi, T | 2 |
| Bapat, A; Goldberg, J; Goldman, N; Gordon, R; Gryn, J | 1 |
| Hiramatsu, H; Ikeda, Y; Ito, H; Katayama, M; Kondo, M; Kubo, A; Kusano, S; Mikata, S; Uematsu, M | 1 |
| Kaku, K; Kaneko, T; Masaoka, T; Miwa, S; Moriyama, Y; Nakahata, T; Shibata, A; Takahashi, M; Yoshida, Y | 1 |
| Argüello, A; Barrantes, JC; Barrantes, M; García, I; Jiménez, R; Lobo-Sanahuja, F | 1 |
| Ishida, H; Kawachi, S; Kojima, H; Mitsuhashi, S; Nagasawa, T; Ninomiya, H; Ohsaka, A; Shibuya, A; Watanabe, N; Watanabe, T | 1 |
| Golding, R; Hoekstra, OS; Ossenkoppele, GJ; Teule, GJ; van Lingen, A | 1 |
| Gerrits, WB; Haak, HL; Kerkhofs, H; Wijermans, PW | 1 |
| Bellomo, R; Binotto, F; Buda, C; Buda, F; Croatto, T; Duchi, M; La Torre, F; Mandoliti, G; Russo, F; Simon, G | 1 |
| Broekmans, FJ; Schutter, EM; Swartjes, JM; Van der Valk, P | 1 |
| Levin, M; Salloum, E | 1 |
| Ashida, T; Ayabe, T; Maekawa, I; Namiki, M; Shibata, Y; Taruishi, M | 1 |
| Benard, BA; Heimans, JJ; Huijgens, PC; Ossenkoppele, GJ; Postma, TJ | 1 |
| Barnett, MJ; Dhaliwal, HS; Gallagher, CJ; Ganesan, TS; Gregory, W; Johnson, PW; Matthews, J; Richards, MA; Rohatiner, AZ; Whelan, JS | 1 |
| Anhalt, GJ; Berg, WA; Fishman, EK | 1 |
| Dorigo, A; Kwan, YL; Mansberg, R | 1 |
| Ansell, SM; Falkson, G | 1 |
| Clarkson, BD; Fuks, Z; Myers, J; Straus, DJ; Varsos, G; Yahalom, J | 1 |
| Bergeron, C; Chatel, M; Darcel, F; Edan, C; Faivre, J; Jouan, H; Le Moine, P; Le Prise-Fleury, E; Patte, C; Tass, P | 1 |
| Bruno, S; Cerutti, I; Corrado, C; Fernández, I; Magnasco, H; Milone, G; Pavlovsky, S; Saslavsky, J; Somoza, N | 1 |
| Oguro, M; Sakai, C; Sampi, K; Sawada, U; Takagi, T | 1 |
| Chisesi, T | 1 |
| Chase, E; Coltman, C; Dahlberg, S; Dana, BW; Fisher, RI; Miller, TP; Nathwani, BN | 1 |
| Bengala, C; Bonadonna, G; Buzzoni, R; Giardini, R; Lombardi, F; Rocca, A; Tondini, C; Valagussa, P; Zanini, M | 1 |
| Aitini, E; Cajozzo, A; Gentilini, P; Leone, G; Mandelli, F; Papa, G; Rossi, G; Tura, S; Zinzani, PL | 1 |
| Armitage, JO; Vose, JM | 1 |
| Anderson, KC; Freedman, AS; Grossbard, M; Mauch, P; Neuberg, D; Rabinowe, SN; Robertson, MJ; Soiffer, RJ; Spector, N; Takvorian, T | 1 |
| Exelby, P; Filippa, D; Heller, G; Lieberman, P; Lindsley, KL; Wollner, N | 1 |
| Hoshino, M; Izumi, T; Miura, Y; Miwa, A; Muroi, K; Ohtaka, A; Sakamoto, S; Sakata, Y; Shinohara, N; Suzuki, T | 1 |
| Dobashi, N; Hirano, A; Isogai, Y; Kobayashi, T; Kuraishi, Y; Takagi, K | 1 |
| Chott, A; Erlacher, L; Knoflach, B; Kürsten, R; Luger, A; Radaszkiewicz, T; Wagner, A; Zrunek, M | 1 |
| Anderson, JR; Chilcote, RR; Coccia, PF; Exelby, PR; Jenkin, RD; Kjeldsberg, CR; Meadows, AT; Siegel, S; Sposto, R; Wilson, JF | 1 |
| Canellos, GP; Janicek, M; Neuberg, D; Shipp, MA; Shulman, LN | 1 |
| Millo, B; Nowacki, P; Zdziarska, B | 1 |
| Kaźmierczak, M; Komarnicki, M; Kroll, R | 1 |
| Plewicka, M; Smok-Ragankiewicz, A; Szelc, S; Szkita, D; Wojcieszek, A | 1 |
| Andersen, JW; Hines, JD; Mann, R; Mazza, JJ; Neiman, RS; O'Connell, MJ; Oken, MM | 1 |
| Flecknoe-Brown, S | 1 |
| Cajozzo, A; Cantonetti, M; Iannitto, E; Leone, G; Martelli, M; Musso, M; Papa, G; Perrotti, A; Storti, S; Zinzani, PL | 1 |
| Hagenbeek, A; Löwenberg, B; Rutten, FF; Uyl-de Groot, CA; Verdonck, LF | 1 |
| Hovgaard, DJ; Mortensen, BT; Nissen, NI | 1 |
| Briere, J; d'Agay, MF; Diebold, J; Fillet, G; Gaulard, P; Haioun, C; Hermine, O; Lavignac, C; Lepage, E; Marolleau, JP; Reyas, F; Salles, G | 1 |
| Audhuy, B; Blanc, M; Brière, J; Coiffier, B; Diviné, M; Dupriez, B; Herbrecht, R; Lederlin, P; Lepage, E; Mineur, P; Pautier, P; Reyes, F; Tilly, H | 1 |
| Bolognesi, A; Ferreri, AJ; Reni, M; Verusio, C; Villa, E | 1 |
| Cheng, AL | 1 |
| Haggag, M; Rodriguez, JM | 1 |
| Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Frassoldati, A; Gobbi, PG; Lombardo, M; Pieresca, C; Silingardi, V; Vallisa, D | 1 |
| Ben-Arieh, Y; Ben-Shahar, M; Epelbaum, R; Freidin, N; Haim, N; Leviov, M; Reshef, R | 1 |
| Burkes, R; Chow, W; Crump, M; Davidson, M; Goss, P; King, M; Myers, R; Poldre, P; Rudinskas, L; Sutton, D | 1 |
| Bloom, AI; Maayan, S; Moses, AE; Okon, E; Polliack, A; Rahav, G; Zimmerman, J | 1 |
| Dobbs, HJ; Lakhani, A; Mijovic, A; Mufti, GJ; Nethersell, A; Pettingale, KW; Samaratunga, IR; Singer, JM | 1 |
| Gaarsdal, E; Hansen, NE; Hansen, PB; Jensen, L; Johnsen, HE; Ralfkiaer, E | 1 |
| Fuzimoto, N; Higuchi, M; Itaya, T; Kawamura, M; Maekawa, I; Morioka, M; Nishi, K; Ohmura, T; Okabe, M; Suzuki, S | 1 |
| Boj, E; Siekierska-Hellmann, M; Sworczak, K | 1 |
| Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Jaffe, E; Magrath, I; Neely, J; Nieder, M; Seibel, N; Shad, A; Venzon, D; Wittes, RA | 1 |
| Bezwoda, WR; Dansey, R | 1 |
| Pfreundschuh, M; Trümper, L | 2 |
| Bairey, O; Blickstein, D; Hadar, H; Lahav, M; Prokocimer, M; Shaklai, M; Shaklai, S; Sulkes, J | 1 |
| Calabresi, F; De Sanctis, V; Fiacchini, M; Gherlinzoni, F; Mandelli, F; Martelli, M; Martelli, MF; Meloni, G; Papa, G; Tura, S; Vignetti, M; Zinzani, PL | 1 |
| Bijnens, L; De Wolf-Peeters, C; Hagenbeek, A; Meerwaldt, JH; Noordijk, EM; Pittaluga, S; Somers, R; Teodorovic, I; Thomas, J | 1 |
| Furusawa, S; Hatake, K; Hoshino, Y; Izumi, T; Komatsu, N; Miura, Y; Muroi, K; Ohtsuki, T; Tomizuka, H; Yamada, M | 1 |
| Kisseberth, WC; London, CA; MacEwen, EG; Moore, FM; Obradovich, JE; Ritter, MA; Vail, DM | 1 |
| Anderson, J; Cassileth, P; Glick, J; Gordon, LI; Habermann, TM; Schilder, RJ; Winter, JN | 1 |
| Bergmann, L; Hoelzer, D; Karakas, T; Knuth, A; Lautenschläger, G; Mitrou, PS | 1 |
| Anderson, NR; Lokich, JJ; Moore, CL | 2 |
| Auger, J; Bendahmane, B; Decaudin, D; Koscielny, S; Munck, JN; Naccache, P | 1 |
| Anderson, L; Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; MacLennan, KA; Milligan, DW; Newland, AC; Stevenson, PA; Vaughan Hudson, B; Vaughan Hudson, G; Wood, JK | 1 |
| Hoederath, A; Lampka, E; Sack, H; Stuschke, M | 1 |
| Gould, AR; Kushner, GM; Steiner, M; Weber, R; Windchy, A | 1 |
| Leccisotti, A; Polito, E | 1 |
| Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M | 1 |
| Buras, RR; Chorny, V; Evans, SR; Korobko, V; Nauta, RJ; Shabahang, M; Shchepotin, IB; Zadorozhny, A | 1 |
| Avilés, A; de la Torre, A; Delgado, S; Guzman, R; Ruiz, H; Talavera, A | 1 |
| Bergmann, L; Hoelzer, D; Jager, E; Karakas, T; Knuth, A; Lautenschlager, G; Mitrou, PS | 1 |
| Breda, E; Pauselli, F; Temperilli, L | 1 |
| Hannda, H; Hirayama, A; Kohno, M; Koike, T; Sato, N; Sawada, KI; Tanngo, M; Yasukouchi, T | 1 |
| Feliu, E; Gómez-Espuch, J; Navarro, JT; Ribera, JM | 1 |
| Fisher, RI; Gaynor, ER | 2 |
| Okamoto, S; Tanosaki, R | 1 |
| Hatake, K; Imagawa, S; Izumi, T; Kuriki, K; Miura, Y; Muroi, K; Ogawa, Y; Ohtsuki, T; Ohya, K; Saito, K; Yoshida, M | 1 |
| Alvarez, M; Bates, SE; Chabner, B; Fojo, AT; Hose, C; Kang, YK; Monks, A; Regis, J; Robey, R; Wilson, WH; Zhan, Z | 1 |
| Burney, IA; Malik, IA | 1 |
| Alterini, R; Bellesi, G; Bernardi, F; Di Lollo, S; Ferrini, PR; Fusco, II; Innocenti, F; Longo, G; Rigacci, L; Stefanacci, S | 1 |
| Callao, V; Esquerda, A; Gomez, X; Macia, J; Marzo, C; Perez, B | 1 |
| Aviles, A; Duque, G; Guzman, R; Talavera, A | 1 |
| Ang, PT; Li, Q | 1 |
| Fujisawa, S; Fukawa, H; Hattori, M; Kanamori, H; Kodama, F; Maruta, A; Motomura, S; Mouri, H; Okubo, T; Sakai, R; Taguchi, J; Tanabe, J; Tomita, N | 1 |
| al-Mulhim, FA; al-Nabhan, AA; Bunyan, RF; Ibrahim, EM; Ibrahim, RE | 1 |
| Bertini, M; Botto, B; Cinieri, S; Ciotti, R; Di Nota, A; Di Vito, F; Freilone, R; Levis, A; Orsucci, L; Pini, M; Resegotti, L; Rota-Scalabrini, D; Todeschini, G; Vitolo, U | 1 |
| Carletti, S; Frondizi, D; Maira, G; Mastronardi, L; Spera, C | 1 |
| Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC | 1 |
| Del Campo, F; Dominguez-Franjo, P; Garcia-Suarez, J; Herrero, B; Munoz, MA; Pardo, A; Piris, MA | 1 |
| Andersen, J; Bauer, KD; Fisher, RI; Gordon, LI; Jiang, S; Neiman, RS; Oken, MM; Variakojis, D; Winter, JN | 1 |
| Avivi, I; Ben-Shahar, M; Blumenfeld, Z; Epelbaum, R; Haim, N; Linn, S | 1 |
| Kidd, P; Quien, ET; Saidi, P; Sandhaus, L; Strair, R; Wallach, B | 1 |
| Alberto, P; Anchisi, S; Dietrich, PY; Laurencet, FM; Mermillod, B; Zulian, GB | 1 |
| Bidoli, E; Comar, M; D'Andrea, M; De Paoli, P; Giacca, M; Simonelli, C; Tirelli, U; Vaccher, E; Zanussi, S | 1 |
| Bieger, R; Haanen, JB; van't Wout, JW | 1 |
| Falkson, CI; Nel, JS | 1 |
| Denk, R; Falk, S; Walther, F | 1 |
| Alcalá, A; Bladé, J; Estapé, J; Faura, MV; Fontanillas, M; García-Conde, J; Hernández-Nieto, L; Llorente, A; López-Guillermo, A; Maldonado, J; Montserrat, E; Viñolas, N; Zubizarreta, A | 1 |
| Bosq, J; Carde, P; Cosset, JM; Decaudin, D; Dhermain, F; Girinsky, T; Hayat, M; Juliéron, M; Koscielny, S; Munck, JN | 1 |
| Aguiló, J; García, F; Gómez, A; Grau, E; Ibáñez, JL; Mirabet, MD; Pastor, E; Perella, M | 1 |
| Bergmann, L; Hoelzer, D; Jäger, E; Karakas, T; Knuth, A; Mitrou, PS; Stutte, HJ; Weidmann, E | 1 |
| Gomi, K; Izuno, I; Oguchi, M; Sasaki, S; Shikama, N; Sone, S; Takei, K | 1 |
| Albrecht, H; Greten, H; Stellbrink, HJ | 1 |
| Avanzini, P; Baldini, L; Cavanna, L; Colombi, M; Federico, M; Gobbi, P; Guffanti, A; Maiolo, AT; Pieresca, C; Silingardi, V | 1 |
| Bergström, SR; Glimelius, BL; Nyman, RS; Rehn, SM; Rodriguez, M | 1 |
| Kiene, J; Klempa, I; Rasche, H; Sezer, O | 1 |
| Devaja, O; Pambakian, H; Papadopoulos, AJ; Raju, KS; Tiptaft, R | 1 |
| Amiot, L; Caulet-Maugendre, S; Diebold, J; Drénou, B; Fardel, O; Fauchet, R; Lamy, T; Le Prisé, PY; Sasportes, M | 1 |
| Brockmeyer, NH; Mertins, L; Pohl, G | 1 |
| Abd El-Warith, A; Berry, J; Ezzat, AA; Khan, BA; Raja, MA; Rhydderch, DC | 1 |
| Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L | 1 |
| Başkal, N; Colak, T; Ekinci, C; Erdoğan, G; Güllü, S; Kamel, AN | 1 |
| Capochiani, E; Caracciolo, F; Papineschi, F; Petrini, M | 2 |
| Dabek, A; Swierz, J; Zieliński, H | 1 |
| Barai, U; Teoh, N | 1 |
| Bardou, VJ; Blaise, D; Bouabdallah, R; Camerlo, J; Chabannon, C; Di Stefano, D; Gastaut, JA; Maraninchi, D; Novakovitch, G; Resbeut, M; Stoppa, AM; Vey, N; Xerri, L | 1 |
| Connors, JM; Gascoyne, RD; Klimo, P; Lee, AY; O'Reilly, SE | 1 |
| Aitini, E; Bendandi, M; Falini, B; Fattori, PP; Gentilini, P; Gherlinzoni, F; Gobbi, M; Guardigni, L; Lauta, VM; Leone, G; Liso, V; Magagnoli, M; Moretti, L; Pavone, E; Storti, S; Tabanelli, M; Tura, S; Venturi, S; Zinzani, PL | 1 |
| Jingu, K; Kunitake, N; Masuda, K; Nakamura, K; Omagari, J; Uehara, S | 1 |
| Adachi, M; Aoki, S; Hayashi, T; Hinoda, Y; Imai, K; Kobayashi, T; Mihara, M; Mori, M; Shimizu, H; Takahashi, T; Tsujisaki, M; Tsukuda, H | 1 |
| Hirayama, S; Koike, T; Koizumi, K; Natoya, A; Sato, N; Sawada, K; Sekiguchi, S; Takahashi, TA; Takano, H; Tarumi, T | 1 |
| Anderson, L; Linch, DC; Vaughan Hudson, B; Vaughan Hudson, G | 1 |
| Bijnens, L; Bron, D; Carde, P; Cosset, JM; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Somers, R; Teodorovic, I; Thomas, J | 1 |
| Cooper, IA; Fox, RM; Matthews, JP; Robertson, TI; Stone, J; Wolf, M | 1 |
| Bernengo, MG; Doveil, GC; Fierro, MT; Quaglino, P; Savoia, P; Verrone, A | 1 |
| Canellos, GP; Janicek, M; Kaplan, W; Neuberg, D; Shipp, MA; Shulman, LN | 1 |
| Kamieńska, E | 1 |
| Bendandi, M; Gherlinzoni, F; Magagnoli, M; Merla, E; Tura, S; Zinzani, PL | 1 |
| Hachiya, T; Harada, T; Hayano, T; Honda, T; Kaneki, T; Kawashima, A; Koizumi, T; Kubo, K; Maruyama, Y; Sekiguchi, M | 1 |
| Ohnishi, K | 1 |
| Kaminski, MS; Lok, AS; Shehab, TM | 1 |
| Bastion, Y; Blanc, M; Blay, JY; Bordessoule, D; Brice, P; Brière, J; Coiffier, B; Deconinck, E; Divine, M; Dumontet, C; Lederlin, P; Salles, B; Sebban, C; Tilly, H | 1 |
| O'Meara, Y; Obrador, GT; Price, B; Salant, DJ | 1 |
| Bayle, C; Corti, C; Cosset, JM; Girinsky, T; Hayat, M; Nasr, F; Ribrag, V; Rougier, P; Theodore, C | 1 |
| Bailey, NP; Barnard, D; Child, JA; Cullen, MH; Earl, H; Fletcher, J; Smith, GM; Woodruffe, CM | 1 |
| Fuse, H; Hirano, S; Ito, H; Masuda, S; Takeshima, M | 1 |
| Chang, WW; Hostetter, RB; Maymind, M; Mergelas, JE; Seibert, DG | 1 |
| Hoppe, RT; Mac Manus, MP | 1 |
| Berard, CW; Donaldson, SS; Link, MP; Murphy, SB; Shuster, JJ | 1 |
| Kato, J; Kawanishi, J; Kogawa, K; Niitsu, Y; Ohya, M; Sakamaki, S; Sato, T | 1 |
| Cassileth, P; Cooper, BW; Fernandez, H; Kutteh, L; Lazarus, HM; Miller, KB; Morelli, J; Pecora, AL; Roitman, D; Schenkein, DP; Stadtmauer, E | 1 |
| Kuma, K; Matsuzuka, F | 1 |
| Escandon, J; Gómez, A; Grau, E; Pastor, E; Perella, M; Real, E | 1 |
| Cario, E; Goebell, H; Layer, P; Metz, K; Rünzi, M | 1 |
| Feng, F; He, X; Zhou, L | 1 |
| Bertoni, F; Capella, C; Cavalli, F; Morandi, E; Pascarella, A; Pedrinis, E; Pinotti, G; Roggero, E; Saletti, P; Santandrea, G; Savio, A; Savio, E; Zucca, E | 1 |
| Goeser, T; Gutzler, F; Kallinowski, B; Möhler, M; Stremmel, W | 1 |
| Joensuu, H; Muhonen, T; Ristamäki, R; Teerenhovi, L; Villikka, K | 1 |
| North, C; Sitzia, J; Stanley, J; Winterberg, N | 1 |
| Avilés, A; Díaz Maqueo, JC; Garcia, EL; Huerta-Guzman, J; Nambo, MJ; Talavera, A | 1 |
| Andersen, N; Anderson, KC; Aster, J; Fisher, DC; Freedman, AS; Gribben, JG; Kroon, M; Mauch, P; Nadler, LM; Neuberg, D; Ritz, J; Schlossman, R; Soiffer, RJ | 1 |
| Bron, D; Errante, D; Kluin-Nelemans, JC; Noordijk, EM; Rosti, G; Somers, R; Teodorovic, I; Thomas, J; Tirelli, U; Van Glabbeke, M; Zagonel, V | 1 |
| Carde, P; De Bock, R; De Wolf-Peeters, C; Hagenbeek, A; Meerwaldt, JH; Raemaekers, JM; Somers, R; Thomas, J; van Glabbeke, M; van Hoof, A | 1 |
| Ben-Shahar, M; Blumenfeld, Z; Haim, N; Ritter, M; Shariki, K; Shen-Orr, Z | 1 |
| McNeil, C | 1 |
| Baccarani, M; Cerno, M; Damiani, D; Fanin, R; Geromin, A; Infanti, L; Rinaldi, C; Savignano, C; Silvestri, F; Sperotto, A; Stocchi, R | 1 |
| Aydin, F; Ovali, E; Ulusoy, S | 1 |
| Goto, S; Kumagai, K; Nakaseko, C; Sakai, C; Takagi, T | 1 |
| Camoriano, JK; Habermann, TM; Kurtin, PJ; Schroeder, G; Witzig, TE | 1 |
| Brice, P; Cazals, D; Deconinck, E; Doyen, C; Gisselbrecht, C; Hamelsand, J; Molina, T; Moulonguet, I; Mounier, N; Neidhart-Berard, AM; Remenieras, L; Verola, O | 1 |
| Burton, GV; Cain, MS; Holcombe, RF | 1 |
| Kuse, R; Sonnen, R | 1 |
| Hiraoka, A; Kageyama, T; Kanamaru, A; Niitsu, N; Ogawa, M; Shishido, T; Taguchi, H | 1 |
| Agnes, A; Zieren, HU; Zippel, K | 1 |
| Chapman, R; Grigg, A; Szer, J | 1 |
| Albertini, P; Ascani, S; Bendandi, M; Buzzi, M; Gherlinzoni, F; Magagnoli, M; Pileri, S; Sabattini, E; Tura, S; Zinzani, PL | 1 |
| Fujii, H; Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakagawa, H; Nakao, M; Nakazawa, N; Ookawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S | 1 |
| Bienvenu, J; Charlot, C; Coiffier, B; Ribeiro, P; Rigal, D; Roy, P; Salles, G; Warzocha, K | 1 |
| Arranz, R; Barón, MG; Carrión, R; Colomer, R; Fernández-Rañada, JM; Flores, E; García-Alfonso, P; García-Laraña, J; Lavilla, E; López, J; Lozano, M; Pérez, G; Pérez-Manga, G; Rayón, C; Sobrino, P; Zamora, P | 1 |
| Nowrousian, MR; Stuschke, M | 1 |
| Busch, M; Freund, M; Hanrath, RD; Helm, G; Herrmann, R; Hiddemann, W; Kaiser, U; Kreuser, ED; Middeke, H; Neubauer, A; Parwaresch, R; Reuss-Borst, M; Stein, H; Terhardt-Kasten, E; Tiemann, M; Trümper, L; Unterhalt, M; Wöltjen, HH | 1 |
| Cadeo, G; Carosi, G; Casari, S; Donisi, A; Re, A; Rossi, G; Stellini, R | 1 |
| Asai, O; Dobashi, N; Kato, A; Katori, M; Kobayashi, T; Kuraishi, Y; Nagamine, M; Tajima, N; Usui, N; Watanabe, H; Yamazaki, H; Yano, S | 1 |
| Bairey, O; Blickstein, D; Epstein, O; Gabbay, U; Lahav, J; Prokocimer, M; Shaklai, M; Stark, P | 1 |
| Kist-Van Holthe, JE; Ten Harkel, AD; Van der Vorst, MM; Van Weel, M | 1 |
| Carracedo, C; Casanova, L; Colomer, R; Cortés-Funes, H; Gómez, H; Hidalgo, M; Otero, J; Pen, DL; Rodríguez, W; Vallejos, C | 1 |
| Begleiter, A; Johnston, JB; Mowat, MR; Navaratnam, S; Pettigrew, NM; Rubinger, M; Williams, GJ | 1 |
| Inoue, K; Kimura, T; Kishimoto, T; Kubota, T; Matsunashi, T; Miyake, S; Nakagawa, M; Ogawa, H; Oji, Y; Sasaki, K; Soma, T; Sugiyama, H; Tani, Y; Tatekawa, T; Yamagami, T | 1 |
| Urasiński, I; Wichert, K; Zdziarska, B; Zuk, E | 1 |
| Bogomolski-Yahalom, V; Lossos, A; Lossos, IS; Okun, E; Polliack, A; Sherman, Y | 1 |
| Adelstein, DJ; Carlin, S; Cassady, JR; Chase, E; Dahlberg, S; Fisher, RI; Grogan, TM; LeBlanc, M; Miller, TP; Spier, CM | 1 |
| Cosset, JM | 1 |
| An, E; Dan, K; Kamikubo, K; Kudoh, S; Nakamura, K; Nomura, T; Ogata, K; Tamura, H; Yokose, N | 1 |
| Colomer, R; Gómez, H | 1 |
| Cabanillas, F; Dong, K; Hagemeister, FB; McLaughlin, P; Moon, T; Rodriguez, MA; Rodriguez-Diaz Pavón, J; Romaguera, JE | 1 |
| Alcalá, A; Alvarez-Carmona, AM; Besses, C; Carbonell, F; Contreras, E; Fontanillas, M; García-Conde, J; Hernando, A; León, P; López-Guillermo, A; Maldonado, J; Montserrat, E; Sancho-Tello, R; Zubizarreta, A | 1 |
| Akiba, H; Harabuchi, Y; Hareyama, M; Hinoda, Y; Hirokawa, N; Kataura, A; Koito, K; Morita, K; Nagakura, H; Oouchi, A; Sakata, K; Satoh, M; Tamakawa, M | 1 |
| Carracedo, C; Casanova, L; Gómez, H; Mas, L; Otero, J; Pen, DL; Rodriguez, W; Santillana, S; Valdivia, S; Vallejos, C | 1 |
| Bulabois, CE; Colombat, P; Dupas, B; Harousseau, JL; Juge-Morineau, N; Mahé, B; Milpied, N; Moreau, A; Moreau, P; Rapp, MJ; Voillat, L | 1 |
| Catovsky, D; Killick, S; Matutes, E; Sternberg, AJ; Wotherspoon, AC | 1 |
| Airoldi, M; Albanese, F; Fazio, M; Gariboldi, A; Mastromatteo, V; Negri, L; Pecchio, F | 1 |
| Centurioni, R; Chisesi, T; Congiu, AM; Contu, A; De Souza, C; Guarnaccia, C; Leoni, P; Majolino, I; Mangoni, L; Nati, S; Olivieri, A; Pescosta, N; Porcellini, A; Rizzoli, V; Rossi, E; Rubagotti, A; Salvagno, L; Santini, G; Sertoli, MR; Soracco, M; Spriano, M; Tedeschi, L; Vespignani, M; Vimercati, R; Zambaldi, G | 1 |
| Caplan, SN; Gyger, M; Langley, R; Lespérance, B; Meyer, RM | 1 |
| Bennett, JM; Glick, JH; Harris, JE; Luger, S; Moore, DF; Oken, MM; Vogl, SE; Wiernik, PH | 1 |
| Imamura, M; Ito, H; Kamada, K; Mitsuoka, S; Nakao, A; Sakagami, K; Uda, M | 1 |
| Nakayama, M; Niitsu, N; Umeda, M; Yamazaki, J | 1 |
| Baro, J; Conde, E; Cuadrado, MA; Gandarillas, MA; Garijo, J; Iriondo, A; Mazorra, F; Recio, M; Richard, C; Zubizarreta, A | 1 |
| Campo, E; Cervantes, F; Esteve, J; Montserrat, E; Rafel, M; Serra, A; Velasco, M | 1 |
| Bando, K; Hasegawa, Y; Ohyama, S; Shirayma, H; Taniguti, M | 1 |
| Botto, F; Lionetto, R; Pensa, F; Pronzato, P; Tognoni, A | 1 |
| Colombat, P; Solal-Céligny, P | 1 |
| Ichinohasama, R; Ishikawa, I; Ito, S; Kadowaki, I; Kameoka, J; Kimura, J; Meguro, K; Miura, I; Ooya, K; Sasaki, O; Takahashi, S; Tanaka, M; Tomiya, Y; Yamada, M | 1 |
| Krulik, M; Renou, P | 1 |
| Ben-Bassat, I; Chetrit, A; Dreiher, J; Raamami, P; Raanani, P; Shpilberg, O | 1 |
| Avanzini, P; Baldini, L; Brugiatelli, M; Carotenuto, M; Clò, V; Di Renzo, N; Dini, D; Federico, M; Gobbi, PG; Lombardo, M; Silingardi, V; Vallisa, D | 1 |
| Bigazzi, C; Bocchia, M; Forconi, F; Lauria, F; Marotta, G | 1 |
| Miller, TP | 1 |
| Cawley, M; Kaplan, B; Narasihman, P; Taha, HM; Venkatesh, L | 1 |
| Hirai, H; Kami, M; Machida, U | 1 |
| Antonopoulos, MJ; Kosmas, C; Malamos, NA | 1 |
| Gisselbrecht, C; Lepage, E; Mounier, N | 1 |
| Decaudin, D | 1 |
| Hirayama, A; Ishigaki, S; Nobuoka, A; Sato, T; Takada, K; Takayama, T | 1 |
| Bernell, P; Björkholm, M; Celsing, F; Grimfors, G; Hedlund, A; Liliemark, J; Merk, K; Osby, E; Svedmyr, E; Widell, S | 1 |
| Guo, XM; Li, JX; Yang, XF | 1 |
| Azaceta, G; Gutierrez, M; Palomera, L; Soria, J; Varo, MJ | 1 |
| Dobashi, N; Kuraishi, Y; Usui, N | 1 |
| Ohnishi, K; Ohno, R | 1 |
| Brozetti, JJ; Dragoo, RA; Enzenauer, RW | 1 |
| Anhalt, GJ; Jonkman, MF; Nieboer, C; Pas, HH; Schulten, EA; van der Waal, RI | 1 |
| Mora, J; Wollner, N | 1 |
| Canaday, DJ; Stadtmauer, EA; Tsai, DE; Vaughn, DJ | 1 |
| Bernacer Borja, M; Contra Gómez, T; Gil López, C; López Pérez, J; Martín Ramos, N; Melero Moreno, C; Palacios López, ME; Torres Valdivieso, MJ; Valverde Moreno, F; Vivanco Martínez, JL | 1 |
| Acar, A; Acar, H; Bulay, O; Ecirli, S; Gündoğan, F | 1 |
| Hanai, M; Horie, T; Irie, T; Kaneita, Y; Kura, Y; Mochimaru, J; Sato, Y; Sawada, U; Yamazaki, T; Yasukawa, K | 1 |
| Hara, K; Shimizu, K; Yatabe, Y | 1 |
| Dalay, N; Inanc, S; Onat, H; Saip, P; Yalcinkaya, L; Yazici, H | 1 |
| Brown, LD; Colgan, JD; Earle, JD; Krigel, RL; McGinnis, WL; O'Fallon, JR; O'Neill, BP; Wang, CH | 1 |
| Ben-Yehuda, D; Lossos, IS | 1 |
| Bremnes, RM; Bremnes, Y; Dønnem, T | 1 |
| Cabanillas, F; Fayad, L; Hagemeister, FB; Hess, M; McLaughlin, P; Rodriguez, J; Rodriguez, MA; Romaguera, J; Santiago, M | 1 |
| Halcox, JP | 1 |
| Alberto, P; Betticher, DC; Guetty-Alberto, M; Iten, PA; Laurencet, FM; Zulian, GB | 1 |
| Beggs, I; Jamieson, KA; Robb, JE | 1 |
| el-Hakim, H; Nunez, DA | 1 |
| Antinori, A; Del Borgo, C; Del Forno, A; Fantoni, M; Ottaviani, F; Turriziani, A | 1 |
| Hagenbeek, A; Huijgens, PC; Sonneveld, P | 1 |
| Peters, FP; Schouten, HC; Ten Haaft, MA | 1 |
| Okumura, H | 1 |
| Kashimura, M; Mori, M; Murai, Y; Muto, Y; Nonaka, Y; Sato, H; Suzuki, K; Takagi, T; Tomiyama, J | 1 |
| Chim, CS; Kwong, YL; Lee, CK; Liang, R; Lie, AK | 1 |
| Barnett, M; Connors, JM; Gascoyne, RD; Horsman, D; Klasa, R; Lesack, D; Macpherson, N | 1 |
| Ariyoshi, K; Kameda, N; Kamei, T; Katsuki, K; Shinohara, K; Takeda, K; Yamada, T | 1 |
| Akiyama, J; Fukushima, K; Hayashi, S; Masaki, N; Matsukawa, M; Muraoka, R; Shimojo, E; Shoda, R; Togawa, A; Umeda, N; Yamato, S | 1 |
| Kamath, SS; Lynch, JW; Marcus, RB; Mendenhall, NP | 1 |
| Brocchieri, A; Grignani, G; Maiolo, A; Merlo, EM; Tua, A | 1 |
| Jockenhövel, F; Kummer, G; Mann, K; Philipp, T; Reinhardt, W; Reinwein, D; Sauter, V; Uppenkamp, M; Witzke, O | 1 |
| Aitini, E; Bendandi, M; Bocchia, M; De Renzo, A; Falini, B; Fattori, PP; Gentilini, P; Gherlinzoni, F; Gobbi, M; Guardigni, L; Lauta, VM; Leone, G; Magagnoli, M; Mazza, P; Moretti, L; Pavone, E; Storti, S; Tabanelli, M; Tura, S; Volpe, E; Zaccaria, A; Zaja, F; Zinzani, PL | 1 |
| Fujii, M; Imanishi, Y; Inuyama, Y; Kanke, M; Kanzaki, J; Ohno, Y; Tokumaru, Y; Tomita, T | 1 |
| Czuczman, MS; Dallaire, B; Gordon, L; Grillo-López, AJ; Jonas, C; Klippenstein, D; LoBuglio, AF; Saleh, M; Varns, C; White, CA | 1 |
| Ember, I; Kiss, I; Raposa, T | 1 |
| Balzarotti, M; Castagna, L; Santoro, A | 1 |
| Berinstein, NL; Campbell, C; Franssen, E; Sawka, C | 1 |
| Amthauer, H; Bittner, RC; Felix, R; Hierholzer, J; Hosten, N; Ludwig, WD; Oellinger, J; Spahn, G; Stroszczynski, C | 1 |
| Cassileth, PA; Flynn, P; Ghosh, C; Glick, J; Gordon, LI; Habermann, TM; Weller, E; Winter, JN; Young, M | 1 |
| Anticoli Borza, P; Bendandi, M; Bocchia, M; Cellini, C; De Renzo, A; Gherlinzoni, F; Gobbi, M; Lauta, VM; Magagnoli, M; Mandelli, F; Martelli, M; Palombi, F; Pavone, E; Ronconi, F; Scaramucci, L; Stefoni, V; Storti, S; Tura, S; Zaja, F; Zinzani, PL | 1 |
| Dubey, SP; Kaleh, LK; Morewaya, JT; Sengupta, SK | 1 |
| Abate, G; Bianco, AR; Catalano, G; D'Aprile, M; Dammacco, F; De Lena, M; De Vita, F; Lauta, VM; Lorusso, V; Lucarelli, G; Mantovani, G; Marzullo, F; Palmieri, G; Polimeno, G | 1 |
| Hermans, J; Heyning, FH; Hogendoorn, PC; Kluin, PM; Kluin-Nelemans, JC; Kramer, MH; Noordijk, EM | 1 |
| Habermann, TM | 1 |
| Verdonck, LF | 1 |
| Ali, NM; Darwish, T; Elattar, I; Gaafar, R; Khaled, HM; Moawad, MS; Mokhtar, N; Zekri, ZK | 1 |
| Buijt, I; Huijgens, PC; Ossenkoppele, GJ; Uyl-de Groot, CA | 1 |
| Chihara, K; Inoue, R; Iwata, N; Kajimoto, Y; Matsui, T; Matsuoka, H; Natazuka, T; Shimoyama, M; Tamekane, A | 1 |
| Alvarez, A; Cervantes, F; Hernández-Boluda, JC; López-Guillermo, A; Montserrat, E | 1 |
| Dey, P; Gupta, SK; Saikia, UN; Vohra, H | 1 |
| Chisesi, T; Congiu, AM; Contu, A; Coser, P; De Souza, C; Marino, G; Nati, S; Olivieri, A; Porcellini, A; Rizzoli, V; Rubagotti, A; Salvagno, L; Santini, G; Sertoli, MR; Truini, M; Zambaldi, G | 1 |
| Chen, JL; Frohlich, DE; Kehoe, KM; Neuberg, D; Van den Abbeele, AD | 1 |
| Hattori, T; Matsuda, M; Seki, S; Tabata, K | 1 |
| Goto, H; Hara, T; Moriwaki, H; Murakami, N; Sawada, M; Tajika, M; Takenaka, K; Tsurumi, H; Yoshimura, K | 1 |
| Hatano, Y; Kume, M; Miura, AB; Miura, I | 1 |
| Ascari, E; Avanzini, P; Baldini, L; Broglia, C; Ghirardelli, ML; Gobbi, PG; Loni, C; Quarta, G; Silingardi, V; Stelitano, C | 1 |
| Delker, G; Grothaus-Pinke, B; Hiddemann, W; Horst, EJ; Koch, P; Kocik, J; Parwaresch, R; Reers, B; Reinartz, G; Tiemann, M; Willich, NA | 1 |
| Ajarim, D; Al-Sayed, A; Bazarbashi, S; Berry, J; El-Foudeh, MO; Ezzat, AA; Ibrahim, EM; Rahal, M; Stuart, RK | 1 |
| Ando, M; Kagami, Y; Kato, T; Morishima, Y; Ogura, M; Okada, Y; Taji, H | 1 |
| Armata, J; Bogusławska-Jaworska, J; Bubała, H; Dłuzniewska, A; Kazanowska, B; Kowalczyk, J; Kołecki, P; Matysiak, M; Rokicka-Milewska, R; Sońta-Jakimczyk, D; Sopyło, B; Stańczak, E; Stefaniak, MJ; Stefańska, K; Wróbel, G | 1 |
| Intragumtornchai, T; Sutcharitchan, P; Sutheesophon, J; Swasdikul, D | 1 |
| Asmar, P; Baringer, JR; Buys, S; Liow, K; Liow, M; Osborn, A; Spanaki, M; Townsend, JJ | 1 |
| Balcerzak, SP; Dana, BW; Fisher, RI; Forman, JD; Gaynor, ER; Kjeldsberg, C; LeBlanc, M; Miller, T; Roy, V; Unger, JM | 1 |
| Cairo, MS; Finlay, JL; Gururangan, S; Meadows, AT; Sposto, R | 1 |
| Chen, CI; Meyer, RM; Skingley, P | 1 |
| Fujisawa, S; Fujita, H; Fukawa, H; Harano, H; Hattori, M; Ishigatsubo, Y; Kanamori, H; Kodama, F; Koharasawa, H; Maruta, A; Matsuzaki, M; Miyashita, H; Motomura, S; Ogawa, K; Sakai, R; Taguchi, J; Tanabe, J; Tomita, N | 1 |
| Bencsáth, M; Császár, A; Falus, A; Kotlán, B; László, V; Matolcsi, A; Pócsik, E; Timár, J; Várkonyi, J; Zalatnai, A | 1 |
| Bouabdallah, R; Cole, BF; Gisselbrecht, C; Haioun, C; Lepage, E; Marit, G; Morel, P; Mounier, N; Ravoet, C; Reyes, F; Salles, G; Sebban, C | 1 |
| Colon-Otero, G; Moreno, A; Solberg, LA | 1 |
| Hamilton-Dutoit, SJ; Hansen, PB; Kirk, O; Kiss, K; Lisse, I; Pedersen, C; Penkowa, M; Skinhøj, P; Zhou, X | 1 |
| Cao, J; Sun, M; Zhang, G | 1 |
| Chen, J; Wang, Z | 1 |
| Wei, Y; Yong, W; Zhang, YT | 1 |
| Luo, Y; Wang, A; Wang, Z | 1 |
| Aboud, W; Berkelhammer, C; Marshall, R | 1 |
| Hasegawa, M; Hayabuchi, N; Hirota, S; Ikeda, H; Isobe, K; Nakamura, K; Oguchi, M; Sasai, K | 1 |
| Haas, R; Ho, AD; Hohaus, S; Martin, S; Moos, M; Pantel, G; Schmidt, P; Voso, MT; Weis, M | 1 |
| Hino, M; Kamitani, T; Kinoshita, Y; Koh, K; Kumura, T; Nishiki, S; Ohta, K; Takubo, T; Tatsumi, N; Yamane, T | 1 |
| Ambinder, RF; Byr, JC; Diehl, L; Flinn, IW; Goodman, SN; Gore, S; Jamison, J; Miller, CB; Post, L; Willis, C | 1 |
| Andreesen, R; Hildebrandt, G; Holler, E; Quarch, G; Reichle, A; Schalke, B; Woenkhaus, M | 1 |
| Budel, L; Doorduijn, JK; Löwenberg, B; Sonneveld, P; Spruit, P; van Der Holt, B; van't Veer, M | 1 |
| Chou, T; Ikeda, S; Itoh, K; Kasai, M; Mizorogi, F; Morishima, Y; Ogura, M; Ohno, T; Ohtsu, T; Sai, T; Sasaki, Y; Taniwaki, M; Tobinai, K; Uike, N; Yoshida, K | 1 |
| Botchan, A; Hauser, R; Paz, G; Tal, R; Yavetz, H; Yogev, L | 1 |
| Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E | 1 |
| Medvedev, PV; Nikitin, EA; Pivnik, AV | 1 |
| Cabanillas, F | 3 |
| Bleehen, NM; Brada, M; Bullimore, J; Glaser, MG; Gregor, A; Ironside, JW; Lantos, P; Mead, GM; Moss, TH; Rampling, RP; Shirley, D; Stenning, SP; Trevor, J; Whaley, JB | 1 |
| Aoyama, Y; Hino, M; Kamitani, T; Kishida, T; Koh, KR; Mugitani, A; Nakamae, H; Ohta, K; Ota, T; Sannomiya, Y; Takubo, T; Tatsumi, N; Yamane, T | 1 |
| Fukawa, H; Harano, H; Hattori, M; Ishigatsubo, Y; Kanamori, H; Kodama, F; Motomura, S; Ogawa, K; Takemura, S; Tanabe, J; Tomita, N; Yamazaki, E; Yoshida, M | 1 |
| Chabner, BA; Cheson, BD; Fojo, A; Gutierrez, M; Jaffe, ES; Pearson, D; Steinberg, SM; Wilson, WH | 1 |
| Barcos, M; Carlisle, TL; Cooper, MR; Johnson, JL; Lichtman, SM; Niedzwiecki, D; Peterson, BA | 1 |
| Cabanillas, FF; Cox, JD; Ha, CS; Hess, MA; Rodriguez, MA; Schlembach, PJ; Tucker, SL; Wilder, RB | 1 |
| Ambrosetti, A; Corato, A; de Wynter, E; Lambiase, A; Nadali, G; Perona, G; Pizzolo, G; Rossi, B; Vincenzi, C | 1 |
| Arveux, P; Cahn, JY; Chartrin, I; Colombat, P; Deconinck, E; Gressin, R; Ifrah, N; Limat, S; Milpied, N; Woronoff-Lemsi, MC | 1 |
| Abgrall, JF; Colombat, P; Cornillet, P; Deconinck, E; Delain, M; Gardembas, M; Kootz, C; Milpied, N; Tourani, JM | 1 |
| Fujii, H; Igarashi, T; Ishizawa, K; Itoh, K; Minami, H; Ohtsu, T; Onozawa, Y; Sasaki, Y; Wakita, H | 1 |
| Anastasopoulou, A; Bron, D; Carbone, A; Carde, P; Kluin-Nelemans, HC; Maes, B; Musson, H; Noordijk, EM; Roozendaal, KJ; Teodorovic, I; Thomas, J; Zagonel, V | 1 |
| Baumelou, E; Brousse, C; Morel, P | 1 |
| di Gennaro, G; Nasti, G; Schioppa, O; Spina, M; Talamini, R; Tirelli, U; Vaccher, E; Vultaggio, G | 1 |
| Balcerzak, SP; Fisher, RI; Gaynor, ER; Grogan, TM; LeBlanc, M; Miller, TP; Mills, GM; Unger, JM; Varterasian, M; White, LA | 1 |
| Jerkeman, M; Longo, G; Messori, A; Rigacci, L; Trippoli, S; Vaiani, M | 1 |
| Cabanillas, FF; Cox, JD; Ha, CS; Hess, MA; Rodriguez, MA; Tucker, SL; Wilder, RB | 2 |
| Chizuka, A; Iijima, K; Niitsu, N | 1 |
| Czuczman, M; Fisher, RI; Gilman, P; Grillo-Lopez, A; Grossbard, ML; Kunkel, LA; Link, BK; Lowe, A; Vose, JM | 1 |
| Aranoff, GS; Feldstein, NA; Garvin, JH; Hays, AP; Levine, LS; Oberfield, SE; Silfen, ME; Starkman, HS; Wong, B | 1 |
| Berenschot, HW; Doekharan, D; Henzen-Logmans, S; Krol, AD; van 't Veer, MB; van der Holt, B | 1 |
| Davis, JW; Moriarty, RP; Schellhammer, PF; Schlossberg, SM | 1 |
| Albertini, P; Alinari, L; Bendandi, M; Gherlinzoni, F; Stefoni, V; Tani, M; Tura, S; Vigna, E; Zinzani, PL | 1 |
| Azzarà, A; Capochiani, E; Carulli, G; Petrini, M; Rizzuti-Gullaci, A | 1 |
| Batlle, M; Feliu, E; Flores, A; Millá, F; Navarro, JT; Oriol, A; Ribera, JM; Romeu, J; Vaquero, M | 1 |
| Ambinder, R; Flexner, C; Grochow, L; Hamzeh, F; Harrington, W; Herndier, B; Kaplan, L; Lee, J; Levine, A; Ratner, L; Redden, D; Scadden, D; Straus, D; Tan, B; Tang, S | 1 |
| Gutierrez, M; Horne, M; Jaffe, ES; Little, RF; Pau, A; Wilson, W | 1 |
| Carr, R; Graham, EM; Stanford, MR; van der Walt, JD; Verity, DH | 1 |
| Mikhaeel, NG; Spittle, MF | 1 |
| Erdkamp, FL; Fickers, MM; Houben, SG; Lalisang, RI; Peters, FP; Schouten, HC; Wals, J; Wils, JA | 1 |
| Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E | 1 |
| Killackey, MA; Trenhaile, TR | 1 |
| Chisesi, T; Congiu, AM; Contu, A; Coser, P; Indrizzi, L; Leoni, P; Majolino, I; Polistena, P; Porcellini, A; Rizzoli, V; Salvagno, L; Santini, G; Zambaldi, G | 1 |
| Jourdan, E; Jourdan, J; Pinzani, V; Topart, D | 1 |
| Matsue, T; Mori, M; Nakagawa, Y; Niitsu, N; Okamoto, R; Takagi, T; Tomiyama, J | 1 |
| Berrebi, A; Klepfish, A; Sarid, R; Schattner, A; Shtalrid, M; Shvidel, L | 1 |
| Dourmas, M; Mandel, L; Surattanont, F | 1 |
| Basu, S; Cade, D; Selvachandran, SN | 1 |
| Fletcher, BD; Harrison, PL; Kaste, SC; Kennedy, W; Neel, MD; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT | 1 |
| Cartron, G; Colombat, P; De Muret, A; Desablens, B; Dugay, J; Foussard, C; Le Maignan, C; Maakaroun, A; Milpied, N; Voillat, L | 1 |
| Angelopoulou, MK; Kalovidouris, A; Mitropoulos, FA; Pangalis, GA; Papalampros, E; Rassidakis, G; Siakantaris, MP; Vayiopoulos, GA | 1 |
| Advani, SH; Akan, H; Aydogdu, I; Azim, HA; Aziz, Z; Bapsy, PP; Buyukkececi, F; Chaimongkol, B; Chen, PM; Cheong, SK; Ferhanoglu, B; Giles, FJ; Hamza, R; Intragumtornchai, T; Jootar, S; Khalid, HM; Kim, SW; Kim, SY; Koc, H; Kumar, L; Kumar, R; Lei, KI; Lekhakula, A; Muthalib, A; Patel, M; Poovalingam, VP; Prayoonwiwat, W; Rana, F; Reksodiputro, AH; Ruff, P; Sagar, TG; Schwarer, AP; Shan, J; Song, HS; Suh, CW; Suharti, C; Supindiman, I; Tee, GY; Thamprasit, T; Villalon, AH; Wickham, NR; Wong, JE; Yalcin, A | 1 |
| Bartlett, NL; Canellos, GP; Gockerman, JP; Johnson, JL; Omura, GA; Parker, BA; Peterson, BA; Petroni, GR; Robert, M; Wagner, ND | 1 |
| Allen, SL; Budman, DR; Fusco, D; Hayes, FA; Hoffman, M; Kolitz, J; Lichtman, SM; Mittelman, A; Schulman, P; Vinciguerra, V | 1 |
| Dodo, Y; Hiraoka, M; Kashii, S; Nagata, Y; Sasai, K; Yamabe, H | 1 |
| Blackwood, LB; Bostock, DE; Dobson, JM; Hoather, TM; McInnes, EF; Nicholls, P; Tom, BD | 1 |
| Erdkamp, FL; Fickers, MM; Peters, FP; Schouten, HC; Wals, J; Wils, JA | 1 |
| Brown, LD; Colgan, JP; Earle, JD; Krigel, RL; McGinnis, WJ; O'Fallon, JR; O'Neill, BP; Wang, CH | 1 |
| Ebsen, M; Kirchner, EM; Kirchner, J; Theegarten, D; Voigtmann, R | 1 |
| Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA | 1 |
| Asaoku, H; Fujihara, M; Kashiwado, K; Kurihara, K; Tani, H; Tari, A; Yoshino, T | 1 |
| Benharroch, D; Cohen, Y; Geffen, DB; German, I; Lavrenkov, K; Mermershtain, W | 1 |
| Egerer, G; Ho, AD; Sauerland, K | 1 |
| Katayama, H; Munemasa, M; Soda, R; Tada, A; Takahashi, K; Takeuchi, M; Yoshino, T | 1 |
| Carter, WB; Delgado, DJ; Ford, JM; Fridman, M; Kerr, RO; Lawless, GD; Lee, MW; Morrison, VA; Picozzi, VJ; Pohlman, BL | 1 |
| Grossbard, M; Jacobson, JO; Neuberg, D; Shulman, LN | 1 |
| Assawametha, N; Intragumtornchai, T; Numbenjapon, T; O'Charoen, R; Prayoonwiwat, W; Swasdikul, D | 1 |
| Jain, VK; Ogden, JL; Wilder, DD | 1 |
| Cabanillas, F; Hagemeister, FB; McLaughlin, P; Medeiros, LJ; Mesina, OM; Rodriguez, MA; Romaguera, JE; Sarris, AH; Visco, C | 1 |
| Caggiano, V; Carter, WB; Delgado, D; Dickman, E; Ford, J; Fridman, M; Kerr, R; Lawless, G; Lee, M; Morrison, VA; Picozzi, V; Pohlman, B; Scott, S | 1 |
| D'Orazio, AI; Maung, K | 1 |
| Motta, M; Pelizzari, A; Puoti, M; Rossi, G | 1 |
| Hartikainen, J; Jantunen, E; Nousiainen, T; Remes, J; Ritanen, E; Vanninen, E; Vuolteenaho, O | 1 |
| Iijima, K; Niitsu, N | 1 |
| Chilcote, RR; Kadin, ME; Kjeldsberg, C; Krailo, MD; Meadows, AT; Morse, M; Siegel, SE; Sposto, R; Steinherz, PG; Termuhlen, AM | 1 |
| Pfreundschuh, M | 1 |
| Hochberg, FH; Tabatabai, G | 1 |
| Ferreri, AJ; Reni, M | 1 |
| Bergui, L; Boccadoro, M; Caracciolo, D; Cuttica, A; de Crescenzo, A; Gavarotti, P; Ladetto, M; Marinone, C; Pagano, M; Pileri, A; Ricca, I; Rossi, G; Salomone, A; Tarella, C; Zallio, F | 1 |
| Baudis, M; Bentz, M; Döhner, H; Fritz, B; Kloess, M; Lichter, P; Schwänen, C; Walenta, K; Wessendorf, S | 1 |
| Gospodarowicz, MK; Tsang, RW | 1 |
| Glass, B; Pfreundschuh, M; Schmits, R; Trümper, L | 1 |
| Klöss, M; Loeffler, M; Nguyen, TP; Pfreunschuh, M; Rübe, C; Trümper, L | 1 |
| Kouroukis, CT; Meyer, RM | 1 |
| Grothaus-Pinke, B; Hiddemann, W; Koch, P; Kocik, J; Parwaresch, R; Reers, B; Reinartz, G; Tiemann, M; Willich, NA | 1 |
| Cavallin-Stahl, E; Hjermstad, M; Jerkeman, M; Kaasa, S; Kvaløy, S | 1 |
| Avilés, A; Neri, N | 1 |
| Baruchel, A; Bertozzi, AI; Boutard, P; Frappaz, D; Laplanche, A; Mechinaud, F; Michon, J; Nelken, B; Patte, C; Schmitt, C | 1 |
| Benyunes, M; Bernstein, SH; Bernstein, ZP; Brown, K; Czuczman, MS; Fallon, A; Grillo-López, AJ; Klippenstein, D; Loud, P; McCarthy, P; Miller, K; Mohr, A; Rock, MK; Skipper, M; Stewart, C; Wentling, D | 1 |
| Cabanillas, F; Cox, JD; Ha, CS; Hess, MA; Romaguera, JE; Tucker, SL; Wilder, RB | 1 |
| Akiba, J; Hayashi, T; Kato, T; Kato, Y; Suzuki, K; Tajima, K; Yoshino, M | 1 |
| Khanna, A; Naresh, T; Rai, M; Shukla, J; Shukla, PK; Singh, VP; Sundar, S | 1 |
| Azad, NS; Bhama, JK; Fisher, WE | 1 |
| Benjaafar, N; el Ghazi, E; el Gueddari, BK; el Omari-Alaoui, H; Erriahni, H; Kebdani, T | 1 |
| Bordessoule, D; Bosly, A; Coiffier, B; Deconninck, E; Divine, M; Dupriez, B; Fillet, G; Gaulard, P; Gisselbrecht, C; Herbrecht, R; Lepage, E; Nouvel, C; Tilly, H | 1 |
| Benedetti, E; Caracciolo, F; Di Renzo, N; Fazzi, R; Federico, M; Galimberti, S; Guerrini, F; Marasca, R; Morabito, F; Oliva, E; Papineschi, F; Petrini, M; Torelli, G | 1 |
| de Almeida, SM; Leite, AG; Leite, PG; Sasaki, Md | 1 |
| Budach, V; Eucker, J; Genvresse, I; Krüger, L; Lange, C; Possinger, K; Schweigert, M; Sezer, O; Späth-Schwalbe, E | 1 |
| Ericsson, SM; Glimelius, BL; Larsson, RL; Nygren, HP; Sundström, C | 1 |
| Flickinger, JC; Germanwala, A; Kondziolka, D; Schiff, D; Singhal, D; Witham, TF | 1 |
| Antoniolli, SZ; Curti, P; D'Amico, A; Ficarra, V; Malossini, G; Martignoni, G; Matteo, B; Novella, G; Porcaro, AB | 1 |
| Dimopoulos, MA; Economopoulos, T; Fountzilas, G; Mellou, S; Nicolaides, C; Papadopoulos, A; Papageogriou, E; Papasavvas, P; Pavlidis, N; Samantas, E; Tsatalas, C | 1 |
| Graf, C; Paira, S; Rossini, J; Roverano, S | 1 |
| Hartikainen, J; Jantunen, E; Nousiainen, T; Vanninen, E | 1 |
| Bergman, S; Creager, AJ; Geisinger, KR | 1 |
| Ansari, MS; Hemal, AK; Nabi, G; Pandey, G; Singh, I | 1 |
| Beretta, G; Bonadonna, G; De Lena, M; Lattuada, A; Milani, F; Monfardini, S | 1 |
| Amiel, JL; Hayat, M; Mathé, G; Pouillart, P; Schwarzenberg, L; Tubiana, M | 1 |
| Halikowski, B; Legutko, L; Pajdak, E; Pituch, A; Zajaçzkowski, J | 1 |
| Bonadonna, G; DeLena, M; Monfardini, S; Tancini, G; Valagussa, P; Villa, E | 1 |
| Donner, L; Klener, P | 2 |
| Schmidt, CG | 1 |
| Anderson, T; Bender, RA; Berard, CW; Chabner, BA; DeVita, VT; Fisher, RI; Norton, L; Young, RC | 1 |
| Coltman, CA; Jones, SE; Luce, JK; McKelvey, EM; Moon, TE | 1 |
| Bennett, JM; Carbone, PP; Ezdinli, E; Johnson, GJ; Lenhard, RE; Pocock, SJ | 1 |
| Blom, H; Flaherty, M; Glidewell, O; Hayes, D; Holland, JF; McIntyre, R; Nissen, NI; Pajak, T | 1 |
| Bonadonna, G; Monfardini, S; Villa, E | 1 |
| Butler, JJ; Fuller, LM; Gamble, JF; Gehan, EA; Martin, RG; Shullenberger, CC; Sinkovics, JG; Wallace, S | 1 |
| Bodey, GP; Cabanillas, F; Freireich, EJ; Rodriguez, V | 1 |
| Menefee, MG; Wright, RC; Zellner, DC | 1 |
| Ikeda, H; Ishino, H; Mii, T; Yokoyama, S | 1 |
| David, R; Duhamel, G; Gorin, NC; Najman, A; Stachowiak, J | 2 |
| Dallow, RI; Sullivan, SF | 1 |
| Davey, FR; Goldberg, J; Gottlieb, AJ | 1 |
| Bartolucci, AA; Dorfman, RF; Durant, JR; Gams, RA | 1 |
| Chaffey, JT; Hellman, S; Moloney, WC; Rosenthal, DS | 1 |
| Berard, CW; Brereton, HD; Canellos, GP; Chabner, BA; DeVita, VT; Johnson, RE; Young, RC | 1 |
| Charron, D; Dumonchel, P; Jorry, F; Laurens, A; Martola, R; Thevenot, J | 1 |
| Gil, JL; Giralt, M; Maicas, M; Raichs, A; Rubio-Félix, D; Rubio-Vitaller, A | 1 |
| Brecher, ML; Freeman, AI; Sinks, LF; Thomas, RR | 1 |
| Einstein, AB; Hafermann, M; Harrison, DT; Neiman, PE; Rudolph, RH; Sullivan, K | 1 |
| Cabanillas, F; Freireich, EJ; Rodriguez, V | 1 |
| Forcier, RJ; Glidewell, O; Holland, JF; McIntyre, OR; Nissen, NI; Pajak, TF | 1 |
| Cuttner, J; Falkson, G; Glidewell, O; Harley, JB; Hayes, DM; Holland, JF; Nissen, NI; Pajak, TF; Rege, V; Silver, RT; Spurr, CL | 1 |
| Papp, GM | 1 |
| Bagshawe, KD; Joekes, AM; Philalithis, PE; Walden, PA | 1 |
| Bloomfield, CD; Kennedy, BJ; Kiang, DT; Peterson, BA; Theologides, A; Vosika, G | 1 |
| Faber, RB; Flexner, JM; Jones, WB; Molin, JA; Rhamy, RK | 1 |
| Canellos, GP; Chabner, BA; DeVita, VT; Johnson, RE; Young, RC | 1 |
| Bostock, DE; Onions, DE; Owen, LN | 1 |
| Bennett, JM; Berard, CW; Carbone, PP; Costello, W; Ezdinli, EZ; Icli, F | 1 |
| Buell, D; Cassady, JR; Jaffe, N; Nathan, DG; Vance, ZB; Weinstein, HJ | 1 |
| Corder, MP; Gingrich, RD; Guthrie, R; Leimert, JT; Maguire, LC; Tewfik, HH | 1 |
| Albahary, C; Amiel, JL; Belpomme, D; de Vassal, F; Depierre, R; Hayat, M; Jasmin, C; Mathé, G; Misset, JL; Musset, M; Pouillart, P; Schwarzenberg, L | 1 |
| Glatstein, E; Kaplan, HS; Portlock, CS; Rosenberg, SA | 1 |
| Young, CW | 1 |
| Bakemeier, R; Berard, CW; Carbone, PP; Horton, JH; Lenhard, RE; Owens, AH; Prentice, RL; Shnider, BI; Stolbach, L | 1 |
| Klein, HO | 2 |
| Coltman, C; Gamble, JF; Gottlieb, JA; Grozea, PN; Gutterman, J; Haut, A; Jones, SE; Lane, M; McKelvey, EM; Moon, TE; Stephens, R; Talley, RW; Wilson, HE | 1 |
| Bar-Meir, S; Golan, A; Pinkhas, J; Vries, A | 1 |
| Aungst, CW; Ezdinli, E; Kaufman, JH; Stutzman, L | 1 |
| Aungst, CW; Bakemeier, R; Bennett, J; Berard, CW; Brunk, SF; Carbone, P; Ezdinli, E; Horton, J; Klaassen, DJ; Lenhard, RE; Perlia, C; Pocock, S; Richter, P; Silverstein, M; Stolbach, L | 1 |
| Blok, J; Cleton, FJ; de Waal, FC; Mulder, E; Smets, LA | 1 |
| Benjamin, RS; Chang, P; O'Connell, MJ; Sutherland, JC; Wiernik, PH | 1 |
| Amiel, JL; de Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Pouillart, P; Rosenfeld, C; Schwarzenberg, L | 1 |
| Patel, AR; Rao, KP; Rhee, HL; Sassoon, H; Shah, PC | 1 |
| Jochimsen, PR; Lawton, RL; Pearlman, NW | 1 |
| Canellos, GP; Chabner, BA; DeVita, VT; Schein, PS; Young, RC | 1 |
| Chandler, HL; Davis, JA; Kantrowitz, PA; Schatzki, SC | 1 |
| Barros, CA; Morgenfeld, MC; Palau, M; Pavlovsky, A; Pavlovsky, S; Somoza, N; Suarez, A | 1 |
| Becker, G; Bruntsch, U; Höffken, K; Passek, S; Reis, HE; Schmidt, CG; Teske, HJ | 1 |
| Berard, C; Canellos, GP; Chabner, BA; DeVita, VT; Schein, PS; Young, RD | 1 |
| Canellos, GP; Chabner, BA; DeVita, VT; Johnson, RE; Schein, PS; Young, RC | 1 |
| Bergsagel, DE; Brown, TC; Reid, J | 1 |
| Fisher, DJ; Slater, A; Whittaker, JA | 1 |
| Clark, RB; Lewis, RA | 1 |
| Boyd, CM; Hall, WH; Padilla, F; Thompson, BW | 1 |
| Abraira, C; Chefec, G; Friedell, MT; Lopez-Majano, V; Sion, A | 1 |
| Garfein, OB | 1 |
| Galen, MA; Hampers, CL; Jaffe, N; Lazarus, JM; Lowrie, EG; Steinberg, SM | 1 |
| Crookston, JH | 1 |
| Bleeker, GM; Humans, W; Oushoorn, HH; Peeters, HJ; van Slooten, EA; Wagenaar, SS | 1 |
| Dommann, C; Gebbers, JO; Honegger, HP; Joss, R; Kroner, T; Maurer, R; Peters, J; Pichert, G; Stahel, RA; Sulser, H | 1 |
| Bianconcini, G; Candini, R; Dallasta, A; Gobbi, F; Mazzali, F | 1 |
| Bar-Ziv, J; Gilon, D; Polliack, A; Putterman, C; Uretzki, G | 1 |
| Dolińska, D; Grzelec, H; Nowacki, P; Stankiewicz, J | 1 |
| Ariyoshi, Y; Asano, S; Ogura, M; Oyama, A; Suzuki, H | 1 |
| Laine, P; Lindqvist, C; Meurman, JH; Murtomaa, H; Pyrhönen, S; Teerenhovi, L; Tenovuo, J | 1 |
| Koivisto, V; Oksanen, K; Sinisalo, M; Vikberg, V | 1 |
| Aversa, SM; Bianco, A; Chiarion-Sileni, V; Contu, A; Endrizzi, L; Fiorentino, MV; Olmeo, N; Salvagno, L; Schintu, GM; Sorarù, M | 1 |
| Nakamura, S; Shiigai, T | 1 |
| Bitran, JD; Platanias, LC; Putterman, AM; Recant, W; Vijayakumar, S; Weichselbaum, RR | 1 |
| Cerrillo, M; Cervantes, G; Gagnière, M; Gorodezky, G; Mohar, A; Neyra, O; Osornio, A; Reynoso, E; Salles, MT; Taja, L | 1 |
| Dujardin, P; Ferrari, E; Fuzibet, JG; Garnier, G; Taillan, B; Vinti, H | 1 |
| Arnold, H; Bross, K; Heidemann, E; Heim, ME; Hoffman, I; Josten, K; Manegold, C; Reinold, HM; Schalk, KP; Steinke, B | 1 |
| Mori, M | 1 |
| Kawanishi, Y; Kuge, S; Kuriyama, Y; Kuwabara, S; Nakano, M; Toyama, K; Yaguchi, M | 1 |
| Arima, K; Fukuda, J; Hanada, T; Harada, K; Irimajiti, S; Matsuoka, Y; Mita, S; Ohosone, Y; Tsukada, K | 1 |
| de Campos, ES; Dodwell, DJ; Radford, JA | 1 |
| Ang, PT; Chua, EJ; Ong, YW; Sng, I; Soh, LT | 1 |
| Mizoguchi, H; Saito, H | 1 |
| Ashiya, M; Hirano, H; Kouda, K; Kura, Y; Sakuma, A; Satou, Y; Sawada, U; Suzuki, K; Tsuboi, I; Yamazaki, T | 1 |
| Andersen, J; Barcos, M; Colgan, J; Glick, J; Gordon, LI; Gottlieb, A; Harrington, D; Mann, R; Neiman, R; Resnick, GD | 1 |
| Kamiike, W; Matsuda, H; Miyata, M; Nakao, K; Sumimura, J; Yamaguchi, T | 1 |
| Andersen, JW; Bhide, V; Borden, EC; Hawkins, MJ; O'Connell, MJ; Oken, MM; Smalley, RV | 1 |
| Armata, J; Balwierz, W; Skoczeń, S; Tacik, J | 1 |
| Demina, EA; Evtushenko, VV; Kruglova, GV | 1 |
| Grigor'eva, MA; Pan'shin, GA; Pivnik, AV; Sotnikov, VM | 1 |
| Quah, TC; Siegel, SE; White, L | 1 |
| Hirschmann, WD; Neuhaus, KL; Zeymer, U | 1 |
| Jakić-Razumović, J; Labar, B; Marusić, M; Petrovecki, M; Radman, I; Uzarević, B | 1 |
| Amadori, S; Guglielmi, C; Mandelli, F; Martelli, M; Papa, G | 2 |
| Hovgaard, D; Nissen, NI | 1 |
| Frisch, H; Schuster, E; Thun-Hohenstein, L | 1 |
| Hanamura, A; Kuwayama, W; Maeda, H; Takano, Y | 1 |
| Carrera, D; Coma, A; Fanjul, F; Jalón, S; Jonte, F; Luño, E; Pinto, V; Rayón, C; Soto, I; Zanabili, Y | 1 |
| Bertocchi, C; Comotti, B; D'Adda, F; Medolago, G; Motta, T; Orlandi, C; Pitì, A; Rottoli, MR; Tespili, M; Virotta, G | 1 |
| Damen, RM; de Jong, RS; Nelis, GF; Westerveld, BD | 1 |
| Endo, N; Imai, S; Shimamoto, Y | 1 |
| Conlon, M; Gerardi, DA; Hellman, RM | 1 |
| Cervantes, G; Corrado, C; Diaz Maqueo, JC; Erazo, A; Garcia Vela, EL; Lluesma Goñalons, M; Magnasco, H; Pavlovsky, S; Santarelli, MT; Somoza, N | 1 |
| Iida, K; Sampi, K; Takagi, T | 1 |
| Fokaefs, E; Matsouka, P; Melekos, MD; Pantazakos, A; Repanti, M | 1 |
| Clarkson, BD; Koziner, B; Lee, BJ; Lowenthal, DA; Schluger, AE; Schneider, AM; Straus, DJ; Wong, G | 1 |
| Forsthuber, T; Fuhr, HG; Gamm, H; Hennekeuser, HH; Hinterberger, R; Kreiter, H; Lindemann, A; Oster, W; Schmitz, G; Thoenes, W | 1 |
| Fuller, LM; Maor, MH; Silvermintz, KB; Velasquez, WS | 1 |
| Golomb, HM; Hoffman, PC; Larson, RA; Mick, R; Olopade, OI; Ultmann, JE; Watson, SM | 1 |
| Nantel, S; Parboosingh, J; Poon, MC | 1 |
| Alter, R; Joshi, SS; Verdirame, JD; Weisenburger, DD | 1 |
| Ambrosetti, A; Benedetti, F; Cetto, GL; Chilosi, M; Meneghini, V; Menestrina, F; Perona, G; Pizzolo, G; Todeschini, G; Veneri, D | 1 |
| Armitage, JO; Bast, M; Conlan, MG; Weisenburger, DD | 1 |
| Kaczmarski, R; Mufti, GJ; Pagliuca, A | 1 |
| Arechaga, S; Bellas, C; Berenguer, A; Calleja, JL; García Villanueva, A; Marcos Robles, J; Montalbán, C; Patier, JL | 1 |
| Advani, SH; Dinshaw, KA; Gopal, R; Iyer, RS; Kurkure, PA; Nair, CN; Pai, SK; Saikia, T | 1 |
| Kosaka, M; Miyamoto, Y; Mizuguchi, T; Tamura, K | 1 |
| Dent, DM; Jacobs, P; King, HS | 1 |
| Rahr, V; Tucker, R | 1 |
| Arai, N; Hara, A; Kaneko, H; Shirai, T | 1 |
| Ajarim, DS; Santhosh-Kumar, CR; Shipkey, FD | 1 |
| Anderson, JR; Barcos, M; Bloomfield, CD; Ginsberg, SJ; Gottlieb, AJ; Henderson, ES; Holland, JF; Nissen, N; Norton, L; Peterson, BA | 1 |
| Diehl, V; Eckert, G; Heitz, W; Hilger, HH; Kirn, E; Krueger, GR; Pothoff, G; Wassermann, K | 1 |
| Asano, S; Furusawa, S; Hirashima, K; Miyazaki, T; Omine, M; Ota, K; Oyama, A; Sanpi, K; Takaku, F; Uzuka, Y | 1 |
| Dahlberg, S; Eyre, HJ; Files, JC; Fisher, RI; Miller, TP; Pendergrass, KB; Weick, JK | 1 |
| Arai, N; Hara, A; Shirai, T; Umeda, M | 3 |
| Matsutomo, S; Okabe, K; Shimokawa, T; Suzue, T; Toki, H | 1 |
| Asano, S; Furusawa, S; Omine, M; Ota, K; Oyama, A; Sawada, U; Takaku, F; Takatani, O; Uzuka, Y; Yoshida, Y | 1 |
| Cossman, J; DeVita, VT; Duffey, PL; Fisher, RI; Gilliom, M; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Wesley, MN | 1 |
| Avilés, A; Díaz-Maqueo, JC; López Vancell, D; Rodríguez, L; Torras, V | 1 |
| Andersen, J; Bentzen, SM; Brincker, H; Christensen, BE; Pedersen, M; Thorling, K | 1 |
| Aoyagi, M; Furusawa, S; Osato, M; Shishido, H; Waku, S | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Hildreth, CR; Johnson, DH; McMaster, ML; Wolff, SN | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
| Balcerzak, SP; Dahlberg, S; Dana, B; Fisher, RI; Miller, TP; Pierce, HI; Weick, JK | 1 |
| Dahlberg, S; Fisher, RI; Miller, TP | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Wolff, SN | 1 |
| DeVita, VT; Fisher, RI; Hubbard, SM; Longo, DL; Miller, TP; Young, RC | 1 |
| Allen, P; Cabanillas, F; Durr, E; Fuller, L; Hagemeister, F; Holmes, L; McLaughlin, P; Redman, J; Swan, F; Velasquez, W | 1 |
| Brack, N; Brittinger, G; Dornoff, W; Engelhard, M; Enne, W; Gassmann, W; Gerhartz, H; Hallek, M; Heise, J; Meusers, P | 1 |
| Cousar, JB; Flexner, JM; Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Stein, RS; Wolff, SN | 1 |
| Canellos, GP; Godleski, J; Jochelson, MS; Shapiro, CL; Shipp, MA; Skarin, AT; Yeap, BY | 1 |
| Bruhn, HD; Delbrück, K; Glander, K; Gram, J; Löffler, H; Pelzer, H; Zurborn, KH | 1 |
| Capnist, G; Chisesi, T; Contu, A; Coser, P; Porcellini, A; Rancan, L; Rizzoli, V; Salvagno, L; Santini, G; Sertoli, M | 1 |
| Bocchia, M; Fiacchini, M; Gherlinzoni, F; Mandelli, F; Martelli, M; Mazza, P; Papa, G; Pileri, S; Tura, S; Zinzani, PL | 1 |
| Abbadessa, V; Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Gobbi, PG; Leone, G; Lombardo, M; Moretti, G; Pitini, V | 1 |
| Armitage, JO; Bashir, RM; Bierman, PJ; Vose, JM; Weisenburger, DD | 1 |
| Mead, GM; Sweetenham, JW; Whitehouse, JM | 1 |
| Bonnet, JD; Coltman, CA; Dabich, L; Dahlberg, S; Eyre, HJ; Grozea, PN; Hartsock, RJ; Liepman, MK; LoBuglio, AF; Weick, JK | 1 |
| Arai, N; Hara, A; Kaneko, H; Shirai, T; Umeda, M | 1 |
| Carde, P; de Pauw, B; de Wolf-Peeters, C; Kluin-Nelemans, JC; Meerwaldt, JH; Monconduit, M; Somers, R; Tanguy, A; Thomas, J; van Glabbeke, M | 1 |
| Smeets, J; Wils, J | 1 |
| Cervos-Navarro, J; Dienemann, D; Jautzke, G; Langford, A; Pohle, HD; Ruf, B; Schürmann, D; Stein, H | 1 |
| Urasiński, I; Zdziarska, B | 1 |
| Cao, C; García, H; Gutiérrez, J; Osorio, G; Vacarezza, R | 1 |
| Chott, A; Erlacher, L; Knoflach, P; Luger, A; Radaszkiewicz, T; Wagner, A; Zrunek, M | 1 |
| Klooswijk, AI; Michiels, JJ; Mulder, AH; Schalekamp, MA; van Gelder, T | 1 |
| Blake, K; Freedman, As; Freeman, G; Gribben, JG; Longtine, JA; Nadler, LM; Pinkus, GS; Shu, RS; Woo, SD | 1 |
| Blackledge, GR; Easterbrook, P; Jones, L; Leonard, RC; MacLennan, IC; O'Brien, ME; Powell, J | 1 |
| Carrión, JR; Delgado, JR; Dominguez, S; Flores, E; Garcia, P; Jaen, J; Santos, JA | 1 |
| Berard, C; Brecher, M; Crist, W; Hvizdala, E; Pullen, J; Ragab, A; Ramirez, I; Shuster, J; Sullivan, MP; Vietti, T | 1 |
| Abdel-Azim, H; el-Ghamrawy, KA; Haggag, M; Zawam, HZ | 1 |
| Andersen, E; Brincker, H; Christensen, BE; d'Amore, F; Hastrup, J; Jensen, MK; Johansen, P; Pedersen, M; Pedersen, NT; Thorling, K | 1 |
| Becker, K; Clemens, MR; Fischer, T; Helm, EB; Knauf, W; Mitrou, PS; Pohl, C; Schrappe-Bächer, M; Serke, M; Westerhausen, M | 1 |
| Amadori, S; Coluzzi, S; Guglielmi, C; Mandelli, F; Martelli, M | 1 |
| Balm, AJ; Drosten, PB; Meyer, CJ; Noorduyn, LA; Ossenkoppele, GJ; Snow, GB; Torenbeek, R; van der Valk, P | 1 |
| Uematsu, M | 1 |
| Amadori, S; Dragoni, F; Guglielmi, C; Mandelli, F; Martelli, M | 1 |
| Björkholm, M; Ideström, K; Johansson, B; Kimby, E; Lindemalm, C; Merk, K; Osby, E | 1 |
| Nielsen, H | 1 |
| Durántez, A; España, P; Garcia-Font, M; Girón, JA; Marazuela, M; Menéndez, JL; Vargas, JA; Yebra, M | 1 |
| Chiba, S; Kikuchi, M; Misago, M; Mori, N; Nagata, K; Nakata, K; Ogawa, R; Sato, T; Tsukada, J; Wake, A | 1 |
| Hattori, M; Sampi, K; Takagi, T; Takouda, K | 1 |
| Kuikka, J; Lahtinen, R; Länsimies, E; Nousiainen, T; Uusitupa, M | 1 |
| Hirota, Y; Hiura, M; Kamei, H; Kondo, M; Okabe, K; Shimokawa, T; Toki, H | 1 |
| Fujise, K; Hashimoto, N; Ishihara, F; Kameda, H; Kawase, H; Kobayashi, S; Kuraishi, S; Sujino, H; Yanagisawa, T; Yazawa, M | 1 |
| Blatt, J | 1 |
| de Andrea, ML; de Camargo, B; Melaragno, R | 1 |
| Debranin, CO | 1 |
| Jalkanen, S; Joensuu, H; Klemi, P | 1 |
| Bruntsch, U; Eschenbach, I; Gropp, C; Köppler, H; Lötzke, E; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, EU; Zeller, W | 1 |
| Ogura, M; Oyama, A; Suzuki, H | 1 |
| Craig, JB; Cruz, JM; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Spurr, CL; White, DR | 1 |
| Ben-Arie, Y; Ben-Shahar, M; Cohen, Y; Epelbaum, R; Faraggi, D; Haim, N; Robinson, E; Ron, Y | 1 |
| Abrahamsen, AF; Bergheim, J; Ostenstad, B; Tangen, JM | 1 |
| Chao, NJ; Horning, SJ; Rosenberg, SA | 1 |
| Akasi, Y; Hayabuchi, N; Jingu, K; Kikuchi, M; Komiyama, S; Masuda, K; Miyoshi, M | 1 |
| Asakura, S; Hirokawa, M; Matsushita, K; Tosaka, A; Yamazaki, A | 1 |
| Nachman, J | 1 |
| Blatsios, V; Bouros, D; Emmanouel, A; Niotis, M | 1 |
| Kamiya, O; Kobayashi, M; Mizuno, H; Mizuta, S; Nagata, K; Ohara, K; Sao, H; Takeyama, H; Watanabe, E; Yamada, H | 1 |
| Hagenbeek, A; Löwenberg, B; Michiels, J; Ruit, JB; Sizoo, W; Verhoef, GE; Wielenga, JJ | 1 |
| Ando, Y; Hashimoto, S; Hiramatsu, H; Kondo, M; Shigematsu, N; Uematsu, M | 1 |
| Fric, M; Hartmann, A; Herberhold, C; Klehr, HU; Pfeifer, U | 1 |
| Aitini, E; Amurri, B; Bocchia, M; Cavazzini, G; Gherlinzoni, F; Gobbi, M; Mazza, P; Tura, S; Zanchini, R; Zinzani, PL | 1 |
| Bernstein-Singer, M; Govindarajan, S; Hu, E; Pinter-Brown, L; Pinto, PC | 1 |
| Heinz, R | 1 |
| Advani, SH; Agarwala, S; Banavali, SD; Dinshaw, KA; Gonsalves, M; Gopal, R; Kurkure, P; Nair, CN; Pai, SK; Saikia, TK | 1 |
| Fornasier, V; Keystone, EC; Sturgeon, JF; Thomson, GT | 1 |
| Bladé, J; Carreras, E; Cervantes, F; Grañena, A; Marín, P; Nomdedeu, B; Ribera, JM; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Chessells, JM; Wheeler, K | 1 |
| Bertolotti, M; Gollini, C; Marchi, M; Mengoli, M; Rota, E; Signorelli, S | 1 |
| du Bois, A; Hillemanns, HG; Runge, M; Schmid, J | 1 |
| Kempf, HG | 1 |
| Bagella, MP; Cherchi, PL; Fadda, G | 1 |
| Duraj, M; Hołowiecki, J; Jarczok, K; Krawczyk-Kuliś, M; Rudzka, E | 1 |
| Chacón, RD; Navigante, AH | 1 |
| Bechard, DE; DeBlois, GG; Fairman, RP; Via, CT | 1 |
| Coiffier, B; Gisselbrecht, C; Lepage, E; Sebban, C | 1 |
| Coltman, CA; Dahlberg, S; Dana, BW; Fisher, RI; Jones, SE; Miller, TP | 1 |
| Connors, JM; Klimo, P | 3 |
| Berhardt, B; Chiarieri, D; Coleman, M; Gerstein, G; Lebowicz, J; Pasmantier, MW; Silver, RT; Topilow, A | 1 |
| Connors, JM; Klimo, P; Turhan, A | 1 |
| Carbone, PP; Creech, RH; Earle, JD; Glick, JH; Harrington, DP; Johnson, GJ; Mann, RB; Neiman, RS; O'Connell, MJ; Silverstein, MN | 1 |
| Cunningham, D; Dagg, JH; Evans, IL; Gilchrist, NL; Hepplestone, A; Soukop, M | 1 |
| Anderson, JR; Barcos, M; Bloomfield, CD; Ginsberg, SJ; Gottlieb, AJ; Holland, JF; Norton, L | 1 |
| Cáp, J; Foltinová, A; Misíková, Z | 1 |
| Cossman, J; Glatstein, E; Lawrence, TS; Steinberg, SM; Sundeen, JT; Urba, WJ; Young, RC | 1 |
| Brittinger, G; Dörken, B; Engelhard, M; Engert, W; Enne, W; Fuchs, R; Gerhartz, HH; Hagen-Aukamp, CH; Huhn, D; Thiel, E | 1 |
| Brittinger, G; Engelhard, M; Gerhartz, H; Heinz, R; Huhn, D; Meusers, P; Neubauer, A; Siegert, W; Stacher, A; Thiel, E | 1 |
| Karrison, T; Larson, R; Meier, P; Sagher, D; Schwartz, JL; Strauss, B | 1 |
| Jahn, H; Jorke, D; Kühn, R; Ruffert, K; Syrbe, G | 1 |
| Arnold, H; Busch, FW; Günther, E; Heim, ME; Kraft, H; Krüger, HU; Steinke, B | 1 |
| Abdel Jabar, A; Abssod, GH; Al-Idrissi, HY; Al-Mulhim, FA; Ibrahim, EM; Satti, MB | 1 |
| Brice, P; Gerota, I; Gisselbrecht, C; Lepage, E; Trédaniel, J | 1 |
| Bajetta, E; Banfi, A; Bonadonna, G; Buzzoni, R; Lattuada, A; Rilke, F; Valagussa, P | 1 |
| DeVita, VT; Glatstein, E; Ihde, DC; Jaffe, ES; Longo, DL; Young, RC | 1 |
| Coltman, CA; Dahlberg, S; Dana, BW; Fisher, RI; Jones, SE; Miller, TP; Weick, JK | 1 |
| Adler, K; Armitage, JO; Beshevkin, M; Coleman, M; Gaynor, M; McDermott, D; Pasmantier, MW; Reisman, AM; Silver, RT; Weisenburger, DD | 1 |
| Chan, TK; Liang, R; Todd, D | 1 |
| Armitage, JO; Glenn, LD; Goldsmith, JC; Howe, D; Sorensen, S; Weisenberger, DD | 1 |
| Carbone, A; Tirelli, U; Trovò, MG; Volpe, R; Zagonel, V | 1 |
| Armitage, JO; Bierman, PJ; Dowling, MD; Howe, D; Hutchins, M; Mailliard, J; Moravec, DF; Sorensen, S; Vose, JM; Weisenburger, DD | 1 |
| Armitage, JO; Bierman, PJ; Kessinger, A; Klassen, LW; Schouten, HC; Vaughan, WP; Weisenburger, D | 1 |
| Diehl, V; Schaadt, M; von Kalle, AK | 1 |
| Bross, K; Heidemann, E; Heim, ME; Hofmann, I; Josten, K; Kraft, A; Löffler, B; Reinold, HM; Richter, C; Steinke, B | 1 |
| Brittinger, G; Engelhard, M; Gerhartz, HH; Heinz, R; Huhn, D; Meusers, P; Siegert, W; Stacher, A; Thiel, E; Wilmanns, W | 1 |
| Castello, A; Coci, A; Inverardi, D; Lazzarino, M; Magrini, U; Merante, S; Morra, E; Orlandi, E; Pagnucco, G; Zei, G | 1 |
| Amoh, K; Fujita, M; Hayasaka, K; Kikuchi, Y; Nishino, S; Saito, Y; Uekita, Y | 1 |
| Brandi, M; Calabrese, P; De Lena, M; Lorusso, V; Maiello, E; Marzullo, F; Mazzei, A; Romito, S | 1 |
| Gutkowska, J; Konopka, L; Pakulska, J; Pawelski, S | 1 |
| Eifel, PJ; McClure, S | 1 |
| Anders, C; Höffken, K; Meier, CR; Nowrousian, MR; Osieka, R; Schmidt, CG; Schoetensack, B | 1 |
| Kojima, M; Naito, M; Nara, M; Shinbo, T; Tanahashi, N; Watanabe, K | 1 |
| Frydecka, I; Kotlarek-Haus, S; Kuliczkowski, K; Kuliszkiewicz-Janus, M; Urbaniak-Kujda, D; Wołowiec, D | 1 |
| Hyjek, E; Krykowski, E; Małecka, E; Olszańska-Skorek, T; Polkowska, E; Płuzańska, A; Stempczyńska, J | 1 |
| Cepelák, V; Cetkovský, P; Jungerová, J; Koza, V; Pittrová, H; Skopek, P; Vozobulová, V | 1 |
| Hoppe, RT | 1 |
| Ingberman, IaKh; Kaplanskaia, IB; Pan'shin, GA; Polianskaia, AM; Sotnikov, VM | 1 |
| Johansson, H; Lenner, P; Lindh, J; Roos, G | 1 |
| Bayle, C; Bergeron, C; Bernard, A; Caillaud, JM; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Luboinski, B; Patte, C | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; López-Vancell, D; Rodríguez, L; Torras, V | 1 |
| Chilcote, RR; Coccia, PF; Jenkin, RD; Kersey, JH; Meadows, AT; Pringle, KC; Rosenstock, J; Siegel, SE; Sposto, R; Stolar, CJ | 1 |
| Horikoshi, N | 1 |
| Hayashi, K; Kimura, I; Mizuta, J; Murashima, M; Ohnoshi, T; Tada, A; Tagawa, S; Ueno, K | 1 |
| Eschenbach, I; Gassel, WD; Hässler, R; Kolb, T; Köppler, H; Lennert, K; Pfab, R; Pflüger, KH; Schmidt, M; Wellens, W | 1 |
| Ben-Shahar, M; Cohen, Y; Epelbaum, R; Haim, N; Ron, Y | 2 |
| Adedeji, MO | 1 |
| Hara, K; Kunii, A; Shimizu, K | 1 |
| Baĭsogolov, GD; Davydov, VA; Polonskaia, NIu; Shakhtarina, SV | 1 |
| Gubareva, AA; Kindzel'skiĭ, LP | 1 |
| Boen-Tan, TN; Rouwen, AJ; Stilma, JS; Wijermans, PW | 1 |
| Andreu, J; Flores, A; Juncà, J; Lorenzo, JC; Millá, F; Navas, JJ | 1 |
| Finlay, JL; Frierdich, S; Link, MP; Trigg, ME | 1 |
| Bey, P; Breed, WP; Hoerni, B; Ruhl, U; Serraino, D; Tangury, A; Thomas, J; Tirelli, U; Tubiana, N; Zagonel, V | 1 |
| Bauer, K; Bettelheim, P; Konrad, K; Lenzhofer, R; Pirker, R; Prischl, F; Radaszkiewicz, T; Schwarzmeier, JD | 1 |
| Earle, JD; Glick, JH; Harrington, DP; Johnson, GJ; Neiman, RS; O'Connell, MJ; Silverstein, MN | 1 |
| Aarbakke, J; Kolmannskog, S; Moe, PJ; Prytz, PS; Slørdal, L | 1 |
| Bernard, A; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C | 1 |
| Burnelli, R; Mancini, AF; Paolucci, G; Paolucci, P; Pession, A; Rosito, P; Serra, L; Vecchi, V; Vivarelli, F | 1 |
| Gregory, WM | 1 |
| Chen, PM; Chiou, TJ; Chiu, CF; Chuang, MW; Hsieh, RK; Liu, JH; Tzeng, CH | 1 |
| Barrantes, J; García, I; Jiménez, E; Jiménez, R; Lobo-Sanahuja, F; Vargas, G | 1 |
| Kondo, M; Mikata, A; Shigematsu, N | 1 |
| Imura, H; Ino, T; Ito, N; Kojima, H; Maruyama, F; Matsui, T; Shimizu, K; Shinkai, K; Shirakawa, S; Sobue, R | 2 |
| Badía Torroella, RM; Cubells Riero, J; González Rivero, MA; Illa Sala, J; Melo Valls, M; Pardo García, N; Turmo Martí, J; Vela Ferrer, E | 1 |
| Bradstock, KF; Carter, J; Castaldi, P; Greenberg, M; Kamath, S; Koutts, J; Lee, CH; Robertson, TI; Stanton, A | 1 |
| Bennett, B; Brown, T; Dawson, AA; Moore, NR | 1 |
| Colly, LP; Peters, WG; Willemze, R | 3 |
| Wollner, N | 1 |
| Castel, V; Ferris, J; Mínguez, JR; Verdeguer, A | 1 |
| Bezanilla Regato, JL; Burgos, J; Moya Calderón, E; Navajas Gutiérrez, A; Zubeldia Sánchez, J | 1 |
| Allan, NC; Dawson, AA; Leonard, RC; Lucraft, HH; McGillivray, JB; Parker, AC; Prescott, RJ; Proctor, SJ | 1 |
| Armata, J; Dłuzewska, A | 1 |
| Cieślińska, A | 1 |
| Berard, C; Callihan, T; Falletta, J; Hvizdala, EV; Sabio, H; Shuster, JJ; Sullivan, M; Wharam, MD | 1 |
| Eschenbach, I; Gassel, WD; Hässler, R; Kolb, T; Köppler, H; Lennert, K; Loetzke, E; Pfab, R; Pflüger, KH; Schmidt, M | 1 |
| Connors, JM; Fairey, RN; Klimo, P; Voss, N | 1 |
| Anderson, J; Ezdinli, EZ; Harrington, DP; Kucuk, O; O'Connell, MJ; Silverstein, MW | 1 |
| Burgers, JM; Duez, N; Hayat, M; Qasim, M; Somers, R; Van Glabbeke, M | 1 |
| Al-Ismail, SA; Gough, J; Whittaker, JA | 1 |
| Brown, PC; Hart, MJ; White, TT | 1 |
| Altamirano-Alvarez, E; Ayon-Cardenas, A; Borrego-Roman, R; Cardenas-Cardoz, R; Lanche-Guevara, T; Lopez-Corella, E; Martinez-Avalos, A; Martinez-Guerra, G; Rivera-Luna, R | 1 |
| Abel, U; Fritze, D; Heim, ME; Ho, AD; Mebes, W | 1 |
| Blackledge, G; Crowther, D; Deakin, DP; Harris, M; Jones, JM; McWilliam, LJ; Scarffe, JH; Steward, WP; Todd, ID; Wagstaff, J | 1 |
| Michiels, JJ | 1 |
| Bowie, M; Hill, I; Rogers, P; Sinclair-Smith, C | 1 |
| Atkinson, CH; Colls, BM; Fitzharris, BM; Palmer, MC; Robinson, BA | 1 |
| Correa Alves, A; de Andrea, ML; de Camargo, B; Franco, EL; Machado, JC | 1 |
| Besa, EC | 1 |
| Alvarez de Mon, M; Bonilla, F; Diego, J; Durántez, A; España, P; Marazuela, M; Yebra, M | 1 |
| Falkson, CI; Falkson, G; Terblanche, AP; Vorobiof, DA | 1 |
| Ikeda, N; Ikuno, Y; Kikuchi, M; Nibu, K; Okamura, J; Tasaka, H; Yamada, S | 1 |
| Horiguchi, M; Kajiyama, K; Mizorogi, F; Nakata, T; Ogasawara, H; Satoi, S; Takaki, K; Tanaka, T; Tsuiki, S | 1 |
| Akashi, M; Akutsu, M; Furukawa, Y; Komatsu, N; Muroi, K; Ohsaka, A; Takagi, S; Takeda, K; Tsuboyama, A; Tsunoda, S | 1 |
| Abate, G; Basso, A; Comella, P; Di Pietro, N; Ganzina, F; Pergola, M; Salvatore, M; Silvestro, P; Zarrilli, D | 1 |
| Jin, BL | 1 |
| Chang, TT; Chen, TS; Chiou, SS; Perng, JJ | 1 |
| Chikada, K; Isono, M; Maeno, H; Nakajima, H; Saito, Y; Sawaki, S; Shinozaki, T; Suzuki, Y; Yamada, H; Yamada, K | 1 |
| Koike, S; Moriwaki, S; Ogawa, T; Okabe, K; Toki, H; Uno, K | 1 |
| de Bruïne, FT; Peters, WG; Tham, RT; Willemze, R | 1 |
| Bernard, JF; Boivin, P; Brousse, N; Chastang, C; Desaint, B; Gaulard, P; Herrera, A; Renoux, M; Solal-Celigny, P | 1 |
| Arlin, Z; Gee, T; Higgins, C; Kempin, S; Koziner, B; McKenzie, S; Mertelsmann, R; Schauer, P; Slater, DE; Straus, D | 1 |
| Barbieri, E; Emiliani, E; Gherlinzoni, F; Lauria, F; Mazza, P; Tabanelli, M; Tura, S; Zinzani, PL | 1 |
| Barcos, M; Gomez, GA; Han, T; Henderson, ES | 1 |
| Amadori, S; Guglielmi, C; Mandelli, F; Mantovani, L; Martelli, M; Papa, G; Ruco, LP | 1 |
| Divine, M; Farcet, JP; Gaulard, P; Haioun, C; Jouault, H; Kuentz, M; Reyes, F | 1 |
| Huzarski, J; Jarczok, K; Kardaszewicz, S; Kubińska, E; Luciak, M | 1 |
| Karim, AB; Langenhuijsen, MM; Mol, JJ; Nauta, JP; Ossenkoppele, GJ; Snow, GB; Veldhuijzen, RW | 1 |
| Armitage, JO; Wen, BC | 1 |
| Amadori, S; Anselmo, AP; Baroni, CD; Biagini, C; Cimino, G; Guglielmi, C; Mandelli, F; Papa, G | 1 |
| Din, GX; He, GF; Sun, ZY; Tang, WY | 1 |
| Abrahamsen, AF; Dahl, IM; Holte, H; Saeter, G | 1 |
| Imura, H; Ino, T; Ito, N; Kojima, H; Maruyama, F; Morikawa, K; Okamoto, M; Shinkai, K; Sobue, R; Takada, T | 1 |
| Barcos, MP; Bishop, JF; Diggs, CH; Kaplan, RS; Sutherland, JC; Wesley, MN; Wiernik, PH | 1 |
| Losonczy, H; Nagy, I | 1 |
| Bieger, R; Hermans, J; Kluin, PM; Noordijk, EM; Schaafsma, MR; Willemze, ER | 1 |
| Leifer, CE; Matus, RE; Page, RL | 1 |
| Kruglova, GV; Setdikov, RA | 1 |
| Schrøder, H | 1 |
| Kondo, M; Tominaga, S | 1 |
| Gallego Melcón, S; Macía Martí, J; Pérez Payarols, J; Prats Viñas, J; Sánchez de Toledo, J | 1 |
| Amiel, JL; Carde, P; Cosset, JM; Habrand, JL; Hayat, M; Henry-Amar, M; Ozanne, F; Tubiana, M | 1 |
| Adair, SE; Camitta, BM; Casper, JT; Kirchner, PA; Kun, LE; Lauer, SJ; Oechler, HW | 1 |
| Hanak, H; Heinz, R; Stacher, A | 1 |
| Poddubnaia, IV | 2 |
| Boyett, J; Crist, W; Doering, EJ; Hvizdala, E; Pullen, J; Ruymann, F; Steuber, CP; Sullivan, MP; Trueworthy, R | 1 |
| Qiu, W | 1 |
| Reed, RE; Silverman, EM | 1 |
| Farhangi, M; Lynfield, YL; Runnels, JL | 1 |
| Corcino, J; Maldonado, N | 1 |
| Kiely, JM | 1 |
| De Souza e Silva, NA; Wilson, DM | 1 |
| de Sèze, S; Druet, P; Dryll, A; Kahn, MF; Ryckewaert, A | 1 |
| Eichwald, EJ; Jalota, R | 1 |
| Bierman, SM; Krain, LS | 1 |
| Aghai, E; Hulu, N; Kende, G; Ramot, B; Virag, I | 1 |
| Gregl, A; Krack, U; Prindul, F; Weigel, F | 1 |
| Thorpe, P | 1 |
| Amiel, JL; Clarysse, A; Hayat, M; Mathé, G; Schwarzenberg, L | 1 |
| Davis, P | 1 |
| Dammert, K; Karma, P; Palva, A; Palva, T | 1 |
| Jacobi, H; Karitzky, D | 1 |
| Cassen, B; Zucker, RM | 1 |
| Gutjahr, P | 1 |
| Costanzi, JJ; Mims, CH | 1 |
| Armata, J; Cyklis, R; Halikowska-Lacka, E; Legutko, L; Zajackowski, J | 1 |
| Gunz, FW; Levi, JA; Lind, DE; Vincent, PC | 1 |
| De Vita, VT; Myers, GH; Sherins, RJ; Van Thiel, DH | 1 |
| Han, T; Reilly, CJ; Slack, NH; Stutzman, L; Webster, J | 1 |
| Nissen, NI; Walbom-Jorgensen, S | 1 |
| Con, I; Daiber, A; Donoso, A; Mora, F; Osorio, G | 1 |
| Armata, J | 2 |
| Carbone, PP | 2 |
| Delobel, J; Le Bourgeois, JP | 1 |
| Rubin, P | 1 |
| De Vries, A; Henig, E; Oliver, I; Pinkhas, J; Spitzer, SA | 1 |
| DeVita, VT; Sherins, RJ | 1 |
| Beathard, GA; Cottom, DL; Cotton, JR; Fish, JC; Lindley, JD; Remmers, AR; Ritzmann, SE; Searls, AG; Townsend, CM | 1 |
| Bagley, CM; Canellos, GP; Chabner, BA; De Vita, VT; Schein, PJ; Young, RC | 1 |
| Abrahamsen, AF; Host, H | 1 |
| Berard, C; Canellos, GP; Chabner, BA; DeVita, VT; Schein, PS; Young, RC | 1 |
| Aungst, CW | 1 |
| Bush, M; Squire, RA | 2 |
| Arseneau, JC; Canellos, GP; DeVita, VT; Sherins, RJ | 1 |
| Barnett, LB; Schwartz, E | 1 |
| Bishop, YM; Moloney, WC; Myerowitz, RL; Pinkus, GS; Skarin, AT | 1 |
| Desser, RK; Golomb, HM; Miller, JB; Moran, EM; Stein, RS; Ultmann, JE | 1 |
| Donati, A; Morici, V; Moscato, V; Rasà, G | 1 |
| Krakoff, IH; Lee, BJ; Mukherji, B; Yagoda, A | 1 |
| Frei, E | 1 |
| Bailey, CC; Campbell, RH | 1 |
| Halkin, H; Meytes, D; Militeanu, J; Ramot, B | 1 |
| Focan, C; Hugues, J | 1 |
| McElwain, TJ | 1 |
| Boiron, M; Jacquillat, C; Weil, M | 1 |
| Bernard, J; Blom, J; Boiron, M; Cuttner, J; Ellison, RR; Forcier, RJ; Gussoff, B; Haurani, F; Hayes, DM; Holland, JF; Hutchison, JL; Jacquillat, C; Karanas, A; Kyle, R; Leone, LA; Moon, JH; Rosner, F; Sawitsky, A; Silver, RT; Spurr, CL; Weil, M | 1 |
| Doak, PB; Montgomerie, JZ; North, JD; Smith, F | 1 |
| Bauters, F; Goudemand, M; Lerche-Habart, B; Sautière-Habay, D | 1 |
| Glidewell, OJ; Harley, JB; Hoogstraten, B; Lenhard, RE; Leone, LA; Miller, S; Olson, KB; Owens, AH; Spurr, CL; Townsend, SR | 1 |
| Aungst, CW; Ezdinli, EZ; Firat, D; Stutzman, L | 1 |
| Eridani, S; Esposito, R; Giangrande, A; Ponti, GB | 1 |
| DeVita, VT; Lowenbraun, S; Serpick, AA | 1 |
| Gunz, FW; Mani, MK; Ravich, RB; Speden, J; Vincent, PC | 1 |
| Crowther, D | 1 |
| Feldman, MJ; Lowenbraun, S; Serpick, AA; Sutherland, JC | 1 |
| Butler, JJ; Fuller, LM; Gamble, JF; Shullenberger, CC | 1 |
| Coltman, CA; Frei, E; Gamble, JF; Gehan, EA; Hewlett, JS; Isaacs, BL; Luce, JK; Monto, RW; Palmer, RL; Wilson, HE | 1 |
| Cohen, ML; Weiss, EB | 1 |
| Lewinski, U | 1 |
| Krakoff, IH; Mukherji, B; Oettgen, HF; Yagoda, A | 1 |
| Brettschneider, L; Hammond, W; Penn, I; Starzl, TE | 1 |
| Becker, H | 1 |
| Presant, CA; Serpick, AA; Wiernik, PH | 1 |
| Cajozzo, A; Carreca, I; Citarrella, P; D'Eredità, F | 1 |
| Bagley, CM; Berard, CW; Canellos, GP; Devita, VT | 1 |
| Kurnick, JE; Robinson, WA | 1 |
| Bloomfield, CD; Brunning, RD; Kennedy, BJ | 1 |
| Czechowicz, Z; Religa, H; Sosin, A | 1 |
| Aur, RJ; Hustu, HO; Pinkel, D; Pratt, CB; Simone, JV | 1 |
| Galton, DA | 1 |
| Blom, J; Burgert, EO; Chevalier, L; Denton, R; Glidewell, O; Hananian, J; Holland, JF; Jones, B; Kung, F; Mills, SD; Nyhan, WL; Sheehe, P; Treat, C; Wolman, IJ | 1 |
| Cline, MJ | 1 |
| Boichis, H; Cohen, BE; Passwell, J | 1 |
| White, LP | 1 |
| De Vita, VT; Emmer, M | 1 |
| Faldini, A; Kutschera, H | 1 |
| Abadi, A; Choi, OS; Hall, TC; Krant, MJ | 1 |
| Carter, VH; Noojin, RO; Self, SJ | 1 |
| Ghosh, L; Muehrcke, RC | 1 |
| Band, PR; Banerjee, TK; Henderson, JF; Little, AS; Silverberg, DS; Ulan, RA; Wensel, RH | 1 |
| Cohen, RA; Glatstein, HR; Rosenbaum, EH | 1 |
171 review(s) available for prednisone and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Immunotherapy, Adoptive; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Prednisone; Receptors, Chimeric Antigen; Risk Assessment; Rituximab; Stem Cell Transplantation; Vincristine; Waldenstrom Macroglobulinemia | 2021 |
Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP as a First-Line Treatment of Indolent Non-Hodgkin's Lymphoma or Mantle-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisone; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2022 |
Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Severity of Illness Index; Vincristine | 2020 |
Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Kidney; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Renal Dialysis; Rituximab; Vincristine; Young Adult | 2021 |
Primary adrenal non-Hodgkin lymphoma: a case report and review of the literature.
Topics: Abdominal Pain; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Fatigue; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Double-Hit Large B Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Rearrangement; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mutation; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Vincristine | 2017 |
The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Glucose-6-Phosphate; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2018 |
Non-Hodgkin lymphoma, diagnostic, and prognostic particularities in children - a series of case reports and a review of the literature (CARE compliant).
Topics: Abdominal Pain; Anemia, Iron-Deficiency; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Diarrhea; Fatal Outcome; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Treatment Outcome; Vincristine; Vomiting; Weight Loss | 2018 |
Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin's lymphoma and responding to doxorubicin treatment: case report and review of the literature.
Topics: Adenoma; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Growth Hormone; Humans; Lymphoma, Non-Hodgkin; Male; Pituitary Neoplasms; Prednisone; Rituximab; Vincristine | 2018 |
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Management; Disease Susceptibility; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Neoplasm Grading; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2019 |
[Non-Hodgkin lymphoma of maxillofacial soft tissue: a report of two cases and review of the literature].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Masseter Muscle; Middle Aged; Muscle Neoplasms; Prednisone; Pterygoid Muscles; Radiotherapy, Adjuvant; Vincristine | 2013 |
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.
Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; HIV; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
Primary non-Hodgkin's lymphoma of the bladder: case report and literature review.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Hematuria; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Rituximab; Urinary Bladder Neoplasms; Vincristine | 2013 |
Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies.
Topics: Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Liposomes; Lymphoma, Non-Hodgkin; Prednisone; Treatment Outcome; Vincristine | 2014 |
[Malignant lymphoma and adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Genetic Markers; Genetic Testing; Hodgkin Disease; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Methylprednisolone; Positron-Emission Tomography; Prednisone; Vincristine | 2014 |
Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Proportional Hazards Models; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2014 |
Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Cyclophosphamide; Doxorubicin; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Middle Aged; Prednisone; Rituximab; Tomography, X-Ray Computed; Vincristine | 2014 |
A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Immunologic Factors; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Thalidomide; Treatment Outcome; Vincristine | 2015 |
CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma--a meta-analysis of randomized controlled trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2016 |
[NON-HODGKIN'S LYMPHOMA OF THE FEMALE GENITAL SYSTEM--A LITERATURE REVIEW].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Genital Neoplasms, Female; Genitalia, Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 2015 |
Limited Stage Aggressive Non-Hodgkin Lymphoma: What Is Optimal Therapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Radioimmunotherapy; Radiotherapy; Treatment Outcome; Vincristine | 2016 |
Indolent Lymphomas That Present With Clinically Aggressive Features: A Subset of Low-Grade Lymphomas With a Behavior Inconsistent With the Histologic Diagnosis.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bone Marrow; Cause of Death; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Humans; Immunophenotyping; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2016 |
Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Bone Marrow; Cyclophosphamide; Doxorubicin; Enterovirus Infections; Fatal Outcome; Female; Humans; Immunoglobulins, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2017 |
Extranodal lymphoma: a reappraisal.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Prospective Studies; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine | 2008 |
Recent developments in the treatment of aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab | 2009 |
[Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Transplantation, Autologous; Vincristine | 2008 |
[Radiotherapy indications in non-Hodgkin lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Phenotype; Prednisone; Radiotherapy Dosage; Vincristine | 2009 |
Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review.
Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prevalence; Retrospective Studies; Rituximab; Scleroderma, Systemic; Sex Factors; Tomography, X-Ray Computed; Vincristine; Young Adult | 2010 |
High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Vincristine | 2010 |
Rituximab-associated neutropenia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Chemokine CXCL12; Cyclophosphamide; Doxorubicin; Etoposide; Granulocytes; Homeostasis; Humans; Incidence; Lymphoma, Non-Hodgkin; Neutropenia; Prednisone; Rituximab; Time Factors; Vincristine | 2010 |
Intrathecal chemotherapy in lymphomatous meningitis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Immunocompetence; Immunocompromised Host; Injections, Spinal; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Meninges; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Risk Factors; Rituximab; Vincristine | 2011 |
[Listeriosis in non-Hodgkin's lymphoma following outpatient R-CHOP therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Listeriosis; Lymphoma, Non-Hodgkin; Male; Prednisone; Vincristine | 2010 |
[Plasmacytoid dendritic cell tumor].
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dendritic Cells; Disease Progression; Doxorubicin; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Acute; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Skin Neoplasms; Transplantation, Homologous; Vincristine | 2011 |
A meta-analysis on Rituximab combined CHOP chemotherapy for non-Hodgkin lymphoma in China.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; China; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2011 |
Lymphoma study group of JCOG.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Approval; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Japan; Kaplan-Meier Estimate; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 2012 |
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Odds Ratio; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Rituximab; Treatment Outcome; Vincristine | 2012 |
[Intravascular NK-cell lymphoma: a clinicopathologic study and literature review].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD56 Antigen; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Granzymes; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; RNA, Viral; Vascular Neoplasms; Vincristine; Young Adult | 2011 |
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chlorambucil; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Forecasting; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Treatment Outcome; Vidarabine; Vincristine | 2002 |
Leptomeningeal involvement in a patient with splenic lymphoma with villous lymphocytes.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid; Cranial Irradiation; Cyclophosphamide; Dexamethasone; Erythrocyte Transfusion; Humans; Lymphocytosis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Meninges; Neoplastic Stem Cells; Prednisone; Splenic Neoplasms; Vincristine; Vitamin B 12; Vitamin B 12 Deficiency | 2002 |
[Treatment of high-grade, disseminated non-Hodgkin's lymphoma in elderly patients].
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Geriatrics; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Prognosis; Quality of Life; Survival Analysis; Vincristine | 2002 |
Non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; United States; Vincristine | 2002 |
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Chills; Cyclophosphamide; Doxorubicin; Fever; Hodgkin Disease; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Multiple Myeloma; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2003 |
Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2003 |
A new approach to the diagnosis and treatment of intravascular lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Gene Rearrangement; Genes, Immunoglobulin; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Spinal Cord Neoplasms; Vascular Neoplasms; Vincristine | 2003 |
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy; Survival Rate; Vincristine | 2003 |
[Erythema nodosum association with malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Erythema Induratum; Erythema Nodosum; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paraneoplastic Syndromes; Prednisolone; Prednisone; Pregnancy; Procarbazine; Remission Induction; Vincristine | 2003 |
Non-hodgkins lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Idarubicin; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Prednisone; Vincristine | 2003 |
[THERAPY OF HEMOLYMPHOPATHIES WITH PREDNISONE AT HIGH DOSES].
Topics: Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid; Liver; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Pathology; Plasmacytoma; Prednisone; Radiography, Thoracic; Sarcoma | 1964 |
New therapeutic approaches to non-Hodgkin's lymphomas.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Radioimmunotherapy; Stem Cell Transplantation; Vincristine | 2003 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Hematologic Neoplasms; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 2003 |
A review of recruitment criteria, patient characteristics and results of CHOP chemotherapy in prospective randomized phase III clinical trials for aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Patient Selection; Prednisone; Prospective Studies; Reproducibility of Results; Survival Analysis; Vincristine | 2003 |
What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Forecasting; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Multicenter Studies as Topic; Pilot Projects; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Teniposide; Treatment Outcome; Vinblastine | 2004 |
Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Genes, bcl-2; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2004 |
Clinical trials for malignant lymphoma in Japan.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Granulocyte Colony-Stimulating Factor; Humans; Japan; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic; Prednisone; Vincristine | 2004 |
Outcome of elderly patients with aggressive Non-Hodgkin's lymphoma refractory to or relapsing after first-line CHOP or CHOP-like chemotherapy: a low probability of cure.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphoma.
Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Gene Expression Regulation, Leukemic; Humans; Lymphoma, Non-Hodgkin; Oligonucleotides, Antisense; Prednisone; Proto-Oncogene Proteins c-bcl-2; Remission Induction; Rituximab; RNA, Messenger; Survival Analysis; Thionucleotides; Transplantation, Heterologous; Vincristine | 2004 |
[Malignant lymphoma, multiple myeloma and myeloproliferative diseases in the elderly].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multiple Myeloma; Myeloproliferative Disorders; Prednisone; Prognosis; Rituximab; Vincristine | 2004 |
New treatment strategies for aggressive lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisolone; Prednisone; Vincristine | 2004 |
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Recurrence; South Africa; Time Factors; Vinblastine; Vincristine | 2005 |
[Progress in therapeutic strategy for malignant lymphoma].
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Rituximab; Salvage Therapy; Vinblastine; Vincristine | 2005 |
Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Prednisone; Treatment Outcome; Vincristine | 2005 |
Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; France; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Prednisone; Vindesine | 2005 |
Overview of Southwest Oncology Group clinical trials in non-Hodgkin lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Meta-Analysis as Topic; Pilot Projects; Prednisone; Treatment Outcome; Vincristine | 2005 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Colorectal Neoplasms; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gastrointestinal Diseases; Gemcitabine; Humans; Incidence; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mucositis; Neoplasms; Prednisone; Radiotherapy; Severity of Illness Index; Stomatitis; Taxoids; Vinblastine; Vincristine; Vinorelbine | 2006 |
Fourth biannual report of the Cochrane Haematological Malignancies Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Europe; Hematologic Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Multicenter Studies as Topic; Multiple Myeloma; National Institutes of Health (U.S.); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Pyrazines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; United States; Vinblastine; Vincristine | 2006 |
Primary uterine lymphoma: report of 2 cases and review of literature.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Radiotherapy Dosage; Uterine Neoplasms; Vincristine | 2006 |
Diffuse aggressive histologies of non-hodgkin lymphoma: treatment and biology of limited disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Vincristine | 2006 |
Treatment of diffuse large B-cell lymphoma: a risk-based approach.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy; Humans; Immunotherapy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prednisone; Prognosis; Risk; Rituximab; Time Factors; Treatment Outcome; Vincristine | 2006 |
Treatment of non-Hodgkin's lymphoma: a look over the past decade.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2006 |
Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; CD4 Antigens; CD56 Antigen; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dendritic Cells; Dexamethasone; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Skin Neoplasms; Vincristine | 2006 |
The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Rituximab; Vincristine | 2007 |
[An update on recent developments in non-Hodgkin's lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prednisone; Prognosis; Radioimmunotherapy; Rituximab; Vincristine | 2007 |
Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Specificity; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow Diseases; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Forecasting; Half-Life; Humans; Immunoglobulin Constant Regions; Immunoglobulin Variable Region; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mice; Prednisone; Randomized Controlled Trials as Topic; Receptors, IgG; Remission Induction; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine | 2007 |
Primary effusion lymphoma.
Topics: Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cyclophosphamide; Doxorubicin; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Pericardial Effusion; Pleural Effusion; Prednisone; Vincristine | 2007 |
[Recent progress in rituximab therapy and its resistance--how do we overcome?].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; CD55 Antigens; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Humans; Lymphoma, Non-Hodgkin; Point Mutation; Prednisone; Pyrazines; Rituximab; Vincristine | 2007 |
Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.
Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Longitudinal Studies; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prevalence; Prognosis; Recombinant Proteins; Survival Rate; Teniposide; Vincristine | 2007 |
[High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Forecasting; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Vincristine | 2008 |
CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Prednisolone; Prednisone; Treatment Outcome; Vincristine | 2008 |
The development of pericarditis following peripheral blood stem cell transplantation: a case report.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Causality; Chest Pain; Cyclophosphamide; Doxorubicin; Early Diagnosis; Echocardiography; Electrocardiography; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nurse's Role; Nursing Assessment; Oncology Nursing; Pericarditis; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine | 2008 |
Advances in adult non-Hodgkin's lymphoma. Current concepts of classification, diagnosis, and management.
Topics: Adult; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Humans; Lymph Nodes; Lymphocytes; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1980 |
Non-Hodgkin's lymphomas.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Immunologic Deficiency Syndromes; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Vincristine; Whole-Body Irradiation | 1984 |
Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Prednisone; Procarbazine; Radiotherapy; Vincristine | 1984 |
Transverse nail ridgings (Beau's lines) induced by chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Head and Neck Neoplasms; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Nail Diseases; Nails; Prednisone; Vincristine | 1994 |
Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Vincristine | 1994 |
[New therapy of patients with malignant lymphoma using G-CSF].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Genetic Therapy; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recombinant Proteins; Vincristine | 1994 |
[CHOP-Bleo therapy in high-malignancy non-Hodgkin lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Vincristine | 1994 |
Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Vincristine | 1995 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Salvage Therapy; Vinblastine; Vincristine | 1995 |
Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?
Topics: Animals; Antibodies, Protozoan; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bone Marrow Transplantation; Chorioretinitis; Combined Modality Therapy; Fatal Outcome; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Opportunistic Infections; Prednisone; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Ocular | 1995 |
[Elderly non-Hodgkin's lymphoma arising in left brachial soft tissue].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arm; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Soft Tissue Neoplasms; Vincristine | 1993 |
Polymyositis-dermatomyositis and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dermatomyositis; Doxorubicin; Fatal Outcome; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Polymyositis; Prednisone; Radiography; Vincristine; Vision Disorders | 1993 |
What treatment for elderly patients with aggressive lymphoma?
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Vincristine | 1994 |
[Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prostatic Neoplasms; Remission Induction; Vincristine | 1994 |
[Recent progress in the chemotherapy of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Survival Rate; Vincristine | 1995 |
[Recent progress in the treatment of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Prednisone; Prognosis; Vincristine | 1994 |
[Therapy of high-grade non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Salvage Therapy; Survival Rate; Vincristine | 1994 |
Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Prospective Studies | 1994 |
[Reversible myelofibrosis in angioimmunoblastic lymphadenopathy].
Topics: Biopsy, Needle; Bone Marrow; Drug Therapy, Combination; Female; Humans; Immunoblastic Lymphadenopathy; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Primary Myelofibrosis; Remission Induction; Vincristine | 1994 |
[Chemotherapy for malignant lymphoma in Western countries and Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Humans; Japan; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Multicenter Studies as Topic; Prednisone; Survival Rate; Vincristine | 1993 |
Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus.
Topics: Aged; Autoantibodies; Biopsy; Combined Modality Therapy; Cyclophosphamide; Cytoskeletal Proteins; Desmoplakins; Humans; Immunoglobulins, Intravenous; Lymphoma, Non-Hodgkin; Male; Paraneoplastic Syndromes; Pemphigus; Plasmapheresis; Prednisone; Radiotherapy; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 1993 |
Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Carmustine; Cyclophosphamide; Doxorubicin; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasms, Second Primary; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1993 |
What is the role of third generation regimens for initial therapy of non-Hodgkin's lymphomas?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1993 |
[High-grade non-Hodgkin lymphoma: diagnosis and therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Transplantation, Autologous; Vincristine | 1996 |
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunologic Factors; Immunophenotyping; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Survival Analysis; Survival Rate; Vincristine | 1996 |
Ifosfamide in the treatment of lymphoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Prednisone; Salvage Therapy; Survival Rate; Vincristine | 1996 |
[Non-Hodgkin lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 1996 |
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 1995 |
[High-clore chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) for patients with malignant lymphoma--its role in the treatment strategy for non-Hodgkin's lymphoma, and ESHAP + PBSCT therapy].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cisplatin; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Prednisone; Transplantation, Autologous | 1996 |
Clinical reversal of multidrug resistance.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, Non-Hodgkin; Prednisone; Verapamil; Vincristine | 1996 |
Primary cerebral lymphoma--a case report and review of the management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 1995 |
Primary extramedullary leukemia of the prostate: case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnostic Errors; Doxorubicin; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prostatectomy; Prostatic Neoplasms; Radioisotope Teletherapy; Remission Induction; Urinary Retention; Vincristine | 1996 |
[Metastatic malignant melanoma in treated non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melanoma; Neoplasm Staging; Neoplasms, Multiple Primary; Prednisone; Skin Neoplasms | 1996 |
[Recent progress in the management of malignant lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Prednisone; Prognosis; Purine Nucleosides; Survival Rate; Vincristine | 1997 |
Acute liver failure due to hepatic involvement by hematologic malignancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Liver Failure, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1997 |
Primary non-Hodgkin's lymphoma of the common bile duct.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cell Lineage; Cholestasis; Combined Modality Therapy; Common Bile Duct Neoplasms; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Survival Rate; Vincristine | 1997 |
Overview of treatment of localized low-grade lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; California; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; England; Humans; Life Tables; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 1997 |
[Diagnosis and therapy of malignant thyroid lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytodiagnosis; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prednisone; Radiotherapy; Thyroid Neoplasms; Vincristine | 1997 |
Diagnostic dilemma in pancreatic lymphoma. Case report and review.
Topics: Azathioprine; Cyclosporine; Diagnosis, Differential; Fatal Outcome; Female; Humans; Kidney Transplantation; Lymphoma, Non-Hodgkin; Middle Aged; Pancreatic Neoplasms; Prednisone; Ultrasonography | 1997 |
[Treatment of lymphoma in the aged].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Palliative Care; Prednimustine; Prednisolone; Prednisone; Prognosis; Vincristine | 1998 |
[Treatment strategy of high malignancy non-Hodgkin lymphomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy, Adjuvant; Treatment Outcome; Vincristine | 1998 |
[A case of retroperitoneal malignant lymphoma successfully treated by chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Remission Induction; Retroperitoneal Neoplasms; Vincristine | 1998 |
[Primary MALT-type lymphoma of the breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Vincristine | 1998 |
[Chylothorax resulting from malignant non Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chylothorax; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1998 |
[Dose-effects and chemotherapy dose intensity of aggressive non-Hodgkin's lymphomas in the adult].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Patient Selection; Prednisone; Recurrence; Remission Induction; Vincristine | 1998 |
A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; CD2 Antigens; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Doxorubicin; Female; Humans; Immunophenotyping; Karyotyping; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nasopharyngeal Neoplasms; Prednisone; Skin; Skin Neoplasms; Spinal Cord Neoplasms; Vincristine | 1998 |
Management of intermediate-grade lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Salvage Therapy; Survival Rate; Vincristine | 1998 |
[Chemotherapy for non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine | 1998 |
[New antitumor drugs for non-Hodgkin's lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Clinical Trials as Topic; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Paclitaxel; Prednisone; Rituximab; Taxoids; Vincristine | 1998 |
Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Epstein-Barr Virus Infections; Fatal Outcome; Female; Gene Rearrangement; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunophenotyping; In Situ Hybridization; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Polymerase Chain Reaction; Prednisone; Receptors, Antigen, B-Cell; Reed-Sternberg Cells; Remission Induction; RNA, Viral; Vincristine | 1999 |
Intermediate and high grade non Hodgkin's lymphoma in the elderly.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Incidence; Lymphoma, Non-Hodgkin; Middle Aged; Netherlands; Prednisone; Vincristine | 1999 |
[Treatment of malignant lymphoma with extranodal lesions--current trends and new strategies in chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Invasiveness; Prednisone; Prognosis; Survival Rate; Vincristine | 1999 |
Intensified CHOP in non-Hodgkin's lymphoma: what we know and what we need to know.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Survival Rate; Vincristine | 1999 |
The prednisone dosage in the CHOP chemotherapy regimen for non-Hodgkin's lymphomas (NHL): is there a standard?
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Practice Patterns, Physicians'; Prednisone; Reference Values; Reproducibility of Results; Vincristine | 2000 |
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Vincristine | 2001 |
Primary non-Hodgkin's lymphoma of the gall bladder.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gallbladder; Gallbladder Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Ultrasonography; Vincristine | 2000 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Boston; Brain Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dexamethasone; Doxorubicin; Eye Neoplasms; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Time Factors; Treatment Outcome; Vincristine | 2001 |
Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2001 |
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Forecasting; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Risk Factors; Rituximab; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vincristine | 2001 |
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Metaphase; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prednisolone; Prednisone; Prospective Studies; Survival Analysis; Vincristine | 2001 |
Management of localized (stage I and II) clinically aggressive lymphomas.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Life Tables; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Therapeutic strategies for aggressive lymphomas: the trials of the DSHNHL.
Topics: Adolescent; Adult; Age Factors; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Germany; Humans; Immunotherapy; International Cooperation; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Risk Factors; Rituximab; Severity of Illness Index; Treatment Outcome; Vincristine | 2001 |
Treatment strategies in elderly patients with aggressive histology lymphoma.
Topics: Age Factors; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Comorbidity; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Rituximab; Survival Rate; Vincristine | 2001 |
Rituximab in the treatment of diffuse large B-cell lymphomas.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Prednisone; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2002 |
Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vidarabine; Vincristine | 2002 |
Immunochemotherapy in indolent non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vidarabine; Vincristine | 2002 |
Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Randomized Controlled Trials as Topic; Rituximab; Survival Rate; Vincristine | 2002 |
Primary lymphoma of the kidney. Report of a case and update of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunophenotyping; Kidney; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Nephrectomy; Prednisone; Vincristine | 2002 |
Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
Topics: Altretamine; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Topics: Adult; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lomustine; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission, Spontaneous; Streptonigrin; Time Factors; Vinblastine; Vincristine | 1977 |
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Prospective Studies; Retrospective Studies; Survival Rate; Vincristine | 1992 |
Non-Hodgkin's lymphomas in children. II. Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Prednisolone; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 1992 |
Non-Hodgkin's lymphoma presenting with cardiac tamponade.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiac Tamponade; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Pericardial Effusion; Prednisone; Vincristine | 1992 |
[Massive bilateral non-Hodgkin's lymphoma of the adrenal glands].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine | 1990 |
The place of third-generation regimens in the treatment of adult aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Rate; Vincristine | 1991 |
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Survival Rate; Vincristine | 1991 |
[Problems of cancer treatment in the elderly from the viewpoint of the chemotherapist--focusing on malignant lymphomas as a model of chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisolone; Prednisone; Survival Rate; Vincristine | 1990 |
[A bulky mass non-Hodgkin's lymphoma with dysuria in the rectovesical space].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Prednisone; Rectal Neoplasms; Urinary Bladder Neoplasms; Urination Disorders; Vincristine | 1990 |
Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Brain Neoplasms; Cell Differentiation; Child; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Doxorubicin; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Rate; United States; Vincristine | 1990 |
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine | 1988 |
European experience with ifosfamide in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Europe; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone | 1989 |
The role of radiation therapy in the management of the non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Mycosis Fungoides; Palliative Care; Prednisone; Radiotherapy Dosage; Skin Neoplasms; Time Factors; Vincristine; Whole-Body Irradiation | 1985 |
[Cancer curable by chemotherapy: malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Prednisone; Remission Induction; Transplantation, Autologous; Vincristine | 1989 |
[Current status of chemotherapy in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine | 1989 |
[Glucocorticosteroids in the treatment of acute leukemia and lymphosarcoma in children].
Topics: Acute Disease; Administration, Oral; Age Factors; Antimetabolites; Antineoplastic Agents; Drug Synergism; Glucocorticoids; Humans; Injections, Intravenous; Leukemia; Lymphoma, Non-Hodgkin; Prednisone; Remission, Spontaneous; Time Factors | 1972 |
Non-Hodgkin's lymphoma: recent observations on natural history and intensive treatment.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine | 1972 |
Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vinca Alkaloids; Vincristine | 1972 |
Recently recognized complications of cancer chemotherapy.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination; Hodgkin Disease; Humans; Hyperkalemia; Infertility, Male; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Neoplasms; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Spermatogenesis; Vincristine | 1974 |
[Danger of hyperuricemia in the treatment of acute leukemia, lymphosarcoma and reticulosarcoma].
Topics: Acute Disease; Allopurinol; Antineoplastic Agents; Child; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Uric Acid; Xanthine Oxidase | 1974 |
[Cancerostatic ingredients of higher plants].
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Colchicine; Drug Combinations; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Methotrexate; Mice; Plant Extracts; Plant Proteins; Plants, Medicinal; Prednisone; Species Specificity; Terpenes; Vincristine | 1971 |
436 trial(s) available for prednisone and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2022 |
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.
Topics: Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Mutation; Neoplasm Recurrence, Local; Prednisone; Radioimmunotherapy; Rituximab; Tumor Suppressor Protein p53; Vincristine | 2023 |
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Prospective Studies; Rituximab; Vincristine | 2021 |
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; DNA, Viral; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Viral Load; Vorinostat | 2020 |
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Hydrazines; Lymphoma, Non-Hodgkin; Mice; Prednisone; Rituximab; Triazoles; Vincristine | 2021 |
Infectious diseases and immunological markers associated with patients with non-Hodgkin lymphoma treated with rituximab.
Topics: Adult; Aged; Antibodies, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Humans; Immunoglobulins, Intravenous; Infections; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumococcal Vaccines; Prednisone; Rituximab; Vincristine | 2018 |
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2018 |
First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Prednisone; Progression-Free Survival; Proportional Hazards Models; Rituximab; Survival Rate; Vincristine | 2019 |
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Prednisone; Rituximab; Sulfonamides; Vincristine | 2019 |
Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 2020 |
Primary non-Hodgkin lymphoma in the pterygopalatine fossa. A peculiar diagnosis with a minimally invasive endoscopic approach.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Endoscopy; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Pterygopalatine Fossa; Rituximab; Skull Neoplasms; Vincristine | 2014 |
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report.
Topics: Acute Kidney Injury; Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Hydrocortisone; Hyperuricemia; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Proteins; Pilot Projects; Prednisone; Prospective Studies; Rituximab; Tumor Lysis Syndrome; Urate Oxidase; Vincristine; Young Adult | 2013 |
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2013 |
A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Vincristine; Young Adult | 2014 |
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Nitrogen Mustard Compounds; Paresthesia; Peripheral Nervous System Diseases; Prednisone; Rituximab; Treatment Outcome; Vincristine; Vomiting | 2014 |
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Lenograstim; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Proteins; Risk Factors; Rituximab; Thrombocytopenia; Vincristine; Young Adult | 2014 |
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Topics: Adenine; Administration, Oral; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Non-Randomized Controlled Trials as Topic; Piperidines; Prednisone; Prognosis; Pyrazoles; Pyrimidines; Rituximab; Severity of Illness Index; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2014 |
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Nervous System Diseases; Prednisone; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine | 2015 |
Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytokines; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphocyte Activation; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2016 |
Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Quality of Life; Rituximab; Surveys and Questionnaires; Vincristine | 2016 |
Phase III of Study of R-CHOP-21 vs R-CHOP-14 for Untreated Stage III and IV B-cell Non-Hodgkin's Lymphoma: a Report from Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Iran; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Rituximab; Survival Rate; Vincristine; Young Adult | 2016 |
Efficacy and safety of triple therapy with aprepitant, ondansetron, and prednisone for preventing nausea and vomiting induced by R-CEOP or CEOP chemotherapy regimen for non-Hodgkin lymphoma: a phase 2 open-label, randomized comparative trial.
Topics: Activities of Daily Living; Adult; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Prednisone; Quality of Life; Treatment Outcome; Vomiting | 2017 |
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP r
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intravenous; Injections; Leukocyte Count; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Platelet Count; Prednisone; Survival Analysis | 2008 |
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Germany; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Risk Factors; Rituximab; Vincristine | 2009 |
[Role of modified radiotherapy in the combined treatment of orbital non-Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cataract; Conjunctivitis; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Dry Eye Syndromes; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Orbital Neoplasms; Prednisone; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Vincristine | 2009 |
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recombinant Proteins; Treatment Outcome; Vincristine | 2009 |
Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Radioimmunotherapy; Rituximab; Treatment Outcome; Vincristine; Yttrium Radioisotopes | 2009 |
Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregio
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Follow-Up Studies; Humans; Italy; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Invasiveness; Prednisone; Radiotherapy, Conformal; Survival Analysis; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2009 |
Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas--the PETAL trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2009 |
In vitro and in vivo study on the antioxidant activity of dexrazoxane.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bleomycin; Chromans; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Free Radical Scavengers; Glutathione; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Razoxane; Time Factors; Uric Acid; Vincristine | 2010 |
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Teniposide; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2010 |
Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Feasibility Studies; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Maximum Tolerated Dose; Middle Aged; Prednisone; Radioimmunotherapy; Remission Induction; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2010 |
Limited chemotherapy and shrinking field radiotherapy for Osteolymphoma (primary bone lymphoma): results from the trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 prospective trial.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Australasia; Australia; Benchmarking; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Early Termination of Clinical Trials; Female; Fractures, Spontaneous; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Radiotherapy; Radiotherapy Dosage; Regression Analysis; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2011 |
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Humans; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Prognosis; Treatment Outcome; Vincristine; Young Adult | 2010 |
Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Japan; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 2011 |
[Treatment outcome analysis of CTOP or CHOP regimen in newly diagnosed aggressive non-Hodgkin's lymphoma patients-results of a prospective, open, randomized, multicenter clinical trial].
Topics: Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prednisone; Prospective Studies; Treatment Outcome | 2010 |
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.
Topics: Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Diarrhea; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Fever; Follow-Up Studies; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Pyrazines; Recurrence; Rituximab; Treatment Outcome | 2011 |
Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Survival Analysis; Treatment Outcome; Vincristine | 2011 |
A long-term follow-up study of prospective 80%-dose CHOP followed by involved-field radiotherapy in elderly lymphoma patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Prednisone; Prognosis; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Vincristine | 2011 |
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Maximum Tolerated Dose; Middle Aged; Prednisone; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2011 |
Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfilgrastim as support.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Polyethylene Glycols; Prednisone; Recombinant Proteins; Remission Induction; Rituximab; Treatment Outcome; Vincristine | 2012 |
Prognostic significance of serum proangiogenic molecules in patients with de novo non-Hodgkin lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenic Proteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Fibroblast Growth Factor 2; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neovascularization, Pathologic; Prednisone; Prevalence; Prognosis; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Thailand; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine; Young Adult | 2012 |
Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG95
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prednisone; Prognosis; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2012 |
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival.
Topics: Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisone; Prognosis; Radiation-Protective Agents; Vincristine | 2012 |
Case report: Sodium dichloroacetate (DCA) inhibition of the "Warburg Effect" in a human cancer patient: complete response in non-Hodgkin's lymphoma after disease progression with rituximab-CHOP.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dichloroacetic Acid; Doxorubicin; Glycolysis; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oxidative Phosphorylation; Prednisone; Remission Induction; Rituximab; Self Medication; Vincristine | 2013 |
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Italy; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Probability; Prognosis; Proportional Hazards Models; Survival Rate; Treatment Outcome; Vincristine | 2002 |
A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Salvage Therapy; Survival Rate; Time Factors; Treatment Failure; Vincristine | 2002 |
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vidarabine; Vincristine | 2002 |
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Quality of Life; Survival Rate; Treatment Outcome; Vidarabine; Vincristine | 2002 |
Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
Topics: Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Recurrence; Testicular Neoplasms; Time Factors; Vincristine | 2002 |
[Effectiveness of high-dose polychemotherapy and autologous hemopoietic cell transplantation in patients with low-grade non-Hodgkin lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Prednisone; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 2002 |
Dose-intensified CHOP (double-CHOP) followed by consolidation with high-dose chemotherapy for high and high-intermediate risk aggressive non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Vincristine | 2002 |
Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cross-Over Studies; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Metoclopramide; Middle Aged; Nausea; Patient Satisfaction; Prednisone; Probability; Treatment Outcome; Vincristine; Vomiting | 2002 |
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednisolone; Prednisone; Survival; Treatment Outcome; Vincristine | 2003 |
A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Analysis of Variance; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lenograstim; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Vincristine | 2003 |
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine | 2003 |
[Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 2003 |
[Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recurrence; Salvage Therapy; Treatment Outcome; Vincristine | 2003 |
[Effectiveness of dose-intensive polychemotherapy with autologous hemopoietic cell transplantation for high-grade non-Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Prednisone; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 2003 |
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Iodine Radioisotopes; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neural Tube Defects; Patient Compliance; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2003 |
A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Interferon-alpha; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prognosis; Time Factors; Treatment Outcome; Vincristine | 2003 |
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy; Survival Rate; Vincristine | 2003 |
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Prednisone; Recombinant Proteins; Survival Rate; Vincristine | 2003 |
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 2003 |
First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neoplasm Staging; Prednisone; Prognosis; Rituximab; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2003 |
CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Rate; Time Factors; Vincristine | 2003 |
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Quality of Life; Treatment Outcome; Vincristine | 2003 |
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Survival Rate; Vincristine; Vindesine | 2003 |
High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Australia; B-Lymphocytes; Bone Marrow Purging; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Europe; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Stem Cell Transplantation; Survival Analysis; Vincristine | 2003 |
Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 2003 |
Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Australia; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Europe; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Pain; Polyethylene Glycols; Prednisone; Recombinant Proteins; Safety; Treatment Outcome; Vincristine | 2003 |
[Clinical trial of the monoclonal antibody drug mabthera (Rituximab) in the treatment of non-Hodgkin lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Rituximab; Time Factors; Treatment Outcome; Vincristine | 2003 |
Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
P-CHOP: cisplatin (P) added to the standard CHOP regimen as first-line treatment for aggressive non-Hodgkin lymphoma: a single-institution phase II study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Vincristine | 2003 |
Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoguazone; Prednisone; Vincristine | 2004 |
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2004 |
Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Radiotherapy, Adjuvant; Treatment Outcome; Vincristine; Viral Load | 2004 |
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Longevity; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Parents; Prednisolone; Prednisone; Prognosis; Survival Analysis; Vincristine | 2004 |
Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Appetite; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Pain; Prednisone; Quality of Life; Sleep; Surveys and Questionnaires; Vinblastine; Vincristine | 2004 |
A phase II trial of adjuvant low-dose total body irradiation in non-Hodgkin's lymphoma patients following standard CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Vincristine; Whole-Body Irradiation | 2004 |
Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Health Care Costs; Health Resources; Hospital Costs; Humans; Infection Control; Lymphoma, Non-Hodgkin; Male; Netherlands; Neutropenia; Prednisone; Recombinant Proteins; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Treatment Outcome; Venezuela; Vincristine | 2004 |
Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Area Under Curve; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Drug Interactions; Female; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 2004 |
Phase II study of cyclophosphamide,epirubicin, vincristine, prednisone, and etoposide (CEOP-E) for aggressive non-Hodgkin 's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Gro
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Incidence; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Prospective Studies; Radiotherapy; Risk Factors; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2004 |
[VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Risk Factors; Vidarabine; Vindesine | 2005 |
Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine; Vindesine | 2005 |
Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncolo
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Remission Induction; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine | 2005 |
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Prednisone; Recurrence; Vincristine | 2005 |
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fertility; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Ovary; Prednisone; Pregnancy; Pregnancy Outcome; Primary Ovarian Insufficiency; Vincristine | 2005 |
Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Inflammation; Interleukin-6; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prednisone; Prognosis; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine | 2005 |
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Frail Elderly; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2005 |
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; HIV Seropositivity; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2005 |
Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prednisone; Prospective Studies; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Vincristine | 2005 |
Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Quality of Life; Recurrence; Remission Induction; Surveys and Questionnaires; Time Factors; Vincristine | 2005 |
Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Gemcitabine; Graft vs Host Disease; Humans; Infections; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Recurrence; Remission Induction; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 2005 |
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Pyruvaldehyde; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Disease-Free Survival; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Remission Induction; Treatment Failure; Vincristine | 2005 |
Autologous stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prednisone; Recombinant Proteins; Remission Induction; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Overview of Southwest Oncology Group clinical trials in non-Hodgkin lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Meta-Analysis as Topic; Pilot Projects; Prednisone; Treatment Outcome; Vincristine | 2005 |
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Injections, Subcutaneous; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Proteins; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Europe; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Risk Factors; Salvage Therapy; Smoking; Societies, Medical; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2005 |
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Rituximab; Survival Analysis; Vincristine | 2005 |
Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Atrial Natriuretic Factor; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Hemodynamics; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Natriuretic Peptide, Brain; Neoplasm Staging; Prednisone; Tetrazoles; Valine; Valsartan; Vincristine | 2005 |
To irradiate or not to irradiate--that is the question.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 2005 |
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine | 2006 |
Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Remission Induction; Risk Factors; Transplantation, Autologous; Vincristine | 2006 |
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2006 |
Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Age Factors; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Prednisone; Prospective Studies; Risk Factors; Survival Analysis; Vincristine | 2006 |
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Vidarabine Phosphate; Vincristine | 2006 |
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Prognosis; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2006 |
Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Stomach Neoplasms; Vincristine | 2006 |
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Time Factors; Treatment Outcome; Vincristine | 2006 |
Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Prednisone; Recurrence; Salvage Therapy; Survival Analysis; Vincristine | 2006 |
Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Proportional Hazards Models; Rituximab; Time Factors; Treatment Outcome; Vincristine | 2006 |
ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Salvage Therapy; Survival Analysis; Treatment Failure | 2006 |
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Health Surveys; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Risk Factors; Survival Rate; Vincristine | 2007 |
The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutrophils; Polyethylene Glycols; Prednisone; Recombinant Proteins; Treatment Outcome; Vincristine | 2006 |
Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Belgium; Child; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Netherlands; Prednisone; Prognosis; Recombinant Proteins; Risk Factors; Vincristine | 2007 |
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Survival Analysis; Survivors; Time Factors; Vincristine | 2007 |
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Recurrence; Time Factors; Treatment Outcome; Vincristine | 2007 |
Community-based trial of R-CHOP and maintenance rituximab for intermediate- or high-grade non-Hodgkin lymphoma with first-cycle filgrastim for older patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Maximum Allowable Concentration; Middle Aged; Neoplasm Staging; Prednisone; Recombinant Proteins; Risk Factors; Rituximab; Treatment Outcome; Vincristine | 2007 |
Rituximab and dose dense chemotherapy in primary breast lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Middle Aged; Nervous System Diseases; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
The impact of high-dose sodium selenite therapy on Bcl-2 expression in adult non-Hodgkin's lymphoma patients: correlation with response and survival.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Down-Regulation; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Sodium Selenite; Vincristine | 2007 |
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Echocardiography, Doppler; Female; Heart; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Risk Factors; Rituximab; Ventricular Dysfunction, Left; Ventricular Function, Left; Vincristine | 2008 |
Herpes zoster--the best approach.
Topics: Adult; Aged; Child; Clinical Trials as Topic; Cytarabine; Herpes Zoster; Hodgkin Disease; Humans; Immunosuppressive Agents; Interferons; Lymphoma, Non-Hodgkin; Prednisone; Triamcinolone; Vidarabine | 1980 |
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Clinical Trials as Topic; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Random Allocation; Vincristine | 1983 |
[Polychemotherapy of lymphosarcoma by the COP program].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1984 |
P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Successful application of a previously derived prognostic index in the analysis of a randomised trial of 281 patients with high grade non-Hodgkin's lymphoma (HIGNHL).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1993 |
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fever; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Infections; Length of Stay; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Procarbazine; Prospective Studies; Recombinant Proteins; Remission Induction; Risk; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Prednisone; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neoplasm Staging; Oncogenes; Polymerase Chain Reaction; Prednisone; Procarbazine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Remission Induction; Treatment Outcome; Vincristine | 1994 |
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Treatment Failure; Vincristine | 1994 |
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine | 1994 |
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Survival Rate; Vincristine | 1994 |
Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine | 1994 |
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vincristine | 1994 |
The cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COPBLAM-I) regimen for intermediate-grade non-Hodgkin's lymphoma. Long term follow-up in 51 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 1994 |
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1994 |
Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Vincristine | 1994 |
Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Risk Factors; Survival Rate; Treatment Failure; United States; Vincristine | 1995 |
Selection of patients for randomised trials: a study based on the MACOP-B vs CHOP in NHL study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Patient Selection; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 1994 |
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1994 |
P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisone; Prognosis; Remission Induction; Survival Rate; Vinblastine | 1994 |
CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
Topics: Actuarial Analysis; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Karnofsky Performance Status; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Treatment Failure; Vincristine | 1995 |
[The effects of COP-BLAM regimen with G-CSF for intermediate and high grade non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Vincristine | 1995 |
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Recombinant Proteins; Remission Induction; Treatment Outcome; Vincristine | 1995 |
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Italy; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Risk Factors; Treatment Outcome; Vincristine | 1995 |
COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Vincristine | 1995 |
[Usefulness of COP-BLAM therapy with concomitant G-CSF in elderly patients with non-Hodgkin's lymphoma in comparison with patients not given G-CSF].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisone; Procarbazine; Remission Induction; Vincristine | 1995 |
FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Recurrence; Vidarabine | 1995 |
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Cyclophosphamide; Doxorubicin; Female; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Nausea; Prednisolone; Prednisone; Prospective Studies; Regression Analysis; Remission Induction; Survival Analysis; Vincristine; Vomiting | 1995 |
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Survival Rate; Teniposide; Vincristine | 1995 |
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polymerase Chain Reaction; Prednisone; Remission Induction; Stereoisomerism; Verapamil; Vincristine | 1995 |
Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Remission Induction; Survival Analysis; Treatment Failure; Vincristine | 1995 |
Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Pilot Projects; Prednisone; Remission Induction; Survival Rate; Vincristine | 1995 |
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Vincristine | 1993 |
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Recurrence; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bleomycin; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Prednisone; Procarbazine; Recombinant Proteins; Survival Rate; Vincristine | 1993 |
Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Treatment Outcome; Vincristine | 1993 |
Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cyclophosphamide; Doxorubicin; Female; Humans; Interleukin-3; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Proteins; Vincristine | 1995 |
Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Thioguanine; Treatment Failure; Vincristine | 1995 |
Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Prednisone; Recurrence; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Gastric Mucosa; Humans; Immunotherapy; Intestinal Mucosa; Lymphoid Tissue; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Time Factors; Vincristine | 1995 |
Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Prospective Studies; Treatment Outcome; Vincristine | 1995 |
Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vincristine | 1995 |
Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Chi-Square Distribution; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Flow Cytometry; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prednisone; Prognosis; Proportional Hazards Models; S Phase; Survival Rate; Vincristine | 1994 |
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 1994 |
Treatment of localized non-Hodgkin's lymphomas of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 1994 |
Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Prospective Studies | 1994 |
New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphom
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Germany; Humans; Interferon-alpha; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Prednimustine; Prednisone; Vincristine | 1994 |
Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Heart Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisolone; Prednisone; Prospective Studies; Vincristine | 1994 |
A phase II study of continuous infusion recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma in first remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infections; Length of Stay; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutrophils; Prednisone; Prospective Studies; Recombinant Proteins; Remission Induction; Vincristine | 1994 |
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine; Vindesine | 1994 |
Combined use of interferon alpha-2, chlorambucil and prednisone in previously treated patients with low-grade non-Hodgkin's lymphomas. Results of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Remission Induction | 1993 |
[Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1993 |
[Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Rate; Vincristine | 1993 |
Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Vincristine | 1993 |
Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Costa Rica; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Infusions, Intravenous; Leucovorin; Life Tables; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1994 |
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Recurrence; Teniposide; Vincristine | 1993 |
A phase II trial of a chemotherapy combination in elderly patients with aggressive lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Remission Induction | 1993 |
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Survival Analysis; Vincristine | 1993 |
[Comparative study of 1st generation versus 2d generation (CAVPE) combinations in intermediate and high-grade lymphomas].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 1993 |
A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1993 |
The rationale of therapy with mitoxantrone in non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Co-operative Study Group, (NHLCSG) Italy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cyclophosphamide; Doxorubicin; Female; Humans; Immunotherapy; Levamisole; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Vincristine | 1993 |
Anthracycline containing regimens in intermediate grade lymphoma. Italian Cooperative Study Group on Intermediate Grade Malignant Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prednisone; Vincristine | 1993 |
Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Prednisone; Prognosis; Vincristine | 1993 |
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Survival Rate; Vincristine | 1993 |
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission Induction; Survival Rate; Vincristine | 1995 |
Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Heart Diseases; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Analysis; Vincristine | 1995 |
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Markov Chains; Middle Aged; Prednisone; Prospective Studies; Quality of Life; Survival Analysis; Vincristine | 1995 |
Pharmacokinetic and pharmacodynamic studies of subcutaneously administered recombinant human interleukin-3 following chemotherapy for non-Hodgkin's lymphoma.
Topics: Administration, Cutaneous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Interleukin-3; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Vincristine | 1995 |
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Life Tables; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Prednisone; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Risk; Vindesine | 1996 |
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Hemoglobins; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Vincristine | 1995 |
Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1995 |
A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neoplasm Staging; Prednisone | 1995 |
Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Cell Count; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Premedication; Recombinant Proteins; Safety; Vincristine | 1995 |
Administration of rhG-CSF increases complete remission rates after CHOP and ProMACE/CytaBOM for non-Hodgkin's lymphoma: a pilot study. Hokkaido Study Group of Malignant Lymphoma and rhG-CSF.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Recombinant Proteins; Remission Induction; Vincristine | 1995 |
Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 1996 |
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 1996 |
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Disease Progression; Disease Susceptibility; Etoposide; Female; Gastrointestinal Diseases; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Remission Induction; Salvage Therapy | 1996 |
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Vincristine | 1996 |
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunologic Factors; Immunophenotyping; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Survival Analysis; Survival Rate; Vincristine | 1996 |
[Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Recombinant Proteins; Remission Induction; Vincristine | 1996 |
Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Pilot Projects; Prednisone; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Analysis; Thrombocytopenia; Vincristine | 1995 |
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Survival Analysis; Vincristine | 1996 |
[Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Time Factors; Vincristine | 1996 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Gallium Radioisotopes; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prednisone; Radioimmunodetection; Radiotherapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 1996 |
Primary non-Hodgkin's lymphoma of the stomach: three radical modalities of treatment in 75 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Gastrectomy; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Postoperative Complications; Prednisone; Procarbazine; Stomach Neoplasms; Vincristine | 1996 |
Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nasopharyngeal Neoplasms; Prednisone; Survival Rate; Tongue Neoplasms; Tonsillar Neoplasms; Vincristine | 1996 |
Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma--a multicenter phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Vincristine | 1995 |
Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: a pilot study for a leukocyte count oriented regimen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; Recombinant Proteins; Survival Rate; Time Factors; Vincristine | 1995 |
A new protocol (MiCEP) for the treatment of intermediate or high-grade non-Hodgkin's lymphoma in the elderly.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome | 1996 |
Interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Patient Acceptance of Health Care; Prednisone; Quality of Life; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bleomycin; Bone Marrow; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ketoconazole; Lymphoma, Non-Hodgkin; Male; Mycoses; Neoplasm Staging; Ofloxacin; Prednisone; Prognosis; Prospective Studies; Recombinant Proteins; Survival Rate; Vinblastine | 1996 |
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.
Topics: Adult; Aged; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Cytarabine; Dexamethasone; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Leucovorin; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Hodgkin Disease; Hormones; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Ovarian Diseases; Ovary; Prednisone; Procarbazine; Prospective Studies; Vincristine | 1996 |
CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial.(PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of Hematology).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 1996 |
Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Patient Compliance; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Radiotherapy; Teniposide; Time Factors | 1996 |
Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 1996 |
A prospective study of VEC-POB and POCE chemotherapy in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prospective Studies; Survival Rate; Vincristine | 1997 |
Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-VABEC regimen in the treatment of intermediate and high grade non-Hodgkin's lymphoma of the elderly.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Marrow; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Life Tables; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
Multiple statistics for multiple events, with application to repeated infections in the growth factor studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Growth Substances; Humans; Infections; Lymphoma, Non-Hodgkin; Markov Chains; Models, Statistical; Multivariate Analysis; Prednisone; Procarbazine; Recurrence; Time Factors; Vincristine | 1997 |
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Prednisone; Treatment Outcome; Vincristine | 1997 |
[Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Remission Induction; Vincristine | 1997 |
Impact of high-dose salvage therapy (BEAM) on overall survival in younger patients with advanced large-cell lymphomas entered into BNLI trials.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Staging; Podophyllotoxin; Prednisone; Salvage Therapy; Treatment Outcome; Vincristine | 1997 |
Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Risk Factors; Teniposide; Treatment Outcome; Vincristine | 1997 |
Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prognosis; Time Factors; Vincristine | 1997 |
Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Recurrence; Treatment Outcome; Vidarabine | 1997 |
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Prednisone; Prospective Studies; Survival Rate; Teniposide | 1997 |
A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Grou
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Prednisone; Recombinant Proteins; Treatment Outcome; Vincristine | 1996 |
Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Erythroid Precursor Cells; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Infant; Life Tables; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Research Design; Survival Analysis; Vincristine | 1997 |
Prognostic factors in elderly patients with non-Hodgkin's lymphoma treated with cyclophosphamide, vincristine, prednisone, bleomycin, Adriamycin, procarbazine (COP-BLAM) therapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Prognosis; Vincristine | 1997 |
A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
Topics: Adult; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Filgrastim; Follow-Up Studies; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leucovorin; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Treatment Outcome; Vincristine | 1997 |
Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Stomach Neoplasms; Treatment Outcome; Vincristine | 1997 |
Stage I non-Hodgkin's lymphoma treated with doxorubicin-containing chemotherapy with or without radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Retrospective Studies; Vincristine | 1997 |
Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1997 |
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Prednimustine; Prednisone; Vincristine | 1998 |
Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Prednisone; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Analysis; Vincristine | 1998 |
Inhibin A concentrations in the sera of young women during and after chemotherapy for lymphoma: correlation with ovarian toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Female; Hodgkin Disease; Hormones; Humans; Inhibins; Lymphoma, Non-Hodgkin; Mechlorethamine; Ovarian Diseases; Prednisone; Procarbazine; Prospective Studies; Vinblastine; Vincristine | 1998 |
CHOP therapy: has shorter-course therapy had an impact on lymphomas?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Time Factors; Vincristine | 1998 |
Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vincristine | 1998 |
Results of treatment with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) for non-Hodgkin's aggressive lymphoma analyzed according to the International Prognostic Index.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Risk Assessment; Treatment Outcome; Vincristine | 1997 |
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1998 |
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Skin Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1998 |
[High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1998 |
Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Ki-1 Antigen; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Phenotype; Prednisone; Prognosis; Survival Analysis; Vincristine | 1998 |
[Clinical study on the inhibitory effect of a 5-HT3 antagonist, granisetron, for nausea and vomiting induced by chemotherapy (CHOP, VEPA, high-dose ETP) for non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Serotonin Antagonists; Vincristine; Vomiting | 1998 |
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Double-Blind Method; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Proteins; Remission Induction; Vincristine | 1998 |
[Value of radiotherapy in disseminated highly malignant non-Hodgkin's lymphoma. Comment on the article by U. Kaiser, R. Pfab, K. Havemann, Strahlenther Onkol 1997, 173, 136-40 (No. 3)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Radiotherapy Dosage; Radiotherapy, Adjuvant; Terminology as Topic; Time Factors; Vincristine | 1998 |
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine; Prednisone; Prospective Studies; Survival Rate; Vincristine | 1998 |
Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Vincristine | 1998 |
[EPOCH therapy for relapsed/refractory lymphoid malignancies].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 1998 |
[Results of treating patients with highly malignant non-Hodgkin's lymphomas; comparison of treatment efficacy with CHOP and CBVPM-AVBP].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Vincristine | 1998 |
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Proportional Hazards Models; Prospective Studies; Radiotherapy; Radiotherapy Dosage; Survival Analysis; Vincristine | 1998 |
Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1998 |
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Vincristine | 1998 |
[Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hem
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Survival Analysis; Time Factors; Vincristine | 1998 |
Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Maximum Allowable Concentration; Middle Aged; Prednisone; Vincristine | 1998 |
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Survival Rate; Vincristine | 1998 |
A phase I trial of standard and cyclophosphamide dose-escalated CHOP with granulocyte colony stimulating factor in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoguazone; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.
Topics: Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1998 |
The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1998 |
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Heart Diseases; Hematologic Diseases; Humans; Idarubicin; Italy; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Analysis; Vincristine | 1998 |
[Clinical observation on 112 cases with non-Hodgkin's lymphoma treated by Chinese herbs combined with chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Child; Cyclophosphamide; Doxorubicin; Drugs, Chinese Herbal; Female; Hemorheology; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Survival Rate; Vincristine | 1997 |
[The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Time Factors; Vincristine | 1998 |
Bcl-2 gene rearrangements and apoptosis rates in patients with non-Hodgkin's lymphoma during chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cyclophosphamide; Epirubicin; Female; Gene Rearrangement; Genes, bcl-2; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Translocation, Genetic; Vincristine | 1999 |
Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52.
Topics: Adult; Age Distribution; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Recurrence; Vincristine | 1999 |
[Study of optimal CHOP dose ranges for elderly patients with non-Hodgkin's lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Prednisone; Treatment Outcome; Vincristine | 1999 |
CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Reproducibility of Results; Treatment Outcome; Vincristine | 1998 |
[Epirubicin containing regimens in advanced malignant tumors report of 516 cases. Epirubicin Collaborative Study Group].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1997 |
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednisone; Remission Induction; Survival Analysis; Vincristine | 1999 |
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Immunoglobulins; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polymerase Chain Reaction; Prednisone; Proto-Oncogene Proteins c-bcl-2; Rituximab; Translocation, Genetic; Vincristine | 1999 |
A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Treatment Failure; Treatment Outcome; Vincristine | 1999 |
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 1999 |
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: long-term results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Analysis; Vincristine | 1999 |
Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin's aggressive lymphoma: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Survival Rate; Vincristine | 2000 |
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Vincristine | 2000 |
Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Feasibility Studies; Humans; Intestinal Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Stomach Neoplasms; Vincristine | 2000 |
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Tamoxifen; Treatment Outcome; Vincristine | 2000 |
A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fever; Humans; Incidence; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Predictive Value of Tests; Prednisone; Vincristine | 2000 |
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Vincristine | 2000 |
Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Infant; Leukemia, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Proportional Hazards Models; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
A comparison of elderly patients with aggressive histology lymphoma who were entered or not entered on to a randomized phase II trial.
Topics: Actuarial Analysis; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Palliative Care; Patient Selection; Prednisone; Prognosis; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA).
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Multivariate Analysis; Prednisone; Quality of Life; Survival Analysis; Transplantation, Autologous; Vindesine | 2000 |
[Different chemotherapy protocols for intermediate and high grade malignant non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Remission Induction; Vincristine | 1997 |
A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Female; Humans; Liposomes; Liver; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Prednisone; Remission Induction; Vincristine | 2000 |
Etoposide, mitoxantrone and prednisone: a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Diseases; Disease Progression; Disease-Free Survival; Etoposide; Female; Humans; L-Lactate Dehydrogenase; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prednisone; Prognosis; Safety; Salvage Therapy; Survival Analysis; Treatment Outcome | 2000 |
Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study G
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lenograstim; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Transplantation, Autologous; Vincristine | 2000 |
[The therapeutic efficacy and toxicity of the liposomal form of daunorubicin (Daunoxome) in lymphosarcoma patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart; Humans; Liposomes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Time Factors; Vincristine | 2000 |
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Survival Analysis; Vincristine | 2000 |
[High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Vincristine | 2000 |
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Stroke Volume; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Culture Techniques; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Time Factors; Vincristine | 2000 |
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cost-Benefit Analysis; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Immunologic; Doxorubicin; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 2000 |
Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Purging; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Genes, bcl-2; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Interstitial; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Neutropenia; Polymerase Chain Reaction; Prednisone; Recurrence; Remission Induction; Sepsis; Survival Analysis; Thrombocytopenia; Translocation, Genetic; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Europe; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2001 |
Primary lymphoma of bone: a prospective study of 28 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Surveys and Questionnaires; Survival Rate; Treatment Outcome; Vindesine | 2000 |
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Teniposide; Treatment Outcome; Vincristine | 2001 |
Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Quinine; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Verapamil; Vincristine | 2001 |
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genes, bcl-2; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polymerase Chain Reaction; Prednisone; Remission Induction; Rituximab; Survival Analysis; Vincristine | 2001 |
Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Therapeutic Equivalency; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Stavudine; Treatment Outcome; Vincristine; Viral Load | 2001 |
Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-hodgkin's lymphoma: an effective and non toxic therapeutic alternative for adult and elderly patients.
Topics: Actuarial Analysis; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Survival Rate; Treatment Outcome | 2001 |
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Retrospective Studies; Salvage Therapy; Vincristine | 2001 |
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Vincristine | 2001 |
A prospective randomized study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: the International Oncology Study Group NHL1 Study .
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Proteins; Survival Rate; Treatment Outcome; Vincristine | 2000 |
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Treatment Outcome; Vincristine | 2001 |
Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednisone; Remission Induction; Survival Analysis; Thiotepa; Vincristine | 2001 |
The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Psychological Tests; Psychomotor Performance; Radiation Injuries; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vincristine | 1999 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
CHOP chemotherapy with preemptive granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma: a dose-intensity analysis.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Lymphoma, Non-Hodgkin; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
CHOP versus CHOP plus ESHAP and high-dose therapy with autologous peripheral blood progenitor cell transplantation for high-intermediate-risk and high-risk aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |
A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Growth Substances; Humans; Hydro-Lyases; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 2001 |
Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Atrial Natriuretic Factor; Autonomic Nervous System; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart Rate; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Prednisone; Prospective Studies; Radionuclide Ventriculography; Stroke Volume; Ventricular Dysfunction, Left; Vincristine | 2001 |
Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study.
Topics: Aged; Aging; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 2001 |
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Heart Diseases; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Prednisone; Recurrence; Stomatitis; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2001 |
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Metaphase; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prednisolone; Prednisone; Prospective Studies; Survival Analysis; Vincristine | 2001 |
Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Germany; Humans; Life Tables; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Radiotherapy in early stage gastrointestinal lymphoma: results of the German GIT-NHL group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Gastrectomy; Gastrointestinal Neoplasms; Humans; Life Tables; Lymph Node Excision; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Health Status; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Quality of Life; Social Behavior; Vincristine | 2001 |
Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Morbidity; Neutropenia; Prednisone; Stomatitis; Vincristine | 2002 |
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2001 |
Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study.
Topics: Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytoprotection; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Treatment Outcome; Vincristine | 2002 |
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Neutropenia; Prednisolone; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.
Topics: Antineoplastic Agents; Bleomycin; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Leukopenia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Radiotherapy; Vincristine | 1975 |
Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
Topics: Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Time Factors; Vincristine | 1977 |
Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
Topics: Altretamine; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Topics: Adult; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lomustine; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission, Spontaneous; Streptonigrin; Time Factors; Vinblastine; Vincristine | 1977 |
Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Team approach to management of non-Hodgkin's lymphomas: past and present.
Topics: BCG Vaccine; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymph Nodes; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Staging; Patient Care Team; Prednisone; Radiation Dosage; Time Factors; Vincristine | 1977 |
Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Gentamicins; Humans; Immunosuppression Therapy; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Nystatin; Patient Isolation; Prednisone; Vancomycin; Vincristine | 1979 |
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
Topics: Carmustine; Cell Cycle; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine; Time Factors; Vincristine | 1977 |
Total-body irradiation in the treatment of lymphocytic lymphoma.
Topics: Blood Platelets; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Radiation Dosage; Radiation Injuries; Time Factors; Vincristine | 1977 |
Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.
Topics: Adult; Aged; Blood Platelets; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Leukocytes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiation Dosage; Radiation Injuries; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Combination chemotherapy of non-Hodgkin lymphoma.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission, Spontaneous; Streptonigrin; Vincristine | 1978 |
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up study.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Remission, Spontaneous; Streptonigrin; Time Factors; Vincristine | 1979 |
Combination versus successive single agent chemotherapy in lymphocytic lymphoma.
Topics: Adult; Aged; Bone Marrow; Cyclophosphamide; Cystitis; Drug Therapy, Combination; Female; Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma.
Topics: Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Time Factors; Vincristine | 1978 |
Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial.
Topics: Cyclophosphamide; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Prospective Studies; Remission, Spontaneous; Vincristine | 1976 |
Combination chemotherapy of the malignant lymphomas: a controlled clinical trial.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Pregnancy; Remission, Spontaneous; Time Factors; Vincristine | 1976 |
Lymphosarcoma. A comparison of extended to conservative chemotherapy.
Topics: Adult; Aged; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Remission, Spontaneous; Vincristine | 1976 |
New experimental and clinical data on leukaemia immunotherapy.
Topics: Adolescent; Adult; Amantadine; Animals; Bacterial Vaccines; BCG Vaccine; Cell Line; Central Nervous System Diseases; Child; Child, Preschool; Corynebacterium; Cyclophosphamide; Doxorubicin; Female; Hepatomegaly; Humans; Immunotherapy; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Propionibacterium acnes; Splenomegaly; Vincristine | 1975 |
Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Leukemia; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Remission, Spontaneous; Vincristine | 1975 |
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Time Factors; Vincristine | 1992 |
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Rate; Vincristine | 1992 |
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Survival Rate; Vincristine | 1992 |
Non-Hodgkin's lymphomas in children. II. Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Prednisolone; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 1992 |
F-MACHOP in advanced aggressive lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluorouracil; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1992 |
A phase I/II study of dose and administration of non-glycosylated bacterially synthesized G-M CSF in chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Recombinant Proteins; Vincristine | 1992 |
Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prospective Studies; Vincristine | 1992 |
Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Time Factors; Vincristine | 1990 |
Combination chemotherapy for advanced diffuse large cell lymphoma. The adverse effects of bone marrow invasion, gastrointestinal tract involvement or high bulk disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Carubicin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Invasiveness; Prednisone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; Vincristine | 1990 |
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1990 |
[Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Prednisone; Recombinant Proteins; Vincristine | 1990 |
Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cause of Death; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Remission Induction; Survival Rate; Vincristine | 1990 |
[A double-blind, cross-over clinical trial of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Japan; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Recombinant Proteins; Vincristine | 1990 |
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1991 |
[Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Methotrexate; Mexico; Prednisone; Remission Induction; Survival Rate; Vincristine | 1990 |
Phase III trial of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) versus cisplatin, etoposide, bleomycin and prednisone (CisEBP) for the treatment of advanced non-Hodgkin's lymphoma of high grade malignancy. The Danish Lymphoma Study Gro
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Random Allocation; Vincristine | 1990 |
Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Vincristine | 1991 |
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Survival Rate; Vincristine | 1991 |
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisolone; Prednisone; Prospective Studies; Survival Rate; Vincristine | 1991 |
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1991 |
ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Procarbazine; Vincristine | 1991 |
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prednisone; Survival Analysis; Vincristine | 1991 |
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoiesis; Humans; Inflammation; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mucous Membrane; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1991 |
Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology Group.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Risk Factors; Survival Analysis; Vinblastine; Vincristine | 1991 |
Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high-grade non-Hodgkin's lymphoma (NHL): the 1980-1985 EORTC trial. The EORTC Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Survival Rate; Teniposide; Vincristine | 1991 |
Phase II study of cyclophosphamide (C), epirubicin (E), oncovin (O), prednisone (P), methotrexate (M) + leucovorin and bleomycin (B) (CEOP-MB) in intermediate and high grade non-Hodgkin lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1991 |
ProMACE-C-MOPP in aggressive non-Hodgkin's lymphoma. Long-term results in 45 patients treated in a single institution.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1991 |
High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Hydrocortisone; Infant; Injections, Spinal; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 1991 |
[Malignant lymphoma associated with HIV infection].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; HIV Infections; HIV Seropositivity; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Vincristine | 1991 |
The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Time Factors; Vincristine | 1991 |
Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Doxorubicin; Epirubicin; Female; Heart; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myocardium; Prednisone; Radionuclide Imaging; Vincristine | 1991 |
A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminary evaluation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Premedication; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Vincristine | 1990 |
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Vincristine; Vindesine | 1990 |
Vincristine infusion with CHOP-CCNU in diffuse large-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1990 |
[Weekly CHOP chemotherapy in the treatment of intermediate-grade non-Hodgkin's lymphomas--cooperative group study by seven institutes].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 1990 |
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Vincristine | 1990 |
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spain; Survival Rate; Teniposide; Thioguanine; Vincristine | 1990 |
[Low-grade non-Hodgkin's lymphoma in the adult: new therapeutic approaches].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Humans; Interferons; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1987 |
Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Time Factors; Vincristine | 1987 |
Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Ketoconazole; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycoses; Nystatin; Prednisone; Prospective Studies; Random Allocation; Time Factors; Vincristine | 1987 |
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Vincristine | 1987 |
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1987 |
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1988 |
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Prednisone; Procarbazine; Vincristine | 1988 |
Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Electrons; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Prospective Studies; Radioisotope Teletherapy; Random Allocation; Vincristine | 1988 |
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Evaluation Studies as Topic; Humans; Leucovorin; Leukemia; Leukemia, Radiation-Induced; Lymph Nodes; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Palliative Care; Prednisone; Procarbazine; Random Allocation; Vincristine | 1988 |
[Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1989 |
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Vincristine | 1989 |
Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Random Allocation; Remission Induction; Vincristine | 1989 |
CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Hydroxyurea; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1987 |
[Modified CHOP-Bleo protocol in the treatment of malignant non-Hodgkin's lymphoma of low cell differentiation].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Differentiation; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Poland; Prednisone; Remission Induction; Vincristine | 1988 |
The role of radiation therapy in the management of the non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Mycosis Fungoides; Palliative Care; Prednisone; Radiotherapy Dosage; Skin Neoplasms; Time Factors; Vincristine; Whole-Body Irradiation | 1985 |
Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Humans; Infant; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Random Allocation; Vincristine | 1989 |
CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Germany, West; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prednisone; Survival Rate; Vincristine | 1989 |
Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Europe; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Retrospective Studies; Vincristine | 1988 |
Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prednisone; Random Allocation; Vincristine | 1988 |
[Multicenter study of the treatment of highly malignant non-Hodgkin's lymphomas with polychemotherapy (CHOPV) and irradiation].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1987 |
Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1987 |
The effect of intensive intermittent maintenance therapy in advanced low-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Random Allocation; Vincristine | 1987 |
EORTC trial non-Hodgkin lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1987 |
Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Random Allocation; Vincristine | 1987 |
Treatment of non-Hodgkin's lymphoma in Mexican children. The effectiveness of chemotherapy during malnutrition.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Female; Humans; Hydrocortisone; Intestinal Perforation; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Nutrition Disorders; Prednisone; Vincristine | 1987 |
[Phase III study of chemotherapy in low-malignancy non-Hodgkin's lymphomas: comparison of vincristine-vindesine combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Vincristine; Vindesine | 1987 |
Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Random Allocation; Vincristine | 1988 |
Lymphoblastic lymphoma in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Thioguanine; Vincristine | 1986 |
Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Random Allocation; Vincristine | 1987 |
A randomized trial of high dose cyclophosphamide, vincristine, and prednisone plus or minus doxorubicin (CVP versus CAVP) with long-term follow-up in advanced non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Hematopoiesis; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1987 |
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Meningeal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Thioguanine; Vincristine | 1985 |
[Possibilities of using polychemotherapy according to the COP protocol in lymphosarcoma of the gastrointestinal tract].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Esophageal Neoplasms; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1985 |
Combination chemotherapy of advanced lymphocytic lymphoma. Importance of histologic classification in evaluating response.
Topics: Biopsy; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1974 |
Combination chemotherapy of lymphomas other than Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Cells; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Paresthesia; Prednisone; Procarbazine; Reflex, Stretch; Remission, Spontaneous; Time Factors; Vincristine | 1974 |
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Examination; Child; Child, Preschool; Cyclophosphamide; Drug Synergism; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission, Spontaneous; Sex Factors; Vincristine | 1971 |
1101 other study(ies) available for prednisone and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Treatment with doxorubicin-based protocol in cardiac involvement diffuse large B-cell lymphoma: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2022 |
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab | 2022 |
Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Feasibility Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Rituximab; Vincristine | 2022 |
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Frail Elderly; Histone Deacetylase Inhibitors; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Retrospective Studies; Rituximab | 2022 |
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Latin America; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Registries; Retrospective Studies; Rituximab; Vincristine | 2022 |
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy.
Topics: Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Humans; Insulins; Lymphoma, Non-Hodgkin; Prednisone | 2022 |
Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Kidney; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Prednisone; Rituximab; Vincristine | 2022 |
Cardiovascular outcomes of patients treated for non-Hodgkin lymphoma with first-line doxorubicin-based chemotherapy.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2022 |
Myocardial work-A new tool for early detection of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy induced-cardiotoxicity in hematological patients.
Topics: Antineoplastic Agents; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Rituximab; Stroke Volume; Ventricular Function, Left; Vincristine | 2023 |
Treatment Resulting Changes in Volumes of High-
Topics: Adipose Tissue; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Orbit; Pericardium; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Vincristine | 2023 |
Primary breast B-cell non-Hodgkin’s lymphoma of the breast. Case Report and review of the literature
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Mexico; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2023 |
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Doxorubicin; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Vinblastine; Vincristine | 2023 |
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.
Topics: Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisone; Receptors, Chimeric Antigen; Recurrence; Rituximab; Vincristine | 2023 |
Rare case of primary bone lymphoma of the femur.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Femur; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Rituximab; Vincristine; Young Adult | 2023 |
Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Ontario; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2023 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Biomarkers; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Trans-Activators; Vincristine | 2023 |
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
Topics: Cyclophosphamide; Doxorubicin; Drug Stability; Epirubicin; Etoposide; Humans; Infusion Pumps; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Vindesine | 2019 |
Modified EPOCH for high-risk non-Hodgkin lymphoma in sub-Saharan Africa.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Malawi; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; RNA, Viral; Vincristine; Young Adult | 2020 |
RNA disruption indicates CHOP therapy efficacy in canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxorubicin; Lymphoma, Non-Hodgkin; Prednisone; Progression-Free Survival; RNA, Neoplasm; Vincristine | 2019 |
[The 475th case: renal tubular acidosis, renal failure, anemia, and lactic acidosis].
Topics: Acidosis, Lactic; Acidosis, Renal Tubular; Anemia; Antineoplastic Agents; Biopsy; Creatinine; Erythropoietin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Nausea; Pneumonia, Pneumocystis; Prednisone; Renal Insufficiency; Sodium Bicarbonate; Treatment Refusal; Vomiting | 2020 |
Cardio-oncology for better lymphoma therapy outcomes.
Topics: Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Prednisone; Rituximab; Vincristine | 2020 |
The justification of vincristine dose capping: tradition, tradition…tradition!
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Incidence; Lymphoma, Non-Hodgkin; Peripheral Nervous System Diseases; Prednisone; Vincristine | 2020 |
An Autopsy Case of Varicella Zoster Virus Encephalitis with Multiple Brain Lesions.
Topics: Acyclovir; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Autopsy; Brain; Cyclophosphamide; Doxorubicin; Encephalitis, Varicella Zoster; Female; Herpesvirus 3, Human; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Prednisone; Rituximab; Vincristine | 2020 |
Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Dosage Calculations; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2020 |
Unilateral multiple serous retinal detachments secondary to non-Hodgkin's lymphoma responsive to systemic steroids.
Topics: Adult; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Prednisone; Retinal Detachment | 2021 |
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisone; Rituximab; Transplantation, Autologous; Vincristine | 2021 |
Early interval and serial positron emission tomography-computed tomography (PET-CT) after an indeterminate response defined by a PET scored 4 on the Deauville scale in lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Vinblastine; Vincristine | 2020 |
Cardiovascular adverse events following treatment for non-Hodgkin lymphoma.
Topics: Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2020 |
Cardiovascular adverse events following treatment for non-Hodgkin lymphoma - Authors' reply.
Topics: Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2020 |
Non-Hodgkin's lymphoma in an elderly patient with renal dysfunction: a case report.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Kidney Diseases; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Vincristine | 2020 |
3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Echocardiography, Three-Dimensional; Female; Humans; Imaging, Three-Dimensional; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myocardium; Predictive Value of Tests; Prednisone; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Vascular Stiffness; Ventricular Dysfunction, Left; Vincristine | 2020 |
Effects of filgrastim versus pegfilgrastim on outcomes of DA-R-EPOCH for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Polyethylene Glycols; Prednisone; Recombinant Proteins; Retrospective Studies; Vincristine | 2021 |
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Child, Preschool; Cyclophosphamide; Doxorubicin; Humans; Incidence; Lymphoma, Non-Hodgkin; Prednisone; Retrospective Studies; Vincristine | 2021 |
Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Janus Kinases; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisone; Progression-Free Survival; Proportional Hazards Models; Rituximab; Treatment Outcome; Tumor Necrosis Factor-alpha; Vinblastine; Vincristine | 2021 |
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Febrile Neutropenia; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2021 |
Individualized Treatment and Palliative Care for A 90-Year-Old Patient with Primary Gastric Diffuse Large-B Cell Lymphoma: 4 Year Follow-up and Inspiration.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Palliative Care; Positron Emission Tomography Computed Tomography; Prednisone; Stomach Neoplasms; Treatment Outcome | 2021 |
Conversion to supportive care with biosimilar pegfilgrastim-cbqv enables budget-neutral expanded access to R-CHOP treatment in non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Drug Costs; Filgrastim; Health Care Costs; Humans; Lymphoma, Non-Hodgkin; Polyethylene Glycols; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2021 |
[Optimization of rituximab dosing schedule in R-CHOP therapy for diffuse large B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Japan; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2021 |
Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Vincristine | 2021 |
Do You Know Pixantrone?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Prednisone; Stem Cell Transplantation; Vincristine | 2017 |
Geographical differences in survival of dogs with non-Hodgkin lymphoma treated with a CHOP based chemotherapy protocol.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxorubicin; Female; Geography, Medical; Lymphoma, Non-Hodgkin; Male; Prednisone; Retrospective Studies; Survival Analysis; United States; Vincristine | 2017 |
Control of Constipation in Patients Receiving CHOP or CHOP-Like Chemotherapy Regimens for Non-Hodgkin's Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Laxatives; Lymphoma, Non-Hodgkin; Magnesium Oxide; Male; Middle Aged; Prednisone; Retrospective Studies; Vincristine; Young Adult | 2017 |
Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Febrile Neutropenia; Female; Humans; Incidence; Japan; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Vincristine | 2017 |
18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Rituximab; Sex Factors; Tomography, X-Ray Computed; Vincristine | 2017 |
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Premedication; Retreatment; Risk Factors; Rituximab; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2017 |
Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin's lymphoma patients undergoing repeated cycles of the CHOP regimen.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Prednisone; Prospective Studies; Quinuclidines; Vincristine; Vomiting; Young Adult | 2018 |
Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP.
Topics: Adult; Aged; Aging; Antibodies, Monoclonal, Murine-Derived; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Prednisone; Quinuclidines; Risk Factors; Rituximab; Sex Characteristics; Treatment Outcome; Vincristine; Vomiting; Young Adult | 2017 |
Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Temozolomide; Vincristine | 2018 |
Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Immunotherapy; Incidence; Lung Diseases, Interstitial; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polyethylene Glycols; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2018 |
Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hyperglycemia; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2018 |
The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin's lymphoma who are candidates for up-front autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Republic of Korea; Retrospective Studies; Risk Factors; Rituximab; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2018 |
An Uncommon Mimic of Acute Coronary Syndrome: Infiltrating Non-Hodgkins Lymphoma.
Topics: Acute Coronary Syndrome; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Rituximab; Ventricular Dysfunction, Right; Vincristine | 2018 |
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemokines; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Immunotherapy; Killer Cells, Natural; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred BALB C; Prednisone; Salmonella; Treatment Outcome; Tumor Microenvironment; Vincristine | 2018 |
Synchronous papillary thyroid cancer and non-Hodgkin lymphoma: Case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Clinical Decision-Making; Cyclophosphamide; Doxorubicin; Drug Monitoring; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Single Photon Emission Computed Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Vincristine | 2018 |
Uncommon cause of dysphagia: paraneoplastic achalasia.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deglutition Disorders; Doxorubicin; Endoscopy, Digestive System; Esophageal Achalasia; Esophageal Neoplasms; Esophagoscopy; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paraneoplastic Syndromes; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2018 |
Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2018 |
[Primary renal lymphoma: a clinical analysis of 5 cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 2018 |
[Enlargement of mandibular canal and lower lip hypoesthesia revealing non-Hodgkin’s lymphoma of the mandible].
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Humans; Hypesthesia; Lip; Lymphoma, Non-Hodgkin; Mandibular Neoplasms; Prednisone; Radiography, Panoramic; Rituximab; Vincristine | 2016 |
Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Botswana; Cyclophosphamide; Doxorubicin; Female; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Rituximab; Treatment Outcome; United States; Vincristine | 2018 |
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Registries; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2018 |
Primary gastric diffuse large B-cell lymphoma: The role of dose-dense chemotherapy.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Remission Induction; Stomach Neoplasms; Vincristine | 2019 |
Primary Cardioprotection Reduces Mortality in Lymphoma Patients with Increased Risk of Anthracycline Cardiotoxicity, Treated by R-CHOP Regimen.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Cyclophosphamide; Doxorubicin; Drug Compounding; Echocardiography; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Vincristine; Young Adult | 2018 |
How dogs are teaching researchers new tricks for treating cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Clinical Trials, Veterinary as Topic; Cyclophosphamide; Disease Models, Animal; Dog Diseases; Dogs; Doxorubicin; Drugs, Investigational; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Medical Oncology; Molecular Targeted Therapy; Prednisone; Recurrence; Research Personnel; Rituximab; Species Specificity; Survival Analysis; Topoisomerase I Inhibitors; Veterinary Medicine; Vincristine | 2018 |
Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxorubicin; Female; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednisone; Retrospective Studies; Vincristine | 2019 |
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Triptorelin Pamoate; Vincristine | 2019 |
Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cancer Survivors; Combined Modality Therapy; Cross-Sectional Studies; Cyclophosphamide; Doxorubicin; Fatigue; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Quality of Life; Rituximab; Time Factors; Transplantation, Autologous; Vincristine; Young Adult | 2019 |
[Comparison of Pegfilgrastim and Filgrastim for the Primary Prophylactic Effect for Preventing Febrile Neutropenia in Patients Undergoing Rituximab with Dose-adjusted EPOCH Chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Febrile Neutropenia; Female; Filgrastim; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polyethylene Glycols; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2019 |
Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Hydrocortisone; Infant; Iraq; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2019 |
Primary non-Hodgkin's lymphoma of the vagina (PNHLV): a gynaecologist's enigma!
Topics: Abdominal Pain; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Colposcopy; Cyclophosphamide; Doxorubicin; Early Detection of Cancer; Female; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Radiotherapy; Remission Induction; Rituximab; Treatment Outcome; Vagina; Vaginal Discharge; Vaginal Neoplasms; Vincristine | 2019 |
[Triple expressor lymphoma in a kidney transplant patient].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Genes, myc; Humans; Kidney Transplantation; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Vincristine | 2019 |
A Novel Predictor of Chemotherapeutic Cardiotoxicity in Patients with Non-Hodgkin Lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Electrocardiography; Female; Humans; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Ventricular Function, Left; Vincristine | 2019 |
Remission of Late-Onset Post-Liver Transplantation Non-Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Doxorubicin; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Prednisone; Remission Induction; Rituximab; Vincristine | 2019 |
Treatments for non-Hodgkin lymphoma in HIV-positive patients: quantifying incremental benefit from 1993 to 2004 by metaregression.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; HIV Seropositivity; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Statistics as Topic; Survival Analysis; Vincristine | 2013 |
The relationship between learned resourcefulness and cancer-related fatigue in patients with non-Hodgkin lymphoma.
Topics: Adaptation, Psychological; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatigue; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oncology Nursing; Patient Education as Topic; Personality; Prednisone; Self Efficacy; Surveys and Questionnaires; Vincristine | 2013 |
Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Practice Guidelines as Topic; Prednisone; Prognosis; Radioimmunotherapy; Rituximab; Vincristine | 2004 |
Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Clostridioides difficile; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prednisone; Radiography; Rituximab; Typhlitis; Vancomycin; Vincristine | 2013 |
Characteristics of children with non-hodgkin lymphoma associated with primary immune deficiency diseases: descriptions of five patients.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Bloom Syndrome; Child; Common Variable Immunodeficiency; Cyclophosphamide; Doxorubicin; Female; Humans; Infant; Infant, Newborn; Lymphoma, Non-Hodgkin; Male; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Vincristine; Wiskott-Aldrich Syndrome | 2013 |
Multifocal primary bone lymphoma: durable complete remission after R-CHOP chemotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Rituximab; Vincristine | 2013 |
Ribonuclease binase inhibits primary tumor growth and metastases via apoptosis induction in tumor cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Cytokines; Doxorubicin; Drug Screening Assays, Antitumor; Endoribonucleases; Injections, Intramuscular; Injections, Intraperitoneal; Liver; Lymphoma, Non-Hodgkin; Melanoma, Experimental; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Transplantation; Prednisone; Reactive Oxygen Species; Tumor Burden; Vincristine | 2013 |
Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; China; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotyping Techniques; Humans; Interleukin-10; Kaplan-Meier Estimate; Leptin; Lymphoma, Non-Hodgkin; Lymphotoxin-alpha; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Prednisone; Prognosis; Receptors, Leptin; Risk Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Vincristine; Young Adult | 2013 |
Mapping the redox state of CHOP-treated non-Hodgkin's lymphoma xenografts in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mice; Mice, Nude; Mitochondria; NAD; Oxidation-Reduction; Prednisone; Vincristine; Xenograft Model Antitumor Assays | 2013 |
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine | 2013 |
Non-Hodgkin lymphoma mimics retroperitoneal fibrosis.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Edema; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Radiography; Retroperitoneal Fibrosis; Rituximab; Vincristine | 2013 |
[Diagnosis and treatment of primary colorectal non-Hodgkin's lymphoma: analysis of 52 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Prednisone; Retrospective Studies; Salvage Therapy; Survival Rate; Vincristine; Young Adult | 2013 |
Prognostic role of serum lactate dehydrogenase beyond initial diagnosis: a retrospective analysis of patients with diffuse large B cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2013 |
[Current technologies in radiotherapy for non-Hodgkin lymphomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Orbital Neoplasms; Plasmacytoma; Prednisone; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
[Treatment outcome in primary testicular non-Hodgkin lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Hungary; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prednisone; Radiotherapy, Adjuvant; Retrospective Studies; Rituximab; Testicular Neoplasms; Treatment Outcome; Vincristine | 2013 |
High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Conso
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Vincristine | 2014 |
Myeloablation for lymphoma--question answered?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Stem Cell Transplantation; Vincristine | 2013 |
AIDS-lymphoma (ARL): one more step along the way.
Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2013 |
Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials, Phase III as Topic; Computer Simulation; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; England; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Rituximab; Vincristine; Wales | 2014 |
[Localized primary bone lymphoma: about four cases].
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Clavicle; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Femoral Neoplasms; Fractures, Spontaneous; Humans; Humeral Fractures; Humerus; Lymphoma, Non-Hodgkin; Male; Mandibular Neoplasms; Middle Aged; Osteolysis; Prednisone; Prognosis; Radioisotope Teletherapy; Remission Induction; Rituximab; Vincristine; Vindesine | 2014 |
Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cardiotonic Agents; Cyclophosphamide; Dexrazoxane; Doxorubicin; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Vincristine; Young Adult | 2014 |
[Diagnosis and treatment of primary testicular non-Hodgkin lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Orchiectomy; Positron-Emission Tomography; Prednisone; Radiotherapy, Adjuvant; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2014 |
Survival of patients with transformed lymphoma in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2014 |
Unilateral lower extremity swelling as a rare presentation of non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Humans; Inguinal Canal; Lower Extremity; Lymph Nodes; Lymphedema; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Vincristine | 2014 |
Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cardiac Output; Cyclophosphamide; Doxorubicin; Echocardiography; Echocardiography, Three-Dimensional; Epirubicin; Female; Heart Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prednisone; Rituximab; Sensitivity and Specificity; Troponin T; Vincristine | 2014 |
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cost-Benefit Analysis; Cyclophosphamide; DNA, Viral; Doxorubicin; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine; Virus Activation | 2014 |
Severe neutropenia and relative dose intensity among patients<65 and ≥65 years with non-Hodgkin's lymphoma receiving CHOP-based chemotherapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Vincristine; Young Adult | 2014 |
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Genes, bcl-2; Humans; Induction Chemotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Proto-Oncogene Proteins c-myc; Rituximab; Tomography, X-Ray Computed; Vincristine | 2014 |
Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polyethylene Glycols; Prednisone; Recombinant Proteins; Risk Factors; Rituximab; Taxoids; Vincristine; Young Adult | 2014 |
Romiplostim before splenectomy in a patient with aggressive non-Hodgkin lymphoma and poor response to platelet transfusions.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancytopenia; Platelet Transfusion; Prednisone; Receptors, Fc; Recombinant Fusion Proteins; Rituximab; Splenectomy; Thrombopoietin; Vincristine | 2014 |
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Evidence-Based Medicine; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Practice Guidelines as Topic; Prednisolone; Prednisone; Vincristine | 2014 |
Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab a
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Brain-Derived Neurotrophic Factor; Cognition Disorders; Cyclophosphamide; Doxorubicin; Electroencephalography; Fatigue; Female; Humans; Interleukin-6; Lymphoma, Non-Hodgkin; Male; Middle Aged; Outcome Assessment, Health Care; Prednisone; Rituximab; Surveys and Questionnaires; Vincristine | 2015 |
Herpes simplex virus-related oral mucositis in patients with lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Herpes Simplex; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Stomatitis; Vincristine | 2014 |
Successful treatment of non-Hodgkin's lymphoma using R-CHOP in a patient with Wiskott-Aldrich syndrome followed by a reduced-intensity stem cell transplant.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Prednisone; Rituximab; Stem Cell Transplantation; Vincristine; Wiskott-Aldrich Syndrome | 2014 |
Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Geriatric Assessment; Hematologic Tests; Humans; Kaplan-Meier Estimate; Leukopenia; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Mucositis; Multivariate Analysis; Prednisone; Prognosis; Prospective Studies; Rituximab; Sepsis; Treatment Outcome; Vincristine | 2015 |
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Female; Genital Neoplasms, Female; Gynecologic Surgical Procedures; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Survival Analysis; Teniposide; Vincristine; Young Adult | 2014 |
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melphalan; Nitriles; Nitrogen Mustard Compounds; Prednisone; Primary Myelofibrosis; Pyrazines; Pyrazoles; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2014 |
A treatment for activated B-cell-like DLBCL?
Topics: Adenine; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2014 |
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; DNA; DNA Damage; Doxorubicin; Hodgkin Disease; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Prednisone; Procarbazine; Semen Analysis; Sperm Count; Spermatogenesis; Spermatozoa; Vinblastine; Vincristine; Young Adult | 2014 |
[Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2015 |
Clinical analysis of chronic lung injury in patients with non-Hodgkin lymphoma after CHOP chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lung Injury; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Young Adult | 2014 |
Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cancer Care Facilities; Cyclophosphamide; Doxorubicin; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Treatment Outcome; Turkey; Vincristine; Young Adult | 2014 |
Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.
Topics: Academic Medical Centers; Aged; Aged, 80 and over; Aging; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Incidence; Japan; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Neutropenia; Prednisone; Prognosis; Retrospective Studies; Risk; Rituximab; Severity of Illness Index; Survival Analysis; Vincristine | 2015 |
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Management; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Prognosis; Retrospective Studies; Rituximab; Spinal Cord Compression; Survival Rate; Vincristine; Young Adult | 2015 |
Retrospective analysis of relative dose intensity in patients with non-Hodgkin lymphoma receiving CHOP-based chemotherapy and pegfilgrastim.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cyclophosphamide; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Prednisone; Recombinant Proteins; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2014 |
Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Lung Diseases, Interstitial; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2015 |
Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma.
Topics: Adult; Age Distribution; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure Determination; Cohort Studies; Confidence Intervals; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Odds Ratio; Prednisone; Retrospective Studies; Risk Assessment; Rituximab; Severity of Illness Index; Sex Distribution; Statistics, Nonparametric; Time Factors; Ventricular Dysfunction, Left; Vincristine | 2014 |
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biphenyl Compounds; Cell Line, Tumor; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Evaluation, Preclinical; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Lymphoma, Non-Hodgkin; Mice, SCID; Morpholines; Neoplasm Transplantation; Prednisolone; Prednisone; Pyridones; Random Allocation; Receptors, Glucocorticoid; Vincristine | 2014 |
[Efficacy and safety of rituximab combined with CHOP or combined with dose fractionated CHOP in the treatment of primary gastric diffuse large B cell lymphoma].
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Stomach Neoplasms; Treatment Outcome; Vincristine | 2014 |
Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.
Topics: Alcohol Oxidoreductases; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Cyclophosphamide; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Genotype; Humans; Lymphoma, Non-Hodgkin; Pharmacogenetics; Polymorphism, Single Nucleotide; Prednisone; Prognosis; Rituximab; Vincristine | 2015 |
BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Immunoglobulin Variable Region; Leukemia, Hairy Cell; Lymphoma, Non-Hodgkin; Male; MAP Kinase Kinase 1; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Prednisone; Pregnancy; Proto-Oncogene Proteins B-raf; Real-Time Polymerase Chain Reaction; Vincristine | 2015 |
A treacherous case of primary non-Hodgkin lymphoma of the bone: appearances can be deceptive.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bone Neoplasms; Contraindications; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Humans; Low Back Pain; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Rituximab; Spondylitis, Ankylosing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2015 |
Testicular non-Hodgkin's lymphoma presenting in a young adult.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Cryopreservation; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Orchiectomy; Prednisone; Semen Preservation; Spermatic Cord; Testicular Neoplasms; Treatment Outcome; Vincristine | 2015 |
[Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2015 |
Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Prednisolone; Prednisone; Radiotherapy Dosage; Radiotherapy, Conformal; Regression Analysis; Retrospective Studies; Rituximab; Salvage Therapy; Time Factors; Vincristine | 2015 |
Adult non Hodgkin's lymphoma patients: experience from a tertiary care cancer centre in north east India.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; India; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Remission Induction; Retrospective Studies; Rituximab; Tertiary Healthcare; Vincristine; Young Adult | 2015 |
[Le lymphome primitif du sein].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Mammography; Middle Aged; Prednisone; Rituximab; Ultrasonography; Vincristine | 2014 |
Organizing pneumonia appearing in B-cell chronic leukemia malignancy progression - a case report.
Topics: Aged; Cryptogenic Organizing Pneumonia; Disease Progression; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung; Lymphoma, Non-Hodgkin; Male; Prednisone; Tomography, X-Ray Computed | 2015 |
Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012).
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cyclophosphamide; Doxorubicin; Female; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Medical Records; Prednisone; Prognosis; Schools, Veterinary; Survival Analysis; Treatment Outcome; United States; Vinca Alkaloids; Vincristine | 2016 |
Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Colorado; Cyclophosphamide; Disease-Free Survival; Dog Diseases; Dogs; Doxorubicin; Female; Immunophenotyping; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2016 |
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prednisolone; Prednisone; Remission Induction; Retrospective Studies; Rituximab; Vincristine | 2015 |
Head and neck extra nodal NHL (HNENL)--Treatment Outcome and Pattern of failure--A Single Institution Experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Head and Neck Neoplasms; Health Status; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Recurrence; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2015 |
Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Frail Elderly; Geriatric Assessment; Glyoxal; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Neoplasm Grading; Prednimustine; Prednisone; Prospective Studies; Republic of Korea; Treatment Outcome; Vincristine | 2015 |
A rare case of primary cardiac lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dyspnea; Heart Neoplasms; Humans; Lethargy; Lymphoma, Non-Hodgkin; Male; Pericardial Effusion; Prednisone; Remission Induction; Rituximab; Tachycardia; Treatment Outcome; Vincristine; Weight Loss | 2015 |
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Disease Susceptibility; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; IgG Deficiency; Immunocompromised Host; Immunotherapy; Incidence; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Prednisone; Proportional Hazards Models; Retrospective Studies; Rituximab; Transplantation, Autologous; Vidarabine; Vincristine; Young Adult | 2015 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine | 2016 |
GALECTIN-3 AS A PROGNOSTIC BIOMARKER IN PATIENTS WITH NON-HODGKIN LYMPHOMA.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Biomarkers; Blood Proteins; Cyclophosphamide; Doxorubicin; Echocardiography; Female; Galectin 3; Galectins; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Remission Induction; Rituximab; Stroke; Survival Analysis; Vincristine | 2015 |
[Clinical Study of Non Hodgkin's Lymphoma Treated with Enhanced Chemotherapy Regimen and Increased Treatment Courses].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Recurrence; Remission Induction; Vincristine | 2015 |
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisone; Prognosis; Rituximab; Survival Rate; T-Lymphocytes; Treatment Outcome; Vincristine | 2016 |
Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Coculture Techniques; Constitutive Androstane Receptor; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Gene Expression Regulation, Neoplastic; Hepatocytes; Histones; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Oxidative Stress; Oximes; Phosphorylation; Prednisone; Rats; Receptors, Cytoplasmic and Nuclear; Thiazoles; Vincristine | 2016 |
Ureteric lymphoma as a rare cause of right lower ureteric obstruction.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Constriction, Pathologic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Tomography, X-Ray Computed; Ureter; Ureteral Neoplasms; Ureteral Obstruction; Vincristine | 2016 |
Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Chemoprevention; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Febrile Neutropenia; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Markov Chains; Polyethylene Glycols; Prednisone; Probability; Recombinant Proteins; Rituximab; Singapore; Vincristine | 2016 |
CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Cyclophosphamide; Doxorubicin; Female; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Malawi; Male; Middle Aged; Prednisone; Survival Analysis; Vincristine | 2016 |
Obese non-Hodgkin lymphoma patients tolerate full uncapped doses of chemotherapy with no increase in toxicity, and a similar survival to that seen in nonobese patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Obesity; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2016 |
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports.
Topics: Aminoquinolines; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Imiquimod; Lymphocyte Activation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Treatment Outcome; Vincristine | 2016 |
'Real Life' experience in a 'difficult to treat' patient population of non-Hodgkin lymphomas using the R-COMP regimen.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2016 |
A retrospective analysis of combination chemotherapy consisting cyclophosphamide, vincristine, prednisolone and procarbazine (C-MOPP) for pretreated aggressive non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2016 |
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2016 |
A retrospective study of R-CHOP/CHOP therapy-induced nausea and vomiting in non-Hodgkin's lymphoma patients: a comparison of intravenous and oral 5-HT3 receptor antagonists.
Topics: Antibodies, Monoclonal, Murine-Derived; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Nausea; Prednisone; Retrospective Studies; Rituximab; Serotonin 5-HT3 Receptor Antagonists; Vincristine; Vomiting | 2016 |
Clinical and Cost Comparison Evaluation of Inpatient Versus Outpatient Administration of EPOCH-Containing Regimens in Non-Hodgkin Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hospitalization; Humans; Inpatients; Lymphoma, Non-Hodgkin; Male; Middle Aged; Outpatients; Prednisone; Prospective Studies; Retrospective Studies; Vincristine | 2017 |
[Efficacy of surgery and rituximab in primary gastric diffuse large B-cell lymphoma].
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Quality of Life; Retrospective Studies; Rituximab; Stomach Neoplasms; Vincristine; Young Adult | 2016 |
The metronomic therapy with prednisone, etoposide, and cyclophosphamide reduces the serum levels of VEGF and circulating endothelial cells and improves response rates and progression-free survival in patients with relapsed or refractory non-Hodgkin's lymp
Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Drug Resistance, Neoplasm; Endothelial Cells; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recurrence; Vascular Endothelial Growth Factor A; Young Adult | 2016 |
Prognostic Significance of New-Onset Atrial Fibrillation in Patients With Non-Hodgkin's Lymphoma Treated With Anthracyclines.
Topics: Aged; Anthracyclines; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Cause of Death; Cyclophosphamide; Doxorubicin; Electrocardiography; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Risk Factors; Rituximab; Vincristine | 2016 |
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Everolimus; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Lymphoma, Non-Hodgkin; Mice, Inbred ICR; Mice, SCID; Oxadiazoles; Prednisone; Protein Kinase Inhibitors; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles; Time Factors; TOR Serine-Threonine Kinases; Transcription Factor RelA; Triazoles; Tumor Burden; Vincristine; Xenograft Model Antitumor Assays | 2016 |
Gastric Mucosa-associated Lymphoid Tissue Lymphoma: Posttransplant Lymphopoliferative Disorder.
Topics: Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Postoperative Complications; Prednisone; Rituximab; Stomach Neoplasms; Vincristine | 2016 |
Bilateral primary adrenal lymphoma with adrenal insufficiency.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Vincristine | 2016 |
Primary non-Hodgkin's lymphoma of the tongue: a diagnostic dilemma of unusual case presentation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Tongue Neoplasms; Treatment Outcome; Vincristine | 2017 |
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Polyethylene Glycols; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine | 2017 |
Reformulating the hazard ratio to enhance communication with clinical investigators.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Models, Statistical; Prednisone; Proportional Hazards Models; Research Design; Vincristine | 2008 |
[Primary cervical epidural low-grade non-hodgkin's lymphoma: a case report and review of the literature].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Prednisone; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2008 |
Progressive respiratory distress in a patient with splenic marginal zone lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Respiratory Distress Syndrome; Splenectomy; Splenic Neoplasms; Tomography, X-Ray Computed; Vincristine | 2008 |
Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.
Topics: Acromegaly; Adenoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cabergoline; Cyclophosphamide; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Octreotide; Prednisone; Thyroid Neoplasms; Thyroidectomy; Thyroxine; Vincristine | 2009 |
Long-term results of dose-intensive chemotherapy with G-CSF support (TCC-NHL-91) for advanced intermediate-grade non-Hodgkin's lymphoma: a review of 59 consecutive cases treated at a single institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Retrospective Studies; Treatment Outcome; Vincristine | 2008 |
Acute upper arm ischaemia: a rare presentation of non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arm; Cyclophosphamide; Doxorubicin; Humans; Immunohistochemistry; Ischemia; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Prednisone; Remission Induction; Rituximab; Thrombosis; Tomography, X-Ray Computed; Vincristine | 2010 |
Paraneoplastic pemphigus associated with non-Hodgkin lymphoma.
Topics: Acantholysis; Animals; Antineoplastic Combined Chemotherapy Protocols; Back; Cyclophosphamide; Doxorubicin; Fatal Outcome; Fluorescent Antibody Technique, Direct; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mouth Mucosa; Paraneoplastic Syndromes; Pemphigus; Prednisone; Rats; Skin; Vincristine | 2008 |
[Prognosis of primary non-Hodgkin's lymphoma of the breast].
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2008 |
A 36-year-old man with paresthesias and a headache.
Topics: Adult; Amlodipine; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Guanine; Headache; Hepatitis B; Humans; Labetalol; Lymphoma, Non-Hodgkin; Male; Paresthesia; Prednisone; Substance Abuse, Intravenous; Sural Nerve; Treatment Outcome; Vasculitis | 2008 |
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Rituximab; Sensitivity and Specificity; Survival Analysis; Vincristine; Young Adult | 2009 |
Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Vincristine | 2008 |
A case of malignant primary non-Hodgkin's lymphoma in skeletal muscle treated by exclusive chemotherapy.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Muscle Neoplasms; Muscle, Skeletal; Prednisone; Thigh; Treatment Outcome; Vincristine | 2009 |
Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cyclophosphamide; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Prednisone; Pyrazines; Rituximab; Vincristine | 2008 |
Clinical investigations in aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Prednisolone; Prednisone; Rituximab; Vincristine | 2008 |
FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polymorphism, Genetic; Prednisone; Receptors, IgG; Rituximab; Vincristine | 2009 |
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Body Weight; Colony-Stimulating Factors; Cyclophosphamide; Doxorubicin; Europe; Female; Humans; Immunosuppressive Agents; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Prevalence; Prognosis; Prospective Studies; Recombinant Proteins; Risk Assessment; Rituximab; Vincristine; Young Adult | 2009 |
A rare diagnosis of pancreatic tumour.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Common Bile Duct; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Pancreatic Neoplasms; Prednisone; Rituximab; Tomography, X-Ray Computed; Vincristine | 2009 |
Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Immunologic Deficiency Syndromes; Immunotherapy; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission Induction; Rituximab; Vincristine | 2009 |
[Non-Hodgkin's primitive lymphoma of the testis: long-term prognosis associated with treatment combining systemic and intrathecal chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Testicular Neoplasms; Vincristine | 2009 |
Neurolymphomatosis mimicking chemotherapy-induced ototoxicity.
Topics: Acyclovir; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Antiviral Agents; Audiometry; Cranial Nerves; Diagnosis, Differential; Female; Hearing Loss, Bilateral; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Peripheral Nervous System Neoplasms; Prednisone | 2009 |
Peripheral neuropathy in a cat with renal lymphoma.
Topics: Animals; Antineoplastic Agents, Hormonal; Cat Diseases; Cats; Euthanasia, Animal; Kidney Neoplasms; Lymphoma, Non-Hodgkin; Male; Paraneoplastic Polyneuropathy; Peripheral Nervous System Diseases; Prednisone | 2009 |
Lymphoma in the Waldeyer ring: a great masquerader.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Endoscopy; Etoposide; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Nasopharyngeal Neoplasms; Prednisone; Prognosis; Rituximab; Tonsillar Neoplasms; Treatment Outcome; Vincristine | 2009 |
Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2009 |
A prospective study of left ventricle function after treatment with rapid-infusion rituximab in patients with non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Cytokines; Doxorubicin; Female; Heart Diseases; Humans; Hyperlipidemias; Hypertension; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Rituximab; Smoking; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Vincristine | 2009 |
Epstein-Barr virus negative large B-cell lymphoma during long term immunomodulatory therapy for T-cell large granular lymphocytic leukaemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Disease Progression; Doxorubicin; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Treatment Outcome; Vincristine | 2010 |
[Therapeutic management of central nervous system lymphomas in a single hematological institute].
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Drug Administration Schedule; Epidural Space; Female; Humans; Hungary; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2009 |
Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Middle Aged; Models, Theoretical; Prednisone; Randomized Controlled Trials as Topic; Receptors, IgG; Rituximab; Vincristine; Young Adult | 2009 |
18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Organoplatinum Compounds; Paranasal Sinus Neoplasms; Paranasal Sinuses; Positron-Emission Tomography; Prednisone; Prognosis; Remission Induction; Tomography, Emission-Computed; Vincristine | 2010 |
A case of bullous disease limited to the skin illustrates the spectrum of neoplasia-induced autoimmunity.
Topics: Aged, 80 and over; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Complement Fixation Tests; Cyclophosphamide; Diagnosis, Differential; Fatal Outcome; Female; Fluorescent Antibody Technique, Indirect; Humans; Lymphoma, Non-Hodgkin; Paraneoplastic Syndromes; Pemphigus; Prednisone; Rituximab; Sepsis; Skin Diseases, Vesiculobullous; Vincristine | 2009 |
[Non-pegylated liposomal doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab for the treatment of non-Hodgkin's lymphoma: study of 26 patients].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Liposomes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2010 |
Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prednisone; Radiography; Rituximab; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2010 |
Clinical features and treatment outcomes of non-Hodgkin's lymphomas involving rare extranodal sites: a single-center experience.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Pancreatic Neoplasms; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2010 |
Non-Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Receptors, Tumor Necrosis Factor; Rituximab; Splenomegaly; Spondylitis, Ankylosing; Thrombocytopenia; Treatment Outcome; Tumor Necrosis Factor-alpha; Ultrasonography; Vincristine | 2011 |
Squamous cell carcinoma of the conjunctiva invading the orbit in a non-Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Invasiveness; Neoplasms, Second Primary; Orbit Evisceration; Orbital Neoplasms; Prednisone; Remission Induction; Tomography, X-Ray Computed; Vincristine | 2009 |
Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2010 |
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2010 |
Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Postoperative Period; Prednisone; Preoperative Period; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2010 |
[Management of lymphoma with respect to pathologic classification: updates and controversies].
Topics: Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Prednisone; Receptor Protein-Tyrosine Kinases; Rituximab; Vinblastine; Vincristine | 2009 |
Reversibility of the effects of the chemotherapeutic regimen for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone, on the male rat reproductive system and progeny outcome.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Cyclophosphamide; Doxorubicin; Epididymis; Female; Humans; Litter Size; Lymphoma, Non-Hodgkin; Male; Prednisone; Random Allocation; Rats; Rats, Sprague-Dawley; Reproduction; Sperm Count; Spermatozoa; Testis; Treatment Outcome; Vincristine | 2010 |
Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin's lymphoma patients.
Topics: Actins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; ROC Curve; Survival Rate; Thymidine Kinase; Time Factors; Vincristine | 2010 |
Indolent lymphoma: can rituximab resolve the watch-and-wait debate?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Survival Rate; Vincristine | 2010 |
Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Lung Diseases, Interstitial; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Severity of Illness Index; Tuberculosis, Pulmonary; Vincristine; Young Adult | 2010 |
[Treatment options in non-Hodgkin lymphomas].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Stem Cell Transplantation; Vincristine | 2010 |
[Tunisian experience in the treatment of aggressive non Hodgkin's lymphoma in adults: about 337 patients].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Analysis; Tunisia; Vincristine; Young Adult | 2010 |
Periorbital non-Hodgkin's lymphoma after blunt trauma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Doxorubicin; Facial Injuries; Head and Neck Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Orbit; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2010 |
Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; DNA, Viral; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Female; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Monitoring, Physiologic; Outcome Assessment, Health Care; Polymerase Chain Reaction; Prednisone; Prognosis; Vincristine | 2010 |
Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experience.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Immunophenotyping; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2011 |
Can a blood test monitor lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; DNA, Viral; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Monitoring, Physiologic; Outcome Assessment, Health Care; Polymerase Chain Reaction; Prednisone; Prognosis; Vincristine | 2010 |
Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies.
Topics: Adult; Aged; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carmustine; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vidarabine; Vincristine; Vindesine | 2010 |
Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Job Syndrome; Lymphoma, Non-Hodgkin; Male; Point Mutation; Prednisone; Remission Induction; STAT3 Transcription Factor; Time Factors; Transplantation, Homologous; Vincristine | 2010 |
Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Florida; Humans; Hyperglycemia; Kaplan-Meier Estimate; Linear Models; Lymphoma, Non-Hodgkin; Male; Medical Records; Middle Aged; Neoplasm Staging; Prednisone; Proportional Hazards Models; Prostatic Neoplasms; Retrospective Studies; Rituximab; Taxoids; Treatment Outcome; Vincristine | 2011 |
Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisolone; Prednisone; Vinblastine; Vincristine | 2010 |
Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2011 |
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Impact of CD40 expression by flowcytometry on outcome of patients with non-Hodgkin's lymphoma.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; CD40 Antigens; Cyclophosphamide; Doxorubicin; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Treatment Outcome; Vincristine | 2009 |
Radiographic enlargement of mandibular canal as first feature of non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Hypesthesia; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Male; Mandibular Neoplasms; Mandibular Nerve; Middle Aged; Periodontitis; Prednisone; Radiographic Magnification; Thermosensing; Tomography, X-Ray Computed; Vincristine | 2010 |
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Time Factors; Vincristine; Young Adult | 2011 |
Rituximab tolerability when given before or after CHOP.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chills; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fever; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2011 |
Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab.
Topics: Aged; Anti-Infective Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Flow Cytometry; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Prednisone; Rituximab; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 2010 |
Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemokine CCL2; Cyclophosphamide; Dog Diseases; Dogs; Doxorubicin; Female; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Monocytes; Prednisone; Prognosis; Retrospective Studies; Vincristine | 2011 |
Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colony-Stimulating Factors; Cyclophosphamide; Doxorubicin; Europe; Female; Fever; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Prospective Studies; Risk Assessment; Risk Factors; Vincristine | 2011 |
Treatment of a patient with adnexal lymphoma with Rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Orbital Neoplasms; Prednisone; Prognosis; Radiotherapy; Recurrence; Remission Induction; Rituximab; Soft Tissue Neoplasms; Vincristine | 2011 |
Unusual presentation of gastric plasmablastic lymphoma in HIV-negative patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; HIV; HIV Infections; HIV Seronegativity; Humans; Immunophenotyping; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Middle Aged; Plasma Cells; Prednisone; Stomach Neoplasms; Vincristine | 2012 |
Outcome and haemato-toxicity of two chemotherapy regimens for childhood non-Hodgkin's lymphoma in a Kenyan hospital.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Kenya; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Retrospective Studies; Treatment Outcome; Vincristine | 2009 |
Cutaneous fusariosis developing in a post-irradiation site.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg Ulcer; Lymphoma, Non-Hodgkin; Opportunistic Infections; Postoperative Complications; Prednisone; Pyrimidines; Radiodermatitis; Radiotherapy; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Japan; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Retrospective Studies; Rituximab; Stomach Neoplasms; Treatment Outcome; Vincristine | 2012 |
Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Polyethylene Glycols; Prednisone; Remission Induction; Risk Factors; Treatment Outcome; Vincristine | 2012 |
Lymphosarcoma associated with Heterobilharzia americana infection in a dog.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxorubicin; Feces; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Prednisone; Trematoda; Trematode Infections; Vincristine | 2011 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Medical Oncology; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Grading; Neoplasm Invasiveness; Prednisolone; Prednisone; Rituximab; Societies, Medical; Vincristine; Young Adult | 2012 |
Neurological syndrome after R-CHOP chemotherapy for a non-Hodgkin lymphoma: what is the diagnosis?
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nervous System Diseases; Prednisone; Rituximab; Syndrome; Vincristine | 2011 |
Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2012 |
Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apolipoprotein A-I; Apolipoprotein A-II; Autoantibodies; Cyclophosphamide; Doxorubicin; Female; Humans; Immunoglobulin G; Lipoproteins, HDL; Lipoproteins, LDL; Lymphoma, Non-Hodgkin; Phosphatidylcholine-Sterol O-Acyltransferase; Prednisone; Rituximab; Severity of Illness Index; Triglycerides; Vincristine | 2012 |
Primary extranodal T-cell non-Hodgkin lymphoma of the tongue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Female; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Prednisone; Tongue Neoplasms; Vincristine | 2012 |
Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Blood Component Removal; Combined Modality Therapy; Cyclams; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Leukocyte Count; Lymphocyte Subsets; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Receptors, CXCR4; Retrospective Studies; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2012 |
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy.
Topics: Adoptive Transfer; Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dog Diseases; Dogs; Doxorubicin; Gene Expression; Immunophenotyping; Lymphoma, Non-Hodgkin; Prednisone; T-Lymphocytes; Vincristine | 2012 |
[A very elderly case of complete remission by chemotherapy in a patient of primary esophageal non-Hodgkin lymphoma].
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Esophageal Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Remission Induction; Rituximab; Vincristine | 2012 |
[Primary pulmonary Non-Hodgkin's lymphoma: report of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Prednisone; Radiography, Thoracic; Vincristine | 2012 |
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult | 2012 |
Non-Hodgkin lymphoma during the 1st trimester of pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 2012 |
Painless, rapidly increasing maxillary swelling and erythematous mucosa: differential diagnosis and therapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Male; Maxillary Neoplasms; Middle Aged; Prednisone; Radiography, Panoramic; Rituximab; Vincristine | 2012 |
Vincristine-induced unilateral ptosis with serendipitous response to modafinil.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzhydryl Compounds; Blepharoptosis; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Modafinil; Neuroprotective Agents; Prednisone; Vincristine | 2011 |
Acute liver failure related to chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure, Acute; Lymphoma, Non-Hodgkin; Male; Prednisone; Rituximab; Stomach Neoplasms; Vincristine; Virus Activation | 2012 |
Renal angiomyolipomatosis and Kaposi's sarcoma: a possible link disrupted by sirolimus.
Topics: Aged; Angiomyolipoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lymphoma, Non-Hodgkin; Nephrectomy; Prednisone; Sarcoma, Kaposi; Sirolimus; Splenectomy; Tomography, X-Ray Computed; Vincristine | 2012 |
Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcus neoformans; Cyclophosphamide; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Meningitis, Cryptococcal; Osteomyelitis; Prednisone; Procarbazine | 2012 |
Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost-be
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Prednisone; Quality of Life; Recombinant Proteins; Retrospective Studies; Surveys and Questionnaires; Vincristine; Young Adult | 2013 |
[Giant splenomegaly and non-Hodking´s lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Spleen; Splenomegaly; Tomography, X-Ray Computed; Vincristine | 2012 |
Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Immunocompromised Host; Incidence; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Opportunistic Infections; Pneumonia, Pneumocystis; Prednisone; Prevalence; Republic of Korea; Retrospective Studies; Risk; Rituximab; Vincristine | 2013 |
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
Generalized granuloma annulare and non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Granuloma Annulare; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Rituximab; Skin; Treatment Outcome; Vincristine | 2013 |
Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Rituximab; Vincristine | 2014 |
Null phenotype non-Hodgkin lymphoma presenting as a large chest wall mass: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Morocco; Phenotype; Prednisone; Thoracic Neoplasms; Vincristine | 2012 |
Primary endometrial non-Hodgkin's lymphoma treated by chemotherapy and radiotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Vincristine | 2013 |
International prognostic index-based outcomes for diffuse large B-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Survival Rate; Vincristine | 2002 |
[Coexistence of pure red cell aplasia and autoimmune hemolytic anemia occurring during remission of malignant lymphoma].
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Remission Induction; Vincristine | 2002 |
Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Combined Modality Therapy; Cyclophosphamide; Cytokines; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-12; Interleukin-12 Subunit p40; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Protein Subunits; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Th1 Cells; Th2 Cells; Vincristine | 2002 |
CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prognosis; Survival Rate; Vincristine | 2002 |
Anemia of cancer in intermediate-grade non-Hodgkin's lymphoma.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Community Health Services; Cyclophosphamide; Doxorubicin; Female; Hemoglobins; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Outcome Assessment, Health Care; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Vincristine | 2002 |
Role of endothelin-1 in the development of a special type of cardiomyopathy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography; Endothelin-1; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Stroke Volume; Vinblastine; Vincristine | 2002 |
A relapsed non-Hodgkin lymphoma presenting as panhypopituitarism successfully treated by chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Female; Humans; Hypopituitarism; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Treatment Outcome; Vincristine | 2002 |
Retrospective comparison between CHOP-PVP and CHOP protocols for non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission Induction; Vinblastine | 2002 |
[Primary malignant non-Hodgkin's lymphoma of the heart].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Doxorubicin; Echocardiography; Female; Heart Neoplasms; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Myocardium; Prednisone; Radiography, Thoracic; Tomography, X-Ray Computed; Vincristine | 2002 |
Optimal therapy of primary ocular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Functional Laterality; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Radiotherapy; Vincristine | 2002 |
Use of random skin biopsy to diagnose intravascular lymphoma presenting as fever of unknown origin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Fatal Outcome; Female; Fever of Unknown Origin; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Skin; Vincristine | 2003 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart Failure; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Ventricular Dysfunction, Left; Vincristine | 2003 |
Successful chemotherapy in a male patient with malignant lymphoma and Leber's hereditary optic neuropathy (LHON).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Combined Modality Therapy; Cyclophosphamide; DNA, Mitochondrial; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Male; Optic Atrophy, Hereditary, Leber; Prednisone; Remission Induction; Vincristine | 2003 |
[Gemcitabine in the treatment of relapsed or refractory non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Salvage Therapy; Secondary Prevention | 2002 |
[Uveal lymphoid infiltration with systemic extension].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Choroid Diseases; Choroid Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Eye Enucleation; Glaucoma, Neovascular; Glaucoma, Open-Angle; Humans; Immunoglobulin kappa-Chains; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Neoplasm Invasiveness; Orbital Neoplasms; Paraproteins; Prednisone; Pseudolymphoma; Remission Induction; Retinal Detachment; Vincristine | 2003 |
Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vincristine | 2002 |
Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Hysterectomy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoadjuvant Therapy; Ovariectomy; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2003 |
[Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nose Neoplasms; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2003 |
[Primary non-Hodgkin's lymphoma of the thyroid. A case report and review of the literature].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyroiditis, Autoimmune; Vincristine | 2003 |
Aggressive lymphoma: improving treatment outcome with rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Randomized Controlled Trials as Topic; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine | 2002 |
Primary non-Hodgkin's lymphoma of the bladder with bone marrow involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; Bone Neoplasms; Cyclophosphamide; Cystoscopy; Doxorubicin; Follow-Up Studies; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms; Urodynamics; Vincristine | 2003 |
Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diphtheria Toxin; Disease Progression; Doxorubicin; Humans; Interleukin-2; Lymphoma, Non-Hodgkin; Male; Peripheral Blood Stem Cell Transplantation; Prednisone; Recombinant Fusion Proteins; Remission Induction; Rituximab; Time Factors; Vidarabine; Vincristine | 2003 |
ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisone; Remission Induction; Retrospective Studies; Survival Analysis; Vincristine | 2003 |
Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Linear Models; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Prednisone; Proportional Hazards Models; Retrospective Studies; Selenium; Survival Analysis; Vincristine | 2003 |
Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Lymphoma, Non-Hodgkin; Male; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation | 2003 |
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation | 2003 |
Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Prednisone; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Social Behavior; Survival; Vidarabine; Vincristine | 2003 |
[Synchronous chromophobe renal carcinoma and centrocytic lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Kidney Neoplasms; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Nephrectomy; Prednisone; Tomography, X-Ray Computed; Vincristine | 2003 |
Abdominal irradiation after chemotherapy in non-Hodgkin's lymphoma: review of 32 patients.
Topics: Abdomen; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Recurrence; Safety; Survival Rate; Treatment Failure; Vincristine | 2003 |
Richter's syndrome: a novel presentation.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nose Neoplasms; Prednisone; Syndrome; Vincristine | 2003 |
[Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Mabthera) versus conventional chemotherapy].
Topics: Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Drug Hypersensitivity; Female; Hospitalization; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Retrospective Studies; Rituximab; Teniposide; Thrombocytopenia; Vincristine; Vomiting | 2003 |
Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Vincristine; Viral Load; Viremia | 2003 |
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vincristine | 2003 |
[A further possible indication for use of prednisone: several mesenchymal neoplasms].
Topics: Child; Humans; Infant; Leukemia; Leukemia, Myeloid; Liver; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Prednisone; Sarcoma; Steroids | 1955 |
[Reticulosarcoma of the scapula; treatment with delta cortisone].
Topics: Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Prednisone; Sarcoma; Scapula | 1957 |
[Massive dosage of prednisone in lymphogranuloma, lymphosarcoma and reticulum cell sarcoma].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Prednisone; Sarcoma | 1957 |
Cutaneous lymphoblastoma: a case of reticulum cell sarcoma with prominent skin manifestations and a brief but dramatic remission with prednisone therapy.
Topics: Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Medical Records; Neoplasms; Prednisone; Sarcoma; Skin Neoplasms | 1958 |
[A case of reticulosarcoma treated with large doses of prednisone].
Topics: Cell- and Tissue-Based Therapy; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Prednisone; Sarcoma | 1959 |
Innovative strategies in lymphoma therapy.
Topics: Alemtuzumab; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cancer Vaccines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Forecasting; Genetic Therapy; Humans; Immunoconjugates; Immunotherapy; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prednisone; Protease Inhibitors; Proteomics; Pyrazines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Rituximab; Signal Transduction; Survival Analysis; Thalidomide; Time Factors; Vincristine | 2003 |
[Contribution to the treatment of lymphosarcoma].
Topics: Antineoplastic Agents; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Prednisone | 1961 |
Large doses of prednisone and prednisolone in the treatment of malignant lymphoproliferative disorders.
Topics: Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Prednisolone; Prednisone | 1962 |
Polyneuritis preceding lymphoblastic lymphoma.
Topics: Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neuritis; Polyradiculopathy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone | 1963 |
[The use of Degranol pills in hemoblastosis and other neoplastic diseases].
Topics: Humans; Leukemia; Leukemia, Lymphoid; Lymphogranuloma Venereum; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mannomustine; Neoplasms; Prednisone; Sarcoma | 1963 |
WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS.
Topics: Anemia; Anemia, Hemolytic; Betamethasone; Chlorambucil; Dexamethasone; Geriatrics; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mercaptopurine; Methylprednisolone; Pharmacology; Prednisone; Radiotherapy; Thrombocytopenia; Triamcinolone | 1964 |
SPINAL-CORD COMPRESSION IN THE MALIGNANT LYMPHOMAS.
Topics: Chlorambucil; Hematopoiesis; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mercaptopurine; Neoplasms; Paraplegia; Prednisone; Spinal Cord Compression | 1964 |
[EXPERIENCES IN THE TREATMENT OF MALIGNANT DISEASES OF THE RETICULOENDOTHELIAL SYSTEM AND LEUKEMIAS. (I)].
Topics: Antineoplastic Agents; Cortisone; Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Military Medicine; Mononuclear Phagocyte System; Neoplasms; Netherlands; Prednisone; Radiography, Thoracic; Sarcoma; Statistics as Topic; Stomach Neoplasms; Triethylenemelamine; Vinblastine | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Chlorambucil; Cytodiagnosis; Fluorouracil; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Mediastinal Neoplasms; Neoplasm Metastasis; Neoplasms; Palliative Care; Prednisone; Sarcoma; Vinblastine | 1964 |
[THE SIGNIFICANCE OF RETICULOSES IN THE AREA OF MALIGNANT HEMATOLOGICAL DISEASES IN CHILDHOOD].
Topics: Child; Cyclophosphamide; Genetic Diseases, X-Linked; Hematologic Diseases; Histiocytosis, Langerhans-Cell; Humans; Leukemia; Leukemia, Hairy Cell; Lymphatic Diseases; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Peptide Nucleic Acids; Prednisone; Severe Combined Immunodeficiency | 1963 |
[THE RETICULO-ENDOTHELIAL SYSTEM AND LYMPHOSARCOMAS].
Topics: Adolescent; Adrenal Cortex Hormones; Geriatrics; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mononuclear Phagocyte System; Neoplasms; Prednisolone; Prednisone; Sarcoma; Triamcinolone | 1964 |
METABOLIC RELATIONSHIPS BETWEEN TUMOR AND HOST DURING MASSIVE DOSES OF PREDNISONE IN HUMAN NEOPLASTIC DISEASE.
Topics: 17-Ketosteroids; Adenocarcinoma; Biomedical Research; Blood; Calcium; Chlorides; Creatine; Creatinine; Drug Therapy; Hodgkin Disease; Humans; Iodine Isotopes; Leukemia; Leukemia, Lymphoid; Liver; Lymphocytes; Lymphoma; Lymphoma, Non-Hodgkin; Metabolism; Multiple Myeloma; Nitrogen; Phosphorus; Potassium; Prednisone; Sodium; Uric Acid; Water | 1964 |
RETICULUM CELL SARCOMA OF THE SMALL BOWEL AND STEATORRHOEA.
Topics: Ascorbic Acid; Blood Transfusion; Body Weight; Bone Marrow Examination; Celiac Disease; Diet; Diet Therapy; Fats; Feces; Folic Acid; Humans; Intestinal Neoplasms; Intestinal Perforation; Intestine, Small; Iron; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nandrolone; Neomycin; Neoplasms; Pathology; Prednisone; Sarcoma; Steatorrhea; Surgical Procedures, Operative; Vitamin A; Vitamin B 12; Vitamin B Complex; Vitamins; Water-Electrolyte Balance | 1964 |
THE SUPERIOR MEDIASTINAL SYNDROME IN CHILDREN WITH CANCER.
Topics: Adolescent; Child; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mediastinal Neoplasms; Mediastinum; Neoplasms; Neuroblastoma; Nitrogen Mustard Compounds; Prednisone; Radiography, Thoracic; Respiratory Insufficiency | 1965 |
Calcification in splenic lymphoma before chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Calcinosis; Causality; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission Induction; Splenic Diseases; Splenic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
Primary gastrointestinal non-Hodgkin's lymphoma: treatment outcome.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2003 |
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Risk Factors; Vindesine | 2004 |
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Female; HIV Infections; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Medical Records; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pleural Effusion; Prednisone; Tamoxifen; Tegafur; Uracil; Vincristine | 2003 |
Synchronous triple lung cancers after treatment for non-Hodgkin's lymphoma: metachronous quadruple cancers.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Prednisone; Radiotherapy; Vincristine | 2003 |
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2003 |
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fever; Hospitalization; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Prednisolone; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Time Factors; Vincristine | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunophenotyping; Lymphocyte Depletion; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vincristine | 2003 |
[Clinical analysis of 282 patients with non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 2003 |
[Principles of treatment and military medical examination of the patients with indolent Non-Hodgkin's lymphomas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disability Evaluation; Doxorubicin; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Military Personnel; Neoplasm Staging; Prednisone; Russia; Vincristine | 2003 |
Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols; Prednisone; Recombinant Proteins; Safety; Treatment Outcome; Vincristine | 2003 |
Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Vincristine | 2004 |
[Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Female; Growth Substances; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Breast cancer after curative chemotherapy in non-Hodgkin's lymphoma: examination of the role of drug resistance and retrospective comparison to the outcome of de novo breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Immunochemistry; Lymphoma, Non-Hodgkin; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Prednisone; Prognosis; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 4; Receptors, Cell Surface; Retrospective Studies; Vincristine | 2004 |
[Bilateral primary non-Hodgkin's lymphomas of the adrenals].
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Middle Aged; Prednisone; Tomography, X-Ray Computed; Vincristine | 2003 |
Multiple clinical manifestation of HTLV1 infection in a single patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dermatitis, Seborrheic; Diagnosis, Differential; Doxorubicin; Female; HTLV-I Infections; Humans; Lymphoma, Non-Hodgkin; Paraparesis, Tropical Spastic; Prednisone; Vincristine | 2003 |
Remitting seronegative symmetrical synovitis with pitting edema syndrome associated with non-Hodgkin's lymphoma: a case report.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Edema; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prednisone; Syndrome; Synovitis; Treatment Outcome; Vincristine | 2004 |
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Positive T-Lymphocytes; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Interferon-gamma; Interleukin-4; Intracellular Fluid; Lymphocyte Count; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells; Vincristine | 2004 |
[Primary non-Hodgkin's lymphoma of bone].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Regeneration; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Femoral Fractures; Femoral Neoplasms; Femur; Follow-Up Studies; Fracture Fixation, Intramedullary; Fractures, Spontaneous; Humans; Ilizarov Technique; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Osteosarcoma; Prednisone; Radiography; Retrospective Studies; Time Factors; Treatment Outcome; Vincristine | 2004 |
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; Female; Gastrointestinal Neoplasms; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vidarabine; Vincristine | 2004 |
[Alveolar hypoxemic interstitial pneumonia related to rituximab therapy].
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Humans; Hypoxia; Lung Diseases, Interstitial; Lymphoma, Non-Hodgkin; Oxygen Inhalation Therapy; Prednisolone; Prednisone; Pulmonary Alveoli; Respiratory Insufficiency; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2004 |
[Primary central nervous system lymphoma: a report of 28 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Teniposide | 2004 |
[Chemotherapy and radiotherapy for non-Hodgkin's lymphomas of the nasal cavity].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Vincristine | 2004 |
[Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 2004 |
Cyclooxygenase-2 (Cox-2) expression in lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclooxygenase 2; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Isoenzymes; Life Tables; Lymphoma; Lymphoma, Non-Hodgkin; Male; Membrane Proteins; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prednisone; Prostaglandin-Endoperoxide Synthases; Survival Analysis; Vinblastine; Vincristine | 2004 |
Adrenal insufficiency due to primary bilateral adrenal non-Hodgkin's lymphoma.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Vincristine | 2004 |
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Treatment Outcome; United States; Vincristine | 2004 |
Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; Recurrence; Survival Rate; Vincristine | 2004 |
Primary mammary (non-Hodgkin) lymphoma presenting as locally advanced breast cancer.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Mammography; Neoplasm Staging; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2004 |
Tositumomab/I-131 tositumomab following chemotherapy effective as first-line treatment of NHL.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neutropenia; Prednisone; Referral and Consultation; Thrombocytopenia; Treatment Outcome; Vincristine | 2004 |
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vascular Endothelial Growth Factor A; Vincristine | 2004 |
[Clinical analysis of liver non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Bilirubin; Cyclophosphamide; Doxorubicin; Female; Humans; Liver Neoplasms; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 2004 |
Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2004 |
The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Regression Analysis; Time Factors; Treatment Outcome; Vincristine | 2004 |
[Clinical analysis of 68 patients with primary gastric lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Gastrectomy; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Radiotherapy, High-Energy; Retrospective Studies; Stomach Neoplasms; Survival Rate; Vincristine | 2004 |
[A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Rituximab; Survival Analysis; Time Factors; Vincristine | 2004 |
A case of facial swelling and proptosis.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Edema; Exophthalmos; Face; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Maxillary Sinus Neoplasms; Prednisone; Rituximab; Vincristine; Vision Disorders | 2004 |
Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Hepatitis B; Hepatitis B virus; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Recurrence; Rituximab; Vincristine; Virus Activation | 2005 |
Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Vincristine | 2005 |
[The choice of second-line chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Prednisone; Salvage Therapy; Vincristine | 2005 |
[A case of secondary non-Hodgkin's lymphoma of the colon after the treatment for Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Radiotherapy Dosage; Remission Induction; Vincristine | 2005 |
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prednisone; Telomere; Transplantation, Autologous; Vincristine | 2005 |
Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nelfinavir; Prednisone; Prospective Studies; Vincristine | 2005 |
Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Prognosis; Vincristine; Vindesine | 2005 |
Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Uterine Cervical Neoplasms; Uterine Neoplasms; Vaginal Neoplasms; Vincristine | 2005 |
Neoadjuvant combined chemotherapy followed by external whole pelvic irradiation in two cases of primary extranodal non-Hodgkin's lymphoma of the uterine cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoadjuvant Therapy; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2005 |
Nephrotic syndrome in patients with peripheral blood stem cell transplant.
Topics: Acute Kidney Injury; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Etoposide; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Rituximab; Sepsis; Staphylococcal Infections; Tacrolimus; Transplantation Conditioning | 2005 |
Dysphagia revealing esophageal involvement by non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deglutition Disorders; Doxorubicin; Esophageal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Radiography; Vincristine | 2005 |
[Clinical analysis of 59 cases of primary gastric non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Retrospective Studies; Stomach Neoplasms; Survival Rate; Vincristine | 2005 |
Endothelin-1 and cardiac function in anthracycline-treated patients: a 1-year follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Down-Regulation; Doxorubicin; Echocardiography, Doppler; Endothelin-1; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left; Vinblastine; Vincristine | 2004 |
Primary breast lymphoma cytologic diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Mammography; Prednisone; Treatment Outcome; Vincristine | 2005 |
Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Reproducibility of Results; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Stage I and II non-Hodgkin's lymphoma: results of combined of THP-COP chemotherapy and radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Treatment of localized lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Vindesine | 2005 |
Treatment of localized lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Survival Analysis; Vincristine; Vindesine | 2005 |
Treatment of localized lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Vincristine; Vindesine | 2005 |
Epstein-Barr virus DNA in serum in a HIV-infected patient during development and treatment of non-Hodgkin's lymphoma.
Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA, Viral; Doxorubicin; Herpesvirus 4, Human; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Switzerland; Vincristine | 2005 |
Non-Hodgkin's lymphoma after kidney transplantation: a single institution study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recurrence; Remission Induction; Rituximab; Vincristine | 2006 |
Long-term follow-up high-dose chemotherapy (drug-only program) followed by autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine | 2005 |
Treatment of a clinically determined lower-risk stage III non-lymphoblastic Non-Hodgkin lymphoma with less intensive therapy does not impact negatively on outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Prospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2006 |
CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 2005 |
[Expression of glycoprotein 90K in non-Hodgkin's lymphoma and its clinical significance].
Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carrier Proteins; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Glycoproteins; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 2005 |
Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2005 |
Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recurrence; Risk Factors; Rituximab; Treatment Outcome; Twins, Dizygotic; Vincristine | 2005 |
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Prednisone; Regression Analysis; Sex Factors; Survival Rate; Vincristine | 2005 |
[Efficacy of different chemotherapy programs, indications for surgery and radiotherapy in primary mediastinal B-cell lymphosarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mediastinal Neoplasms; Methotrexate; Prednisone; Remission Induction; Vincristine | 2005 |
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vinblastine; Vinorelbine | 2006 |
Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Vincristine | 1989 |
Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Hydroxyurea; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Treatment Outcome; Vincristine | 1989 |
A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neck; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Thyroid Neoplasms; Vincristine | 2005 |
Primary non-Hodgkin's lymphoma of the spleen presenting as space occupying lesion: a case report and review of literature.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Ki-1 Antigen; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Sensitivity and Specificity; Splenectomy; Splenic Neoplasms; Tomography, X-Ray Computed; Vincristine | 2006 |
Complete regression of cardiac non-Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Echocardiography; Heart Neoplasms; Humans; Kidney Neoplasms; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Prednisone; Remission Induction; Retroperitoneal Neoplasms; Rituximab; Tomography, Emission-Computed, Single-Photon; Vincristine | 2006 |
Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoenia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukocyte Count; Leukopenia; Lymphoma, Non-Hodgkin; Male; Mathematics; Middle Aged; Models, Biological; Prednisone; Risk Factors; Severity of Illness Index; Vincristine | 2006 |
[Malignant non-Hodgkin diffuse lymphoma with extranodal orbital involvement--a clinical case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Orbital Neoplasms; Prednisone; Treatment Outcome | 2005 |
Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography; Exercise Test; Female; Heart; Heart Function Tests; Humans; Lung; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Respiratory Function Tests; Sex Factors; Ventricular Function, Left; Vincristine | 2006 |
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Mediastinal Neoplasms; Positron-Emission Tomography; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2006 |
[Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Topics: Adolescent; Adult; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Lymphoma, B-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prednisone; Remission Induction; Survival Rate; Vincristine; Young Adult | 2006 |
[Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Quality of Life; Retrospective Studies; Survival Rate; Tonsillar Neoplasms; Vincristine; Young Adult | 2006 |
[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Vincristine; Young Adult | 2006 |
A case of non-hodgkin's lymphoma of the ovary: usefulness of 18F-FDG PET for staging and assessment of the therapeutic response.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2006 |
Retroperitoneal fibrosis after chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Retroperitoneal Fibrosis; Retroperitoneal Neoplasms; Vincristine | 2007 |
Primary bone lymphoma: a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Retrospective Studies; Survival Analysis; Vincristine | 2006 |
Fertility status among women treated for aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Fertility; Humans; Infertility, Female; Kinetics; Lymphoma, Non-Hodgkin; Menstrual Cycle; Prednisone; Remission Induction; Risk; Time Factors; Vincristine | 2006 |
Treatment results of chemoradiation therapy for localized aggressive lymphomas: A retrospective 20-year study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Radiotherapy Dosage; Receptors, Interleukin-2; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 2006 |
[Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Heart; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Ventricular Dysfunction, Left; Vinblastine; Vincristine | 2006 |
New concepts in treatment approaches and prognostic factors in aggressive NHL.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Gene Expression Profiling; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Prednisone; Prognosis; Rituximab; Vincristine | 2006 |
Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Prednisone; Psoriasis; Stem Cell Transplantation; Vincristine | 2006 |
[Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Male; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Particle Accelerators; Prednisone; Radiotherapy, High-Energy; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2006 |
[Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Intestinal Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 2006 |
[Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography; Female; Heart; Heart Diseases; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Ventricular Dysfunction, Left; Vinblastine; Vincristine | 2006 |
False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; False Positive Reactions; Humans; Ifosfamide; Laparoscopy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Spleen; Splenectomy; Tomography, X-Ray Computed; Unnecessary Procedures; Vincristine | 2006 |
[Clinical study of shenqi fuzheng injection and chemotherapy in CHOP protocol in treating malignant lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Injections, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Phytotherapy; Prednisone; Quality of Life; Vincristine | 2006 |
Defining the cost of cure: infertility among female survivors of lymphoma.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infertility, Female; Kinetics; Lymphoma, Non-Hodgkin; Menstrual Cycle; Patient Education as Topic; Prednisone; Remission Induction; Risk; Vincristine | 2006 |
Something old, something new....
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Recurrence; Stem Cell Transplantation; Time Factors; Treatment Outcome; Vinblastine; Vinorelbine | 2006 |
Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Rituximab; Vincristine | 2006 |
Same day Pegfilgrastim and CHOP chemotherapy for non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Polyethylene Glycols; Prednisone; Recombinant Proteins; Retrospective Studies; Rituximab; Vincristine | 2006 |
Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Cyclophosphamide; Doxorubicin; Humans; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Translocation, Genetic; Trisomy; Vincristine | 2006 |
Primary retroperitoneal non-Hodgkin lymphoma presenting with torturous generalized pruritus in an elderly.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Pruritus; Retroperitoneal Neoplasms; Vincristine | 2007 |
Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Europe; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Registries; Retrospective Studies; Risk Factors; Vincristine | 2006 |
Conservative management in primary genital lymphomas: the role of chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fertility; Genital Neoplasms, Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Vincristine | 2007 |
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Osteonecrosis; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Retrospective Studies; Vincristine | 2006 |
Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; B-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esophageal Diseases; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunity, Cellular; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Lichenoid Eruptions; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mucositis; Paraneoplastic Syndromes; Pemphigus; Prednisone; Recurrence; Rituximab; T-Lymphocytes; Vidarabine; Vincristine | 2007 |
[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prednisone; Proportional Hazards Models; Radiotherapy, High-Energy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2006 |
[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Immunophenotyping; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Radiotherapy, High-Energy; Remission Induction; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2006 |
Primary gastric lymphoma.
Topics: Abdominal Pain; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Gastrectomy; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Saudi Arabia; Stomach Neoplasms; Vincristine | 2007 |
Sudden onset of herpes zoster following chemotherapy for orbital lymphoma in a HIV positive patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Female; Herpes Zoster; HIV Seropositivity; Humans; Lymphoma, Non-Hodgkin; Orbital Neoplasms; Prednisone; Vincristine | 2007 |
Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases.
Topics: Aged; Aged, 80 and over; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rheumatoid Factor; Rituximab; Vincristine | 2007 |
[Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Radiotherapy Dosage; Recurrence; Remission Induction; Vincristine | 2007 |
Primary large B-cell lymphoma of the bone marrow.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Vincristine | 2007 |
[Long term results for intermediate and high grade localized non Hodgkin lymphoma, treated with chemotherapy and radiotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 8; Chromosomes, Human, X; Clone Cells; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Female; Genes, myc; Humans; Karyotyping; Lymph Nodes; Lymphoma, AIDS-Related; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Mutagenesis, Insertional; Pleural Effusion, Malignant; Prednisone; Rituximab; Translocation, Genetic; Trisomy; Vidarabine; Vincristine | 2007 |
The effect of short-term intensive chemotherapy on reactivation of tuberculosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Mycobacterium tuberculosis; Prednisone; Retrospective Studies; Tuberculosis; Vincristine; Virus Activation | 2007 |
Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Diagnosis, Differential; Diagnostic Errors; Disease Progression; Doxorubicin; HLA-DR Antigens; Humans; Killer Cells, Natural; Lymph Nodes; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Neoplasm Proteins; Prednisone; Proto-Oncogene Proteins c-bcl-2; Pseudolymphoma; Radiography; Skin Neoplasms; Vincristine | 2007 |
Aggressive primary thyroid non Hodgkin's lymphoma with pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Thyroid Neoplasms; Vincristine | 2007 |
[A case of primary malignant lymphoma of thyroid in young man].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission Induction; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyroxine; Ultrasonography; Vincristine | 2006 |
[Primary non-Hodgkin's lymphoma of the adrenals. A case report].
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Prednisone; Shock, Septic; Tomography, X-Ray Computed; Vincristine | 2007 |
False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prostatic Neoplasms; Rituximab; Vincristine | 2007 |
[Hypercalcaemia and malignant lymphoma. One case report].
Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcitriol; Diphosphonates; Glucocorticoids; Humans; Hypercalcemia; Lymphoma, Non-Hodgkin; Male; Palliative Care; Pamidronate; Prednisone; Testicular Neoplasms | 2007 |
Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Plasma Exchange; Prednisone; Rituximab; Vincristine | 2007 |
Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorine Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Thymidine; Treatment Outcome; Vincristine | 2007 |
Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Sarcoidosis; Spleen; Tomography, X-Ray Computed; Vincristine | 2007 |
The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkin's lymphoma patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Vincristine | 2002 |
How can we determine the role of radiotherapy in the treatment of localized aggressive non-Hodgkin's lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Radiotherapy Dosage; Radiotherapy, Adjuvant; Recurrence; Research Design; Vincristine | 2007 |
Complete remission by chemotherapy in stage IE-IIE primary gastric lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Preoperative Care; Prospective Studies; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
[Genitourinary manifestations of lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Kidney; Kidney Neoplasms; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nephrectomy; Prednisone; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Testicular Neoplasms; Testis; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine | 2007 |
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine; Whole Body Imaging | 2008 |
A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Vincristine | 2008 |
Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lupus Erythematosus, Systemic; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2007 |
A case of primary cardiac lymphoma: analysis of the role of echocardiography in early diagnosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Early Diagnosis; Echocardiography; Female; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Middle Aged; Prednisone; Rituximab; Vincristine | 2007 |
[Primary diffuse large B-cell lymphosarcoma of the spleen].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy; Remission Induction; Splenectomy; Splenic Neoplasms; Treatment Outcome; Vincristine | 2007 |
[CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Retrospective Studies; Survival Analysis; Thrombocytopenia; Vincristine | 2007 |
[Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cote d'Ivoire; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome; Vincristine | 2007 |
[Prognostic factors of invasive non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Vincristine | 2007 |
Primary testicular lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Orchiectomy; Prednisone; Prognosis; Retrospective Studies; Survival; Testicular Neoplasms; Treatment Outcome; Turkey; Vincristine | 2007 |
Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Germany; Hematologic Diseases; Hospitalization; Humans; Infections; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Models, Statistical; Multicenter Studies as Topic; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; Prednisone; Prognosis; Risk Assessment; Risk Factors; Thrombocytopenia; Vincristine | 2008 |
Diffuse lymphomatous infiltration of kidney presenting as renal tubular acidosis and hypokalemic paralysis: case report.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adult; Antigens, CD19; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Female; Hepatomegaly; Humans; Hypokalemia; Kidney; Kidney Neoplasms; Lymphoma, Non-Hodgkin; Muscle Weakness; Paralysis; Potassium Chloride; Prednisone; Radiography; Splenomegaly; Treatment Outcome; Ultrasonography; Vincristine | 2007 |
Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Neoadjuvant Therapy; Prednisone; Pregnancy; Uterine Cervical Neoplasms; Vincristine | 2007 |
Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET.
Topics: Antineoplastic Combined Chemotherapy Protocols; Belgium; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Europe; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Vincristine | 2008 |
Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Sjogren's Syndrome; Treatment Outcome; Vincristine | 2008 |
Expression of PLK1 and survivin in non-Hodgkin's lymphoma treated with CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Proteins; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Lymphoma, Non-Hodgkin; Microtubule-Associated Proteins; Middle Aged; Neoplasm Staging; Polo-Like Kinase 1; Prednisone; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Survivin; Treatment Outcome; Vincristine; Young Adult | 2008 |
Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Belgium; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Medical Audit; Middle Aged; Prednisone; Retrospective Studies; United Kingdom; Vincristine | 2008 |
[Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine; Young Adult | 2008 |
Necrotizing leukoencephalopathy following CHOP chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cerebral Cortex; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Vincristine | 2008 |
[Intravascular lymphoma revealed by generalized arborescent telangiectasia and repeated venous thrombosis].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Rituximab; Skin Diseases; Telangiectasis; Treatment Outcome; Venous Thrombosis; Vincristine | 2008 |
Erythema elevatum diutinum with rare distribution as a first clinical sign of non-Hodgkin's lymphoma: a novel association?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Erythema; Humans; Lymphoma, Non-Hodgkin; Male; Paraproteinemias; Prednisone; Vincristine | 2008 |
Comment on: 'Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome'.
Topics: Administration, Oral; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Multicenter Studies as Topic; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine | 2008 |
Complete remission in chronic lymphocytic leukemia and leukolymphosarcoma.
Topics: Aged; Chlorambucil; Female; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Splenectomy | 1967 |
Toxic epidermal necrolysis and malignant lymphoma.
Topics: Adult; Aged; Bendroflumethiazide; Chloramphenicol; Cyclizine; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Meperidine; Nitrogen Mustard Compounds; Prednisone; Semicarbazides; Stevens-Johnson Syndrome | 1967 |
Management of the indolent non-Hodgkin's lymphomas.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Radiography; Vincristine | 1980 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1982 |
Clinical and histological staging as prognostic determinants in advanced cutaneous T cell lymphomas treated by sequential polychemotherapy with bleomycin, vinblastine and prednisone. Preliminary results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycosis Fungoides; Prednisone; Prognosis; Skin Neoplasms; T-Lymphocytes; Vinblastine | 1982 |
Combination chemotherapy ("MABOP") in advanced refractory lymphocytic lymphoma with unfavorable histology.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Prognosis; Vincristine | 1982 |
Chronic lymphocytic leukemia in the elderly.
Topics: Aged; B-Lymphocytes; Chlorambucil; Diagnosis, Differential; Glucosephosphate Dehydrogenase; Humans; Hypersensitivity, Delayed; Immune Tolerance; Immunoglobulin Light Chains; Isoenzymes; Leukemia, Hairy Cell; Leukemia, Lymphoid; Lymphocyte Activation; Lymphocytosis; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; T-Lymphocytes; T-Lymphocytes, Regulatory | 1982 |
Malignant lymphocytic lymphoma. Demonstration of a serum inhibitor of myelopoiesis and response to combination chemotherapy.
Topics: Antineoplastic Agents; Colony-Forming Units Assay; Cyclophosphamide; Drug Therapy, Combination; Hematopoiesis; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; T-Lymphocytes, Regulatory; Vincristine | 1983 |
Composite lymphoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1984 |
Myeloproliferative disorder with profound hypereosinophilia associated with chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Eosinophilia; Female; Humans; Lymphoma, Non-Hodgkin; Mastectomy; Melphalan; Middle Aged; Myeloproliferative Disorders; Prednisone; Vincristine | 1984 |
Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vinblastine; Vindesine | 1983 |
Systemic lupus erythematosus and lymphoma. A family study.
Topics: Adult; Autoimmune Diseases; Azathioprine; Child; Drug Therapy, Combination; Female; Humans; Killer Cells, Natural; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Neoplasms; Pedigree; Prednisone; Splenic Neoplasms; T-Lymphocytes; Time Factors | 1983 |
[Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Humans; Leukopenia; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Vincristine | 1983 |
Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Prednisone; Vincristine | 1983 |
Reversal of red cell aplasia and marrow fibrosis in non-Hodgkin's lymphoma.
Topics: Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Primary Myelofibrosis; Procarbazine; Vincristine | 1983 |
Dexamethasone binding to chromatin, inhibition of in vitro RNA synthesis, and therapeutic effect on human lymphosarcoma.
Topics: Child; Chromatin; Dexamethasone; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Prednisone; RNA, Neoplasm | 1980 |
[Non-Hodgkin's lymphoma and pregnancy treated with chemotherapy. Report of a case].
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Lymphoma, Non-Hodgkin; Prednisone; Pregnancy; Pregnancy Complications; Vincristine | 1981 |
Malignant pheochromocytoma. Severe clinical exacerbation and release of stored catecholamines during lymphoma chemotherapy.
Topics: Adrenal Gland Neoplasms; Catecholamines; Cyclophosphamide; Drug Therapy, Combination; Humans; Hypertension; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Multiple Primary; Pheochromocytoma; Prednisone; Syncope; Tachycardia; Time Factors; Vincristine | 1982 |
Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia.
Topics: Animals; Asparaginase; Cyclophosphamide; Cytarabine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Hypercalcemia; Lymphoma, Non-Hodgkin; Male; Prednisone; Vincristine | 1982 |
Chemotherapy of advanced non-Hodgkin lymphomas: a report of 35 cases.
Topics: Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Prednisone; Vincristine | 1982 |
Primary lymphoblastic lymphoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Teniposide; Vincristine | 1982 |
An intensive care chemo- or chemoimmunotherapy regimen for patients with intermediate and poor-prognosis acute lymphatic leukemia and leukemic lymphoblastic lymphosarcoma: preliminary results with 14-month median follow-up.
Topics: Adolescent; Asparaginase; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunotherapy; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis | 1982 |
Lymphoblastic lymphoma in adults: results of a pilot protocol.
Topics: Adolescent; Adult; Asparaginase; Central Nervous System Diseases; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Vincristine | 1981 |
[T-cell lymphoblastic lymphomas. Clinico-pathological study of 17 cases and short- and long-term therapeutic responses].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Meningeal Neoplasms; Middle Aged; Prednisone; T-Lymphocytes; Vincristine | 1982 |
Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma: a progress report.
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Probability; Prognosis; Time Factors | 1980 |
[Results of chemotherapy with cyclophosphamide, vincristine, methotrexate and prednisone in recurring or disseminated non-Hodgkin lymphomas in the University of Kiel Radiology Clinic].
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vincristine | 1981 |
Deferral of initial therapy for advanced indolent lymphomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine | 1982 |
Non-Hodgkin's lymphoma in Manitoba, 1968-77: the impact of chemotherapy.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Histiocytes; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Manitoba; Prednisone; Vincristine | 1982 |
Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine, prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematuria; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Recurrence; Survival Rate; Vincristine | 1995 |
Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Treatment Outcome; Vincristine | 1995 |
[Effect of combination chemotherapy for elderly patients with malignant lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prednisone; Retrospective Studies; Vincristine | 1993 |
Prevention of chemotherapy-induced neutropenia using G-CSF with VACOP-B--a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Vincristine | 1993 |
Oculomotor nerve palsy associated with vincristine treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Oculomotor Nerve Diseases; Prednisone; Skin Neoplasms; Vincristine | 1993 |
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Stomach Neoplasms; Vincristine | 1994 |
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Radiotherapy Dosage; Remission Induction; Survival Rate; Vincristine | 1994 |
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
Topics: Age Factors; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Infection Control; Length of Stay; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Safety; Teniposide; Treatment Outcome; Vincristine | 1994 |
High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: the EBMT experience. Lymphoma Working Party of the European Group for Bone Marrow Transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Vincristine | 1994 |
Localized, late-onset, high-grade lymphoma following bone marrow transplantation: response to combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Granulocyte Colony-Stimulating Factor; Herpesviridae Infections; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Male; Neck; Neoplasms, Second Primary; Polymerase Chain Reaction; Prednisone; Tomography, X-Ray Computed; Tumor Virus Infections; Vincristine | 1994 |
A cooperative study on ProMACE-CytaBOM in aggressive non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Feasibility Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1994 |
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lomustine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melphalan; Methotrexate; Middle Aged; Phosphoramide Mustards; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 1994 |
Long-term results with MACOP-B in the treatment of aggressive non-Hodgkin's lymphomas. The experience in Brazil.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Socioeconomic Factors; Survival Rate; Vincristine | 1994 |
Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Retrospective Studies; Vincristine | 1994 |
[Clinical analysis of 126 cases with NHL in extra-node of head and neck patients in stage I and II].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Rate; Vincristine | 1994 |
[Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchoalveolar Lavage Fluid; Collagen; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peptide Fragments; Prednisone; Procarbazine; Procollagen; Pulmonary Fibrosis; Vincristine | 1994 |
[Evaluation of pulmonary function and bronchoalveolar lavage fluid in elderly non-Hodgkin's lymphoma before and after COP-BLAM III therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchoalveolar Lavage Fluid; Cyclophosphamide; Doxorubicin; Female; Humans; Lung; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Respiratory Function Tests; Vincristine | 1994 |
Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Immunoproliferative Small Intestinal Disease; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Neoplasm Staging; Prednisone; Proportional Hazards Models; Retrospective Studies; Sex Ratio; Treatment Outcome; Turkey; Vincristine | 1994 |
Intrapleural bleomycin in the treatment of chylothorax.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chylothorax; Cyclophosphamide; Doxorubicin; Drug Administration Routes; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Pleura; Prednisolone; Prednisone; Vincristine | 1994 |
Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blotting, Southern; CD4 Lymphocyte Count; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; DNA, Neoplasm; DNA, Viral; Doxorubicin; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Genes, myc; Granulocyte-Macrophage Colony-Stimulating Factor; Herpesvirus 4, Human; Humans; Immunoglobulin Variable Region; Immunologic Factors; Leucovorin; Life Tables; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Methotrexate; Polymerase Chain Reaction; Prednisone; Proportional Hazards Models; Radiotherapy, Adjuvant; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Adhesion Molecules; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Luminescent Measurements; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Proteins; Neutropenia; Neutrophils; Prednisone; Recombinant Proteins; Respiratory Burst; Vincristine | 1995 |
Acute myocardial infarction in man treated with epirubicin for non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Lymphoma, Non-Hodgkin; Male; Myocardial Infarction; Prednisone; Vincristine | 1995 |
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Glyoxal; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multivariate Analysis; Prednimustine; Prednisolone; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Vinblastine; Vincristine | 1995 |
Primary lymphoma of the mandible: report of a case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Mandibular Neoplasms; Prednisone; Radiotherapy, Adjuvant; Vincristine | 1995 |
Non-Hodgkin's lymphoma in the old old.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Prednisone; Radiotherapy, Adjuvant; Vincristine | 1995 |
Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Treatment Outcome; Vincristine | 1995 |
Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Radiation Dosage; Vincristine | 1995 |
Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Vincristine | 1995 |
Control theory as a conceptual framework for intensive care monitoring.
Topics: Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Artificial Intelligence; Computer Simulation; Critical Care; Cyclophosphamide; Decision Making, Computer-Assisted; Decision Trees; Doxorubicin; Feedback; Hematology; Humans; Information Systems; Information Theory; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Oncology Service, Hospital; Patient Care Planning; Prednisone; Vincristine | 1995 |
[Daily oral low-dose etoposide therapy for aged patients with relapsed aggressive lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Quality of Life; Recurrence; Remission Induction; Vincristine | 1995 |
CHOP versus m-BACOD in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1993 |
Primary chemotherapy for obstructive jaundice caused by intermediate-grade non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestasis; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Vincristine | 1993 |
CHOP-Bleo plus interferon for stage IV low-grade lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Interferon Type I; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Recombinant Proteins; Survival Rate; Vincristine | 1993 |
Brief induction chemotherapy followed by involved-field irradiation for the treatment of localized intermediate- and high-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Time Factors; Vincristine | 1993 |
Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; HIV Seropositivity; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Vincristine | 1993 |
Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Erythropoietin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-3; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Zidovudine | 1993 |
[Thyroid lymphoma in a 51-year-old woman].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Postoperative Care; Prednisone; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1993 |
Successful treatment of non-Hodgkin's lymphoma in a patient with common variable immunodeficiency.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Common Variable Immunodeficiency; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Rectal Neoplasms; Vincristine | 1993 |
[Treatment of high risk non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protocols; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prognosis; Remission Induction; Risk; Survival Rate; Vincristine | 1993 |
Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Stevens-Johnson Syndrome; Vincristine | 1993 |
[High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine; Whole-Body Irradiation | 1993 |
CHOP versus intensive regimens in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1993 |
Pulmonary toxicity in patients with non-Hodgkin's lymphoma treated with bleomycin-containing combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lung; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Pulmonary Diffusing Capacity; Respiratory Function Tests; Retrospective Studies; Vincristine | 1993 |
Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dexamethasone; DNA, Neoplasm; Doxorubicin; Environmental Exposure; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; HIV Infections; Hodgkin Disease; Humans; Incidence; Leucovorin; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Prednisone; Procarbazine; Remission Induction; Vincristine | 1993 |
Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Ovarian Diseases; Prednisone; Retrospective Studies; Testicular Diseases; Vincristine | 1993 |
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Vincristine | 1993 |
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Survival Analysis; Vincristine | 1993 |
[COP-BLAM III regimen for elderly non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Vincristine | 1993 |
HIV-associated lymphoma of the gastrointestinal tract: the University of Toronto AIDS-Lymphoma Study Group experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Gastrointestinal Neoplasms; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Ontario; Prednisone; Survival Analysis; Vincristine | 1995 |
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Treatment Failure; Vincristine | 1995 |
Primary non-Hodgkin's lymphoma of the mediastinum: a clinicopathological report of six cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Vincristine | 1995 |
Recurrent lymphoma in a cardiac allograft recipient.
Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Transplantation, Homologous | 1994 |
CHOP chemotherapy of intermediate and high-grade non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
[Evaluation of the method of treating non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Rate; Teniposide; Vincristine | 1994 |
Low power and striking results--a surprise but not a paradox.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Confidence Intervals; Cyclophosphamide; Data Interpretation, Statistical; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Treatment Outcome; Vincristine | 1995 |
[Non-hodgkin's malignant lymphoma in the uterine cervix].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Radiotherapy Dosage; Uterine Cervical Neoplasms; Vincristine | 1993 |
Myelodysplastic syndrome after autologous transplant for lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Myelodysplastic Syndromes; Neoplasms, Radiation-Induced; Prednisone; Procarbazine; Risk Factors; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 1994 |
Scintigraphic flare in skeletal lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Female; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Prednisone; Radionuclide Imaging; Tomography, X-Ray Computed; Vincristine | 1994 |
Aggressive non-Hodgkin's lymphoma in elderly patients: where to go from here?
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Patient Selection; Prednisolone; Prednisone; Treatment Outcome; Vincristine | 1994 |
Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine; Vindesine | 1993 |
Excretion of Ascaris lumbricoides during total body irradiation.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascariasis; Ascaris lumbricoides; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Contents; Humans; Intestinal Diseases, Parasitic; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine; Vomiting; Whole-Body Irradiation | 1994 |
Primary colonic lymphoma. Clinical presentation, histopathologic features, and outcome with combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1994 |
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Herpesvirus 3, Human; Humans; Immunocompromised Host; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Recurrence; Vincristine; Virus Activation | 1994 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Infertility; Luteinizing Hormone; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Ovarian Diseases; Prednisone; Procarbazine; Testicular Diseases; Vincristine | 1994 |
Interferon alfa plus chemotherapy for non-Hodgkin's lymphoma: five-year follow-up.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Interferon-alpha; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1993 |
Pentostatin increases the acute toxicity of high dose cyclophosphamide.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Synergism; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Pentostatin; Prednisone; Rats; Rats, Inbred Lew; Salvage Therapy; Shock, Cardiogenic; Ventricular Fibrillation; Vidarabine; Vincristine | 1993 |
Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring. Limited chemotherapy and radiation therapy versus radiation therapy alone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Prednisone; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Tongue Neoplasms; Vincristine | 1993 |
[Effect of THP-CVP regimen for elderly patients with malignant lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission Induction; Survival Rate; Vincristine | 1993 |
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxyglucose; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisone; Time Factors; Tomography, Emission-Computed, Single-Photon; Vincristine | 1993 |
[Case histories of extranodal non-Hodgkin's lymphomas with primary gastrointestinal appearance].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Prednisone; Remission Induction; Vincristine | 1993 |
Primary malignant lymphoma of the uterus: localization in a cervical polyp.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cervix Uteri; Cyclophosphamide; Doxorubicin; Female; Humans; Hyperplasia; Immunohistochemistry; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Polyps; Prednisone; Uterine Cervical Neoplasms; Vincristine | 1993 |
CHOP versus intensive regimens in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1993 |
[Successful oral administration of etoposide therapy for refractory malignant lymphoma treated with frequent combination chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Salvage Therapy; Vincristine | 1993 |
Long-term effects of vincristine on the peripheral nervous system.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neuromuscular Diseases; Peripheral Nervous System Diseases; Prednisone; Reflex, Abnormal; Sensation Disorders; Surveys and Questionnaires; Treatment Outcome; Vincristine | 1993 |
Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Analysis; Vincristine | 1993 |
Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction | 1993 |
Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Prospective Studies; Radiotherapy Dosage; Recurrence; Survival Rate; Vincristine | 1993 |
Primary peripheral nodal lymphoma in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymph Nodes; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Sex Factors; Thioguanine; Vincristine | 1993 |
[Severe bleeding in a case of factor VIII inhibitor associated with intravascular lymphomatosis].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Factor VIII; Hemangioendothelioma; Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Skin Diseases; Skin Neoplasms; Vincristine | 1993 |
[Spontaneous splenic rupture in a case of non-Hodgkin's lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Splenic Rupture; Vincristine | 1993 |
[Manifestation of malignant lymphomatous polyposis of the nasopharynx].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Endoscopy; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Nasal Polyps; Nasopharyngeal Neoplasms; Prednisone; Vincristine | 1993 |
High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cells; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Pilot Projects; Prednisone; Prognosis; Vincristine | 1995 |
[Dysfunction of the blood-brain barrier in patients with acute leukemias or lymphomas of high grade malignancy].
Topics: Adolescent; Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood-Brain Barrier; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Serum Albumin; Vincristine | 1995 |
[Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Stomach Neoplasms; Tongue Neoplasms; Vincristine | 1995 |
[Non-Hodgkin's lymphoma of the uterine cervix].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Uterine Cervical Neoplasms; Vincristine | 1995 |
Alpha-interferon and corticosteroids as initial treatment in small cleaved-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Interferon Type I; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Recombinant Proteins; Remission Induction | 1995 |
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Vindesine | 1996 |
Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Immunocompetence; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Retrospective Studies; Survival Rate; Vincristine | 1995 |
Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Contraindications; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glucocorticoids; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prospective Studies; Vincristine; Virus Activation | 1996 |
VACOP-B chemotherapy for high grade non-Hodgkin's lymphoma in pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Lymphoma, Non-Hodgkin; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Vincristine | 1995 |
Primary lymphoma of the esophagus in a patient with AIDS.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Esophageal Diseases; Esophageal Neoplasms; Esophagoscopy; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Ulcer; Vincristine | 1995 |
VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Survival Rate; Vincristine | 1995 |
[Sarcoidosis-lymphoma syndrome in a woman with acromegaly].
Topics: Acromegaly; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Remission Induction; Sarcoidosis; Syndrome; Vincristine | 1995 |
Aggressive non-Hodgkin's lymphoma: long-term results of full dose CHOP chemotherapy, and analysis of prognostic determinant.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Survival Analysis; Time Factors; Vincristine | 1996 |
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Dog Diseases; Dogs; Doxorubicin; Female; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplastic Stem Cells; Nucleolus Organizer Region; Predictive Value of Tests; Prednisone; Prognosis; Proliferating Cell Nuclear Antigen; Remission Induction; Silver Staining; Treatment Outcome; Vincristine | 1996 |
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Costs and Cost Analysis; Cyclophosphamide; Disposable Equipment; Doxorubicin; Drug Costs; Etoposide; Fees, Medical; Fees, Pharmaceutical; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Models, Economic; Prednisone; Survival Rate; Vincristine | 1996 |
Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Fees, Pharmaceutical; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Medicare; Methotrexate; Prednisone; Private Practice; Reimbursement Mechanisms; United States; Vincristine | 1996 |
[Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cryopreservation; Cyclophosphamide; Dacarbazine; Doxorubicin; Fertilization in Vitro; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Oligospermia; Prednisone; Procarbazine; Retrospective Studies; Semen Preservation; Sperm Count; Vinblastine; Vincristine | 1996 |
[Assessment of cardiac toxicity by 123I-MIBG myocardial SPECT in elderly non-Hodgkin lymphoma patients treated with COP-BLAM and G-CSF].
Topics: 3-Iodobenzylguanidine; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Granulocyte Colony-Stimulating Factor; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphoma, Non-Hodgkin; Nervous System Diseases; Prednisone; Procarbazine; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Vincristine | 1995 |
Effects of chemotherapy in patients with dental implants.
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dental Care for Chronically Ill; Dental Implantation, Endosseous; Dental Implants; Female; Humans; Lymphoma, Non-Hodgkin; Osseointegration; Prednisone; Time Factors; Vincristine; Wound Healing | 1995 |
Prognosis of orbital lymphoid hyperplasia.
Topics: Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Follow-Up Studies; Humans; Hyperplasia; Incidence; Lacrimal Apparatus Diseases; Lymphoid Tissue; Lymphoma, Non-Hodgkin; Neoplasm Staging; Orbital Diseases; Orbital Neoplasms; Prednisone; Prognosis; Retrospective Studies | 1996 |
Primary ovarian lymphoma with liver metastases: report of one case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Prednisone; Vincristine | 1996 |
[Effect of granulocyte colony-stimulating factor after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Vincristine | 1996 |
Therapy-related leukemia with a novel 21q22 rearrangement.
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 21; Core Binding Factor Alpha 2 Subunit; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Neoplasms, Second Primary; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Proto-Oncogene Proteins; Transcription Factors; Vincristine | 1996 |
Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Vinblastine; Vincristine | 1996 |
Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers, Tumor; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Neoplasm Proteins; Prednisone; Prognosis; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vincristine | 1996 |
[Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1996 |
Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin's lymphoma in Saudi Arabia: clinical results and analysis of prognostic factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Regression Analysis; Saudi Arabia; Survival Analysis; Vincristine | 1996 |
Cervical spontaneous epidural hematoma as a complication of non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hematoma, Epidural, Cranial; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Spinal Cord Compression; Thrombocytopenia; Vincristine | 1996 |
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1996 |
EBV-positive non-Hodgkin's lymphoma developing after phenytoin therapy.
Topics: Anticonvulsants; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epilepsy; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Male; Middle Aged; Phenytoin; Prednisone; Proto-Oncogene Proteins c-bcl-2; Tumor Virus Infections; Vincristine | 1996 |
[Treatment of aggressive non Hodgkin's lymphoma: the experience of a general hospital].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Hospitals, General; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Survival Analysis; Vincristine; Vindesine | 1996 |
The effects of antineoplastic chemotherapy on HIV disease.
Topics: Antineoplastic Agents; CD4 Lymphocyte Count; CD8 Antigens; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Granulocyte Colony-Stimulating Factor; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic; Prednisone; Randomized Controlled Trials as Topic; RNA, Viral; Vincristine | 1996 |
Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infection.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cyclophosphamide; Hepatitis B; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Second Primary; Prednisone; Vincristine | 1996 |
Granulocyte-colony stimulating factor fails to prevent leucopenia caused by CEMP in elderly patients with aggressive lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Mitoxantrone; Prednisone; Recombinant Proteins | 1996 |
[Diagnosis and therapeutic management of gastric lymphomas].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gastrectomy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Prednisone; Radioisotope Teletherapy; Remission Induction; Retrospective Studies; Spain; Stomach Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1996 |
Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Recurrence; Survival Rate; Vincristine | 1997 |
Resolution of HIV-associated cystic benign lymphoepithelial lesion of the parotid gland in a patient undergoing chemotherapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cysts; Didanosine; Doxorubicin; Fatal Outcome; HIV Infections; Humans; Hyperplasia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Parotid Diseases; Prednisone; Vincristine; Zidovudine | 1996 |
A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Pilot Projects; Prednisone; Remission Induction; Survival Analysis; Treatment Failure; Vincristine | 1997 |
Tumour inhomogeneities on magnetic resonance imaging, a new factor with prognostic information in non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Treatment Outcome; Vincristine | 1997 |
[Gastrointestinal lymphomas: results of multimodal therapy in 57 patients of one center].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Prednisone; Survival Rate; Vincristine | 1996 |
Caecocystoplasty and bilateral oophorectomy followed by chemotherapy for diffuse, non-Hodgkins lymphoma of the ovary involving the bladder. Case report.
Topics: Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cecum; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Invasiveness; Ovarian Neoplasms; Ovariectomy; Prednisone; Urinary Bladder Neoplasms; Vincristine | 1997 |
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; CD3 Complex; CD56 Antigen; Cell Nucleus; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Herpesvirus 4, Human; Humans; Idarubicin; Immunophenotyping; Killer Cells, Natural; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methylprednisolone; Neoplasm Invasiveness; Neoplasm Proteins; Neoplastic Stem Cells; Pelvic Neoplasms; Prednisone; Quinine; Vincristine | 1997 |
Combination of chemotherapy and antiviral therapy for Epstein-Barr virus-associated non-Hodgkin's lymphoma of high grade malignancy in cases of HIV infection.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine | 1997 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Muramidase; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Secretory Rate; Statistics, Nonparametric; Vinblastine; Vincristine | 1997 |
Non-Hodgkin's lymphoma presenting as thyroid and adrenal gland involvement.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 1997 |
[Primary non-Hodgkin's lymphoma of the prostate].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prostatic Hyperplasia; Prostatic Neoplasms; Vincristine | 1996 |
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.
Topics: Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Pilot Projects; Platelet Transfusion; Prednisone; Thrombocytopenia; Treatment Outcome; Vincristine | 1997 |
Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Salvage Therapy; Survival Rate; Time Factors; Vincristine | 1997 |
Primary non-Hodgkin's lymphoma of the maxillary sinus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Radiotherapy, Adjuvant; Retrospective Studies; Vincristine | 1997 |
Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Movement; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Leukocyte Count; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Prednisone; Recombinant Proteins; Transplantation, Autologous; Vincristine | 1996 |
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Prednisone; Remission Induction; Sezary Syndrome; Skin Neoplasms; Vincristine | 1997 |
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 1997 |
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Prognosis; Risk Factors; Thioguanine; Vinblastine; Vincristine | 1996 |
[Tumor lysis syndrome after treatment for mediastinal non-Hodgkin's lymphoma].
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Prednisone; Respiratory Insufficiency; Tumor Lysis Syndrome; Vincristine | 1997 |
Acute renal failure due to lymphomatous infiltration of the kidneys.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Hematuria; Humans; Kidney; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Ultrasonography; Vincristine | 1997 |
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1996 |
[Malignant lymphoma of the testis: report of two cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Testicular Neoplasms; Vincristine | 1997 |
Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; DNA Primers; DNA, Viral; Doxorubicin; Follow-Up Studies; Glucosinolates; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lymphoma, Non-Hodgkin; Male; Mutation; Polymerase Chain Reaction; Prednisone; Vincristine; Virus Activation | 1997 |
THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: a prospective study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
A new effective treatment for indolent lymphoma: a pilot study with fludarabine, idarubicin and prednisone combination (FLIDA).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Prednisone; Vidarabine | 1997 |
[Cutaneous B-cell lymphoma with aggressive clinical presentation: apropos of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Hemorrhage; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Necrosis; Prednisone; Remission Induction; Skin Neoplasms; Skin Ulcer; Vincristine | 1997 |
[Etoposide combination chemotherapy for malignant lymphoma: a report of 91 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1996 |
Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Doxorubicin; Fatal Outcome; Hepatitis C; Humans; Liver; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Prednisone; Tomography, X-Ray Computed; Vincristine | 1997 |
Side effects of CHOP in the treatment of non-hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatigue; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Vincristine | 1997 |
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vincristine | 1998 |
Non-Hodgkin's lymphoma trials in elderly look beyond CHOP.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisolone; Prednisone; Teniposide; Vincristine | 1998 |
[Interstitial pneumonia in patients treated with VACOP-B therapy for malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Diseases, Interstitial; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1998 |
Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Tomography, X-Ray Computed; Vincristine | 1998 |
[Long term results of treatment of highly-malignant non-Hodgkin lymphoma in the elderly (70 years and older)].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Comorbidity; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Time Factors; Vincristine | 1998 |
[Surgical therapy of non-Hodgkin lymphoma of the stomach].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Gastrectomy; Gastric Mucosa; Gastroscopy; Humans; Lymph Node Excision; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Retrospective Studies; Stomach Neoplasms; Survival Rate; Vincristine | 1998 |
Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Drug Synergism; Female; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Pneumonia, Viral; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vidarabine; Vincristine; Viral Load | 1998 |
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; DNA, Neoplasm; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Genotype; Haplotypes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prednisone; Proportional Hazards Models; Survival Analysis; Transcription, Genetic; Treatment Outcome; Tumor Necrosis Factor-alpha; Vincristine; Vindesine | 1998 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrin Fibrinogen Degradation Products; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Mitoxantrone; Partial Thromboplastin Time; Plasminogen; Prednisone; Procarbazine; Protein C; Protein S; Thrombophilia; Time Factors; Vinblastine; Vincristine | 1997 |
Alkalinization and the tumor lysis syndrome.
Topics: Adolescent; Bicarbonates; Fluid Therapy; Furosemide; Humans; Hypocalcemia; Lymphoma, Non-Hodgkin; Male; Prednisone; Tumor Lysis Syndrome; Uric Acid | 1998 |
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Rate; Vincristine | 1998 |
Expression of p53 predicts treatment failure in aggressive non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mutation; Prednisone; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine | 1998 |
High incidence of chemotherapy-induced acral erythema in female patients with non-Hodgkin's lymphoma treated with the VACOP-B regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Erythema; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Prednisone; Retrospective Studies; Sex Distribution; Vincristine | 1998 |
Intravascular lymphomatosis--an indolent or aggressive entity?
Topics: Aged; Arthritis, Rheumatoid; Asthma; Blood Sedimentation; Bone Marrow; Brain Neoplasms; Disease Progression; Erythema; Fatal Outcome; Female; Fever of Unknown Origin; Humans; Immunocompromised Host; Immunophenotyping; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Prednisone; Prostatectomy; Skin Neoplasms; Thigh; Vascular Neoplasms | 1998 |
Chemoradiotherapy for localized non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Prednisone; Radiotherapy; Radiotherapy Dosage; Vincristine | 1998 |
Diagnosis and treatment of malignant lymphoma of the parotid gland.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Parotid Neoplasms; Prednisolone; Prednisone; Radiotherapy Dosage; Vincristine | 1998 |
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Pilot Projects; Prednisone; Survival Rate; Transplantation, Autologous; Vincristine | 1998 |
Prolonged disease-free survival in relapsed/refractory low-grade lymphoma treated with fludarabine: a report of four cases.
Topics: Adult; Anthracyclines; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vidarabine; Vincristine | 1998 |
[Urinary enzymes during some antiblastic chemotherapy protocols].
Topics: alpha-Glucosidases; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Lymphoma, Non-Hodgkin; Muramidase; Neoplasm Proteins; Predictive Value of Tests; Prednisone; Sensitivity and Specificity; Vincristine | 1983 |
Pirarubicin-induced myocardial damage in elderly patients with non-Hodgkin's lymphoma.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Electrocardiography, Ambulatory; Fatty Acids; Granulocyte Colony-Stimulating Factor; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Tomography, Emission-Computed, Single-Photon; Vincristine | 1998 |
Biweekly THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate- and high-grade non-Hodgkins's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Survival Analysis; Vincristine | 1998 |
[Prognostic factors in low-grade lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Spain; Treatment Outcome; Vincristine | 1998 |
[Non-Hodgkin malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1998 |
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 1998 |
Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
Topics: Aged; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Humans; Immunosuppressive Agents; Incidence; Infection Control; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Retrospective Studies; Vidarabine | 1998 |
Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Patient Dropouts; Prednisone; Vincristine | 1998 |
Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Vincristine | 1998 |
Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Confounding Factors, Epidemiologic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Proportional Hazards Models; Survival Analysis; Vincristine | 1998 |
Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Radiotherapy Dosage; Vincristine | 1998 |
[A case of primary hepatic lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1998 |
Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancytopenia; Prednisone; Primary Myelofibrosis; Vidarabine; Vincristine | 1998 |
Central retinal vein occlusion in a patient with IgG lambda monoclonal gammopathy.
Topics: Aged; Bone Marrow; Chlorambucil; Drug Therapy, Combination; Fluorescein Angiography; Humans; Hypergammaglobulinemia; Immunoglobulin G; Immunoglobulin lambda-Chains; Lymphoma, Non-Hodgkin; Male; Paraproteinemias; Prednisone; Retinal Vein Occlusion; Tomography, X-Ray Computed; Visual Acuity; Vitreous Hemorrhage | 1999 |
Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Paraneoplastic Syndromes; Pemphigus; Prednisone; Tongue Neoplasms; Vincristine | 1998 |
Primary epidural non-Hodgkin lymphoma: spinal cord compression syndrome as the initial form of presentation in childhood non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Epidural Neoplasms; Fatal Outcome; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Spinal Cord Compression; Syndrome; Treatment Outcome; Vincristine | 1999 |
Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Vincristine | 1998 |
Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Female; Fusion Proteins, bcr-abl; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1999 |
[Clinical outcomes in low grade follicular lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vincristine | 1999 |
Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Necrosis; Prednisone; Razoxane; Skin; Vincristine | 1999 |
High-grade non-Hodgkin's lymphoma treated in northern Norway--treatment, outcome, and prognostic factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Norway; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine | 1999 |
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Prognosis; Risk Factors; Severity of Illness Index; Survival Analysis; Vincristine | 1999 |
Non-surgical CHOP cures right ventricular outflow obstruction.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Echocardiography; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Ventricular Outflow Obstruction; Vincristine | 1999 |
Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Drug Administration Schedule; Feasibility Studies; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Waldenstrom Macroglobulinemia | 1999 |
Synovial presentation of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Humans; Knee Joint; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Prednisone; Sarcoma, Synovial; Vincristine | 1998 |
Non-Hodgkin's lymphoma of the lacrimal sac and concomitant pansinusitis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Headache; HIV Seronegativity; Humans; Lacrimal Apparatus Diseases; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Sinusitis; Vincristine | 1998 |
Non-Hodgkin's lymphoma of the maxillary sinus in a patient with acquired immunodeficiency syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Maxillary Sinus Neoplasms; Middle Aged; Prednisone; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral; Vincristine | 1998 |
[Dose reduction is not recommended for elderly patients undergoing chemotherapy for non-Hodgkin lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Netherlands; Prednisone; Vincristine | 1999 |
Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, myc; Humans; Immunophenotyping; Karyotyping; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Translocation, Genetic; Vincristine | 1999 |
Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Prednisone; Spinal Cord Neoplasms; Vincristine | 1999 |
[Exacerbation of hepatitis B and the expression of M proteinemia during the treatment of malignant lymphoma: a case study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Doxorubicin; Hepatitis B; Humans; Lymphoma, Non-Hodgkin; Male; Paraproteinemias; Prednisone; Vincristine; Virus Activation | 1999 |
The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Survival Rate; Vincristine | 1999 |
Hypophyseal non-Hodgkin's lymphoma presenting with diabetes insipidus: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diabetes Insipidus; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Male; Methotrexate; Middle Aged; Pituitary Neoplasms; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1999 |
Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide).
Topics: Adult; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Granulomatosis with Polyangiitis; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Middle Aged; Prednisone; Recurrence; Scleritis; Thyroid Function Tests; Thyroid Gland; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine; Triiodothyronine, Reverse | 1999 |
[Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck--multivariate analysis of prognostic factors and evaluation of therapeutic modalities].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Survival Rate; Vincristine | 1999 |
The usefulness of in vivo gene expression investigations from peripheral white blood cells: a preliminary study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Doxorubicin; Gene Expression; Genes, Tumor Suppressor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1999 |
Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Palliative Care; Prednisone; Retrospective Studies; Treatment Outcome; Vincristine | 1999 |
[Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Prednisone; Prognosis; Sensitivity and Specificity; Vincristine | 1999 |
Adult head and neck lymphomas in Papua New Guinea: a retrospective study of 70 cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; New Guinea; Prednisone; Procarbazine; Registries; Retrospective Studies; Vincristine | 1999 |
Response and adverse drug reactions to combination chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma: comparison of CHOP, COP-BLAM, COP-BLAM III, and THP-COPBLM.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Retrospective Studies; Treatment Outcome; Vincristine | 1999 |
Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Vincristine | 1999 |
Non-Hodgkin's lymphoma: present status and future prospects.
Topics: Adult; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Rituximab; Salvage Therapy; Vincristine | 1999 |
High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Consensus Development Conferences as Topic; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Netherlands; Prednisone; Randomized Controlled Trials as Topic; Transplantation, Autologous; Vincristine | 1999 |
Stem cell transplantations in patients with malignant lymphoma: costs in a Dutch university hospital in the period 1984-1995.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hospital Costs; Hospital Units; Hospitalization; Humans; Length of Stay; Lymphoma, Non-Hodgkin; Melphalan; Netherlands; Parenteral Nutrition; Patient Isolation; Podophyllotoxin; Prednisone; Retrospective Studies; Transplantation, Autologous; Vincristine | 1999 |
Non-Hodgkin's lymphoma following untreated essential thrombocythemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Thrombocythemia, Essential; Vincristine | 2000 |
DNA flow cytometry of non-Hodgkin's lymphomas: correlation with cytologic grade and clinical relapse.
Topics: Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Flow Cytometry; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Vincristine | 2000 |
When is hilar uptake of 67Ga-citrate indicative of residual disease after CHOP chemotherapy?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Gallium; Gallium Radioisotopes; Humans; Lung; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prednisone; Retrospective Studies; Time Factors; Tomography, Emission-Computed, Single-Photon; Vincristine | 2000 |
[A case of non-Hodgkin lymphoma in the central nervous system, developing during treatment of galactorrhea amenorrhea syndrome].
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Galactorrhea; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Prednisone; Syndrome; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1999 |
[Two cases of orbital non-Hodgkin's lymphoma presenting with hemophagocytic syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Histiocytosis, Non-Langerhans-Cell; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Orbital Neoplasms; Prednisone; Vincristine | 2000 |
Translocation (1;11)(q23;p15), a novel simple variant of translocation (7;11)(p15;p15), in a patient with AML (M2) accompanied by non-Hodgkin lymphoma and gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Cyclophosphamide; Doxorubicin; Humans; Immunohistochemistry; Karyotyping; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Prednisone; Stomach Neoplasms; Translocation, Genetic; Vincristine | 2000 |
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Recurrence; Survival Rate; Vincristine | 2000 |
[Characteristics of blood cells during peripheral blood stem cell mobilization following chemotherapy in patients with non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Time Factors; Vincristine | 2000 |
[The analysis of failures in the treatment of children with non-B non-Hodgkin's lymphoma. Polish pediatric leukemia/lymphoma study group report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Staging; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Treatment Failure; Vincristine | 1998 |
Intravascular lymphomatosis: contribution of cerebral MRI findings to diagnosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Prednisone; Vincristine | 2000 |
Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Central Nervous System; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Incidence; L-Lactate Dehydrogenase; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Meninges; Methotrexate; Neoplasm Proteins; Neurologic Examination; Predictive Value of Tests; Prednisolone; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Secondary cutaneous infiltration in B cell chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Histidine Decarboxylase; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Prednisolone; Prednisone; Recombinant Proteins; Salvage Therapy; Skin; Vincristine | 2000 |
Human immunodeficiency virus-associated malignant lymphoma in eastern Denmark diagnosed from 1990-1996: clinical features, histopathology, and association with Epstein-Barr virus and human herpesvirus-8.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Denmark; DNA, Viral; Doxorubicin; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; In Situ Hybridization; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Polymerase Chain Reaction; Prednisone; Retrospective Studies; RNA, Viral; Treatment Outcome; Vincristine | 2000 |
[Ten-case report on primary cervical lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Retrospective Studies; Uterine Cervical Neoplasms; Vincristine | 1997 |
[Comparison of CHEP and CHOP chemotherapy in the management of non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Vincristine | 1997 |
[Multivariate analysis on prognostic factors of non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Survival Rate; Vincristine | 1997 |
Pseudomembranous colitis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonoscopy; Cyclophosphamide; Enterocolitis, Pseudomembranous; Etoposide; Humans; Intestinal Mucosa; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission, Spontaneous | 2000 |
Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Radiation Injuries; Radiotherapy Dosage; Survival Rate; Vincristine | 2000 |
In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Immunosuppressive Agents; Leukapheresis; Lymphocyte Depletion; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Pilot Projects; Polymerase Chain Reaction; Prednisone; Rituximab; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 2000 |
Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble Fas, soluble Fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Fas Ligand Protein; fas Receptor; Female; Hepatocyte Growth Factor; Histiocytosis, Non-Langerhans-Cell; Humans; Interleukin-18; Lymphoma, Non-Hodgkin; Membrane Glycoproteins; Neoplasm Proteins; Prednisone; Receptors, Transferrin; Splenectomy; Tumor Virus Infections; Vincristine | 2000 |
Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Charcot-Marie-Tooth Disease; Cyclophosphamide; Doxorubicin; Electrophysiology; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Middle Aged; Muscle Fibers, Skeletal; Prednisone; Vincristine | 2000 |
Follow-up of sperm concentration and motility in patients with lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Infertility, Male; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Semen Preservation; Sperm Count; Sperm Motility; Vinblastine; Vincristine | 2000 |
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine | 2000 |
Interferon does not prolong progression-free survival after ProMACE-MOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Interferon-alpha; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 2000 |
[Treatment outcome in elderly patients with aggressive non-Hodgkin's lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome; Vincristine | 2000 |
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Prospective Studies; Vincristine | 2000 |
Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Prednisone; Recombinant Proteins; Vincristine | 2000 |
Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: lessons learned and challenges remaining.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Europe; Humans; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic; Prednisone; Recurrence; Risk Factors; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 2001 |
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Radiotherapy Dosage; Regression Analysis; Vincristine | 2001 |
A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Japan; Life Tables; Lymphocyte Activation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Radiotherapy, High-Energy; Receptors, Interleukin-2; Remission Induction; Solubility; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diabetes Insipidus; Disease Progression; Doxorubicin; Dwarfism, Pituitary; False Negative Reactions; Genetic Predisposition to Disease; Human Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Hypothyroidism; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Pituitary Hormones; Pituitary Neoplasms; Prednisone; Remission Induction; Vincristine | 2001 |
Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Vincristine | 2001 |
Bilateral testicular lymphoma treated with chemotherapy and radiation without orchiectomy: complete response relapsed at 52 months in the vitreous humor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Eye Neoplasms; Humans; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Multiple Primary; Orchiectomy; Prednisone; Radiotherapy Dosage; Retroperitoneal Space; Testicular Neoplasms; Vincristine; Vitreous Body | 2001 |
Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD18 Antigens; Cell Movement; Chemotaxis, Leukocyte; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Filgrastim; Glycosylation; Granulocyte Colony-Stimulating Factor; Humans; Image Processing, Computer-Assisted; Lenograstim; Lymphoma, Non-Hodgkin; Methotrexate; Neutrophils; Prednisone; Protein Processing, Post-Translational; Recombinant Proteins; Vincristine | 2001 |
Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 2001 |
HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biopsy, Needle; Cyclophosphamide; Doxorubicin; Etoposide; Flow Cytometry; HIV Infections; Humans; Immunohistochemistry; Immunophenotyping; Incidence; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Thrombolytic Therapy; Venous Thrombosis; Vincristine | 2001 |
Hypopyon uveitis and iris nodules in non-Hodgkin's lymphoma: ocular relapse during systemic remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Eye Neoplasms; Humans; Iris; Lymphoma, Non-Hodgkin; Male; Prednisone; Recurrence; Remission Induction; Uveitis; Vincristine | 2000 |
Nasal natural killer-cell lymphoma: a disease with very poor prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Debridement; Doxorubicin; Fatal Outcome; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nose Neoplasms; Prednisone; Prognosis; Salvage Therapy; Tomography, X-Ray Computed; Vincristine | 2000 |
Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Netherlands; Prednisolone; Prednisone; Retrospective Studies; Survival Analysis; Vincristine | 2001 |
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Gemcitabine; Humans; Hypertension; Hypocalcemia; Hypotension; Infusions, Intravenous; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Paclitaxel; Pancreatic Neoplasms; Platinum; Prednisone; Premedication; Retrospective Studies; Vincristine | 2001 |
Primary pelvic non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Pelvic Neoplasms; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Vincristine | 2001 |
Chlorambucil/prednisone-induced seizures in a patient with non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Drug Interactions; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Seizures | 2001 |
Reduced-dose chop therapy for elderly patients with non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Pilot Projects; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 2001 |
Primary effusion lymphoma (PEL) in HIV-negative patients--a distinct clinical entity.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Cyclophosphamide; DNA, Viral; Doxorubicin; Granulocyte Colony-Stimulating Factor; Herpesvirus 8, Human; HIV Seronegativity; Humans; Lymphoma, Non-Hodgkin; Male; Pleural Effusion, Malignant; Prednisone; Remission Induction; Vincristine | 2001 |
T-cell lymphoma in the parotid region after cardiac transplant: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Heart Transplantation; Humans; Immunosuppression Therapy; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Parotid Neoplasms; Prednisone; Vincristine | 2001 |
Synchronous colonic tumours of dual pathology.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Colectomy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Prednisone; Vincristine | 2001 |
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, Replacement, Hip; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Femur Head Necrosis; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; Vincristine | 2001 |
Non-Hodgkin's lymphoma of the ocular adnexa.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Combined Modality Therapy; Conjunctival Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Eyelid Neoplasms; Female; Humans; Immunoenzyme Techniques; Immunophenotyping; Japan; Lacrimal Apparatus Diseases; Life Tables; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Prednisone; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Prognostic variables in canine multicentric lymphosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dog Diseases; Dogs; Female; Immunophenotyping; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Proportional Hazards Models; Treatment Outcome; Vincristine | 2001 |
The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Remission Induction; Rituximab; Vinblastine; Vincristine | 2001 |
[Evaluation of non-surgical therapy for the malignant lymphomas located mainly in the stomach and duodenum].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Duodenal Neoplasms; Female; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Stomach Neoplasms; Vincristine | 2001 |
Primary malignant lymphoma of the prostate--a report of three cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Male; Prednisone; Prostatic Neoplasms; Treatment Outcome; Vincristine | 2001 |
Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cyclophosphamide; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Pancytopenia; Prednisone; Red-Cell Aplasia, Pure; Rituximab; Treatment Outcome; Vidarabine; Vincristine | 2001 |
Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; In Situ Hybridization; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vincristine | 2001 |
Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Growth Substances; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Prednisolone; Prednisone; Reference Values; Retrospective Studies; Severity of Illness Index; Time Factors; Vincristine | 2001 |
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prognosis; Retrospective Studies; Testicular Neoplasms; Vincristine | 2001 |
The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Odds Ratio; Prednisone; Retrospective Studies; Risk Factors; Vincristine | 2001 |
6th European Hematology Association Meeting. Frankfurt, Germany. June 21-24, 2001.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prednisone; Radioimmunotherapy; Recurrence; Rituximab; Treatment Outcome; Vincristine | 2001 |
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hodgkin Disease; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Vidarabine; Vincristine; Virus Activation | 2001 |
Lymphoma 2000. The First International Symposium on Biology and Treatment of Aggressive Lymphomas: The stagnation seems to be over.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Prednisone; Radiotherapy, Adjuvant; Rituximab; Vincristine; World Health Organization | 2001 |
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomycin; Body Height; Body Weight; Child; Child Development; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Intelligence; Leukemia; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Vinblastine; Vincristine | 2001 |
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Radiation; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Vincristine | 2002 |
[Superior mesenteric venous thrombosis during treatment of malignant lymphoma and of pure red cell aplasia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mesenteric Veins; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Venous Thrombosis; Vincristine | 2002 |
Non-Hodgkin's lymphoma with pure red cell aplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Red-Cell Aplasia, Pure; Treatment Outcome; Vincristine | 2001 |
Primary anorectal lymphoma presenting as a perianal abscess in an HIV-positive male.
Topics: Abscess; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Diseases; Biopsy, Needle; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Drainage; Follow-Up Studies; HIV Seropositivity; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Prednisone; Treatment Outcome; Vincristine | 2002 |
[Non-Hodgkin's lymphoma of the uterus: apropos of 4 cases and review of the literature].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cervix Uteri; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Follow-Up Studies; Humans; Hysterectomy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Radiotherapy Dosage; Time Factors; Uterine Cervical Neoplasms; Uterine Neoplasms; Uterus; Vincristine | 2002 |
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Purging; Combined Modality Therapy; Cyclin D1; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Genes, bcl-2; Humans; Immunoglobulin Heavy Chains; Leukapheresis; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Neoplasm, Residual; Polymerase Chain Reaction; Predictive Value of Tests; Prednisone; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Bilateral peripheral facial palsy secondary to lymphoma in a patient with HIV/AIDS: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Facial Paralysis; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Vincristine | 2002 |
Assessment of drug activity and proliferation ex vivo for prediction of outcome in aggressive non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunophenotyping; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Methotrexate; Mitotic Index; Neoplasm Staging; Prednisone; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2002 |
Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; HIV-1; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Vincristine | 2002 |
Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Colectomy; Colorectal Neoplasms; Edema; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Paraneoplastic Syndromes; Prednisone; Prognosis; Retrospective Studies; Risk Assessment; Serologic Tests; Severity of Illness Index; Synovitis | 2002 |
Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Heart; Heart Failure; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Myocardium; Predictive Value of Tests; Prednisone; Radionuclide Imaging; ROC Curve; Ventricular Dysfunction, Left; Ventricular Function, Left; Vincristine | 2002 |
Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infections; Ki-67 Antigen; Lymphocytes, Null; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Melanoma; Neoplasm Recurrence, Local; Neutrophils; Prednisone; Radiotherapy, Adjuvant; T-Lymphocytes; Vincristine | 2002 |
Colovesical fistula an unusual complication of cytotoxic therapy in a case of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epiglottis; Humans; Intestinal Fistula; Lymphoma, Non-Hodgkin; Male; Prednisone; Sigmoid Diseases; Tongue Neoplasms; Urinary Bladder Fistula; Vincristine | 2001 |
Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Topics: Adult; Antineoplastic Agents; Azirines; Bleomycin; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Teniposide; Triethylenemelamine; Vinblastine; Vincristine | 1975 |
[Immunological aspects in the L-asparaginase treatment of children with lymphoproliferative diseases].
Topics: Adolescent; Anaphylaxis; Antibodies; Antibody Specificity; Asparaginase; Child; Child, Preschool; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Leukemia, Lymphoid; Leukocyte Count; Lymphocytes; Lymphoma, Non-Hodgkin; Prednisone | 1976 |
Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1977 |
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Triazenes; Vinblastine; Vincristine | 1977 |
[Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Burkitt Lymphoma; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymphatic Diseases; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Mycosis Fungoides; Prednisone; Vincristine | 1977 |
The Sézary syndrome. A case with fetal-type glycogen and lymphocytic lymphoma.
Topics: Chlorambucil; Cytoplasmic Granules; Dermatitis, Exfoliative; Glycogen; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Syndrome; Vincristine | 1978 |
[A case of infiltrating type of lymphosarcoma with remission of 3 and a half years' duration].
Topics: Adrenocorticotropic Hormone; Brain Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Penicillins; Prednisone; Remission Induction; Time Factors | 1975 |
Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Remission, Spontaneous; Vincristine | 1977 |
Intraocular reticulum cell sarcoma: its dramatic response to systemic chemotherapy and its angiogenic potential.
Topics: Aged; Ciliary Body; Cyclophosphamide; Drug Therapy, Combination; Eye Neoplasms; Female; Glaucoma; Humans; Iris; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Retinal Diseases; Retinal Vessels; Ultrasonography; Uveal Diseases; Vincristine | 1977 |
Histiocytic lymphoma of B cell origin.
Topics: B-Lymphocytes; Cell Membrane; Humans; Immunoglobulins; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vincristine | 1977 |
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Prednisone; Teniposide | 1977 |
[Therapy of non-Hodgkin lymphomas with COP and COPP regimens (author's transl)].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Vincristine | 1977 |
Non-Hodgkin's lymphoma in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Heart Failure; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens.
Topics: Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Steroid-induced femoral head necrosis.
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Female; Femur Head Necrosis; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiography; Skin Diseases | 1977 |
Development of a lymphocytic lymphoma during immunosuppressive therapy with azathioprine for systemic lupus erythematosus with renal involvement induced by phenylbutazone.
Topics: Azathioprine; Female; Humans; Kidney Diseases; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Middle Aged; Nasopharyngeal Neoplasms; Phenylbutazone; Prednisone | 1977 |
Lymphocele. A complication of cancer chemotherapy.
Topics: Aged; Antineoplastic Agents; Cyclophosphamide; Cysts; Drug Therapy, Combination; Female; Humans; Lymph; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Retroperitoneal Space; Vincristine | 1978 |
Leukocyte migration inhibition responses in canine lymphosarcoma.
Topics: Animals; Antigens, Neoplasm; BCG Vaccine; Cell Migration Inhibition; Cyclophosphamide; Dogs; Immunization; Leukocytes; Lymph Nodes; Lymphoma, Non-Hodgkin; Neoplasm Transplantation; Prednisone; Remission, Spontaneous; Sarcoma, Experimental; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 1978 |
Diffuse well-differentiated lymphocytic lymphoma (DLWD): response and survival.
Topics: Aged; Antineoplastic Agents; Carmustine; Cell Differentiation; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphocytosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Improved prognosis for patients with mediastinal lymphoblastic lymphoma.
Topics: Adolescent; Adult; Child; Child, Preschool; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Prednisone; Prognosis; Vincristine | 1979 |
Total body irradiation and cyclophosphamide, vincristine, prednisone in the treatment of favorable prognosis non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission, Spontaneous; Vincristine | 1979 |
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Seeding; Podophyllotoxin; Prednisone; Remission, Spontaneous; Teniposide | 1975 |
Non-Hodgkin's lymphomas-present status of chemotherapy.
Topics: Adult; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Vinblastine; Vincristine | 1975 |
[Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Mitotic Index; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1976 |
[Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
Topics: Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Remission, Spontaneous; Vincristine | 1976 |
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
Topics: Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1976 |
Malignant lymphoma presenting as unilateral exophtalmos and thyroid nodule (author's transl)
Topics: Axilla; Exophthalmos; Heart Neoplasms; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Optic Atrophy; Orbital Neoplasms; Prednisone; Thyroid Neoplasms; Vincristine | 1975 |
Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress report.
Topics: Adult; Aged; Chlorambucil; Cyclophosphamide; Drug Combinations; Ethylnitrosourea; Evaluation Studies as Topic; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Time Factors | 1976 |
Early responses to chemotherapy detected by pulse cytophotometry.
Topics: Adult; Antineoplastic Agents; Asparaginase; Bone Marrow; Bone Marrow Cells; Cell Division; Child; Cytarabine; DNA, Neoplasm; Doxorubicin; Fluorometry; Humans; Leukemia; Lymphoma, Non-Hodgkin; Melphalan; Prednisone; Vincristine | 1976 |
A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Maryland; Middle Aged; Nausea; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Prognosis; Vincristine; Vomiting | 1976 |
Cyclophosphamide therapy and interstitial pulmonary fibrosis.
Topics: Adult; Aged; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Pulmonary Fibrosis; Rhabdomyosarcoma; Vincristine | 1976 |
Pancreatic carcinoma as a sequel to therapy of lymphoma.
Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Agents; Carmustine; Cyclophosphamide; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Radiation-Induced; Pancreatic Neoplasms; Prednisone; Radiotherapy; Radiotherapy Dosage; Stomach Neoplasms; Vincristine | 1976 |
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Time Factors; Vincristine | 1975 |
Reversible achalasia due to reticulum-cell sarcoma.
Topics: Aged; Deglutition Disorders; Esophageal Achalasia; Esophageal Neoplasms; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Male; Manometry; Prednisone; Radionuclide Imaging; Vincristine | 1975 |
Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Vincristine; Vomiting | 1975 |
Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine | 1975 |
[Cytostatic therapy of primary lympho- and reticulosarcoma of the stomach].
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Stomach Neoplasms; Vincristine | 1975 |
Results of combination chemotherapy of non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1975 |
The influence of chemotherapy on the management of non-Hodgkin's lymphomata at the Princess Margaret Hospital. A comparison of the results from 1962-64 with 1967-69.
Topics: Adult; Aged; Cyclophosphamide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Retrospective Studies; Vincristine | 1975 |
Letter: Reticulum-cell sarcoma and Sjögren's syndrome in a patient treated with azathioprine.
Topics: Azathioprine; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Sjogren's Syndrome | 1976 |
Infiltrative retinopathy in systemic lymphoma.
Topics: Cobalt; Cyclophosphamide; Eye Neoplasms; Female; Fluorescein Angiography; Fundus Oculi; Humans; Isoniazid; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Metastasis; Optic Nerve; Prednisone; Pyridoxine; Retina; Retinal Hemorrhage; Vincristine; Visual Acuity | 1975 |
Protein-losing enteropathy in lymphoma of the small intestine.
Topics: Adult; Biopsy; Cyclophosphamide; Humans; Intestinal Neoplasms; Intestine, Small; Lymphocytes; Lymphoma, Non-Hodgkin; Male; Prednisone; Protein-Losing Enteropathies; Vincristine | 1975 |
Subacute thyroiditis associated with lymphosarcoma of the thyroid.
Topics: Autopsy; Biopsy; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precancerous Conditions; Prednisone; Radionuclide Imaging; Thyroid Function Tests; Thyroid Neoplasms; Thyroiditis, Autoimmune | 1975 |
Lymphosarcoma of the right atrium. Angiographic and hemodynamic documentation of response to chemotherapy.
Topics: Adult; Angiocardiography; Cardiac Catheterization; Coronary Circulation; Heart Atria; Heart Neoplasms; Hemodynamics; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Prednisone; Quinidine; Tachycardia; Tricuspid Valve; Vincristine | 1975 |
Hemodialysis for acute anuric uric acid nephropathy.
Topics: Abdominal Neoplasms; Acute Kidney Injury; Allopurinol; Child; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Male; Oliguria; Prednisone; Renal Dialysis; Uric Acid; Vincristine | 1975 |
Hemolytic anemia with IgG and IgM autoantibodies and allontibodies.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoantibodies; Blood Transfusion; Humans; Immunoglobulin G; Immunoglobulin M; Isoantibodies; Lymphoma, Non-Hodgkin; Male; Prednisone; Temperature | 1975 |
Orbital inflammatory pseudo-tumours: immunological aspects.
Topics: Aged; Diagnosis, Differential; Eye Diseases; Female; Humans; Immunoglobulin M; Inflammation; Lymphoma, Non-Hodgkin; Male; Orbit; Orbital Neoplasms; Paraproteinemias; Prednisone | 1975 |
Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: clinical results and analysis of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Vincristine | 1992 |
[Primary non-Hodgkin's lymphoma of paranasal sinuses. Review of the literature and a case report].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Ethmoid Sinus; Etoposide; Female; Frontal Sinus; Humans; Lymphoma, Non-Hodgkin; Maxillary Sinus Neoplasms; Methotrexate; Paranasal Sinus Neoplasms; Prednisone; Vincristine | 1992 |
Right ventricular outflow tract obstruction due to extrinsic compression by non-Hodgkin's lymphoma: importance of echocardiographic diagnosis and follow up.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Echocardiography; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Pulmonary Valve Stenosis; Ventricular Function; Vincristine | 1992 |
Impairment of peripheral nervous system in patients with non-Hodgkin's lymphomas treated with CBVPM/AVBP and CHOP schedules.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Median Nerve; Methotrexate; Middle Aged; Neural Conduction; Peroneal Nerve; Prednisone; Reflex, Abnormal; Reflex, Stretch; Ulnar Nerve; Vincristine | 1992 |
The clinical use of RHG-CSF for malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Neutropenia; Prednisone; Recombinant Proteins; Vincristine | 1992 |
Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Immunoglobulin G; Immunoglobulin M; Leucovorin; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Salivation; Secretory Rate; Sex Factors; Vinblastine; Vincristine | 1992 |
[Vibrio cholerae can be encountered even at home].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Immunocompromised Host; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Stomatitis; Vibrio cholerae; Vibrio Infections; Vincristine | 1991 |
A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone | 1992 |
[Non-Hodgkin lymphoma with Ki-1 antigen: a case report].
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Ki-1 Antigen; Lymphoma, Non-Hodgkin; Prednisone; Remission Induction; Vincristine | 1992 |
Treatment and prognosis of orbital non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Prednisone; Prognosis; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Vincristine | 1992 |
Constitutional translocation (8;13) in a patient with non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chromosome Banding; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Karyotyping; Lymphoma, Non-Hodgkin; Male; Prednisone; Translocation, Genetic; Vincristine | 1992 |
[Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1992 |
[Progress in hematological malignancy of aged--therapy of malignant lymphoma in aged].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Prednisone; Survival Rate; Vincristine | 1992 |
Clinical and prognostic significance of monoclonal small cells in the peripheral blood and bone marrow of various B-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Flow Cytometry; Humans; Leucovorin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Remission Induction; Vincristine | 1992 |
Successful treatment of primary gastric non-Hodgkin's lymphoma with chemotherapy and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Stomach Neoplasms; Vincristine | 1992 |
Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Humans; Immunocompromised Host; Liver Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Vincristine | 1992 |
[Treatment of elderly patients with hematological malignancies].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Vincristine | 1992 |
Treatment of diffuse non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisolone and bleomycin (MACOP-B).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Vincristine | 1992 |
Non-Hodgkin's lymphomas: a review of the M.D. Anderson experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy; Texas; Vincristine | 1992 |
Primary malignant lymphoma of the spleen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Splenic Neoplasms; Tomography, X-Ray Computed; Vincristine | 1992 |
[Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Child, Preschool; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radius; Vincristine | 1992 |
[The use of novantrone in combination with other preparations in hematosarcoma patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Remission Induction; Time Factors; Vincristine | 1992 |
[The chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in the III-IV stages of the disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Radiotherapy Dosage; Radiotherapy, High-Energy; Recurrence; Remission Induction; Vincristine | 1992 |
Left main coronary stenosis by a mediastinal lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Coronary Disease; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Procarbazine; Vincristine | 1992 |
AgNORs predictive value of prognosis in non-Hodgkin's lymphoma: comparison with flow cytometric cell cycle analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Female; Flow Cytometry; Follow-Up Studies; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Nucleolus Organizer Region; Prednisolone; Prednisone; Prognosis; Survival Analysis; Vincristine | 1992 |
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Radiation; Female; Growth; Humans; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Pituitary Gland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Somatomedins; Vincristine | 1992 |
[Infiltration into the aqueous humor (uveitis) in a patient with malignant lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aqueous Humor; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Neoplasm Invasiveness; Prednisone; Rectal Neoplasms; Uveal Neoplasms; Uveitis; Vincristine | 1992 |
[Low-grade non-Hodgkin's lymphomas. Study of 73 cases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Vincristine | 1992 |
Abnormal uptake of technetium-99m hexakis-2-methoxyisobutylisonitrile in a primary cardiac lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Organotechnetium Compounds; Prednisone; Radionuclide Imaging; Remission Induction; Technetium Tc 99m Sestamibi; Vincristine | 1992 |
[2 patients with a non-Hodgkin lymphoma located in the pancreas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancreatic Neoplasms; Prednisone; Tomography, X-Ray Computed; Vincristine | 1992 |
[Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Nimustine; Prednisone; Remission Induction; Vincristine | 1992 |
To CHOP or not to CHOP ... is that the question?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 1992 |
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recurrence; Vincristine; Vindesine | 1992 |
Stage I malignant lymphoma of Waldeyer's ring: frequent relapse after radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Retrospective Studies; Tonsillar Neoplasms; Vincristine | 1992 |
Primary non-Hodgkin's lymphoma of the urinary bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Greece; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine | 1992 |
MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Vincristine | 1990 |
Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Gastroscopy; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Stomach; Stomach Neoplasms; Vincristine | 1990 |
Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Rate; Vincristine | 1990 |
Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Infant, Newborn; Infant, Premature; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Multiple; Twins; Vincristine | 1990 |
Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin.
Topics: Antibodies, Anti-Idiotypic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cells; Humans; Immunoglobulins; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Red-Cell Aplasia, Pure; Vincristine | 1990 |
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Remission Induction; Sclerosis; Sex Factors; Survival Rate; Vincristine | 1990 |
Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; T-Lymphocytes; Vincristine | 1990 |
Palmar-plantar erythema associated with combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1990 |
[Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Fibrosis; Humans; Kidney; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Necrosis; Prednisone; Spleen; Vincristine | 1990 |
Multifocal extranodal lymphomas: an expression of homing phenomenon.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Movement; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1990 |
[Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Colony-Stimulating Factors; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Vincristine | 1990 |
Nursing care of the patient with non-Hodgkin's lymphoma. A case study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Patient Care Planning; Prednisone; Vincristine | 1990 |
[The COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine | 1990 |
Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Hypercalcemia; Leucovorin; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1990 |
[Acute pneumocystosis during polychemotherapy following the MACOP-B protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bronchi; Bronchoalveolar Lavage Fluid; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; HIV Seropositivity; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Pneumocystis; Pneumonia, Pneumocystis; Prednisone; T-Lymphocyte Subsets; Time Factors; Vincristine | 1990 |
[Expansion of peripheral blood progenitors by recombinant human granulocyte colony-stimulating factor].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Vincristine | 1990 |
[Assessment of the antitumor effect after remission induction therapy for non-Hodgkin's lymphoma--an approach to a response-adapted therapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Vincristine | 1990 |
A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate | 1991 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomycin; Body Height; Body Weight; Child; Child Development; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulins; Intelligence; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Sex Characteristics; Vinblastine; Vincristine | 1991 |
A clinical phase II study of ProMACE-CytaBOM.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1991 |
Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Survival Rate; Vincristine | 1991 |
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1991 |
Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Calcium; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Radiography; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1991 |
Influence of cytostatic treatment on the coagulation system and fibrinolysis in patients with non-Hodgkin's lymphomas and acute leukemias.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Bleomycin; Blood Coagulation; Cyclophosphamide; Doxorubicin; Fibrinolysis; Fibrinopeptide A; Humans; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Peptide Hydrolases; Prednisone; Procarbazine; Vincristine | 1991 |
Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Central Nervous System Neoplasms; Chi-Square Distribution; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Risk Factors; Survival Rate; Vincristine | 1991 |
Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Vincristine | 1991 |
[A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Remission Induction; Vincristine | 1991 |
[The COP-BLAM III therapy of non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine | 1991 |
Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Female; HIV Seropositivity; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Vincristine | 1991 |
[Indicators of nonspecific immunity in patients with non-Hodgkin's lymphoma of high grade malignancy in the remission phase of the disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; CD4-CD8 Ratio; Cyclophosphamide; Doxorubicin; Female; Humans; Immunoglobulins; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; T-Lymphocytes; Vincristine | 1991 |
[Malignant lymphomas. Preliminary report of the National Protocol of Antineoplastic Drugs].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1991 |
[Malignant lymphomatous polyposis of the gastrointestinal tract].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Endoscopy; Gastrointestinal Neoplasms; Humans; Intestinal Polyps; Lymphoma, Non-Hodgkin; Male; Prednisone; Rectal Neoplasms; Sigmoid Neoplasms; Stomach Neoplasms; Vincristine | 1992 |
Renal insufficiency due to bilateral primary renal lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 1992 |
All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Gene Rearrangement; Humans; Lymphoma, Non-Hodgkin; Molecular Sequence Data; Polymerase Chain Reaction; Prednisone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Remission Induction; Salvage Therapy; Translocation, Genetic; Vincristine | 1991 |
The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Vincristine | 1991 |
[Hodgkin's disease associated with LDH-M subunit deficiency].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Macromolecular Substances; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 1991 |
Risk factors in intermediate and high-grade non-Hodgkin's lymphomas of adults: a need for a new staging system.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Risk Factors; Vincristine | 1991 |
Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Risk Factors; Sex Factors; Vincristine | 1991 |
The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluorouracil; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1991 |
Clinical and pathological restaging in aggressive non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prospective Studies; Vincristine | 1991 |
Sinonasal non-Hodgkin's lymphomas and Wegener's granulomatosis: a clinicopathological study.
Topics: Adult; Antibodies, Neoplasm; Cyclophosphamide; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Male; Nose Neoplasms; Paranasal Sinus Neoplasms; Prednisone; Survival Analysis | 1991 |
[Limited chemotherapy and radiotherapy for stage I-II intermediate or high grade lymphoma of nodal sites or Waldeyer's ring].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Tonsillar Neoplasms; Vincristine | 1991 |
Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non-Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHL.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine | 1991 |
Salvage therapy with PROMACE in relapsed non-Hodgkin malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone | 1991 |
Late relapse with nodular lymphoma after treatment for diffuse non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Vincristine | 1991 |
[Modified CHOP therapy in patients with non-Hodgkin's lymphoma].
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Rate; Vincristine | 1991 |
[Similar efficacy of less than 6 and 7-10 courses of therapy with anthracycline-based combination chemotherapy for localized non-Hodgkin's lymphoma of extranodal type].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Vincristine | 1991 |
Successful chemotherapy on a pregnant non-Hodgkin's lymphoma patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Vincristine | 1990 |
[A case of B-cell non-Hodgkin's lymphoma with prominent splenomegaly and high serum titer of cold agglutinin].
Topics: Adult; Agglutinins; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Combined Modality Therapy; Cryoglobulins; Cyclophosphamide; Doxorubicin; Humans; Immunoglobulin kappa-Chains; Immunoglobulin M; Lymphoma, Non-Hodgkin; Male; Prednisone; Splenectomy; Splenomegaly; Vincristine | 1990 |
Excessive chemotherapy-related granulocytopenia in a child with non-Hodgkin's lymphoma and a congenital abnormality of purine salvage.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Pentosyltransferases; Prednisone; Purine-Nucleoside Phosphorylase; Vincristine | 1990 |
ECAPP chemotherapy for lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Vincristine | 1990 |
Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Adhesion Molecules; Combined Modality Therapy; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Female; Flow Cytometry; Humans; Interphase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Ploidies; Prednisone; Prognosis; Receptors, Immunologic; Receptors, Lymphocyte Homing; Vincristine | 1990 |
Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Sex Factors; Survival Rate; Vincristine | 1990 |
Interleukin-2 receptor levels in non-Hodgkin's lymphoma. Correlation to histological degree of malignancy and presence of constitutional symptoms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Receptors, Interleukin-2; Vincristine | 1990 |
CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Injections, Intravenous; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Remission Induction | 1990 |
[Radiotherapy and chemotherapy in stages I and II non-Hodgkin's lymphomas of Waldeyer's ring].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Tonsillar Neoplasms; Vincristine | 1990 |
Primary non-Hodgkin's lymphoma of the larynx treated only by chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Laryngeal Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1990 |
Phase II study of lomustine, cytarabine, mitoxantrone, and prednisone (CAMP) combination chemotherapy for doxorubicin-resistant intermediate- and high-grade malignant non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Remission Induction; Survival Rate | 1990 |
[Non-Hodgkin's lymphoma of the Waldeyer's ring: the treatment results of the past 22 years and the significance of CHOP].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Tonsillar Neoplasms; Vincristine | 1990 |
[Regression of cerebral post-transplantation lymphoma under cyclosporin A reduction].
Topics: Adult; Biopsy; Brain Neoplasms; Cyclosporins; Humans; Kidney Transplantation; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Regression, Spontaneous; Prednisone; Tomography, X-Ray Computed; Tonsillar Neoplasms | 1990 |
Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Female; Hepatitis B; Hepatitis B Surface Antigens; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Liver Function Tests; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone | 1990 |
Long-term follow-up of CHOP-treated non-Hodgkin lymphoma of high-grade malignancy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1990 |
Continuous cyclophosphamide, doxorubicin, vincristine, and prednisolone. A new, innovative protocol for diffuse aggressive lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Remission Induction; Survival Rate; Vincristine | 1990 |
Erythema nodosum and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Erythema Nodosum; Etoposide; Female; Humans; Intestinal Obstruction; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Periarthritis; Prednisone | 1990 |
UKALL X--an effective treatment for stage III mediastinal non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Vincristine | 1990 |
Primary non-Hodgkin's lymphoma of the esophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Esophageal Neoplasms; Esophagoscopy; Esophagus; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Remission Induction; Time Factors; Vincristine | 1990 |
[Disseminated, highly malignant non-Hodgkin's lymphoma and pregnancy: polychemotherapy in the 2d and 3d trimester].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Infant, Newborn; Lymphoma, Non-Hodgkin; Neoplasms, Multiple Primary; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Vincristine | 1990 |
[Non-Hodgkin's lymphoma of the parotid gland].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Parotid Gland; Parotid Neoplasms; Prednisone; Retrospective Studies; Vincristine | 1990 |
Non-Hodgkin lymphoma: a rare primary vulvar localization.
Topics: Brain Neoplasms; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vulvar Neoplasms | 1990 |
Lymphoblastic lymphoma in a female with chronic granulocytic leukaemia.
Topics: Adolescent; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; DNA Nucleotidylexotransferase; Doxorubicin; Female; Humans; Karyotyping; Leukemia, Myeloid; Lymph Nodes; Lymphoma, Non-Hodgkin; Mitolactol; Prednisone; Vincristine | 1985 |
[Lactic acidosis in non-Hodgkin's lymphoma].
Topics: Acidosis, Lactic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Vincristine | 1985 |
Fatal pulmonary fibrosis from low-dose bleomycin therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Pulmonary Fibrosis; Vincristine | 1987 |
Updated clinical experience with MACOP-B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Time Factors; Vincristine | 1987 |
Advances in chemotherapy for large cell lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Tolerance; Forecasting; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Procarbazine; Prognosis; Time Factors; Vincristine | 1987 |
Minimizing toxicity of MACOP-B.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Stomatitis; Vincristine | 1987 |
Failure of conventional chemotherapy in aggressive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Vinblastine; Vincristine | 1987 |
Non-Hodgkin's lymphoma in children. Results of therapy.
Topics: Abdominal Neoplasms; Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1987 |
Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Radiotherapy, High-Energy; Retrospective Studies; Vincristine | 1988 |
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia; Lymphocytes; Lymphoma, Non-Hodgkin; Mechlorethamine; Methyltransferases; O(6)-Methylguanine-DNA Methyltransferase; Prednisone; Procarbazine; Reference Values; Vinblastine; Vincristine | 1988 |
Results of treating stage III and IV malignant non-Hodgkin's lymphomas (NHL).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prognosis; Retrospective Studies; Vincristine | 1988 |
Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine | 1988 |
Non-Hodgkin's lymphoma in Saudi Arabia: prognostic factors and an analysis of the outcome of combination chemotherapy only, for both localized and advanced disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Risk Factors; Saudi Arabia; Time Factors; Vincristine | 1988 |
Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Evaluation; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1988 |
The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Vincristine | 1988 |
MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Vincristine | 1988 |
HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1988 |
Pulmonary emboli in patients receiving chemotherapy for non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Phosphoramide Mustards; Prednisone; Pulmonary Embolism; Pulmonary Fibrosis; Vinblastine | 1988 |
Non-Hodgkin's lymphoma in the elderly: a retrospective evaluation of toxicity related to aggressive vs. conservative treatments.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Random Allocation; Retrospective Studies; Vinblastine; Vincristine | 1988 |
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Vincristine | 1988 |
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Reoperation; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 1989 |
Bone marrow and blood involvement by non-Hodgkin's lymphoma: a study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Invasiveness; Prednisone; Prognosis; Vincristine | 1989 |
[Effective evaluation of combination chemotherapy in stage I-II of non-Hodgkin's lymphoma--a comparison of treatment with multivariate analysis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Vincristine | 1989 |
Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mouth Mucosa; Prednisone; Radiation Injuries; Recurrence; Stomatitis; Tonsillar Neoplasms; Vincristine | 1989 |
Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1989 |
B-cell lymphoma associated with eosinophilia.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; Cyclophosphamide; Doxorubicin; Eosinophilia; Humans; Immunohistochemistry; Leucovorin; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1989 |
[Results of the treatment of non-Hodgkin's lymphoma with 6 cytostatic drug combination].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1989 |
[Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1989 |
[Chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in stages I to II of the disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Radiotherapy Dosage; Remission Induction; Vincristine | 1989 |
Monoclonal B-cells in blood in non-Hodgkin lymphoma. Correlation with clinical features and prognoses.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow Diseases; Cyclophosphamide; Doxorubicin; Female; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Survival Rate; Vincristine | 1989 |
[Clinical, anatomo-pathologic aspects and therapeutic results in 63 malignant ORL non-Hodgkin's lymphomas in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Prednisone; Retrospective Studies; Vincristine | 1989 |
[Long-term results in the treatment of lymphomas using polychemotherapy (CHOP)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Mexico; Middle Aged; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 1989 |
[Treatment of large cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Israel; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Vincristine | 1989 |
The malignant lymphomas in Benin City, Nigeria.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nigeria; Prednisone; Vincristine | 1989 |
[Evaluation of the response of advanced diffuse large cell lymphomas (LSG classification) to weekly CHOP therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1989 |
[Combined (poly-chemo-radio) therapy of non-Hodgkin's lymphomas].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1989 |
[Indirect endolymphatic chemotherapy of patients with lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Injections, Intralymphatic; Lomustine; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Procarbazine; Prospidium; Remission Induction; Vinblastine; Vincristine | 1989 |
Intraocular non-Hodgkin's lymphoma treated with systemic and intrathecal chemotherapy and radiotherapy. A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Female; Humans; Injections, Spinal; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Retinal Diseases; Uveitis; Vincristine; Visual Acuity; Vitreous Body | 1989 |
Multilobated non-Hodgkin lymphoma of B-cell type: leukemization and multiorganic involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow; Cell Nucleus; Cyclophosphamide; Cytoplasm; Doxorubicin; Female; Histocytochemistry; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Vincristine | 1989 |
Poor-risk non-lymphoblastic lymphoma of childhood: results of an intensive pilot study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Humans; Infant; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Pilot Projects; Prednisone; Prognosis; Sex Factors; Vincristine | 1989 |
B-immunoblastic lymphoma arising in angioimmunoblastic lymphadenopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cells, Cultured; Cyclophosphamide; Drug Resistance; Female; Humans; Immunoblastic Lymphadenopathy; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Vincristine | 1986 |
Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Evaluation Studies as Topic; Humans; Lymphoma, Non-Hodgkin; Prednisone; Radiotherapy, High-Energy; Remission Induction; Vincristine | 1988 |
High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokinetics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Half-Life; Humans; Infusions, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Stomatitis; Vincristine | 1987 |
High-dose methotrexate and continuous infusion Ara-C in children's non-Hodgkin's lymphoma: phase II studies and their use in further protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Diseases; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1986 |
Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Evaluation Studies as Topic; Humans; Italy; Life Tables; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Survival Rate; Syndrome; Vincristine | 1986 |
Adjusting survival curves for imbalances in prognostic factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hemoglobins; Humans; Lymphoma, Non-Hodgkin; Mathematics; Mortality; Prednisone; Prognosis; Risk Factors; Serum Albumin; Time Factors; Vincristine | 1988 |
[A comparative trial of C-novantrone OP(CNOP) vs C-adriamycin OP(CHOP) in the treatment of stage II-IV malignant lymphoma--the preliminary report].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisolone; Prednisone; Remission Induction; Vincristine | 1988 |
[Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prognosis; Remission Induction; Vincristine | 1988 |
Prognostic factors of stage I and II non-Hodgkin's lymphomas of the head and neck: the value of the working formulation and need for chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Vincristine | 1988 |
[Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 1988 |
[Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
Improved treatment results for lymphoblastic lymphoma in adolescents and adults using a doxorubicin-based (APO) protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1988 |
Treatment of diffuse histiocytic and diffuse mixed non-Hodgkin lymphomas with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1988 |
The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Damage; Doxorubicin; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Sister Chromatid Exchange; Vinblastine; Vincristine | 1988 |
Short-term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine | 1988 |
Non-Hodgkin's lymphoma in children; diffuse lymphoblastic histology; diffuse non-lymphoblastic histology; LSA2-L2 experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
[Non-Hodgkin's lymphoma. Results of a therapeutic protocol].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
[Results of the treatment of 46 non-Hodgkin's lymphomas in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1988 |
[THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Vincristine | 1988 |
Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Nausea; Prednisone; Prognosis; Remission Induction; Vincristine; Vindesine | 1988 |
[Evaluation of the results of treatment of non-Hodgkin's lymphoma in children by the Wollner method].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Time Factors; Vincristine | 1988 |
[A case of lymphoma of a higher stage of malignancy treated with cytostatics and interferon].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Interferon Type I; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Vincristine | 1988 |
Pancreatic lymphoma, diagnosis and management.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancreatic Neoplasms; Prednisone; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 1987 |
Treatment of malignant non-Hodgkin's lymphoma in elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1988 |
Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Humans; Immunoproliferative Small Intestinal Disease; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1988 |
High grade nonHodgkin's lymphoma: management with moderate dose combination chemotherapy.
Topics: Aged; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1988 |
Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Nutritional Status; Prednisone; Prognosis; Time Factors; Vincristine | 1988 |
Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Autoantibodies; Combined Modality Therapy; Female; Hematocrit; Hodgkin Disease; Humans; Immunoglobulin G; Immunoglobulin M; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Prednisone; Recurrence; Time Factors | 1988 |
[Second tumors in patients treated for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Time Factors; Vincristine | 1988 |
Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednisone; Vincristine | 1988 |
[Results of treatment in children with diffuse large cell lymphoma].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1987 |
[A case of mantle-zone lymphoma with salivary gland swelling as the initial manifestation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Remission Induction; Salivary Glands; Sjogren's Syndrome; Vincristine | 1987 |
[Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 1987 |
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclophosphamide; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 1987 |
Short-term high-dose treatment in bad-risk ALL and lymphoblastic NHL.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1987 |
Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1987 |
[Clinical efficacy of combined treatment in a late-stage malignant tumor of the head and neck].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1987 |
[non-Hodgkin's lymphoma treated with modified LSA2-L2 protocol--a clinical experience and case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission Induction; Vincristine | 1987 |
[Treatment of non-Hodgkin's lymphoma with CHOP therapy: analysis of lymphocyte subsets and interleukin 2 activity during CHOP therapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Interleukin-2; Lymphocytes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1986 |
[A case of non-Hodgkin's lymphoma manifesting an eyelid tumor as a major symptom].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Eyelid Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Vincristine | 1987 |
Pulmonary complications of cytosine-arabinoside therapy: radiographic findings.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lung; Lymphoma, Non-Hodgkin; Prednisone; Radiography; Remission Induction; Respiratory Insufficiency | 1987 |
Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Teniposide | 1987 |
Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Teniposide; Vincristine | 1987 |
Combination chemotherapy for the treatment of diffuse aggressive lymphomas: F-MACHOP update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Vincristine | 1987 |
Failure of combination chemotherapy of advanced follicular (low-grade) non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Teniposide; Time Factors; Vincristine | 1987 |
[Analysis of the course and treatment of primary non-Hodgkin's lymphoma of the gastrointestinal tract].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Mitomycins; Prednisone; Vincristine | 1987 |
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II non-Hodgkin's lymphoma of the upper digestive and respiratory tract.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Nose Neoplasms; Paranasal Sinus Neoplasms; Parotid Neoplasms; Prednisone; Respiratory Tract Neoplasms; Retrospective Studies; Vincristine | 1987 |
Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Vincristine | 1987 |
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1987 |
[Short-term result of non-Hodgkin's lymphoma treated by the COMP regimen].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1987 |
Progressive loss of vision in patients with high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Optic Neuritis; Prednisone; Vincristine | 1987 |
[C-MOPP therapy in advanced diffuse lymphoma, large cell type (LSG)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Vincristine | 1987 |
Activation of haemostasis by combined chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hemostasis; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasms; Prednisone; Vincristine | 1987 |
Staging and treatment of non-Hodgkin's lymphoma of intermediate-grade malignancy: a retrospective study of 102 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Retrospective Studies; Vincristine | 1987 |
Uric acid and phosphorus excretion in dogs with lymphosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dog Diseases; Dogs; Female; Lymphoma, Non-Hodgkin; Male; Phosphates; Prednisone; Uric Acid; Vincristine | 1986 |
[Clinical picture, diagnosis and treatment of the brain lesions in lymphosarcomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Drug Combinations; Female; Gamma Rays; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Time Factors; Vincristine | 1986 |
Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Separation; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cells; Humans; Kinetics; Lymphoma, Non-Hodgkin; Methotrexate; Neutrophils; Prednisone; Vincristine | 1987 |
[Combined CHOP and radiotherapy in non-Hodgkin's lymphoma of unfavorable histology].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1986 |
[Non-Hodgkinś lymphoma in childhood, preliminary results of the LSA2 L2 protocol modified by high-dose methotrexate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1987 |
An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Teniposide; Time Factors | 1985 |
Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1985 |
Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Humans; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Vincristine | 1985 |
[Results of the treatment of lymphosarcoma of the large intestine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Cecum; Colectomy; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Evaluation Studies as Topic; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Prednisolone; Prednisone; Radiotherapy Dosage; Rectal Neoplasms; Rectum; Vincristine | 1985 |
[Experience treating 30 cases of oromaxillofacial non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Facial Neoplasms; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Maxillary Neoplasms; Middle Aged; Mouth Neoplasms; Prednisone; Vincristine | 1985 |
The nitroblue tetrazolium test in lymphoma.
Topics: Adult; Diagnosis, Differential; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutrophils; Nitro Compounds; Pneumococcal Infections; Prednisone; Recurrence; Remission, Spontaneous; Sepsis; Staining and Labeling; Tetrazolium Salts | 1973 |
Generalized herpes simplex complicating lymphoma.
Topics: Aged; Chloramphenicol; Culture Techniques; Cyclophosphamide; gamma-Globulins; Herpes Simplex; Humans; Idoxuridine; Isoniazid; Lymphoma, Non-Hodgkin; Male; Pneumonia, Pneumocystis; Prednisone; Proteus Infections; Pseudomonas Infections; Simplexvirus; Virus Cultivation | 1969 |
Biclonal gammopathy in a patient with a lymphoproliferative disease.
Topics: Aged; Blood Protein Electrophoresis; Bone Marrow Cells; Female; gamma-Globulins; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Prednisone | 1968 |
Symptomatic control of fever in lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Aminopyrine; Analgesics; Aspirin; Female; Fever; Hodgkin Disease; Humans; Indomethacin; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Prednisone | 1969 |
Hypercalcemia associated with chronic lymphocytic leukemia. Treatment with mithramycin.
Topics: Bone Neoplasms; Diuretics; Humans; Hypercalcemia; Kidney; Leukemia, Lymphoid; Lung; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Plicamycin; Prednisone; Sodium Chloride | 1973 |
[Rheumatoid polyarthritis and chronic lymphoid leukemia. Studies of 7 cases of association of these 2 diseases].
Topics: Adult; Age Factors; Aged; Animals; Antibodies; Arthritis, Rheumatoid; Autoimmune Diseases; Chlorambucil; Female; Fluorescent Antibody Technique; Hodgkin Disease; Humans; Immunoelectrophoresis; Immunosuppressive Agents; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Sex Factors; Statistics as Topic; Virus Diseases | 1969 |
Chronic immunosuppression and occult lymphoma: a case report.
Topics: Adult; Azathioprine; Bone Neoplasms; Cadaver; Carcinoma, Squamous Cell; Cytomegalovirus Infections; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Lip Neoplasms; Lymphoma, Non-Hodgkin; Male; Mycobacterium Infections; Neoplasms, Multiple Primary; Prednisone; Transplantation, Homologous | 1972 |
Pemphigus vulgaris and internal malignancy.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Dexamethasone; Female; Glucocorticoids; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pemphigus; Prednisone; Thymoma; Urinary Bladder Neoplasms; Uterine Neoplasms | 1974 |
Childhood non-Hodgkin's lymphoma--a study of 17 cases in Israel.
Topics: Abdominal Neoplasms; Adolescent; Age Factors; Allopurinol; Antigens, Viral; Arabia; Bone Marrow Diseases; Brain Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Ethnicity; Female; Herpesvirus 4, Human; Humans; Israel; Jaw Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1974 |
[Therapy and course of malignant diseases of the lymphoreticular system in infancy and early childhood].
Topics: Age Factors; Antineoplastic Agents; Child, Preschool; Hodgkin Disease; Humans; Infant; Infant, Newborn; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Radiography | 1973 |
Polymyalgia rheumatica: a not so benign syndrome.
Topics: Adrenocorticotropic Hormone; Aged; Arrhythmias, Cardiac; Blood Protein Electrophoresis; Diagnosis, Differential; Female; Heart Failure; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Phenylbutazone; Polyarteritis Nodosa; Polymyalgia Rheumatica; Prednisone; Prognosis; Prospective Studies; Sjogren's Syndrome | 1969 |
The place of the L-asparaginase in the treatment of acute leukemias.
Topics: Acute Disease; Adolescent; Adult; Animals; Asparaginase; Child; Child, Preschool; Chronic Disease; Drug Hypersensitivity; Female; Graft Rejection; Graft vs Host Reaction; Hematopoiesis; Humans; Immunosuppression Therapy; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Liver Function Tests; Lymphoma, Non-Hodgkin; Melanoma; Middle Aged; Polycythemia Vera; Prednisone; Sheep; Vincristine | 1970 |
Lymphosarcomatous arthropathy.
Topics: Arthritis; Biopsy; Cyclophosphamide; Female; Foot; Hand; Hematocrit; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Pain; Prednisone; Procarbazine; Radiography; Vincristine | 1974 |
Malignant lymphoma invading the facial nerve.
Topics: Child; Cochlear Nerve; Colon; Electric Stimulation; Facial Nerve; Facial Paralysis; Female; Humans; Ileum; Intestinal Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Nicotinic Acids; Peripheral Nervous System Neoplasms; Prednisone | 1974 |
[IgM paraproteinaemia in lymphoblastic lymphosarcoma in a child (author's transl)].
Topics: Blood Protein Disorders; Blood Protein Electrophoresis; Chromatography, Gel; Humans; Immunoelectrophoresis; Immunoglobulin M; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1974 |
Effect of chemotherapy with cyclophosphamide on the buoyant density separation and volume distributions of lymphocytes in chronic lymphocytic leukemia and lymphosarcoma.
Topics: Centrifugation, Density Gradient; Chromatin; Cyclophosphamide; Electronics, Medical; Humans; Leukemia, Lymphoid; Leukocyte Count; Lymphocytes; Lymphoma, Non-Hodgkin; Prednisone; Serum Albumin, Bovine | 1974 |
[The treatment of lymphosarcoma in childhood (author's transl)].
Topics: Age Factors; Antineoplastic Agents; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Vincristine | 1974 |
Conversion of Hodgkin's disease to lymphoblastic lymphosarcoma.
Topics: Aged; Cyclophosphamide; Doxorubicin; Female; Hodgkin Disease; Humans; Liver; Lymph Node Excision; Lymphography; Lymphoma, Non-Hodgkin; Neoplasms, Multiple Primary; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Splenectomy; Vincristine | 1974 |
[L-asparaginase in combined treatment of lymphosarcoma in children].
Topics: Adolescent; Age Factors; Asparaginase; Child; Child, Preschool; Drug Therapy, Combination; Humans; Lymphoma, Non-Hodgkin; Prednisone; Remission, Spontaneous | 1974 |
Development of acute leukaemia in a patient with lymphosarcoma.
Topics: Autopsy; Bone Marrow; Bone Marrow Cells; Chlorambucil; Humans; Immunoglobulins; Karyotyping; Leukemia, Myeloid, Acute; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Muramidase; Neoplasms, Multiple Primary; Prednisone | 1973 |
[Chemotherapy of malignant tumors and acute leukoses. New developments and results].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Prednisone; Vincristine | 1972 |
Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
Topics: Adult; Biopsy; Cell Count; Clomiphene; Cyclophosphamide; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Hydrazines; Infertility, Male; Luteinizing Hormone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Radioimmunoassay; Semen; Spermatogenesis; Spermatozoa; Testis; Testosterone; Vincristine | 1972 |
Reticulum cell sarcoma. A review of radiotherapeutic experience.
Topics: Adolescent; Adult; Aged; Chlorambucil; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radiotherapy; Radiotherapy Dosage | 1972 |
[Hodgkin's disease and other malignant lymphomas].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Vincristine | 1972 |
[Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Injections, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1972 |
[Chylous effusion during reticulosarcoma].
Topics: Abdominal Neoplasms; Chylothorax; Humans; Hydrazines; Inguinal Canal; Lumbosacral Region; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Vincristine | 1973 |
Management of patients with non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Lymphography; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy Dosage; Vinblastine; Vincristine | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1973 |
Pulmonary nocardiosis complicating malignant lymphoma successfully treated with chemotherapy.
Topics: Agammaglobulinemia; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Humans; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nocardia asteroides; Nocardia Infections; Prednisone; Sulfadiazine; Sulfamethoxazole; Therapeutic Irrigation; Trimethoprim; Vincristine | 1973 |
Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Biopsy; Burkitt Lymphoma; Cyclophosphamide; Germ Cells; Hodgkin Disease; Humans; Libido; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Sertoli Cells; Spermatogenesis; Spermatozoa; Testis; Time Factors; Vincristine | 1973 |
The appearance of reticulum cell sarcoma at the site of antilymphocyte globulin injection.
Topics: Amphotericin B; Antibodies; Antilymphocyte Serum; Azathioprine; Buttocks; Cadaver; Cryptococcosis; Cryptococcus neoformans; Humans; Injections, Intramuscular; Kidney Transplantation; Lymphoma, Non-Hodgkin; Male; Meningitis; Middle Aged; Postoperative Care; Prednisone; Spleen; Transplantation, Homologous | 1973 |
Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injections, Intravenous; Leukocyte Count; Leukopenia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Thrombocytopenia; Vinblastine | 1973 |
Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma.
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Vincristine | 1974 |
Treatment of Hodgkin's disease and other malignant lymphomas.
Topics: Alkylating Agents; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Nitrosourea Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Vinblastine; Vincristine | 1973 |
The therapy of canine and feline lymphosarcoma.
Topics: Ampicillin; Animals; BCG Vaccine; Cat Diseases; Cats; Chloramphenicol; Cyclophosphamide; Dog Diseases; Dogs; Drug Therapy, Combination; Escherichia coli Infections; Klebsiella Infections; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1973 |
Cerebral reticulum cell sarcoma after multiple renal transplants.
Topics: Adult; Azathioprine; Brain Neoplasms; Dactinomycin; Glomerulonephritis; Humans; Immunosuppression Therapy; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Lymphoma, Non-Hodgkin; Male; Occipital Lobe; Prednisolone; Prednisone; Radiation Effects; Temporal Lobe; Transplantation Immunology; Transplantation, Homologous | 1974 |
[Primary lymphosarcoma of the stomach].
Topics: Diagnosis, Differential; Drug Therapy, Combination; Histological Techniques; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Stomach Neoplasms; Vincristine | 1974 |
A clinical study of the natural history of lymphosarcoma and reticulum cell sarcoma.
Topics: Adult; Aged; Chlorambucil; Cyclophosphamide; Female; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Radiography; Recurrence; Vincristine | 1974 |
Status and perspectives in chemotherapy of Hodgkin's disease.
Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Evaluation Studies as Topic; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Mitosis; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1973 |
Lymphosarcoma presenting as Löffler's syndrome.
Topics: Asparaginase; Biopsy; Blood Cell Count; Bone Marrow; Child, Preschool; Diagnosis, Differential; Hepatomegaly; Humans; Lung; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Prednisone; Pulmonary Eosinophilia; Radiography; Splenomegaly; Vincristine | 1973 |
Multiple lymphomatous polyposis of the gastrointestinal tract.
Topics: Autopsy; Biopsy; Celiac Disease; Chlorambucil; Gastrointestinal Neoplasms; Humans; Intestinal Polyps; Israel; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Tetracycline | 1973 |
[Polychemotherapy using prednisone, cyclophosphamide, and vincristine in stage IV lymphosarcoma].
Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous; Vincristine | 1973 |
Chemotherapy of the lymphomas.
Topics: Adult; Burkitt Lymphoma; Child; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Vinblastine; Vincristine | 1974 |
[Treatment of lymphosarcoma by the triple combination vincristine-rubidomycin-prednisone].
Topics: Antibiotics, Antineoplastic; Child; Humans; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1967 |
Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Platelets; Blood Transfusion; Bone Marrow Examination; Cell Nucleus; Cytarabine; Drug Tolerance; Erythrocytes; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone | 1968 |
Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.
Topics: Adult; Azathioprine; Brain Neoplasms; Female; Herpes Simplex; Humans; Kidney Transplantation; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Tongue Neoplasms; Transplantation, Homologous | 1968 |
[Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Synergism; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Time Factors; Vincristine | 1968 |
Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma.
Topics: Adolescent; Adult; Aged; Body Weight; Cyclophosphamide; Drug Synergism; Hemoglobinometry; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Vincristine | 1969 |
Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia.
Topics: Cortisone; Glucocorticoids; Hodgkin Disease; Hydrocortisone; Leukemia, Lymphoid; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mycoses; Prednisone | 1969 |
[The role of vinblastine in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vinblastine | 1968 |
Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzoates; Bone Marrow; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Time Factors; Vincristine | 1970 |
The use of etiocholanolone for the measurement of marrow granulocyte reserves.
Topics: Acute Kidney Injury; Adolescent; Adult; Agranulocytosis; Blood Urea Nitrogen; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Endotoxins; Etiocholanolone; Female; Fever; Hodgkin Disease; Humans; Kidney Transplantation; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Leukocytes; Lymphoma, Non-Hodgkin; Male; Multiple Myeloma; Polycythemia Vera; Prednisone; Renal Dialysis; Transplantation Immunology | 1970 |
L-asparaginase and human malignant disease.
Topics: Animals; Antineoplastic Agents; Asparaginase; Blood Coagulation; Central Nervous System; Drug Hypersensitivity; Drug Synergism; Escherichia coli; Fever; Humans; Hyperglycemia; In Vitro Techniques; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Ligases; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Molecular Weight; Prednisone; Sarcoma, Experimental; Stereoisomerism; Tritium; Uridine; Valine; Vincristine; Vomiting | 1971 |
Transformation of reticulum cell sarcoma to acute leukemia.
Topics: Acute Disease; Biopsy; Bone Marrow; Central Nervous System; Humans; Jaw Neoplasms; Leukemia; Lymph Nodes; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Sarcoma; Vincristine | 1971 |
Combined chemotherapy and radiotherapy for advanced Hodgkin's disease and reticulum cell sarcoma: a preliminary report.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Neoplasm Metastasis; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1971 |
Pneumocystitis carinii pneumonia: percutaneous lung biopsy and review of literature.
Topics: Adolescent; Adult; Agammaglobulinemia; Amphotericin B; Anuria; Azathioprine; Biopsy; Bis-Trimethylammonium Compounds; Busulfan; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Pneumonia, Pneumocystis; Prednisone; Transplantation, Homologous; Vincristine | 1971 |
[Prolonged remission of reticulum cell sarcoma].
Topics: Cyclophosphamide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Remission, Spontaneous | 1971 |
Cyclic chemotherapy in lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Female; Humans; Leukopenia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Thrombocytopenia; Vincristine | 1971 |
Malignant lymphomas in transplantation patients.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Brain Neoplasms; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Plasmacytoma; Prednisone; Splenectomy; Thymectomy; Thyroid Neoplasms; Transplantation Immunology; Transplantation, Homologous | 1969 |
Disseminated extrapulmonary nocardiosis presenting as a renal abscess.
Topics: Abscess; Adult; Anemia, Hemolytic, Autoimmune; Autopsy; Brain Diseases; Chlorambucil; Diagnosis, Differential; Female; Humans; Kidney Diseases; Lymphoma, Non-Hodgkin; Nocardia Infections; Prednisone; Skin Diseases; Sulfonamides; Waldenstrom Macroglobulinemia | 1970 |
[Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Vinblastine; Vincristine | 1970 |
Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.
Topics: Adult; Aged; Blood Cell Count; Blood Platelets; Cyclophosphamide; Drug Synergism; Female; Hematologic Diseases; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1972 |
Combination chemotherapy of advanced lymphomas.
Topics: Adult; Age Factors; Benzoates; Blood Cell Count; Blood Platelets; Cyclophosphamide; Drug Combinations; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Middle Aged; Prednisone; Procarbazine; Time Factors; Vincristine | 1972 |
Daunorubicin therapy in adult acute lymphatic leukemia.
Topics: Adolescent; Adult; Bone Marrow; Daunorubicin; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Time Factors | 1972 |
[Case of thyroid lymphosarcoma].
Topics: Aged; Female; Humans; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Prednisone; Radiography, Thoracic; Thyroid Neoplasms | 1971 |
Comments on treatment of leukemia in the cat.
Topics: Animals; Cat Diseases; Cats; Cyclophosphamide; Dog Diseases; Dogs; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1971 |
Therapy of localized and regional lymphosarcoma of childhood.
Topics: Adolescent; Child; Child, Preschool; Cobalt Isotopes; Cyclophosphamide; Head and Neck Neoplasms; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Peritoneal Neoplasms; Prednisone; Radioisotope Teletherapy; Remission, Spontaneous; Time Factors; Vincristine | 1971 |
Some problems in the management of leukaemia and lymphoma.
Topics: Antineoplastic Agents; Busulfan; Cyclophosphamide; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1966 |
Chemotherapy of the leukemic transformation of lymphosarcoma.
Topics: Adolescent; Bone Marrow Examination; Child; Child, Preschool; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone | 1967 |
Prediction of in vivo cytotoxicity of chemotherapeutic agents by their effect on malignant leukocytes in vitro.
Topics: Blood Cell Count; Cytarabine; DNA; Humans; In Vitro Techniques; Injections, Intravenous; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mercaptopurine; Multiple Myeloma; Prednisone; RNA; Tritium; Uridine; Vincristine | 1967 |
Hyperuricemic nephropathy. Report of a case of lymphoblastic lymphosarcoma.
Topics: Acetazolamide; Acute Kidney Injury; Allopurinol; Bicarbonates; Biopsy; Child; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Prednisone; Radiography, Thoracic; Thoracic Neoplasms; Uric Acid | 1970 |
Leukemia and lymphoma.
Topics: Antineoplastic Agents; BCG Vaccine; Burkitt Lymphoma; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1970 |
The successful treatment of pneumocystis carinii pneumonitis in an adult with lymphosarcoma. A comment on pentamidine isethionate nephrotoxicity.
Topics: Amidines; Animals; Anuria; Biopsy; Blood Urea Nitrogen; Creatinine; Cyclophosphamide; Female; Humans; Kidney; Kidney Failure, Chronic; Kidney Tubules; Lung; Lymphoma, Non-Hodgkin; Middle Aged; Pneumonia, Pneumocystis; Potassium; Prednisone; Proteinuria; Vinblastine | 1969 |
[Multiple plasmocytoma with immature cells with transition into reticulosarcoma].
Topics: Aged; Blood Protein Electrophoresis; Bone Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Plasmacytoma; Prednisone | 1965 |
High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
Topics: Adolescent; Adult; Aged; Cortisone; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Infections; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mental Disorders; Methylprednisolone; Middle Aged; Prednisolone; Prednisone | 1967 |
Disseminated lymphocytoma cutis. Case reports of miliarial and nodular types.
Topics: Adult; Biopsy; Diagnosis, Differential; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Skin Diseases; Skin Neoplasms; Triamcinolone Acetonide | 1969 |
Nephrotic syndrome: a prodrome to lymphoma.
Topics: Adolescent; Aged; Biopsy; Hodgkin Disease; Humans; Kidney; Lymphoma, Non-Hodgkin; Male; Microscopy, Electron; Microscopy, Fluorescence; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1970 |
Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol.
Topics: Adult; Allopurinol; Autopsy; Cyclophosphamide; Humans; Kidney Calculi; Kidney Pelvis; Lymphoma, Non-Hodgkin; Male; Prednisone; Uric Acid; Vincristine; Xanthine Oxidase; Xanthines | 1970 |
[Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Longevity; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Prednisone; Retrospective Studies; Triethylenemelamine; Vinblastine | 1967 |
Vaccination of a patient receiving immunosuppressive therapy for lymphosarcoma.
Topics: Agammaglobulinemia; Aged; Animals; Autoimmune Diseases; Body Weight; Female; Globulins; Guinea Pigs; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Skin Tests; Smallpox Vaccine; Travel | 1966 |